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Gambling disorder (GD) is the most widely studied behavioural addiction (BA), however 
there is still an unmet need for more effective treatment strategies. With the aim to 
improve the understanding of transcranial direct current stimulation (tDCS) as a potential 
treatment intervention for GD, four experiments were conducted using different protocols 
and participant samples to measure neuromodulation effects during gambling-related task 
performance. In Experiments I and II, the effects of tDCS were investigated in low 
impulsive (LI) and high impulsive (HI) participants. Different high definition (HD) tDCS 
montages were used to target right dorsolateral prefrontal cortex (rDLPFC) and 
ventromedial prefrontal cortex (vmPFC), brain areas associated with decision-making 
and reward processing, respectively. Results revealed effects of tDCS on gambling task 
performance, but no difference on tDCS effects between rDLPFC and vmPFC targets, or 
between participant groups. In Experiment III, the potential cumulative effects of 
rDLPFC tDCS combined with cognitive behavioural therapy (CBT) were investigated 
across eight sessions, in two patients diagnosed with GD. The intervention combining 
tDCS and CBT resulted in reductions in gambling severity and cravings, but this effect 
was also seen in the sham tDCS case. In Experiment IV, physiological data, including 
electrodermal activity (EDA), electrocardiogram (ECG) and electroencephalogram 
(EEG), was used to investigate rDLPFC tDCS effects on the autonomous nervous system 
(ANS), in LI and HI gamblers. Results showed that real stimulation was associated with 
increased sympathetic activation compared with sham, which was higher during 
gambling-related wins compared with losses, and in HI compared with LI. There were 
significant correlations between gambling severity, cognitive outcomes and physiological 
variables, which helped to identify biological markers associated with GD. These results 
helped refine the knowledge of specific cognitive and physiological underpinnings of 
reward processing in different participant samples, and contributed to the development of 
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1 Chapter 1. General Introduction 
1.1 Classification and prevalence of gambling disorder 
Addictions are among the most predominant psychiatric disorders. From the clinical perspective, 
losing control over specific behaviours can lead to neglect of personal physical and mental health 
(Thege, Hodgins, & Wild, 2016). The classification of behavioural addictions (BAs) has been 
continuously debated, however the consensus that BAs are similar to substance use disorders (SUDs) 
has been growing since the inclusion of gambling disorder (GD) in the category substance‐related and 
addictive disorders, in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders 
(DSM‐V) in 2013 (American Psychiatric Association, 2013). BAs show a wide range of similarities 
with SUDs, including symptoms such as craving, tolerance and withdrawal, comorbidities, genetic 
factors and brain alterations (Clark, 2014).  
 
In particular, GD is characterised by persistent recurrent and maladaptive gambling behaviour that 
disrupts personal, social and professional life, and has been associated with higher morbidity and 
mortality rates (Fong, 2005), and high risk of suicide (Wardle, John, Dymond, & McManus, 2020). 
The impact of excessive gambling represents an increasing public health concern (Shaffer & Korn, 
2002), with prevalence rates during the past 12 months worldwide ranging from (0.12–5.8%), and 
from (0.7–6.5%) during lifetime (Calado & Griffiths, 2016). In particular, GD prevalence in Great 
Britain was estimated to be 0.4% as assessed by the DSM-V. The risk for developing GD is affected 
by genetic and environmental contributors, which seem to be associated with different stages on the 
progression from initiation to addiction. Particularly, the initiation in gambling appears to be mediated 
by environmental experiences that constitute risk factors for developing GD (Shaffer et al., 2004), 
which include childhood maltreatment (Felsher, Derevensky, & Gupta, 2010), parental gambling 
behaviour (Schreiber, Odlaug, Kim, & Grant, 2009), and availability of gambling (Welte, Wieczorek, 
Barnes, Tidwell, & Hoffman, 2004).  
 
1.2 Gambling features 
Gambling usually comprises an element of consideration of something valuable, an element of risk in 




(Derevensky & Griffiths, 2019). However, while gambling represents a recreational activity for the 
majority of people, it can become a very serious behavioural disorder for others (Ferland, Fournier, 
Ladouceur, Brochu, & Pâquet, 2008). Particularly, some forms of gambling are more addictive than 
others, with fixed odd betting terminals (FOBT) and gaming machine gambling being associated with 
higher gambling severity (Ronzitti et al., 2016). Research into game characteristics found that sounds 
and flashing lights can contribute to arousal and become a form of reward. Nonetheless, more 
important than the rewards per se, the reinforcement schedule, especially random distributions, 
promote persistence to continue playing (King, Delfabbro, & Griffiths, 2010).  
 
In addition, games that offer a high frequency of rewards create a wining sensation, even though the 
pay-out is lower than the amount wagered, which is known as “loss disguised as win”. Games that 
include “near misses” features, which show an unsuccessful outcome near to a designated win, create 
the sensation to be nearly winning, rather than constantly losing (King et al., 2010; Zack, Featherstone, 
Mathewson, & Fletcher, 2014). Moreover, providing the player with a choice, such as pressing a stop 
button in slot machines, produces an illusion of control that increases the confidence to win, even 
when the event is understood to be random (Harrigan, Collins, Dixon, & Fugelsang, 2010). The 
characteristics of gaming and gambling products have a powerful influence on people´s behaviours, 
and contribute to the maintenance of GD.  
 
In the past few years, internet gambling has introduced the possibility to gamble at any time and 
location, involving large stakes with instant feedback and access to unlimited products. In addition, 
the inclusion of gambling within gaming is concerning, as gambling features have been embedded 
into video games (sometimes recommended for children as young as 3 +), which include high pay out 
rates that could create a sense of confidence in young people when gambling. Furthermore, the 
introduction of loot boxes brought forward the use of real money to buy virtual items or bundles that 
provide a selection of prizes by chance. With the increased availability of gambling linked to 
technological advances in recent years, the severity of GD has become more evident, as the urgency 
to develop treatment strategies for GD (Derevensky & Griffiths, 2019; Gainsbury, 2015).  
 
1.3 Comorbidities 
GD is highly comorbid with other psychiatric disorders, such as attention deficit hyperactivity 




others (Dell’Osso, Allen, & Hollander, 2005). Particularly, alcohol use disorder (AUD) is one of the 
most frequent comorbidities of GD, which has been shown to influence gambling episodes by 
decreasing self-control and increasing risk-taking (Baron & Dickerson, 1999; Zois et al., 2014), and 
has been linked to poorer response to GD treatment (Jiménez-Murcia et al., 2016). The diagnosis and 
treatment in individuals with co-occurring pathologies can be complicated by the interaction between 
the disorders, in which one condition might masked others, or in which behaviours could appear 
alternating with each other (Freimuth et al., 2008).  
 
A cross-sectional study found that around 95% of responders that had GD during lifetime, also met 
the criteria of one or more other psychiatric disorders. Particularly, in almost 75% of the cases, at least 
one of the comorbid conditions began at an earlier age than GD, suggesting that some disorders might 
represent risk factors for developing GD, while GD might be a risk factor for developing other 
conditions. This study also found that although around 50% of responders with lifetime GD received 
some form of treatment (often to treat emotional problems or SUDs), none of the interventions were 
directed to treat GD (Kessler et al., 2008). It is crucial that treatment interventions are adapted to offer 
integrated strategies to tackle comorbid disorders successfully (Konkolÿ et al., 2016). Individual 
variation in GD has produced discrepancies in the literature (Singer, Anselme, Robinson, & Vezina, 
2014), which highlights the complexity of finding adequate treatment protocols for each particular 
case. Therefore, there is an urgent need to investigate cognitive and physiological characteristics 
associated with GD in order to develop individualised treatment interventions.  
 
1.4 Treatment strategies 
The most common treatment interventions for GD include: gamblers anonymous (GA), which consist 
of mutual aid groups that share experiences and support each other in relation to these shared gambling 
problems (Choi et al., 2017); cognitive behavioural therapy (CBT), which integrates cognitive 
therapies that focus on changing cognitive distortions and erroneous beliefs, and includes behavioural 
interventions that attempt to identify triggers that might cause loss of control over gambling, and help 
determine how to regulate related behaviours; and motivational interviewing (MI), which addresses 
patients engagement with treatment and guide them to pursue healthier choices. Treatment 
interventions can be delivered in different setups: self-directed through workbooks or internet; 
remotely via telephone calls; or in person, which can be individual or in groups, and comprises 




although CBT has been the form of treatment that showed to be most effective in GD (Petry, Ginley, 
& Rash, 2017).  
 
Furthermore, pharmacological treatment has been prescribed to patients with severe gambling 
problems that seem not to benefit from therapy interventions. Double blind studies demonstrated the 
efficacy of the opioid antagonist naltrexone to improve GD severity (Hloch, Mladěnka, Doseděl, 
Adriani, & Zoratto, 2017). However, no drug has been officially approved for treating GD (Menchon, 
Mestre-Bach, Steward, Fernández-Aranda, & Jiménez-Murcia, 2018). Alternative novel interventions 
include: mindfulness based interventions (MBIs), which have been shown to reduce gambling-related 
symptomatology (Melero Ventola, Yela, Crego, & Cortés-Rodríguez, 2020); virtual reality, which 
seems to be a promising tool to investigate and treat substance use disorders (SUDs) and behavioural 
addictions (BAs; Segawa et al., 2020); and non-invasive brain stimulation (NIBS), which has shown 
certain efficacy to modulate addictive behaviours, including craving in SUDs and GD (Martinotti, 
2019). Nevertheless, more research is clearly needed to identify specific protocols to target particular 
risk-factors associated with specific disorders, and to create individualised approaches for different 
types of patients. 
 
1.5 Reward circuitry  
To better understand the neurobiology of GD and its relationship with other conditions, it is essential 
to find more objective brain-based traits that serve as concrete markers of the underlying etiology of 
GD (Grant, Odlaug, & Chamberlain, 2016). The brain reward system evolved to promote essential 
behaviours such as feeding, sexual behaviour and social interactions (Gardner, 2011). In particular, 
the mesolimbic reward circuit consists of a dopaminergic pathway linking the ventral tegmental area 






Figure 1-1. Reward system. Hypothalamic-mesocorticolimbic pathways involving reward, motivation, cognitive control 
and learning circuits (the arrows represent the direction of signal transmission). Inhibitory control has been associated 
with dorsal and medial prefrontal cortex (PFC) and the anterior cingulate cortex (ACC). Motivation and drive are 
associated with the orbitofrontal cortex (OFC) and the subgenual cingulate cortex (SCC). Reward and salience are 
associated with ventral tegmental area (VTA) and nucleus accumbens (NAc). Learning and memory are associated with 















The function of NAc is related to the association of a specific value or desire to a stimuli, and has 
been shown to have a crucial role in reinforcing addictive behaviours (Berridge & Kringelbach, 2015; 
Koob & Volkow, 2010). The mesocortical pathway involves dopaminergic connections between VTA 
to the PFC, and is implicated in cognitive control, motivation and regulation of emotional responses 
(McClure, Laibson, Loewenstein, & Cohen, 2004). The VTA is a region composed largely by 
dopaminergic neurons that project to the NAc and to the PFC, but also to other areas, including the 
amygdala and hippocampus, which are associated with emotion and memory, respectively (Koob & 
Volkow, 2010). Dopaminergic projections from VTA to NAc can increase reward behaviour, whereas 
projections from VTA to the PFC have been associated with aversion (Cooper, Robison, & Mazei-
Robison, 2017; Lammel, Lim, Ran, Huang, & Betley, 2012). External influences, such as drugs or 
monetary reward cues, have a direct influence on the reward pathways (Limbrick-Oldfield et al., 
2017), and can compromise the natural function of this system (Quester & Romanczuk-Seiferth, 2015; 
Volkow, Wang, Fowler, Tomasi, & Baler, 2011).  
 
The PFC has an essential role in emotion regulation and executive functions, including inhibition 
control (Brevet-Aeby, Brunelin, Iceta, Padovan, & Poulet, 2016), decision-making (Hämmerer, 
Bonaiuto, Klein-Flügge, Bikson, & Bestmann, 2016), impulsivity (Korponay et al., 2017), cognitive 
flexibility (Jansen et al., 2015), and monetary reward processing (Balodis et al., 2013). The 
orbitofrontal cortex (OFC) seems to be involved in punishment sensitivity (Cooper et al., 2017), and 
together with the subgenual cingulate cortex (SCC), is implicated in motivation and drive regulation, 
whereas the anterior cingulate cortex (ACC) is associated with interoception and inhibitory control 
(Volkow & Baler, 2014). Impairment of regions of the PFC that are involved in top-down regulation 
can result in the inability to control specific behaviours despite negative consequences (Zilverstand, 
Huang, Alia-Klein, & Goldstein, 2018). Specifically, these regions have been linked to dysfunctions 
in gambling-related decision-making and GD (Goudriaan, De Ruiter, Van Den Brink, Oosterlaan, & 
Veltman, 2010; Murch & Clark, 2016; Potenza et al., 2003).  
 
As a key structure in the reward system, the amygdala has been shown to be closely related to 
anticipation of reward and cravings (Koob & Volkow, 2010). Cravings represent an intense desire for 
the reward stimuli (Volkow & Baler, 2014), and are one of the crucial mechanisms involved in 
addiction (Kober et al., 2016) that have been investigated as a potential target to modify addictive 
behaviours (Coles, Kozak, & George, 2018; Zack et al., 2016). Particularly, the amygdala is 




Interactions between the amygdala and vmPFC are mediated by the dorsolateral PFC (DLPFC). 
DLPFC is crucial for decision-making considering different sources of information, whereas vmPFC 
is more relevant in decisions based on reward values (Reuter et al., 2005; Zare-Sadeghi, Oghabian, 
Zare-Bidoky, Batouli, & Ekhtiari, 2019). Functional connectivity between DLPFC and vmPFC has 
been associated with increased self-control (Hare, Hakimi, & Rangel, 2014). In particular, increased 
activity in DLPFC was shown during attempts of self-control and reducing cravings (Shahbabaie et 
al., 2014). The inability to avoid particular addictive behaviours might arise from disruption in 
functional brain circuits. Top-down regulation, reflected by the cognitive control over the temptation 
for the reward stimuli, seems to be in part controlled by the DLPFC and vmPFC network. Therefore, 
investigating the role of these areas in gambling-related decision-making could provide insights into 
the mechanisms underlying addiction and GD (Fecteau, Pascual-Leone, et al., 2007; Gay et al., 2017; 
Potenza et al., 2003; Zare-Sadeghi et al., 2019).    
 
1.6 Cognitive characteristics of gambling disorder 
Individual differences in personality traits might help to identify risks for developing GD, and to 
disentangle specific characteristics of co-occurring disorders. In particular, GD has been widely 
associated with impulsivity, cognitive distortions and risk-taking behaviour. Impulsivity can be 
defined as a multidimensional construct, characterised by the tendency to rapid, poorly considered 
and disinhibited actions, despite negative consequences (Evenden, 1999). Impulsive decision-making 
might increase the acceptance of erroneous beliefs during gambling (Michalczuk, Bowden-Jones, 
Verdejo-Garcia, & Clark, 2011). These erroneous beliefs, known as cognitive distortions, imply for 
example that gamblers are susceptible to assume superstitions or rituals driven by an illusion of 
control, or have the sensation that can predict the outcome of a bet, and thus, fail to appreciate the 
random characteristics of the game (Raylu & Oei, 2004).  
 
High impulsivity has been shown to precede general risky behaviours and gambling participation in 
college students (Cyders & Smith, 2008). In addition, pre-existing negative affect and inhibitory 
control deficits related with elevated impulsivity, have been suggested to be risk-factors associated 
with GD (Lobo & Kennedy, 2009; Slutske, Avshalom Caspi, Moffitt, & Poulton, 2005; Slutske et al., 
2001). This is illustrated in a developmental work, which found that impulsivity predicted depressive 




contributed to the maintenance of both pathologies (Dussault, Brendgen, Vitaro, Wanner, & 
Tremblay, 2011).  
 
Moreover, higher delay discounting rates (preference for small immediate rewards rather than larger 
but more delayed rewards) were associated with GD compared with healthy controls, and in gamblers 
with comorbid SUDs compared with gamblers without comorbidity (Petry, 2001). Individuals with 
GD, with and without comorbid disorders, showed deficits in decision-making (Zois et al., 2014), 
which might also affect at-risk gamblers (Ioannidis, Hook, Wickham, Grant, & Chamberlain, 2019). 
In fact, it could be possible that cognitive deficits appear in people at risk before developing GD, or 
alternatively, that the progression of the disorder influences the emergence of these deficits (Hodgins, 
Stea, & Grant, 2011). Studies investigating GD symptomatology after periods of abstinence would 
provide insights into the nature of the alterations produced by the disorder. Nevertheless, whether 
some factors precede the development of GD, or if they appear as a consequence of it, is a question 
that is still under investigation (Rash, Weinstock, & Patten, 2016).  
 
1.7 Physiological characteristics of gambling disorder  
The behavioural manifestation of cognitive alterations in GD has a basis in functional brain changes 
involved in self-regulation (Goudriaan, Oosterlaan, De Beurs, & Van Den Brink, 2004). 
Neurotransmitter systems contribute to arousal, impulse control, reward processing and cravings 
(Leeman & Potenza, 2012a). Dopamine is one of the most commonly studied neurotransmitters in 
addiction, given that it has the function to mediate incentive motivation that promotes survival 
behaviours, and that addictive substances can hijack this circuitry developing a similar drive to pursue 
drugs, despite adverse consequences. GD is associated with dysfunctions in the dopamine system, 
which codes reward anticipation and outcome evaluation (Linnet, 2014). The association between 
dopamine and GD is emphasised by research revealing that dopaminergic medication prescribed to 
Parkinson´s disease patients can lead to the development of GD (Bhattacharjee, 2018; Dodd et al., 
2005; Kelley, Duker, & Chiu, 2012). Nevertheless, dopamine activation in the brain can also occur 
by engaging in certain behaviours without a chemical agent hijacking the neural circuitry (Zack, 
George, & Clark, 2020). In this way, reward uncertainty activates dopaminergic systems during 
gambling, similarly to chronic exposure to drugs (Zack et al., 2014). Interestingly, dopamine is 




per se. Therefore, the inability to predict reward outcomes might determine the motivation to gamble 
(Anselme & Robinson, 2013).  
 
In fact, reward uncertainty is a core part of the definition of gambling, which consists of wagering 
something of value on an event with an uncertain outcome (Derevensky & Griffiths, 2019). The 
definition of gambling involves other aspects of human and non-human animal behaviours. In 
ecological systems there is a natural order of gambling, of taking potential risks (with health, 
hierarchy, mate access etc.) in order to seek psychosocial, health and environmental gains, and 
improve survival. Nonetheless, while the dopaminergic function to keep the motivation to continue 
searching for food in unpredictable situations might have been an evolutionary advantage in nature, 
(in which most environments are probabilistic), in gambling, most games are entirely random, and 
this raises some problems for cognition (Clark, 2014). Usually people try to make sense of the 
environment, however in events involving chance, the lack of causality explaining specific outcomes 
results in the assumption of non-existent contingencies between independent events to predict future 
consequences, and these assumptions are expressed in form of cognitive distortions (Ladouceur, 
2004), which were described in section 1.6 of this chapter.  
 
Furthermore, the distinction between reward anticipation (defined as dopaminergic processes 
occurring before receiving the reward outcome), and the reward response, (defined as dopaminergic 
processes occurring after receiving the reward outcome), may have relevant implications to 
understand dopaminergic alterations in GD (Linnet, 2014). Similarly, cues associated with rewards 
following an unpredictable reward delivery, may induce dopamine activation and reinforce learning 
and repetition of specific behaviours, akin to the effects which drug cues produce in SUDs (Clark, 
Boileau, & Zack, 2018). Therefore, dopaminergic coding of uncertainty could account for 
neurobiological dysfunctions in GD, and the persistent gambling behaviour despite continuous losses 
(Linnet, 2020).  
 
Altered dopaminergic activity might lead to increased affective reactions and impaired decision-
making. According to the Somatic Marker Hypothesis (SMH), decision-making is based on the 
integration of emotions and affective information associated with reward and punishment events 
(Damasio, 1996). This hypothesis suggests that unconscious physical responses in the body, known 




feelings generated by secondary emotions that have been connected by learning processes, and help 
predict future scenarios. Heart rate (HR) and electrodermal activity (EDA) are somatic markers, which 
are regulated by the autonomous nervous system (ANS). The ANS can be separated into sympathetic 
and parasympathetic branches that are activated in a complementary way. The sympathetic nervous 
system (SNS) produces physiological changes associated with “flight or fight” responses to stress, 
including increased cardiac response and vasoconstriction, whereas the parasympathetic nervous 
system (PNS) is responsible of maintaining processes that are inhibited during stress, such as normal 
maintenance of internal organs or growth, associated with relaxation (Diamond & Cribbet, 2013).  
 
Skin conductance responses (SCRs), as a form of EDA, and HR, change by exposure to emotional 
experiences, but can also be induced by activation of neural pathways, for example recalling past 
experiences, or thinking of a hypothetical situation. Research suggested that reduced SCRs might be 
associated with high impulsivity and altered dopaminergic activation in GD (Peterson et al., 2010a), 
and that SCRs could affect decision-making by altering dopaminergic transmission (Sevy et al., 2006). 
Therefore, somatic markers facilitate intuitive decision-making, and inadequate signalling of 
emotional responses to specific cues might produce the inability to make advantageous decisions. 
Indeed, patients with ventromedial prefrontal cortex (vmPFC) damage and individuals with SUDs 
showed decreased generation of somatic markers during gambling task performance (Bechara, 
Damasio, Tranel, & Damasio, 1997). The inability to inhibit gambling behaviour in individuals with 
GD might be due to reduced somatic responses to risky choices (Blaszczynski & Nower, 2002; 
Sharpe, 2002). Therefore, investigating somatic markers can reveal emotional states and personality 
traits, and the consideration of different autonomic measures can provide varied information. While 
EDA can be used to quantify aspects of emotional arousal, HR is more sensitive to the valence of 
emotional response and attentional and cognitive processing (Sohn, Sokhadze, & Watanuki, 2001). 
Therefore, investigating both components simultaneously might provide more detailed information 
about the sympathetic and parasympathetic balance in each individual (Angioletti, Siri, Meucci, 
Pezzoli, & Balconi, 2019).  
 
Individual differences in ANS functioning reflect stress and emotion regulation capability, and 
therefore, are associated with social behaviour. The neurovisceral integration model suggests that 
PNS activity is associated with emotional self-regulation, which is fundamental for maintaining social 
relationships (Diamond & Cribbet, 2013). This model accounts for reciprocal relationships between 




prefrontal cortex (PFC) is associated with increased parasympathetic and decreased sympathetic 
activity (Thayer & Lane, 2000). A recent study provided anatomical substrates for this model, 
showing that heart rate variability (HRV) served as an index of the integrative neural network, 
involving amygdala, dorsal and medial PFC and anterior cingulate cortex, which processed affective, 
cognitive and physiological responses towards goal-directed behaviour (Wei, Chen, & Wu, 2018). 
Consistently with the model, GD individuals have shown reduced autonomic activity, indicated by 
decreased SCRs and lower HR, and poorer gambling task performance, compared with healthy 
controls (Goudriaan, Oosterlaan, de Beurs, & van den Brink, 2006).  
 
Dysfunctions in PFC and subcortical networks projecting to the PFC have been widely associated 
with addiction (Goudriaan et al., 2004; Rash et al., 2016). Autonomic activity has been shown to 
modulate the cingulate anterior cortex, vmPFC (Nagai, Critchley, Featherstone, Trimble, & Dolan, 
2004) and dorsolateral prefrontal cortex (DLPFC) activity. Particularly, during reward delay the 
activity in orbitofrontal cortex was modulated by uncertainty, however, DLPFC activity was 
modulated by anticipatory arousal (Critchley, Mathias, & Dolan, 2001). This suggests that altered 
SCRs and HR in GD might inform about abnormal functioning of these brain areas (Goudriaan et al., 
2006). The dorsal PFC has a central role in how PFC exerts control over behaviour, whereas the 
medial PFC is closely associated with limbic structures for long-term memory and processing of affect 
and motivation (Miller & Cohen, 2001). In particular, gamblers showed decreased dorsal PFC and 
medial PFC activation during control inhibition (Goudriaan et al., 2010; Potenza et al., 2003; Ruiter 
et al., 2009). Prefrontal control circuit alterations may underlie vulnerability to gambling cues, and 
reduced control over craving and negative emotions (Spagnolo, Gómez Pérez, Terraneo, Gallimberti, 
& Bonci, 2018).  
 
Corticostriatal-limbic activity alterations have been associated with GD (Reuter et al., 2005), showing 
that decreased ventral striatum and ventromedial prefrontal cortex (vmPFC) activations during 
simulated gambling, might contribute to cognitive processes characterised by impaired impulse 
control in GD (Potenza, 2014). Increased sensation seeking was associated with dopamine activation 
in the striatum, which supports the idea that high impulsivity constitutes a risk-factor to develop 
addictive behaviours (Gjedde, Kumakura, Cumming, Linnet, & Møller, 2010). Therefore, 
dysfunctional neural networks, associated with genetic or developmental deficits, can destabilise the 
interaction between brain circuits, increasing the vulnerability to develop addiction (Volkow, Wang, 




with the ANS functioning during gambling, might help understand better individual differences in 
GD, and therefore help identify particular risk-factors and biomarkers associated with GD, and 





2 Chapter 2. Methods to investigate gambling disorder 
2.1 Transcranial direct current stimulation 
2.1.1 Mechanisms  
The field of non-invasive brain stimulation (NIBS) englobes a wide range of interventional 
technologies designed to modulate activity within the nervous system, with the aim to achieve a 
therapeutic effect that modify pathological disorders (Bashir & Yoo, 2016). Transcranial direct 
current stimulation (tDCS) is a NIBS technique that delivers a very weak electric current to the scalp, 
increasing or decreasing cortical excitability, depending on the polarity of the stimulation. Generally, 
anodal stimulation increases cortical excitability by depolarising neurons, whereas cathodal 
stimulation decreases cortical excitability by hyperpolarising neurons (Nitsche & Paulus, 2000). 
However, the general polarity-specific effects of tDCS can invert due to the neuronal orientation, with 
axon orientation determining whether the current is excitatory or inhibitory (Kabakov, Muller, 
Pascual-Leone, Jensen, & Rotenberg, 2012).  
 
The immediate effects of tDCS consist of changes of resting membrane potential and the modulation 
of neurons excitability. In addition, secondary after-effects of tDCS include long term potentiation 
(LTP) and depression (LTD) that induce long lasting effects in the nervous system. The effects of 
tDCS on plasticity are not only seen in the targeted area, but in the connected network, in which 
neuronal cells and non-neuronal cells, such as glia and vascular systems are also altered. The effects 
of tDCS have also been studied in relation to Glutamate and GABA mechanisms, including 
neuromodulators such as dopamine, serotonin and acetylcholine that are involved in neuroplasticity 
alterations, which are particularly relevant for the study of psychiatric disorders (Jamil & Nitsche, 
2017). However, the basic physiological mechanisms of tDCS are still not well understood, and this 
constitutes a fundamental step towards creating potential clinical neuromodulation interventions. 
 
Beyond the polarity dependent effects of the tDCS current, the stimulation intensity (or dose) has also 
been shown to alter the outcomes of neuromodulation studies. Higher anodal tDCS intensities have 
been associated with increases of cerebral blood flow (CBF), whereas higher cathodal tDCS 
intensities were associated with decreases of CBF (Jamil et al., 2020). In theoretical models or strictly 
controlled environments, such us in-vitro studies, it could be assumed that the current flow intensity 




these interactions grows. The electric field varies with individual anatomy, and the effects of the 
current are brain state dependent and can change according to the measurements employed 
(Esmaeilpoura et al., 2018). In fact, research revealed that cortical excitability after both, anodal and 
cathodal tDCS, showed a non-linear relationship with the current intensities delivered (Benwell, 
Learmonth, Miniussi, Harvey, & Thut, 2015; Jamil et al., 2017). However, further research is needed 
to better understand tDCS dose-response mechanisms, which is essential to create individualised 
neuromodulation interventions.  
 
The majority of tDCS research has focused on investigating behavioural effects of the stimulation 
simply by placing electrodes over a target area and assuming that brain function will be modified, 
however the underlying neural mechanisms have often not been assessed. Research should also 
consider issues including tDCS intensity, the physics of current flow, and the relationships between 
cortical activity and behavioural performance (Giordano et al., 2017). Particularly, therapeutic 
interventions that aim to induce long-term behavioural changes should be able to demonstrate 
functional changes in the cortex, which would occur through modulation of synaptic plasticity (Stagg 
& Nitsche, 2011). The experimental manipulation of neuronal excitability with tDCS over specific 
neural circuits could be used to investigate causal relationships between brain activity and behaviour. 
This might inform about the physiological characteristics associated with typical and dysfunctional 
cognitive functioning, helping ultimately to identify potential biomarkers of gambling disorder (GD).  
 
2.1.2 Specificity  
Anatomical specificity of tDCS results from the accuracy of driving the electrical current to the brain 
target of interest, whereas functional specificity depends on ongoing activity of the targeted neuronal 
networks, with tDCS acting preferably on brain circuits that are already activated (Bikson & Rahman, 
2013). Anatomical specificity of tDCS can be improved by the use of high definition (HD) montages 
involving multiple electrodes, and employing computational modelling approaches that investigate 
the most effective protocol, including intensity, direction of the current and electrode placement, to 
achieve a more focal effect on the desired brain target (Ruffini et al., 2013). However, the effects of 
tDCS depend also on the existent brain activity during stimulation. The nervous system is a dynamic 
entity, and therefore neuromodulation effects depend on brain state and neural plasticity (Bashir & 
Yoo, 2016). Brain state manipulations could be used as a functional priming of specific neural circuits 
(Silvanto, Bona, & Cattaneo, 2017). Recent research has shown that tDCS over DLPFC induced an 




2018). Therefore, if tDCS can modulate dopamine signalling associated with motivational processes, 
coupling the stimulation with relevant cognitive tasks, such as cue-reactivity tasks in addiction (Dinur-
Klein et al., 2014), might facilitate inherent learning processes that could help improve the functional 
specificity of potential treatment interventions (Bikson & Rahman, 2013; Spagnolo, Montemitro, 
Pettorruso, Martinotti, & Di Giannantonio, 2020). In fact, tDCS focality has been shown to be higher 
when combined with cognitive tasks (Lapenta, Minati, Fregni, & Boggio, 2013).  
 
2.1.3 Potential therapeutic interventions 
In recent years, research has been investigating tDCS as a potential neuromodulation intervention to 
restore the altered brain circuitry in psychiatric disorders, including GD (Dunlop, Hanlon, & Downar, 
2017; Lefaucheur et al., 2017; Martinotti et al., 2018). As an emergent procedure, tDCS has certain 
advantages over other treatment approaches, such as therapy or pharmacological interventions. To 
begin with, tDCS is a non-expensive (Bashir & Yoo, 2016) and safe technique (Bikson et al., 2016; 
Lefaucheur et al., 2016), with varied capabilities, including the modulation of cognitive processes 
(Ouellet et al., 2015), adjusting neurophysiological brain circuitry (Hone-Blanchet, Edden, & Fecteau, 
2016) and reduction of addiction severity and cravings (Martinotti et al., 2018), with substantially 
fewer associated adverse events compared with pharmacological medications (Kampman & Jarvis, 
2015; Yip & Potenza, 2014). In addition, NIBS can be used in combination with other treatment 
interventions. Given that pharmacological medications, therapeutic interventions and cognitive tasks 
affect brain activity, coupling them with NIBS might help identify individual variability factors, and 
contribute to improve clinical treatment outcomes. Nevertheless, further research is needed to 
establish the most effective protocols to create clinical interventions for specific disorders, but the 
prospect of combining pharmacological and therapy interventions with NIBS, seems to be a promising 
approach for treating psychiatric disorders, including addiction (Spagnolo et al., 2020).  
 
Various therapeutic interventions have been coupled with tDCS to guide functional specificity. For 
example, physical therapy coupled with tDCS has shown to promote recovery after brain injury 
(Edwards et al., 2009), and cognitive behavioural therapy (CBT) has also been shown to enhance 
modulatory effects of prefrontal stimulation (Tan, Hizli Sayar, Önen Ünsalver, Arat, & 
Karamustafalioğlu, 2015). Therefore, clinical interventions for GD might benefit from the 
combination of NIBS with CBT, which could offer further control of neural activity on the engaged 
brain network (Sathappan, Luber, & Lisanby, 2019). Studies should also consider that each brain area 




functional effects of tDCS might not be specific, but instead, be associated with enhancement and 
inhibition of different cognitive processes simultaneously. Therefore, it is crucial to investigate the 
basis of tDCS specificity to develop protocols capable of targeting specific risk-factors associated 
with particular disorders (Bikson & Rahman, 2013).  
 
Beyond tDCS specificity that depends on the protocols used, and that also changes according to 
individual variability factors, such as patients anatomy and comorbidities (Bashir & Yoo, 2016), 
another aspect that seems to affect the results of neuromodulation interventions is the number of 
stimulation sessions. Multiple session interventions seem to produce an accumulative effect of the 
stimulation (Schluter, Daams, van Holst, & Goudriaan, 2018; Ulam et al., 2015), showing increasing 
tDCS effects after each session (Boggio et al., 2009). The frequency of stimulation can led also to 
different cumulative effects of tDCS, with daily stimulation showing increased changes in cortical 
excitability compared with stimulation every two days (Alonzo, Brassil, Taylor, Martin, & Loo, 
2012).  
 
2.1.4 Research in gambling disorder 
Few studies have investigated the use of NIBS in behavioural addictions (Gomis-Vicent, Thoma, 
Turner, Hill, & Pascual-Leone, 2019). Specifically, a recent systematic review found 11 studies 
investigating NIBS effects in GD (Zucchella, Mantovani, Federico, Lugoboni, & Tamburin, 2020), 
from which only four were conducted using tDCS (Dickler et al., 2018; Martinotti et al., 2018; 
Martinotti, et al., 2019; Soyata et al., 2018). All NIBS studies targeted DLPFC, and one targeted 
medial PFC (Zack et al., 2016). The selection of the tDCS target was based on the interest of studying 
altered functions in GD, involving the cognitive control circuit, which includes the medial PFC, the 
DLPFC, orbital and vmPFC and the anterior cingulate cortex (Van Holst, Van Den Brink, Veltman, 
& Goudriaan, 2010). The cognitive control circuit provides flexibility to adapt to the changing 
environment by producing task processing strategies, attentional allocation and managing information 
interferences, and inhibition of inappropriate responses (Huster, Enriquez-Geppert, Lavallee, 
Falkenstein, & Herrmann, 2013). In particular, tDCS studies targeted DLPFC bilaterally, with the 
intention to modulate simultaneously cravings with anodal tDCS over the left side, and impulsivity, 
with anodal tDCS over the right side (Boggio et al., 2010; Fecteau, Knoch, et al., 2007; Martinotti et 
al., 2018). However, the evidence on the use of tDCS in GD is still very limited and heterogeneous, 






2.1.5 Effects on physiological measures 
Research started to use electroencephalogram (EEG) measures to disclose possible tDCS effects on 
spontaneous cortical activity (Mangia, Pirini, & Cappello, 2014), and studies with varied protocols 
revealed different outcomes. For example, studies using the same stimulation target have produced 
varied results, with anodal tDCS over left DLPFC being associated with a decrease of delta power in 
one study (Keeser et al., 2011), but producing an increase of frequencies below 15 Hz (including delta 
band) in another study (Boonstra, Nikolin, Meisener, Martin, & Loo, 2016). Additionally, since the 
first reports in the 1960s about the capability of tDCS to modulate autonomic control (Bindman, 
Lippold, & Redfearn, 1964; Costain, Redfean, & Lippold, 1964), remarkably, very few studies have 
continued to investigate this (Clancy, Johnson, Raw, Deuchars, & Deuchars, 2014). NIBS could be 
applied to investigate the ANS function, and at the same time, ANS measures could inform about 
neurophysiological mechanisms underlying NIBS (Schestatsky, Simis, Freeman, Pascual-Leone, & 
Fregni, 2013). Research protocols and results in this field are heterogeneous too, showing that tDCS 
over the motor cortex increased sympathetic activation, indexed by heart rate variability (HRV) 
measures (Clancy et al., 2014), and that tDCS over right inferior frontal cortex decreased skin 
conductance responses (SCRs), indicative of sympathetic activation (Herrmann et al., 2018). 
Similarly, tDCS over DLPFC produced an increase in parasympathetic arousal by increasing high 
frequency (HF) HRV power, while no affecting sympathetic activation (Boonstra et al., 2016). In 
addition, NIBS research using repetitive transcranial magnetic stimulation (rTMS) in GD found no 
variations in clinical outcomes, but rTMS effects on autonomic measures, showing a decrease in 
diastolic blood pressure (Zack et al., 2016).  
 
The results of these studies highlight the potential impact of investigating the capability of NIBS to 
study cortical activity and autonomic control mechanisms, and to directly modulate the ANS and 
associated cognitive processes. Furthermore, these studies emphasise the significance of using 
physiological measures to quantify the effects of NIBS interventions, and that relaying only on the 
use of clinical or behavioural outcomes might not allow to detect specific effects on the underlying 
brain circuits (Gomis-Vicent et al., 2019). Many questions remain to be investigated, such as optimal 
stimulation protocols, including selection of anatomical and functional targets, duration, intensity and 
direction of the stimulation, and generally, how to adapt neuromodulation procedures to account for 





2.2 Physiological measures 
Autonomic arousal influences decision-making and motivational behaviour (Bechara et al., 1997), 
features that have been linked to addiction and GD (Peterson et al., 2010b; Schutter & Van Honk, 
2005; Worhunsky, Potenza, & Rogers, 2017). Previous experiments have shown cortical and 
subcortical effects on sympathetic arousal control (Critchley et al., 2001; Patron, Mennella, Messerotti 
Benvenuti, & Thayer, 2019; Zhang et al., 2014). For example, prefrontal cortex EEG activation has 
been associated with autonomic control of heart rate (HR) at rest (Patron et al., 2019), and vmPFC 
functional activation lead to a decrease of skin conductance (Zhang et al., 2014). Dysfunctional 
alterations on cortical plasticity have been shown to reduce the capability of PFC to provide executive 
control over addictive behaviours (Kalivas & Volkow, 2005). In particular, GD has been associated 
with altered serum brain derived neurotrophic factor (BDNF), indicative of synaptic plasticity (Choi 
et al., 2016; Geisel, Banas, Hellweg, & Müller, 2012). Individual variability factors, such as cortical 
plasticity, have been shown to influence the response to NIBS (Cheeran et al., 2008), and in turn, 
NIBS has the capability to induce plasticity like effects (Huang et al., 2017). Therefore, altered 
cortical plasticity in participants with GD might result in different responsiveness to tDCS.  
 
Cortical excitability can be modulated with tDCS, which holds promise as a means to improve 
addiction interventions. However, a fundamental question that needs to be investigated is the existent 
variability in tDCS results, which are to a large extent subject to participant individual differences. 
Individual variability factors that influence the response to tDCS can be investigated through the 
analysis of autonomic responses, including electrodermal activity (EDA) and cardiovascular function, 
indicative of sympathetic/parasympathetic balance (Clancy et al., 2014; Feeser, Prehn, Kazzer, 
Mungee, & Bajbouj, 2014; Santarnecchi et al., 2014). Neuroimaging techniques, such as EEG, could 
also help to identify individual differences that might affect the response to interventions, and to 
quantify the physiological effects of tDCS (Accornero et al., 2014; Keeser et al., 2011; Ulam et al., 
2015). Therefore, research exploring a more complete understanding on the individual cognitive and 
physiological characteristics associated with different types of gamblers, and the capabilities of tDCS 
to directly modulate autonomous nervous system (ANS) processes, might contribute to the 
development of specific neuromodulation protocols as potential individualised treatment 





2.2.1 Electrodermal activity 
Electrodermal activity (EDA) reflects autonomic changes in the electrical properties of the skin 
(Boucsein, 2012), and has been proposed to be one of the most reliable measures of changes in 
emotional and cognitive states in association with sympathetic activity, without parasympathetic 
activity signal interferences (Braithwaite et al., 2015). Specifically, EDA can be used to measure 
attentional processing and emotional responses that might happen unconsciously (Nagai et al., 2004). 
Skin conductance responses are generated by sweat secretion, and are measured by applying an 
electrical potential between two points that result in a current flow. Skin conductance is measured in 
micro Siemens (µS), and refers to the capability of the skin to conduct electricity when a direct 
constant voltage is applied externally (Figner & Murphy, 2011). EDA complex includes two main 
components: the tonic skin conductance level (SCL), which is a measure of slower background 
activity and general changes of arousal, and the skin conductance responses (SCRs), which constitute 
the phasic component that changes more rapidly after exposure to specific stimulus (Braithwaite et 
al., 2015).  
 
The majority of physiological research on gambling has measured average changes on tonic arousal 
over periods of several minutes. However, the identification of arousal responses to specific gambling 
features, such as reward anticipation and outcome phases or responses to wins and losses, requires the 
use of phasic measures (Lole, Gonsalvez, Barry, & Blaszczynski, 2014). The physiological responses 
during gambling are affected by several processes. Gambling trials usually involve a decision phase, 
during which participants are presented with a choice; an anticipation phase, during which participants 
wait to receive the reward outcome; and the outcome phase, during which participants receive the 
reward outcome. Research investigating separately these processes might reveal insights into the 
underlying mechanisms of gambling behaviour more accurately, helping to identify target measures 
to investigate in GD (Agren, Millroth, Andersson, Ridzén, & Björkstrand, 2019).  
 
2.2.2 Electrocardiogram 
An electrocardiogram (ECG) measures cardiovascular responses, including heart rate variability 
(HRV), which reflects the changes in time intervals between adjacent heart beats, and is generated by 
brain-heart interactions and ANS processes. HRV levels are associated with executive functions and 
emotional processing (Luque-Casado, Perales, Cárdenas, & Sanabria, 2016; Wei et al., 2018). In 




relative power into frequency bands, including low frequency (LF) band from (0.04-0.15 Hz) and 
high frequency (HF) band from (0.15-0.40 Hz). The LF/HF ratio can be used to estimate the balance 
between sympathetic nervous system (SNS) and parasympathetic nervous system (PNS). The LF band 
is typically measured during a minimum period of two minutes, and is assumed to be produced by 
sympathetic-parasympathetic activity with a dominant sympathetic component. The HF band is 
typically measured during a minimum period of one minute, and is associated with parasympathetic 
activity. Therefore a high LF/HF ratio will reflect sympathetic dominance (Park et al., 2019; Shaffer 
& Ginsberg, 2017), which can be due to an increase of sympathetic activity, and/or a decrease of 
parasympathetic activity (Clancy et al., 2014). Absolute power is measured in milliseconds (ms) 
squared divided by cycles per second (ms2/Hz). Relative power is calculated dividing the absolute 
power for a specific frequency band by the summed absolute power of LF and HF bands, and is 
expressed in percentage of total HRV or in normal units (nu). In terms of the recording length for 
HRV, short term measurements have been widely used in research and are based on five minutes of 
data (Berntson et al., 1997; Report, 1996).  
 
Heart rate (HR) is measured in beats per minute (bpm). Faster HR results from lower time between 
successive heartbeats, and consequently lower HRV. Inversely, slower HR is associated with longer 
times between heartbeats, which increases the opportunities for the inter beat interval to vary, and 
therefore results in higher HRV (McCraty & Shaffer, 2015). HR can be used to measure phasic 
responses, for example showing that HR responses during risky choices vary depending on the 
probability of winning or losing (Studer & Clark, 2011). The investigation of physiological factors 
underlying individual variance has clinical relevance to develop addiction interventions (Studer, 
Scheibehenne, & Clark, 2016). HRV has previously been used in research as a predictor of 
behavioural results (Pappens et al., 2014), and is widely used measure of physiological response to 
stress and changes in mental load (Luque-Casado et al., 2016). The type of information that EDA and 
cardiovascular measures can provide is diverse. While EDA activity indicates emotional arousal, HR 
is more sensitive to the valence of the emotional response, attention and cognitive processing (Sohn 
et al., 2001). Therefore, research using simultaneously both types of physiological measures may 
provide more precise information about individual physiological responses associated with GD 






Electroencephalography is a neuroimaging technique that measures the electrical activity of 
underlying neurons. The neurons membrane maintain a voltage gradient due to differences in charged 
ions of sodium, potassium, chloride and calcium. When the voltage changes significantly due to the 
movement of ions across the membrane channels, an action potential is generated, which electrical 
activity can be measured and displayed as a brain wave. This pulse is transferred from one neuron to 
another neuron across a connection known as synapse (Zhang, 2019). Electroencephalogram (EEG) 
measures current flows during synaptic excitation in the cortex. EEG can measure electrical activity 
only from large populations of active neurons, as the current has to pass through different neuronal 
layers, skull and skin. This is done by electrodes placed on the scalp that amplify massively the 
electrical signals detected (Teplan, 2002). Therefore, EEG power represents the sum of neurons firing 
synchronously, which might reflect cortical information processing performance (Kanda, Anghinah, 
Smidth, & Silva, 2009). EEG has a high temporal resolution, and this together with its non-invasive 
characteristics, makes it a widely used method to study brain activity during affective responses 
(Rajamanickam Yuvaraj et al., 2014).  
 
Quantitative EEG involves power spectral analysis of frequency band waves, such as delta (1–4 Hz), 
theta (4–8 Hz), alpha (8– 12 Hz) and beta (12–30 Hz). Previous research suggested that slow waves 
power (delta and theta bands) is associated with low cortical arousal, whereas beta power is associated 
with higher excitability of the central nervous system (Kim, Choi, Lee, & Kim, 2018). A recent review 
investigating EEG spectral analysis in different psychiatric disorders, including addiction, found a 
high variability on EEG data reported in research. The majority of studies investigated absolute power, 
which measures the amplitude of electrical activity in microvolts (µV). In addition, some studies 
included also relative power, usually calculated by dividing the power of each band by the sum of 
power across all bands. Although absolute power has been more widely used, relative power results 
were more consistent between studies, so the consideration of both measures would allow to produce 
more reliable interpretations. In addition, results were reported for broad cortical regions or individual 
channels, and using eyes opened or eyes closed conditions.  
 
The review found that across all psychiatric disorders, lower frequency bands (delta and theta) were 
generally associated with power increases, whereas decreases in power dominated alpha band, and 
particularly beta band was associated with either increases or decreases of power, compared with 




addition, results showed that correlations between band power and symptomatology were not specific 
of any disorder, however this might be due to the overlap of similar symptoms and comorbidities 
across different disorders (Newson & Thiagarajan, 2019). Therefore, further research is needed to 
better understand individual differences in cortical excitability, and whether specific EEG frequency 
bands are associated with GD and different responsiveness to tDCS.  
 
2.3 Main aims of the research project 
With the current GD prevalence rates ranging from (0.7–6.5%) during lifetime worldwide (Calado & 
Griffiths, 2016), which represents an increasing public health concern (Shaffer & Korn, 2002), there 
is an urgent need to develop treatment strategies for GD (Paglieri et al., 2014). Cognitive behavioural 
therapy (CBT) has become the most widely used treatment intervention for GD (Menchon et al., 
2018), however novel methodologies such as tDCS, might offer improved treatment opportunities for 
GD. Research has shown that there is not a unique mechanism explaining how all neuromodulation 
interventions act (Bikson & Rahman, 2013; Spagnolo et al., 2020). While tDCS might be used as a 
tool to investigate how behaviours arise from underlying neuronal circuitry, and ultimately be used 
as an intervention to modulate these mechanisms, multiple influencing factors should be examined. 
These include the investigation of neural networks targeted and specific stimulation protocols, short 
and long term effects, electrical current interactions with individual characteristics, comorbid 
disorders and simultaneous therapeutic treatment interactions (Bashir & Yoo, 2016). With such 
complexity involving numerous interrelated factors, it is fundamental to quantify the effects of the 
stimulation with methods that allow the measurement of functional and anatomical changes, such as 
neuroimaging and physiological techniques, in combination with cognitive measurements, to allow a 
more complete understanding of neuromodulation effects.  
 
To investigate some of these questions, four experiments were conducted throughout the project. In 
Experiments I and II, a two session crossover design was used to investigate tDCS effects over 
different brain areas in non-gambler and gambler participants. Furthermore, in Experiment III, the 
cumulative effects of tDCS combined with cognitive behavioural therapy (CBT) across eight sessions 
were investigated in two patients diagnosed with GD. Lastly, in Experiment IV, the effects of tDCS 
on the autonomous nervous system (ANS) were investigated with a two session crossover design, in 
low and high risk gamblers. An overview of the aims and methodology used across experiments is 





The main aims of the project were:  
- To investigate the effects of tDCS on different participant samples involving non-gamblers, at 
risk gamblers and individuals with GD (Experiments I, II, III and IV). 
- To investigate the effects of tDCS during gambling task-performance using protocols designed 
to target different brain areas associated with GD (Experiments I and II). 
- To investigate the cumulative effects of tDCS across sessions combined with CBT 
(Experiment III).  
- To investigate the effects of tDCS on cortical excitability and the ANS (Experiment IV). 
- To investigate potential risk-factors associated with GD by exploring different cognitive and 
physiological responses associated with gambling behaviour in different participant samples 
(involving low risk and high risk gamblers) during different gambling phases (anticipation, 









Figure 2-1. General overview of the research project. Simplified summary of aims and methodology used in the experiments.  
  
Experiments I and II
- tDCS effects over 
different brain areas
- Crossover design
- Two sessions (real 
stimulation and sham)
- Non-gambler and 
gambler participants




- Cumulative effects of 
tDCS combined with CBT
- Two case studies
- Eight sessions (real 
stimulation or sham)
- Patients diagnosed with 
gambling disorder
- Measures: gambling 
related task performance, 
gambling symptoms and 
EEG
Experiment IV
- tDCS effects on cortical 
excitability and autonomous 
nervous system
- Crossover design
- Two sessions (real 
stimulation and sham)
- Low and high risk 
gamblers
- Measures: gambling 
related task performance, 






3 Chapter 3. Experiments I and II: effects of tDCS montages designed 
to target rDLPFC and vmPFC on gambling task performance 
3.1 Summary 
Two experiments were conducted to investigate the effects of high definition (HD) tDCS montages 
with a ring configuration (1x4), on different brain areas. Non-gambler and gambler participants were 
divided according to their self-reported impulsivity levels into two groups: high impulsive (HI) and 
low impulsive (LI). In Experiment I, two tDCS montages were designed to target right dorsolateral 
prefrontal cortex (rDLPFC) and ventromedial prefrontal cortex (vmPFC), brain areas associated in 
general with decision-making and reward processing, respectively. Results showed significant tDCS 
effects on gambling task performance, but no difference between tDCS effects depending on brain 
target or participant groups. Particularly, tDCS was associated with higher quality of decision-making 
(QDM) and risk-taking (RT) behaviour, but did not affect delay aversion (DA). In Experiment II, the 
tDCS montage to target rDLPFC was modified by increasing the distance between the anode and the 
return electrodes, to investigate potential focality differential effects of tDCS between both brain 
regions. In this case, the tDCS montage designed for vmPFC used in Experiment I was compared with 
a new montage designed to target rDLPFC. Results in Experiment II replicated the findings from 
Experiment I. In conclusion, the significant tDCS effects found on cognitive-task performance, 
together with the lack of significant differences identified on tDCS effects between both brain areas, 
emphasised the need for further research investigating neuromodulation effects over this circuitry in 
combination with neuroimaging techniques.  
 
3.2 Introduction 
Gambling disorder (GD) has been associated with specific personality traits, including deficits in 
decision-making and increased impulsivity, RT behaviour, DA, negative affect and cognitive 
distortions (Cyders & Smith, 2008; Lobo & Kennedy, 2009; Michalczuk et al., 2011; Petry, 2001; 
Slutske et al., 2005; Zois et al., 2014). Cognitive alterations can be linked to functional brain changes 
(Goudriaan et al., 2004). In particular, decreased activation during inhibition control was associated 
with decreased dorsal prefrontal cortex (PFC) and medial PFC, in gamblers (Goudriaan et al., 2010; 
Potenza et al., 2003; Ruiter et al., 2009). The capability of PFC to exert control over addictive 




GD has shown altered synaptic plasticity in previous research (Choi et al., 2016; Geisel, Banas, 
Hellweg, & Müller, 2012). Addictive behaviours have been associated with dysfunctions on 
dorsolateral prefrontal cortex (DLPFC) and ventromedial prefrontal cortex (vmPFC) areas in various 
studies (Coles et al., 2018; Cyders et al., 2014; Genauck et al., 2017; Park et al., 2010). The role of 
these areas was associated with the expression of personality characteristics, such as impulsivity and 
RT behaviour (Brevet-Aeby et al., 2016; Fauth-Bühler, Mann, & Potenza, 2017; Verdejo-García, 
Lawrence, & Clark, 2008). In fact, similar decision-making processes might underlie delay 
discounting and RT, which are associated with subjective value of reward (Brevet-Aeby et al., 2016). 
Broadly, DLPFC has been linked to cognitive functions, such as decision-making, whereas vmPFC 
has been associated with reward processing (Koenigs & Grafman, 2009)1.  
 
Transcranial direct current stimulation (tDCS) can be used for the manipulation of cortical excitability 
of specific brain networks associated with GD. This might inform about individual differences and 
risk-factors that could be targeted with future neuromodulation interventions. However, there is a high 
variability in tDCS results across studies, in part due to individual variability, the heterogeneity of 
methodologies used, and in general, the lack of understanding of which protocols are more effective 
to target specific symptoms. Individual variability factors, such as cortical plasticity, can influence 
the particular response to NIBS (Cheeran et al., 2008). Regarding the methodologies used, high 
definition (HD) tDCS montages, involving multiple electrodes, can be used to improve tDCS 
anatomical specificity by avoiding shunting of electrical current to broader brain areas, and therefore 
help to investigate neuromodulation effects of tDCS on specific cortical regions (Villamar et al., 
2013). Specifically, electrode distance and size of electrodes have been shown to affect stimulation 
focality (Moliadze, Antal, & Paulus, 2010; Nitsche et al., 2007). Configurations of HD tDCS 
montages can be modified to improve stimulation targets (Dmochowski, Datta, Bikson, Su, & Parra, 
2011). In particular, the 4x1 ring configuration uses a central electrode placed over the brain target of 
interest, and which determines the polarity of the stimulation, surrounded by four return electrodes. 
The radius between the central electrode and the return electrodes limit the area of stimulation, 
resulting in higher target focality, compared with traditional bipolar montages (Datta et al., 2009). In 
addition, tDCS acts preferably over brain areas that are already activated. Therefore, coupling tDCS 
with cognitive tasks designed to investigate gambling-related behaviours, such as the Cambridge 
gambling task (CGT), might improve functional specificity by facilitating tDCS neuromodulation 
                                                 
1 Prefrontal cortex subdivisions (rDLPFC and vmPFC) functions were discussed in more detail in the general introduction 




effects over relevant cognitive processes associated with GD (Bikson & Rahman, 2013; Dinur-Klein 
et al., 2014; Lapenta et al., 2013).   
 
Most non-invasive brain stimulation (NIBS) studies in addiction that showed reduction of symptoms 
(e.g. impulsivity, cravings) used montages designed to target DLPFC (Coles et al., 2018). Specifically, 
all the studies using NIBS in GD targeted DLPFC, and one study also targeted medial PFC (Zack et 
al., 2016; Zucchella et al., 2020). Apart from NIBS research in GD, other tDCS studies found that 
anodal tDCS over rDLPFC was associated with a reduction of RT behaviour in a sample of impulsive 
individuals (Gilmore, Dickmann, Nelson, Lamberty, & Lim, 2018), and also in samples of healthy 
volunteers, who chose the safest options more often under anodal tDCS compared with sham, 
indicative of more advantageous decision-making performance associated with tDCS (Fecteau, 
Knoch, et al., 2007; Gorini, Lucchiari, Russell-Edu, & Pravettoni, 2014).  
 
Brain imaging research also identified a dysregulation of the reward-circuitry related to vmPFC in 
both substance use disorders (Konova et al., 2019) and behavioural addictions (Yoon et al., 2017). 
Particularly in GD, cognitive alterations were identified consistently in relation to risk-reward 
decision-making, associated with vmPFC, rather than DLPFC (Potenza, 2014). More recently, tDCS 
research has started to investigate ventral PFC areas. Particularly, a reduction of negative emotions 
and mind-wandering was associated with tDCS stimulation of medial PFC, and right ventrolateral 
PFC (Abend et al., 2019; Bertossi, Peccenini, Solmi, Avenanti, & Ciaramelli, 2017; Vergallito, Riva, 
Pisoni, & Romero Lauro, 2018). Decision-making and impulse control were improved after tDCS 
over orbitofrontal cortex (OFC; Ouellet et al., 2015). Moreover, while impulsive behaviour was 
reduced after anodal stimulation of vmPFC, cathodal stimulation was associated with increased 
impulsivity levels (Manuel, Murray, & Piguet, 2019). Evidence revealed functional connectivity 
between both areas during reward-based decisions (Hare et al., 2014). Higher connectivity between 
rDLPFC and vmPFC was shown when fairness and self-interest were in conflict in healthy 
individuals, demonstrating the role of this circuit on decision-making and reward processing 
(Baumgartner, Götte, Gügler, & Fehr, 2012). Therefore, further exploration of the potential effects of 
neuromodulation on these areas is necessary to better understand their specific contribution to 
dysfunctional behaviours in GD. Interventions could be directed to decreasing impulsive reward 
circuit activity, or to increasing the executive control circuit. Most interventions have focused on the 






The main objectives of Experiments I and II2 were to investigate whether different HD tDCS 
montages designed to target right DLPFC (rDLPFC) and vmPFC would be associated with different 
gambling-related cognitive outcomes, and to investigate whether different addiction-related 
participant characteristics would be a dependent factor of the effects of tDCS on gambling task 
performance. Specifically, it was hypothesised that tDCS real stimulation would be associated with 
improved decision-making and reduced RT and DA compared with sham. It was also hypothesised 
that tDCS over rDLPFC would be related to increases in decision-making, whereas stimulation of 
vmPFC would be more linked to RT and DA reduction, compared with sham. Lastly, it was 
hypothesised that individuals with higher GD severity and impulsivity levels would show poorer 
cognitive outcomes, including decreased decision-making and increased RT and DA.  
 
3.3 Methods 
3.3.1 Participants  
In Experiment I, 24 participants were recruited, and 40 participants in Experiment II. Recruitment 
was carried out through advertisements within the University of East London and participants were 
compensated for their time with shopping vouchers. Participants were allocated into two groups 
according to the tDCS montage that they were tested with: rDLPFC (n=12, mean age 27.92 ± 4.48 
years) and vmPFC (n=12, mean age 26.92 ± 3.26 years) in Experiment I, and rDLPFC (n=19, mean 
age 24.32 ± 6.71 years) and vmPFC (n=21, mean age 26.86 ± 7.35 years) in Experiment II. 
Furthermore, considering participants impulsivity levels measured with the negative urgency (NU) 
trait of the urgency premeditation perseverance sensation seeking scale (UPPS-P NU), two groups 
were created using NU trait scores median split (low impulsive (LI, n=12, 28 ± 3.27 years, and high 
impulsive (HI), n=12, 26.83 ± 4.45 years) in Experiment I, and (LI, n=21, 27.62 ± 7.61 years and HI, 
n=19, 23.47 ± 5.90 years) in Experiment II. In Experiment I, UPPS-P NU scores range by group was 
(LI=15-26; HI=27-40), and (LI=13-26; HI=27-40) in Experiment II. Participants were screened for 
the study inclusion criteria. This included male or females between 18-65 years who could speak and 
read English, capable of giving informed consent, and not having any of the exclusion criteria (based 
on non-invasive brain stimulation safety recommendations).  
                                                 
2 Experiments I and II are presented together in the same chapter because the same rational, methodology and outcome 
measures were used in both experiments, and the results are interrelated and complement each other. Therefore, it was 






a. History or evidence of chronic or residual neurological disease. 
b. A pacemaker. 
c. Metal implants in head or neck area (e.g. postoperative clips after intracerebral aneurysm; arterial 
aneurysm in the vascular system, implantation of an artificial hearing aid). 
d. Intracerebral ischemia/history of bleeding. 
e. Prior evidence of epileptic seizures, history of epilepsy. 
f. History of head injury with loss of consciousness. 
g. Any serious medical conditions (disease of the internal organs). 
h. Pregnancy or breast-feeding. 
 
The sample size was planned based on previous studies using similar tDCS with protocols involving 
a two session crossover design, in different addictions, including: smoking with samples of 20 
participants (Fecteau et al., 2014), and 24 participants (Fregni et al., 2008) and alcohol use disorder 
with a sample of 13 participants (Boggio et al., 2008).  
 
The original plan was to group participants according to their gambling severity scores using the South 
Oaks gambling screen (SOGS), however, the number of participants who classified as disordered 
gamblers was low. It was therefore decided to group participants according to their impulsivity scores 
using the UPPS-P NU, which helped increase group sizes and strengthened the analyses. Impulsivity 
has been broadly linked to addictive behaviours (Clark, Robbins, Ersche, & Sahakian, 2006; Leeman 
& Potenza, 2012b)  and in particular, the NU trait has been shown to be strongly associated with GD 
(Albein-Urios, Martinez-González, Lozano, Clark, & Verdejo-García, 2012; Cyders et al., 2007; 
Michalczuk et al., 2011; Mick et al., 2016; Navas et al., 2017). Specifically, the NU trait of impulsivity 
has been described as a risk-factor factor influencing the development and maintenance of addictive 
behaviours (Boothby, Kim, Romanow, Hodgins, & McGrath, 2017; Mallorquí-Bagué et al., 2018; 
Rømer Thomsen et al., 2018). In addition, grouping participants by impulsivity levels is supported by 




and substance use disorder (SUDs) participants, who were grouped using median split of impulsivity 
scores (Tziortzis, Mahoney, Kalechstein, Newton, & La Garza, 2011).  
 
3.3.2 Materials 
A tDCS Starstim 8 tDCS device (Neuroelectrics, Barcelona) was used with Ag/AgCl Pistim electrodes 
with a circular contact area of π cm², filled with Signagel conductive saline gel. The Cambridge 
Neuropsychological Test Automated Battery (CANTAB) Cambridge Gambling Task (CGT) was used 
to measure quality of decision-making (QDM), risk-taking (RT) and delay aversion (DA). The UPPS-
P was used as a measure of self-reported impulsivity. Gambling severity was measured with the 
SOGS. The questionnaire Gambling Related Cognition Scale (GRCS) was used to measure cognitive 
distortions. To control for alcohol dependence, participants completed the Severity of Alcohol 
Dependence Questionnaire (SADQ).  
 
- The South Oaks gambling screen (SOGS; Lesieur & Blume, 1987): it is a 20-item self-report 
questionnaire based on Diagnostic and Statistical Manual (DSM)-III criteria to screen for life- 
time pathological gambling. It has shown to have high validity and internal consistency reliability.  
Some examples of the questions are: ‘have you ever claimed to be winning money gambling but 
weren´t really? in fact, you lost?’; ‘have you ever felt guilty about the way you gamble?’; ‘have 
you ever borrowed money from someone and not paid them back as a result of gambling?’. 
 
- The Urgency Premeditation Perseverance Sensation Seeking scale (UPPS-P; Cyders et al. 2007): 
it is a 59-item self-report questionnaire using a Likert scale, from 1 (I agree strongly) to 4 (I 
disagree strongly), to assess five impulsivity subscales, including: urgency (inability to inhibit 
action impulses, especially in a negative motivational state despite long-term consequences); 
premeditation (inability to anticipate the consequences of one's actions); perseverance (inability 
to continue with boring or difficult tasks); sensation seeking (tendency to seek novel situations). 
Some examples of subscales questions are: negative urgency (e.g. ‘sometimes when I feel bad, I 
can’t seem to stop what I am doing even though it is making me feel worse’); positive urgency 
(e.g. ‘when over joyed, I feel like I can’t stop myself from going overboard’); (lack of) 
premeditation (e.g. ‘I usually make up my mind through careful reasoning’); (lack of) 
perseverance (e.g. ‘I finish what I start’); and sensation seeking (e.g. ‘I would enjoy the sensation 





- The gambling related cognitions scale (GRCS; Raylu & Oei, 2004): it is a 23-item self-report 
questionnaire that uses a seven-point Likert scale from 1 (strongly disagree) to 7 (strongly agree) 
to assess five subscales: predictive control (e.g. ‘losses when gambling are bound to be followed 
by a series of wins’); illusion of control (e.g. ‘I have specific rituals and behaviours that increase 
my chances of winning’); interpretive bias (e.g. ‘relating my winnings to my skill and ability 
makes me continue gambling’); gambling expectancies (e.g. ‘gambling makes things seem 
better’); and inability to stop gambling (e.g. ‘I’m not strong enough to stop gambling’).  
 
- The severity of alcohol dependence questionnaire (SADQ; Stockwell, Hodgson, Edwards, Taylor, 
& Rankin, 1979): it is a self-report questionnaire divided into five sections: physical symptoms of 
withdrawal (‘my hands shake first thing in the morning’); affective symptoms of withdrawal (‘I 
am frightened of meeting people first thing in the morning’); craving and withdrawal-relief 
drinking (‘I like to have a morning drink’); typical daily consumption (‘I drink more than a quarter 
of a bottle of spirits per day (4 doubles or 1 bottle of wine or 4 pints of beer’); and rapidity of 
reinstatement of symptoms after a period of abstinence (‘my body would shake’). For all 
questions, the respondents were instructed to focus on their most recent period of heavy drinking. 
All withdrawal symptom items refer to how the respondent felt when waking up, because this is 
the most common time for such symptoms to occur. Each item has its own frequency scale ranging 
from 'almost never' to 'nearly always' and, in addition, the items themselves were designed to 
cover a range of severity of symptomatology.  
 
- The Cambridge gambling task (CGT; Zois et al., 2014): it is a cognitive task that measures 
decision-making, impulsivity and RT behaviour. On each trial, the participants are presented with 
a row of 10 boxes coloured red and blue, in different ratios of red:blue boxes (9:1, 8:2, 7:3, 6:4), 
which represent the risk conditions, where the ratio 6:4 constitutes the most risky condition. The 
participants were asked to make a probability judgement followed by a bet. First, participants 
chose under which colour a token is most likely hidden, and after that, they could place a bet at 
one of five levels: 5%, 25%, 50%, 75% or 95% of their total points available. In the assessed 
stages, participants started with 100 points and selected a proportion of these points to bet on their 
decision. The bet was offered under two different conditions: in the ascending condition, the 
amount of points that participants can bet appeared in the screen starting at 5% of their points, 




step-down to 5% of their current points. A number on the screen displayed the current bet value 
in points, which either incrementally increased or decreased. One of the key features of the CGT 
is that it allows to dissociate risk-taking from impulsivity. This is because in the ascending 
condition, the participant who seeks to make a risky bet has to wait for it to appear on the screen, 
however, in the descending condition, riskier bets would not require to wait. The variables 
measured were: QDM, which is the proportion of trials where the majority colour was selected 
(sometimes referred as the proportion of rational responses); RT, which measures the proportion 
of points bet when the participant chose the most likely option to win; and DA, as a measure of 
impulsivity, is the difference in risk-taking behaviour between descending and ascending 









Figure 3-1. Cambridge gambling task (CGT) stages. The participants were asked to guess under which colour a token 
was most likely hidden. First, they selected the colour on the bottom of the screen and subsequently a bet appeared in 
ascending or descending order with proportions 5%, 25%, 50%, 75% and 95% of their current points. The bet was shown 
as the number of points that can be gained or lost (rather than the proportion itself), which participants must select, as the 
















3.3.3 Procedure  
Both experiments were conducted to investigate the effects of transcranial direct current stimulation 
(tDCS) using high definition (HD) montages designed to target two different brain areas: right 
dorsolateral prefrontal cortex (rDLPFC) and ventromedial prefrontal cortex (vmPFC). Two groups of 
participants were created depending on the montage with which they received tDCS (rDLPFC, n=12; 
vmPFC n=12) in Experiment I, and (DLPFC, n=19; vmPFC n=21) in Experiment II. Moreover, to 
understand the possible influence of addiction-related personality characteristics on the effects of 
tDCS in gambling task performance, a separate analysis was conducted grouping participants by their 
impulsivity levels.  
 
The experiments involved two sessions with crossover design, in which each participant received 
tDCS in a counterbalanced order (real stimulation and sham) one week apart, using a single blind 
mode (the participant was not aware of the tDCS condition). Participant allocation to each group was 
not random in Experiment I because the original plan was to compare the effects of tDCS in both 
brain areas throughout two different experiments (the first using a rDLPFC montage and the second 
using a vmPFC montage). However, after a reconsideration, it was decided to change the approach to 
ensure having more data informing about the potential effects of both montages on gambling task 
performance, before continuing with the following experiment. Consequently, two participant groups 
were created in each experiment according to the tDCS montage that was used with each participant. 
Therefore, the first nine participants were tested with the rDLPFC montage, the next nine participants 
with the vmPFC montage, and consecutively each new participant was allocated to a group with a 
different montage to the previous participant, which continued in the following experiment. In 
Experiment II, it was decided to create a new montage designed to target rDLPFC, which was 
compared against the same vmPFC used in Experiment I. Therefore, three different tDCS montages 
were used: one to target vmPFC used in both experiments, and two different montages to target 
rDLPFC (the details of the montages are explained in the next section 3.3.4 of this chapter).  
 
Each testing session had a duration of one hour, and in addition, the setting up and cleaning of the 
equipment took around 40 minutes. A total of 64 sessions were conducted, including both 
experiments. Before participation in the study, written informed consent was obtained, which was 




Appendix D). All experimental procedures were conducted following the Declaration of Helsinki. On 
each session, participants completed a series of questionnaires to measure individual gambling-related 
characteristics (SOGS, UPPS-P, GRCS and SADQ), and after that the CGT was administered during 
tDCS stimulation. All participants completed the CGT ascending condition first (Zois et al., 2014) 
because it was demonstrated that ascending/descending conditions order did not influence CGT 
performance (Lawrence, Luty, Bogdan, Sahakian, & Clark, 2009). 
 
3.3.4 Transcranial direct current stimulation (tDCS) high definition (HD) montages 
Experiments were conducted using different tDCS HD montages (1 x 4, anode-returns) targeting 
rDLPFC and vmPFC with an intensity of 1.5 milliamps (mA) and a ramp up and ramp down of 30 
seconds. In the active session, participants received 20 minutes of real stimulation, whereas in the 
sham session, there was no electrical current delivered between the ramping up and ramping down. 
The montage designed to target vmPFC was the same in both experiments (anode: Fpz, returns: F7, 
F3, F4, F8), and it was compared against montages designed to target rDLPFC: (anode: F4, returns: 
F8, C4, Fz, Fp2) in Experiment I, and (anode: F4, returns: Fpz, F3, Cz, T8) in Experiment II. The 
electrode positions followed the international 10-10 EEG system with the central Cz position aligned 
to the vertex of the head, and are represented in Figure 3-2.  
 
The same montage was used to target vmPFC in both experiments because in vmPFC the targeted 
area is not very accessible, and there were no alternative electrode positions that would fit well a HD 
montage that maintained the four return electrodes at a similar distance from the anode (Fpz), without 
separating them more than it was intended to. However, rDLPFC target is more accessible, so two 
different montages were designed with different return positions and the same anode (F4). In 
Experiment I, the return electrodes were closer to the anode, whereas in Experiment II the location of 
the return electrodes was separated  slightly, with the intention to increase the relative amount of 
current traveling through the scalp to the targeted brain area (Bikson, Datta, Rahman, & Scatturo, 






Figure 3-2. Transcranial direct current stimulation (tDCS) high definition (HD) montages in Experiment I and Experiment 
II. Electrode positions were based on the International EEG 10-10 system. The circles in red represent the electrode 
positions of the montage designed to target vmPFC (anode: Fpz, returns: F7, F3, F4, F8) in both experiments. Blue dots 
indicate electrode positions of the rDLPFC montage in Experiment I (anode: F4, returns: F8, C4, Fz, Fp2), and the yellow 
dots indicate electrode positions of the rDLPFC montage in Experiment II (anode: F4, returns: Fpz, F3, Cz, T8). Montage 
tDCS effects for vmPFC (red) and rDLPFC (blue) were compared in Experiment I, and montage tDCS effects for vmPFC 






3.3.5 Analysis plan in Experiments I and II 
The statistical analysis was conducted with IBM SPSS (Statistical Package of the Social Sciences, 
Version 23, SPSS Inc., Chicago, IL). Significance threshold was set at α = 0.05. Demographic data 
(age/gender) were analysed using t-tests and Chi-square tests. Data was checked for skewness, 
kurtosis and normality. Non-normally distributed data according to Kolmogorov-Smirnov test was 
transformed using logarithmic transformation, or arcsine transformation for variables expressed as a 
proportion. When sphericity was not satisfied, Greenhouse-Geisser correction was employed.  
 
The effects of tDCS session order on CGT performance were analysed with a repeated measures 
ANOVA with between participants factor being session order, with two levels (real stimulation first 
or sham first). To take into account the interaction of the tDCS stimulation condition with the order 
of the session, when session order was significant, session order was used as a covariate, and a 
repeated measures mixed factor ANCOVA was employed. Significant group interactions were 
analysed using independent sample t-tests (2-tailed), and significant tDCS condition interactions were 
analysed with paired sample t-tests (2-tailed).  
 
The variable QDM was analysed with a 2 x 2 x 2 x 4 mixed factor repeated measures ANOVA, with 
within-participants factors being tDCS, with two levels (real stimulation and sham), condition, with two 
levels (ascending and descending) and risk conditions (box ratio), with four levels (6:4, 7:3, 8:2, 9:1), 
and group as the between-participants factor (HI and LI, or rDLPFC and vmPFC). RT was analysed 
using a 2 x 2 x 2 x 4 mixed-factor repeated measures ANCOVA, with within-participants factors 
condition, with two levels (ascending and descending), tDCS, with two levels (real stimulation and 
sham) and box ratio, with four levels (6:4, 7:3, 8:2, 9:1), and group as the between-participants factor 
(HI and LI, or rDLPFC and vmPFC), and session order as a covariate. DA was analysed using a 2 x 
2 x 4 mixed factor repeated measures ANOVA with within-participants factor tDCS, with two levels 
(real stimulation and sham), box ratio, with four levels (6:4, 7:3, 8:2, 9:1), and group as the between-







3.4.1 Results in Experiment I 
Demographic data and questionnaires are reported in Table 3-1, including groups divided by 
impulsivity levels (LI and HI) and by tDCS target (rDLPFC and vmPFC). Independent sample t-test 
for age differences between LI (M=28 ± 3.27) and HI (M=26.83 ± 4.45) were not significant (t (22) 
= .535, p = .472). Chi-square tests were not significant for gender interactions with UPPS-NU group 
(X2 (1) = .178, p=.673) and for education level interactions with UPPS-P NU group (X2 (1) = .178, 
p=.673). For the participants grouping by tDCS target, independent t-tests for age differences between 
rDLPFC (M=27.92) and vmPFC (M=26.92) were not significant (t (22) = .625, p=.538). Chi-square 
tests revealed no inter-group differences for gender interactions with tDCS target groups (X2 (1) = 
.178, p=.673) and no differences for education level interactions with tDCS target group (X2 (1) = 
.178, p=.673). Independent sample t-test analysis for UPPS-P total score differences between LI and 
HI was significant (t (22) = -2.865, p=.009), but non-significant between rDLPFC and vmPFC groups. 
No other measures including SADQ, GRCS and SOGS showed significant differences between 
groups. Data that was not normally distributed was log transformed (GRCS, SADQ, SOGS) and 






















In Experiment I there were no significant differences of tDCS effects between montages designed to 
target rDLPFC and vmPFC in any of the variables, including QDM (F (1, 22) =.001, p= .998, ηp2 = 
.001), RT (F (1, 22) =.878, p= .359, ηp2 = .038) and DA (F (1, 22) =.148, p= .704, ηp2 = .007). 
Experiment results are reported below using participant groups split by impulsivity levels. Groups 
were created using median split of NU scores (median = 26.5). Therefore participants scoring 26 or 
lower in NU were allocated to LI group, and participants scoring 27 or higher in NU were allocated 
























t (22) = .625, p=.538 
Gender   
X2 (1) = .178, p=.673 
  
X2 (1) = .178, p=.673 Females 5 4 4 5 
Males 7 8 8 7 
Education       
Primary - -  - -  
Secondary 8 7 X2 (1) = .178, p=.673 8 7 X2 (1) = .178, p=.673 















































t (22) = 1.345, p=.192 
Notes: SOGS, South Oaks gambling screen; UPPS-P, urgency, premeditation, perseveration, sensation seeking 
scale; GRCS, gambling related cognitions scale; SADQ, severity of alcohol dependence questionnaire. Participant 
groups are divided by impulsivity (high: HI; low: LI) and by tDCS target area (right dorsolateral prefrontal cortex 
(rDLPFC) and ventromedial prefrontal cortex (vmPFC)). Values represent mean and inside the parenthesis 







Figure 3-3. Histogram in Experiment I. Distribution of the negative urgency (NU) scores across participants from the urgency, 





There were significant main effects of tDCS in QDM (F (1, 22) = 4.788, p= .040, ηp2 = .179), with 
real stimulation enhancing decision-making compared to sham, and in RT, in which real stimulation 
was associated with higher RT compared with sham (F (1, 21) = 10.072, p= .004, ηp2 = .179). In RT, 
there were also main effects of task condition (F (1, 21) = 7.719, p= .011, ηp2 = .338), showing that 
RT was lower in ascending condition compared to descending condition, and a main effect of risk (F 
(1, 21) = 6.633, p= .001, ηp2 = .240), showing that RT was lower as risk conditions increased. There 
was an interaction of tDCS x session order, showing that RT was higher in the second session (F (1, 
21) = 14.685, p= .001, ηp2 = .269), and also risk condition x group interactions (F (3, 63) = 2.942, p= 
.040, ηp2 =.123) represented in Figure 3-4. Independent samples t-test to compare the interaction with 
groups, showed that HI was associated with significantly lower RT in real stimulation ascending 
lowest risk condition (9:1) compared with LI (t (22) = 2.583, p=.017), however in descending highest 
risk condition (6:4), HI had higher RT compared with LI, but this difference was not significant (t 
(22) = -1.760, p=.092). There were no significant differences between the groups in sham condition. 
No significant differences were found in the variable DA (F (1, 22) =.588, p= .451, ηp2 = .026).  
 
In addition, 2-tailed Pearson´s correlation indicated that UPPS-P NU correlated positively with GRCS 
subscale inability to stop gambling, DA, and with RT in the highest risk condition, but negatively 
with RT in the lowest risk condition. Gambling severity measured with SOGS correlated positively 
with alcohol dependence measured with SADQ, with GRCS total, and with the subscales gambling 
expectancies, and interpretive bias. No other correlations were significant (all p > .005). Correlation 






Table 3-2. Correlations between questionnaires and task scores with UPPS-P NU and SOGS in Experiment I. 
 
  
 UPPS-P NU SOGS 
 r p r p 
UPPS-P NU - - .135 .529 
UPPS-P total .728 .001 ** .071 .743 
SOGS .135 .529 - - 
GRCS total .113 .598 -.451 .027 * 
SADQ .351 .092 .682 .001 ** 
GRCS inability to stop gambling .410 .047 * .371 .075 
GRCS illusion of control .044 .838 .318 .130 
GRCS predictive control -.013 .950 .252 .234 
GRCS gambling expectancies .044 .838 .451 .027 * 
GRCS interpretative bias .150 .484 -.502 .012 * 
DA .428 .037 * .106 .622 
QDM .067 .755 .116 .590 
RT in CGT 9:1 -.454 .026 * .178 .405 
RT in CGT 8:2 -.312 .138 -.089 .678 
RT in CGT 7:3 -.324 .122 -.009 .678 
RT in CGT 6:4 .471 .020 * .027 .899 
Note: UPPS-P NU, negative urgency trait of urgency, premeditation, perseverance and sensation 
seeking scale; SOGS, South Oaks gambling screen; GRCS, gambling related cognition scale; SADQ, 
severity of alcohol dependence questionnaire; DA, delay aversion; QDM, quality of decision-making; 









Figure 3-4. Cambridge gambling task (CGT) groups interactions in Experiment I. Risk-taking (RT) in ascending and 
descending task conditions across different risk conditions, represented by box ratios (9:1, 8:2, 7:3 and 6:4) in low 
impulsive (LI) and high impulsive (HI) groups, during tDCS real stimulation and sham. Data represents mean and SEM 









3.4.2 Results in Experiment II 
Demographic data and questionnaires are reported in Table 3-3, including groups divided by 
impulsivity levels (LI and HI) and by tDCS target (rDLPFC and vmPFC). Independent t-test to 
analyse age differences between LI (M=27.62 ± 7.61) and HI (M=23.47 ± 5.90) groups, were not 
significant (t (38) = -1.138, p=.262). Chi-square tests for gender interactions with UPPS-P NU group 
were significant (X2 (1) = 5.414, p=.020), and not significant for education level interaction with 
UPPS-P NU group (X2 (1) = .018, p=.894). For the participants grouping by tDCS target, independent 
t-tests analysis for age differences between rDLPFC (M=27.92) and vmPFC (M=26.92) were not 
significant (t (22) = .625, p=.538). Chi-square tests revealed no inter-group differences for gender 
interactions with tDCS target grouping (X2 (1) = .178, p=.673), and no interactions for education level 
and tDCS target grouping (X2 (1) = .658, p=.451). Independent t-tests analysis for UPPS-P total score 
differences between LI and HI was significant (t (22) = -2.865, p=.009), and non-significant between 
rDLPFC and vmPFC groups. No other measures including SOGS, GRCS and SADQ showed 
significant differences between groups. Kurtosis, skewness and normality was assessed and data that 
was not normally distributed according to Kolmogorov-Smirnov test was log transformed (DA, 




























t (38) = -1.138, p=.262 
Gender   
X2 (1) = 5.414, p=.020* 
  
X2 (1) = .819, p=.366 Females 9 15 10 14 
Males 12 4 9 7 
Education       
Primary - -  - -  
Secondary 18 16 X2 (1) = .018, p=.894 17 17 X2 (1) = .658, p=.451 












































t (38) = .821, p=.417 
SOGS, South Oaks gambling screen; UPPS-P, urgency, premeditation, perseveration, sensation seeking scale; 
GRCS, gambling related cognitions scale; SADQ, severity of alcohol dependence questionnaire. Participant groups 
are divided by impulsivity (high: HI; low: LI) and by tDCS target area (right dorsolateral prefrontal cortex (rDLPFC) 
and ventromedial prefrontal cortex (vmPFC)). Values represent mean and inside the parenthesis standard deviation, 
except in gender and education, in which values represent number of participants (* p < .05). 
 
 
In Experiment II there were no significant differences of tDCS effects between montages designed to 
target rDLPFC and vmPFC in any of the variables, including QDM (F (1, 38) =.907, p= .347, ηp2 = 
.023), RT (F (1, 38) = .001, p= .996, ηp2 = .001) and DA (F (1, 38) = .034, p= .855, ηp2 = .001). 
Experiment results are reported using participant groups split by impulsivity levels. Groups were 
created using median split of NU scores (median = 26.5). Therefore participants scoring 26 or lower 
in NU were allocated to LI group, and participants scoring 27 or higher in NU were allocated to the 





Figure 3-5. Histogram in Experiment II. Distribution of the negative urgency (NU) scores across participants from the urgency, 





There was a main effect of task condition (F (1, 38) = 7.183, p=.011, ηp2 = .159), indicating that QDM 
was lower in ascending condition. Also, a main effect of risk (F (3, 114) = 4.484, p=.015, ηp2 = .106), 
showed that QDM was lowest in the highest risk condition and highest in the lowest risk condition. 
There was an interaction tDCS x risk condition (F (3, 114) = 3.519, p=.032, ηp2 = .085), showing that 
in the sham condition the difference in QDM between the lowest (9:1) and the highest (6:4) risk 
conditions (with higher QDM in the lowest risk condition), was significant in both ascending (t (39) 
= 2.922, p=.006), and descending conditions (t (39) = 2.282, p=.028), however, in real stimulation 
there were no significant differences between risk conditions (Figure 3-6). In multivariate analysis 
there was an interaction risk condition x group (F (3, 36) = 3.830, p=.018, ηp2 = .242), indicating that 
LI showed higher QDM compared with HI in the risk condition 8:2 in real stimulation (t (38) = 2.569, 
p=.014).  
 
There was also a main effect of tDCS in RT (F (1, 37) = 12.458, p=.001, ηp2 = .252), showing that 
RT was higher in real stimulation compared with sham, a main effect of condition (F (3, 114) = 5.285, 
p=.027, ηp2 = .125), indicating that RT was lower in ascending condition, and a main effect of risk (F 
(3, 111) = 3.802, p=.030, ηp2 = .093), showing that RT was lower as risk conditions increased. There 
were also interactions between tDCS x session order (F (1, 37) = 14.960, p=.001, ηp2 = .288), 
indicating that RT was higher in the second session of tDCS. An interaction condition x groups (F (1, 
37) = 5.252, p=.028, ηp2 = .124), an interaction risk x groups (F (3, 111) = 6.255, p=.004, ηp2 = .145) 
and a three way interaction tDCS x condition x risk (F (3, 111) = 3.174, p=.030, ηp2 = .085), 
represented in Figure 3-7 and Figure 3-8.  
 
Independent samples t-test to compare group interactions, showed that compared with HI, LI showed 
significantly lower RT in real stimulation descending highest risk conditions 7:3 (t (38) = -2.282, 
p=.028), and 6:4 (t (38) = -3.244, p=.002),  and in sham descending condition 6:4 (t (38) = -2.609, 
p=.013). Paired samples t-test to compare tDCS interactions, showed that RT was higher in 
descending conditions compared with ascending conditions in real stimulation 9:1 (t (39) = -3.128, 
p=.004), 8:2 (t (39) = -3.196, p=.003), 7:3 (t (39) = -2.225, p=.032), and in sham 9:1 (t (39) = -5.723, 
p=.001), 8:2 (t (39) = -4.421, p=.001), 7:3 (t (39) = -4.443, p=.001) and 6:4 (t (39) = -4.867, p=.001), 
and that tDCS real stimulation was associated with significantly higher RT in ascending highest risk 





In addition, 2-tailed Pearson´s correlation indicated that UPPS-P NU correlated positively with 
gambling severity measured with SOGS, GRCS subscales gambling expectancies, illusion of control, 
predictive control, inability to stop gambling, interpretive bias and total GRCS. Also, UPPS-P NU 
correlated positively with RT in the highest risk condition (6:4). Gambling severity (SOGS) correlated 
positively with UPPS-P NU, as mentioned previously, and UPPS-P total, and with GRCS subscales 
inability to stop gambling, interpretive bias and GRCS total, and with RT risk conditions 7:3 and 6:4. 
In addition, SOGS correlated negatively with QDM. Correlations are represented in Table 3-4.  
 













 UPPS-P NU SOGS 
 r p r p 
UPPS-P NU - - .347  .028 * 
UPPS-P total .810 .001 ** 335  .035 * 
SOGS .347  .028 * - - 
SADQ .083 .612 .008 .961 
GRCS total .448  .004 * .392  .012 * 
GRCS inability to stop gambling .434  .005 * .645  .001 ** 
GRCS illusion of control .325  .041 * .252 .117 
GRCS predictive control .350  .027 * .153 .347 
GRCS gambling expectancies .418  .007 * .276 .084 
GRCS interpretative bias .397  .011 * .440  .004 * 
DA .136 .403 -.146 .368 
QDM -.201 .213 -.329  .038 * 
RT in CGT condition 9:1 -.003 .985 .189 .242 
RT in CGT condition 8:2 -.061 .707 .166 .305 
RT in CGT condition 7:3 .215 .182 .312  .050 * 
RT in CGT condition 6:4 .348 .028 * .527  .001 ** 
Note: UPPS-P NU, negative urgency trait of urgency, premeditation, perseverance and sensation seeking 
scale; SOGS, South Oaks gambling screen; SADQ, severity of alcohol dependence questionnaire; 
GRCS, gambling related cognition scale; DA, delay aversion; QDM, quality of decision-making; RT, 














Figure 3-6. Cambridge gambling task (CGT) quality of decision-making (QDM) interactions with tDCS in Experiment 
II. QDM in tDCS real stimulation and sham across different risk conditions, represented by box ratios (9:1, 8:2, 7:3 and 
6:4), for low impulsive (LI) and high impulsive (HI) groups in ascending and descending task conditions. Significant 
differences were found between sham lowest (9:1) and highest (6:4) risk conditions, and between LI and HI in 8:2 in real 










Figure 3-7. Cambridge gambling task (CGT) risk-taking (RT) tDCS interactions in Experiment II. RT in tDCS real 
stimulation and sham across different risk conditions, represented by box ratios (9:1, 8:2, 7:3 and 6:4), for low impulsive 














Figure 3-8. Cambridge gambling task (CGT) risk-taking (RT) interactions with groups in Experiment II. RT in ascending 
and descending task conditions, across different risk conditions, represented by box ratios (9:1, 8:2, 7:3 and 6:4), for low 









These two experiments investigated the effects of different HD tDCS montages (1 x 4, anode-returns) 
designed to target rDLPFC and vmPFC on gambling task performance, and whether addiction-related 
participant characteristics, particularly, the impulsivity trait of negative urgency (NU), was related to 
the effects of tDCS. Two experiments were conducted using the same methodology but different tDCS 
montages and different sample sizes (24 and 40 participants, respectively). In both experiments it was 
used the same tDCS montage designed to target vmPFC, and this was compared against two different 
montages designed to target rDLPFC. In Experiment I, the rDLPFC montage was designed with the 
return electrodes positioned closer to the anode, but in Experiment II, the return electrodes were 
positioned with slightly more distance to the anode, with the aim to increase the amount of current 
traveling through the scalp to the target area. Self-reported impulsivity measured with the UPPS-P 
NU was used to create two groups of participants (LI and HI), to investigate whether potential tDCS 
effects on gambling task performance varied across participants with different impulsivity levels. 
Results showed significant effects of tDCS on quality of decision-making (QDM) and risk-taking 
(RT), as well as different gambling task performance between LI and HI participants, but no 
difference on tDCS effects between rDLPFC and vmPFC areas or impulsivity participant groups.  
 
Both experiments revealed similar results on the Cambridge Gambling Task (CGT) performance: 
results showed that real stimulation enhanced QDM and increased RT compared with sham, but there 
were no tDCS effects on DA. Both experiments revealed that tDCS effects did not differ between LI 
and HI participants, or between montages designed to target rDLPFC and vmPFC. Results also 
showed that RT decreased with increasing risk conditions, and that RT was higher in descending 
condition compared with ascending condition. The fact that RT was higher in the descending 
condition might indicate that participants betting choice was driven more by impulsivity rather than 
by a deliberate intention to increase the bet itself. This interpretation is based on the characteristics of 
the CGT (Fauth-Bühler et al., 2017), which allows for differentiation between impulsive choice and 
RT behaviour. In the ascending condition, participants need to wait for higher bets to appear on the 
screen, however, in the descending condition the highest bet appears first, and participants have to 
wait to choose a smaller bet until it appears on the screen. Nevertheless, even though this argument 
could be sustained due to the task characteristics, it has to be noted that there were no effects on DA, 
which measures the difference in RT between descending and ascending conditions, as a behavioural 
impulsivity measure. However, if impulsivity did not influence bet choice, in principle it could be 




contrary to what it was found. Therefore, there is some evidence to support that participants bet choice 
was driven by impulsivity, but results are not strong to confirm the argument.  
 
There were significant differences in RT across different risk conditions between LI and HI, as well 
as a session order effect in both experiments, showing that RT was higher in the second testing session, 
perhaps due to participants getting used to the experimental procedure, and therefore feeling more 
eager to take risks. In both experiments there were positive correlations between UPPS-P NU and RT 
in the highest risk condition (6:4), between UPPS-P NU and GRCS subscale inability to stop 
gambling, and between gambling severity (SOGS) and GRCS total score and subscales inability to 
stop gambling and interpretive bias.  
 
In contrast, there were also outcomes that varied across the experiments. In Experiment I, LI showed 
higher RT in the lowest risk condition (9:1) compared with HI, and in Experiment II, HI showed 
higher RT in the highest risk condition (6:4) compared with LI. Although these two outcomes are not 
exactly the same, they are not conflicting either. In addition, significant interaction effects were found 
with tDCS in QDM and RT in Experiment II that were not present in Experiment I. Accordingly, 
Experiment II revealed that QDM was higher in the lowest risk condition (9:1) compared with the 
highest risk condition (6:4) in sham, but no significant differences in QDM across risk conditions 
were found in real stimulation. This result could be explained considering also the effect of tDCS on 
QDM found in both experiments (which associated real stimulation with higher QDM). If tDCS real 
stimulation helped increase QDM, especially in the highest risk conditions compared with sham3, this 
would result in a more stable task performance between risk conditions, and therefore explain the lack 
of significant differences in QDM between the lowest and highest risk conditions in real stimulation, 
but in sham, as it was found. Nevertheless, this argument is just an assumption that could help explain 
the results, but a more reliable interpretation cannot be asserted because of the lack of statistical 
evidence supporting the statement.  
 
Moreover, RT was higher in the ascending highest risk condition (6:4) in real stimulation compared 
with sham. This effect of tDCS on RT in Experiment II, together with the results found in both 
experiments, showing that increased RT was associated with real stimulation, and that independently 
of the stimulation participants showed higher RT in descending condition (which could be an 
                                                 




indication of impulsive behaviour, as discussed above), could indicate that real stimulation might 
increase RT behaviour, rather than modulating impulsive choice, which would be consistent with the 
fact that there were no tDCS effects on DA.  
 
Besides the significant correlations found in both experiments mentioned above, in Experiment I, it 
was identified a positive correlation between UPPS-P NU and DA, and a negative correlation between 
UPPS-P NU and RT in the lowest risk condition (9:1). In addition, SOGS correlated positively with 
SADQ and GRCS subscale gambling expectancies. In Experiment II, UPPS-P NU correlated 
positively with gambling severity (SOGS) and with GRCS total score and subscales of gambling 
expectancies, illusion of control, predictive control and interpretive bias, whereas SOGS correlated 
negatively with QDM. The correlations revealed in these experiments are consistent with previous 
research showing that CGT variables were mediated by impulsivity in GD, with irrational choices 
being negatively associated with impulsivity scores (Zois et al., 2014). In a similar way, other studies 
also showed that impulsivity was correlated positively with the level of gambling cognitive distortions 
measured with the GRCS (Michalczuk et al., 2011), and with gambling severity measured with SOGS 
(Steel & Blaszczynski, 1998), which is consistent with these results.  
 
The association of impulsivity with gambling-related variables that was found, is in line with previous 
research that suggested that impulsivity could be a potential marker to target in addiction, and 
specifically in GD (Leeman & Potenza, 2012b; Verdejo-García et al., 2008). There were more 
correlations between variables in Experiment II, as well as interaction effects that were not present in 
Experiment I. This could be explained by the difference in sample size between the experiments. 
Having 40 participants in Experiment II, compared with the smaller sample of 24 participants in 
Experiment I, could have facilitated finding significant interactions and more correlations between 
variables in the second experiment. In any case, the different interactions found in the two experiments 
suggested similar interpretations of the results, and correlations between variables followed the same 
direction in both experiments.  
 
These results showed that real stimulation over dorsal and ventral areas of PFC improved QDM 
compared with sham, which is in line with research showing that tDCS over orbitofrontal cortex 
(OFC), was associated with improved decision-making (Ouellet et al., 2015) and that bilateral DLPFC 




experiments revealed that real stimulation increased RT behaviour. This result is inconsistent with 
previous research showing that right DLPFC tDCS was associated with decreased RT in a sample of 
healthy participants (Ota, Shinya, & Kudo, 2019) and in a clinical impulsive sample (Gilmore et al., 
2018). Nonetheless, these results are consistent with research showing that anodal tDCS over DLPFC 
was associated with increased RT in cannabis users (Lapenta, Marques, Rego, Comfort, & Boggio, 
2018), and studies that showed that tDCS over left DLPFC increased RT behaviour in cocaine 
dependent users (Gorini et al., 2014), and that bilateral tDCS over DLPFC was associated with 
participants choosing more risky options in real stimulation compared with sham, regardless of the 
DLPFC side of the stimulation (Ye et al., 2015).  
 
The laterality of tDCS stimulation has been a subject of debate, and results showing that unilateral 
anodal tDCS over DLPFC did not change RT behaviour, but a decrease of RT was found when 
cathodal modulation of the contralateral DLPFC anodal stimulation was applied (Fecteau, Pascual-
Leone, et al., 2007), highlight the importance of investigating the effects of different types of tDCS 
montages designed to target different brain areas, to better understand the mechanisms of tDCS on 
brain circuitries. Also, research has shown conflicting effects of tDCS depending on participant 
clinical characteristics: while real stimulation compared with sham was associated with less risky 
behaviours in a sample of healthy participants, chronic marijuana users risky behaviour was higher 
with both left and right DLPFC tDCS (Boggio et al., 2010). Unlike previous research that identified 
different tDCS effects depending on participant clinical characteristics, in these experiments tDCS 
effects did not vary between participants with different impulsivity levels.  
 
In addition, there were no different effects of tDCS between rDLPFC and vmPFC targets, however 
previous studies showed that risky decision-making performance changed when comparing dorsal 
and ventral areas of PFC, indicating that right anodal/left cathodal stimulation of DLPFC increased 
preference of risk, whereas right anodal/left cathodal stimulation of OFC decreased preference of 
ambiguity (Yang, Gao, Shi, Ye, & Chen, 2017). More research investigating the effects of tDCS in 
different types of participants and exploring tDCS mechanisms in the brain, will help to establish the 
most effective protocols to target specific cognitive functions, in order to better understand the 





These experiments have several limitations. Both experiments were conducted using a single blind 
design (participants were not aware of the experimental condition - real stimulation or sham), however 
double or triple blind designs (neither the participant, the researcher conducting the testing session 
nor the researcher analysing the data are aware of the experimental condition), would be more robust 
to ensure that results are less likely to be biased. Results identified a gender interaction with groups 
in Experiment II, showing a higher number of females in the high impulsive group. Matching groups 
for gender in future studies is recommended given that GD has been associated with gender-related 
differences in motivations to gamble and also in the problematic consequences of gambling (Potenza 
et al., 2001). In addition, due to the changes of design during recruitment discussed in section 3.3.3 
of this chapter, participants allocation to groups in Experiment I was not randomised, which reduced 
the strength of the experimental procedure.  
 
Moreover, the design of the tDCS HD montages was done simply by positioning the anode on the 
electrode location that was identified with the brain area of interest: F4 for rDLPFC and Fpz for 
vmPFC (Zheng et al., 2016), with the four return electrodes creating a ring at a similar distance around 
the anode. However, using computational models could help improve tDCS focality, by identifying 
the most effective electrode positions and current intensity to be delivered through each electrode, to 
reach the targeted brain area more accurately (Ruffini et al., 2013). In addition, only behavioural 
outcomes were employed to measure the effects of tDCS. With this approach, it could only be 
speculated that the electrical current reached the desired brain areas, based on previous studies using 
similar protocols. However, combining tDCS with neuroimaging and physiological methodologies 
would provide more reliable information about the functional effects of neuromodulation that might 
not be identified using only behavioural measures (Gomis-Vicent et al., 2019). Lastly, the experiments 
followed a two session crossover design to investigate the short term effects of real stimulation 
compared with sham, however the effects of tDCS have been shown to accumulate across different 
sessions (Boggio et al., 2009). Therefore, conducting multiple session studies might help to identify 








4 Chapter 4. Experiment III: Clinical trial at the National Problem 
Gambling Clinic (NPGC) 
4.1 Summary  
A clinical trial was conducted to investigate the cumulative effects of tDCS in combination with 
cognitive behavioural therapy (CBT) across eight weekly sessions. The experiment was designed as 
a randomised control trial, however due to recruitment complications data was analysed as single-
participant studies. Two patients diagnosed with gambling disorder (GD) were recruited at the 
National Problem Gambling Clinic (NPGC). Each patient was allocated to one tDCS condition (real 
stimulation and sham) and treatment progression was assessed across sessions. There were limitations 
resulted from the change of analysis approach, and it was not possible to investigate the efficacy of 
tDCS alone, or to distinguish between the effects of the tDCS procedure (which involved cognitive 
task performance), and the effects of the CBT. Nevertheless, results showed that in both cases, 
gambling severity and cravings were reduced at the end of the intervention. In addition, there were 
significant correlations between gambling severity and electroencephalogram (EEG) power in both 
cases.  
 
Specifically, in the patient receiving tDCS real stimulation, there was a high variability in EEG results 
across sessions, which could be explained in part by the modifications in the experimental protocol 
caused by schedule changes in the CBT treatment. This, complicated establishing reliable conclusions 
about the intervention progression. Nevertheless, tDCS appeared to induce a short term increase of 
mean frequency power in the majority of sessions, however no clear direction of long term effects 
was found. In the patient allocated to sham tDCS, more consistent interpretations of the 
electrophysiological results were suggested. Findings indicated that short and long term increases of 
EEG power could be explained by concurrent stop signal task (SST) performance during the tDCS, 
while potential cumulative effects of CBT could account for the long term reduction of EEG power 
found at the end of the intervention. Moreover, in this case there were significant correlations between 
gambling severity, cognitive task performance and mean frequency power, suggesting that these 
electrophysiological measures could potentially be used in future research as biomarkers to assess 
changes in cognitive states, and as targets for neuromodulation studies in GD. Overall, contributions 
derived from this experiment to research in this field include the methodological implications raised 




clinical sites availability or the CBT format allocation to patients with specific characteristics, which 
may be useful to consider prior conducting future clinical studies.  
 
4.2 Introduction 
4.2.1 Clinical settings  
The clinical and neurobiological component of GD was not formally recognised until the changes 
made in the DSM-V, in 2013 (Clark, 2014). This was a fundamental step towards creating clinical 
treatment interventions for GD. Research investigating the prevalence of GD identified that gambling 
problems affect 0.7–6.5% of the population during lifetime worldwide (Calado & Griffiths, 2016). 
GD has been associated with increased mortality, suicidality and psychiatric comorbid disorders 
(Karlsson & Håkansson, 2018), and only 7-12% of people with GD seek treatment (Slutske, 2006), 
which is in part explained by the limited availability of services offering interventions for GD (Petry 
et al., 2017). Furthermore, treatment providers are usually not trained to recognise behavioural 
addictions (BA). Especially, when patients seek treatment for comorbid addiction and psychiatric 
disorders, BA are often underestimated, and when co-occurring addictions and mental health 
disorders are not identified and treated concurrently, the effectiveness of treatment interventions could 
be compromised (Freimuth et al., 2008).  
 
Interventions addressing maladaptive thought and behavioural patterns have shown benefits for both 
GD and substance use disorders (SUDs). However, long term effects of these interventions are not so 
clear (Petry et al., 2017). Current treatment available for GD consist mainly on therapy interventions, 
which have been shown to decrease GD symptoms, and seem especially useful for patients with 
comorbid disorders. In particular, cognitive behavioural therapy (CBT), is the most common 
psychological intervention for GD (Menchon et al., 2018). CBT focuses on altering cognitive 
components of gambling, such as cognitive distortions, and behavioural aspects like promoting 
alternative responses to problematic behaviour (Grant & Chamberlain, 2020). There is no 
pharmacological treatment that has been officially approved for GD, however previous studies have 
shown that GD without comorbidities seem to benefit from naltrexone (Hloch et al., 2017). Novel 
intervention approaches such as tDCS might offer improved opportunities for treating GD. However, 
further research is needed to identify neurocognitive targets more accurately and long term effects of 
neuromodulation, which might help developing individualised treatment interventions that account 





Only 11 studies have investigated the effects of non-invasive brain stimulation (NIBS) in GD 
(Zucchella et al., 2020), and two of those consisted of case report studies (Martinotti et al., 2018; 
Pettorruso et al., 2019). Four studies were conducted using tDCS, and all targeted the DLPFC. These 
studies involved tDCS stimulation during two sessions with a crossover design (Dickler et al., 2018), 
three sessions (Soyata et al., 2018) and five sessions (Martinotti, 2019), following a design with 
parallel assignment, and a case report, investigating tDCS stimulation twice a day for 10 days, 
followed by stimulation once a week for three months, and consecutively once every two weeks for 
another three months (Martinotti et al., 2018). All studies, reported reduction of gambling behaviours, 
and related symptoms, including cravings. In addition, the combination of NIBS with other 
therapeutic interventions has been shown to increase functional specificity of neuromodulation, and 
improve the outcome of the treatment (Edwards et al., 2009; Spagnolo et al., 2020; Tan et al., 2015).  
 
Individual variability factors that affect NIBS responsiveness might be identified through the analysis 
of physiological responses, such as electroencephalogram (EEG). Specific patterns of EEG have been 
shown to be associated with addiction and GD, including increases of low frequency bands and 
reduced high frequency bands (Lee et al., 2017a; Newson & Thiagarajan, 2019). Furthermore, low 
cortical arousal has been associated with increased power of slow waves (delta and theta bands), 
whereas increased power in fast waves (alpha and beta) was associated with higher excitability of the 
nervous system  (Kim et al., 2018). As a tool to modulate cortical excitability, tDCS over the DLPFC 
showed that real stimulation increased beta frequency power measured in the mid-frontal region 
(Song, Shin, & Yun, 2014), and reduced left frontal delta absolute power (Keeser et al., 2011). EEG 
might provide an improved understanding of neuromodulation effects on the nervous system, and 
help identify potential risk-factors to target with tDCS (Al-Kaysi et al., 2017). Therefore, 
psychophysiological research investigating the use of tDCS coupled with therapy interventions, might 
support the development of novel clinical strategies for treating GD.  
 
The main aim of this experiment was to investigate the cumulative effects of multiple sessions of 
tDCS coupled with CBT in patients with GD. Specifically, whether tDCS could help to improve the 
outcomes of the CBT intervention. It was hypothesised that GD symptomatology would improve 
across sessions in both real stimulation and sham conditions (due to the CBT effects), and that real 
stimulation condition would be associated with further improvements on treatment outcomes 





In terms of the cognitive task performance (which could also improve due to the CBT treatment), it 
was hypothesised that real stimulation would be associated with an increased improvement of 
cognitive performance compared with sham. This would include also the tasks that were performed 
before tDCS in each session, due to the potential cumulative effect of the intervention. In Cambridge 
gambling task (CGT), it would be expected to find higher quality of decision-making (QDM), lower 
risk-taking (RT) and lower delay aversion (DA)4, and larger differences between the groups in higher 
risk conditions of the task. In the information sampling task (IST), higher number of boxes opened, 
probability of correct response (P (correct)) at point of decision and total correct trials. In SST lower 
stop signal task reaction time (SSRT), higher total correct stop trials and total correct go trials. In 
addition, it was expected to find a short term effect of tDCS, indexed by a reduction of EEG slow 
waves (delta and theta) and an increase of EEG fast waves (alpha and beta), after each session, in 
larger extent during real stimulation compared with sham. Lastly, it was hypothesised to find 
correlations between electrophysiological and clinical outcomes.  
 
4.2.2 Clinical research designs 
Randomised controlled trials (RCTs) are robust research designs that allow to identify the effects 
associated with an intervention, with the intention to probe its efficacy. However, the resources 
required to implement RCTs involve substantial amounts of funding, time, and employees, as well as 
large sample sizes of participants that meet specific inclusion criteria, which beyond complicating 
recruitment procedures, also limit the generalisation of the results to patients with the particular 
characteristics that made them suitable to take part in the study. Although RCTs are strong designs to 
investigate novel treatment interventions, often are difficult to implement. Besides these 
complications, conducting only RCTs could have other disadvantages, like inclining the development 
of interventions towards some patients, while not addressing the needs of others. In addition, RCTs 
results are often presented as group means, and therefore might not represent any individual 
participant. As an alternative, other study designs, such as single participant studies, can offer 
scientific base to investigate the effects of treatment interventions in specific circumstances (Lobo, 
Moeyaert, Cunha, & Babik, 2017).  
                                                 
4 Although in Experiments I and II results showed an increase of RT and no changes of DA after tDCS targeting both 
rDLPFC and vmPFC, it was hypothesised that tDCS might reduce RT and DA due to the changes in the HD montage used 
in this experiment, the different sample characteristics, and based on previous literature discussed in the Introduction 





There are different types of single participant designs. The case report or case study/series involves 
the participation of a single subject, but there is not a purposeful manipulation of an independent 
variable (participants are observed across time without experimental manipulation of the 
intervention), there are not necessarily repeated measures, and is usually presented in a narrative way. 
In contrast, single-case studies are stronger designs that are presented numerically or graphically, the 
dependent variables (outcome measures) are recorded repeatedly for individual participants across 
time, and there are different levels (phases) of an intervention (independent variable) that is 
systematically manipulated to allow hypothesis testing. One phase is used as a baseline so each 
participant serves as their own control. Single-case studies allow establishing causal inferences for 
experimental assessment of intervention effects, and although this design has been often undervalued 
in comparison with RCTs, there are advantages and disadvantages to both types of design (Lobo et 
al., 2017). 
 
4.2.3 Clinical trial settings at the UK National Problem Gambling Clinic  
Until September 2019, the UK National Problem Gambling Clinic (NPGC) was the only NHS clinic 
in UK dedicated to treat GD. This highlights the limited availability of public services offered in 
relation to the increasing GD-related public health concerns during the past years. The clinical trial 
design planned to be conducted at the NPGC consisted of a RCT with two groups (real stimulation 
and sham), that attended eight sessions of tDCS combined with the treatment offered at the clinic. 
Recruitment at the NPGC was sustained for 11 months after the NHS Health Research Authority 
(HRA) ethical approval was obtained, which application process took one year to complete.  
 
Recruiting participants was a much more complicated process than originally anticipated. The clinical 
trial inclusion criteria was one of the most important factors that made recruitment challenging. Most 
patients that were referred to the clinic had a complicated profile, with severe GD and comorbid 
substance use disorders (SUDs) and mental health conditions that were reason for exclusion of the 
study. In addition, the design of the clinical trial planned for this project implied the combination of 
tDCS with a specific form of treatment delivered at the clinic, to investigate whether tDCS could help 
improve current treatment interventions. The form of treatment provided at the clinic to be combined 
with tDCS was conveyed in collaboration with the psychiatrist and psychologists working at the 




were: remote CBT (participants needed to attend the sessions in person to receive tDCS, therefore, 
patients allocated to remote treatment were not considered); group CBT (there was only one tDCS 
device dedicated to the clinical trial, consequently, it was not possible to test all participants allocated 
to each group having to combine both interventions, which consisted of delivering tDCS just before 
the CBT session. Also, offering the opportunity to participate in the trial to only one person of the 
group could have contributed negatively to the whole group dynamics, and could have influenced 
treatment outcomes. Therefore, group CBT patients were not considered for the trial); and 
pharmacological medication that was prescribed to severe cases of GD (receiving pharmacological 
medication was a reason for exclusion of the study, due to the lack of data that informed of possible 
interactions between tDCS and the chemical components of the medication). Therefore, individual 
CBT was the form of treatment that was more appropriate for the combination with tDCS in the 
clinical trial. In turn, this was also an added complication that limited the number of potential 
participants suitable for the study, especially because the patients that were allocated to individual 
CBT, often had co-occurring mental health disorders (which was part of the exclusion criteria).  
 
In addition, even when patients met the inclusion criteria, and agreed to take part in the study, the 
limited availability of the services was another hurdle, because patients usually had to wait for around 
three months to start treatment, and sometimes by the end of the waiting period they had changed 
their mind, could not get enough time off work to come for the extra time to take part in the research, 
or even decided to drop the CBT treatment at the clinic. In an effort to improve recruitment rates, the 
inclusion criteria was broadened to avoid excluding patients with common comorbid psychiatric 
disorders such as anxiety, obsessive compulsive disorder or depression (if patients were not currently 
taking medication). However, this did not result in any increase of participants recruited, because even 
though the number of potential participants was higher, these patients were usually taking medication 
or not agreeing to take part in the research. Therefore, as part of the PhD project, there was an essential 
limit of time and resources that could be dedicated to pursue completing an RCT, and with the 






4.3 Methods  
4.3.1 Participants 
Two patients that attended eight sessions at the NPGC were recruited. Recruitment was carried out 
through NPGC staff who assessed NHS patients that were referred to the clinic to receive treatment 
for GD. NPGC staff screened that potential participants met the study inclusion criteria, involving 
male or females between 18-65 years diagnosed with GD based on the Problem Gambling Severity 
Index (PGSI), who could speak and read English, capable of giving informed consent, and not having 
any of the exclusion criteria (for exclusion criteria details see section 3.3.1 in Chapter 3). In addition, 
patients had to be allocated to a specific type of treatment at the clinic, which consisted on attending 
individual CBT sessions. Participants were compensated for their time with shopping vouchers. One 
participant was allocated to the real stimulation condition (male, 44 years) and the other participant 
(male, 46 years) was allocated to sham condition.  
 
4.3.2 Materials  
This experiment was conducted with a tDCS Starstim 8 tDCS device (Neuroelectrics, Barcelona) and 
Ag/AgCl NG Geltrode electrodes with a contact area of 1 cm² that were filled with Signagel 
conductive saline gel. EEG resting state was recorded with 8 Ag/AgCl electrodes (Neuroelectrics, 
Starstim 8) and spectral analysis was conducted with the software LabChart 8 (ADInstruments) for 
each electrode individually. The CANTAB battery of tasks was used to measure gambling-related 
behavioural performance, including the Cambridge gambling task (CGT), information sampling task 
(IST) and stop signal task (SST). The CGT was used as an end of the intervention assessment 
measuring quality of decision-making (QDM), risk-taking (RT) and delay aversion (DA). IST was 
used as a priming task and to assess reflection-impulsivity, measuring the variables mean probability 
of making a correct decision (Mean P (correct)) and number of boxes opened per trial. The SST was 
used to measure inhibition control during tDCS, through the variables total correct on go and stop 
trials, and stop signal reaction time (SSRT). The Yale-Brown obsessive compulsive scale (PG-
YBOCS) was used to measure gambling severity, whereas the gambling symptom assessment scale 
(G-SAS) was used to measure gambling symptoms, and the visual analogue scale (VAS) to measure 
gambling cravings. PG-YBOCS and VAS allowed to assess changes of gambling severity and 
cravings across sessions. The tDCS events sham questionnaire was used to control for participants 
sensations associated to tDCS. For more detailed information about the CANTAB CGT, see section 





- Yale-Brown Obsessive Compulsive Scale adapted for Pathological Gambling (PG-YBOCS; 
(Pallanti, 2005)5: it is a 10-item questionnaire that measures gambling severity. The scores range from 
0 to 4 in each question, and the total score ranges from 0 to 40. The questions 1 to 5 assess urges and 
thoughts associated with gambling disorder, and the rest of the questions assess the behavioural 
component of the disorder. Gambling severity is higher with higher PG-YBOCS scores.  
 
- Gambling Symptom Assessment Scale (G-SAS; Kim, Grant, Adson, & Shin, 2001): it is a 12-item 
scale to measure gambling symptoms. Each of the 12 questions has a score ranging from 0 to 4 based 
on the last week. It is useful to measure changes during treatment. The total score ranges from 0 to 
48. The symptoms severity is higher with higher G-SAS scores. 
 
- Visual Analogue Scale (VAS; Sauvaget et al., 2018): a VAS consists of a horizontal line of length 
10 cm, where the left side corresponds to the lowest score and the right side to the highest score (total 
range from 0 to 10). The participant draws a mark on the line indicating a level that best represents 
their gambling craving/urge to gamble at the current time. Higher VAS scores indicate higher levels 
of craving/urge.  
 
- Events sham questionnaire (Brunoni et al., 2011; Reckow et al., 2018):  this questionnaire is widely 
used to control for participants awareness of the stimulation sensations to control the blinding 
procedure, and to inform about possible adverse events that could be associated with non-invasive 
brain stimulation methodologies. 
 
- Information sampling task (IST; Clark, Roiser, Robbins, & Sahakian, 2009): this task was 
administered on a touch-sensitive monitor. Participants were presented with a 5x5 array of grey boxes 
on the screen and two larger coloured panels below these boxes. Participants were instructed that they 
were playing a game for points, which they could win by making a correct decision about which 
colour was in the majority under of the 25 boxes. They had to select the grey boxes one at a time, 
                                                 
5 In Experiments I and II, gambling severity was measured with the South Oaks gambling screen (SOGS) because this 
was a commonly used questionnaire in previous gambling studies (Goudriaan et al., 2004; Zilberman, Yadid, Efrati, 
Neumark, & Rassovsky, 2018). However, in Experiment III, the PG-YBOCS was chosen to measure gambling severity 




these then opened up immediately to reveal one of the two colours shown at the bottom of the screen. 
Once a box had been selected, it remained open. When the participants made their decision about 
which colour was in the majority, they selected the panel of that colour at the bottom of the screen to 
indicate their choice. The task was presented in two different conditions, fixed and decreased. In the 
fixed condition, participants could win 100 points for a correct response, independently of how many 
boxes they opened. However, in the decreased condition, 250 were available at the start, and decreased 
10 points with each box opened. In this condition there is a conflict between the level of certainty and 
the reward available. In both conditions, incorrect responses result in a deduction of 100 points. The 
IST is represented in Figure 4-1. The variables measured with this task include total correct trials, 
mean number of boxes opened and the probability of making a correct response (P(correct)), which 
is related to the levels of uncertainty tolerated during decision-making.  
 
- The Stop Signal Task (SST; Logan, Cowan, & Davis, 1984; Ouellet et al., 2015): this task measures 
response inhibition or impulse control and was administered on a touch-sensitive monitor. Participants 
are presented by go and stop trials. On go trials, stimuli represented by arrows pointing to the right or 
to the left are displayed randomly, and participants are required to match the direction of the arrow 
by selecting one of two options on the bottom of the screen. On stop trials, the arrows are immediately 
followed by an auditory signal, which indicated that participants have to refrain from responding. The 
SST is represented in Figure 4-2. The difference between go reaction time and stop signal delay 
represents the time available to execute the act of control. Therefore, the response can be inhibited 
only if the act of control finishes before the go response. The stop signal reaction time (SSRT) 









Figure 4-1. Information sampling task (IST). Participants were presented with a 5x5 array of grey boxes on the screen 
and two larger coloured panels below these boxes. Participants could win points by making a correct decision about which 
colour was in the majority under the 25 boxes. They selected the grey boxes one at a time to reveal one of the two colours 
shown at the bottom of the screen. When participants made their decision about which colour was in the majority, they 
selected the panel of that colour at the bottom of the screen. The decreased condition is represented, in which 10 points 




















Figure 4-2. Stop signal task (SST). The SST paradigm requires the intentional inhibition of a voluntary speed response. 
Participants had to respond to a go stimulus represented by an arrow, by selecting one of two options, depending on the 
direction in which the arrow pointed to. If an audio tone was displayed, participants had to withhold making that response 







Each participant received 20 minutes of tDCS in each session during eight weeks (eight sessions). 
Each session had a duration of one hour, with the setting up and cleaning of the equipment taking 
around 40 minutes more. A total of 16 sessions were conducted. Before participation in the study, 
written informed consent was obtained, which was approved by the University of East London 
Research Ethics Committee (UREC_171823) and by the NHS Health Research Authority (HRA) 
Research Ethics Committee (NHS IRAS_241677, REC_18/LO/1454) included in Appendix D. All 
experimental procedures were conducted following the General Data Protection Regulation (GDPR). 
 
In session one and session eight, participants completed the G-SAS and the CGT, before the 
tDCS/EEG protocol. These two tests were only performed in the first and last sessions to avoid 
repetition, and to assess the final outcome of the treatment. In addition, to measure intervention effects 
across sessions, participants completed in every session the PG-YBOCS, the VAS, and the IST, before 
the tDCS/EEG protocol, and the SST during tDCS.  
 
Electroencephalogram (EEG) resting state was recorded with eyes open while participants remained 
still looking at a fixed mark on the screen for five minutes before and after tDCS, to inform about the 
neurophysiological effects of the intervention. The IST was used before tDCS as a priming task, with 
the aim to help activate the brain areas involved in gambling-related cognitive functions of interest to 
be targeted with tDCS. This should help to increase the effects of neuromodulation by facilitating 
reaching the membrane action potential during real stimulation (Colombo, Bartesaghi, Simonelli, & 
Antonietti, 2015; Fertonani, Brambilla, Cotelli, & Miniussi, 2014; Fujiyama et al., 2017). IST 
ascending and descending conditions were administered in a counterbalanced order across sessions, 
to introduce some variation, trying to lessen as much as possible the practice effects, given that the 
task was used in all sessions. At the end of the last session participants completed the tDCS events 
sham questionnaire to assess participants sensations related to the stimulation, and awareness of the 
stimulation condition they had been allocated to. 
 
4.3.4 Transcranial direct current stimulation high definition montage modelling  
A computational model created by Neuroelectrics (STIMWEAVER SPR0122), was used to identify 




were performed with total injected current of 4 mA and a maximum current per electrode of 1.8 mA6. 
The montage selected involved the use of six electrodes for tDCS stimulation (with eight electrodes 
being used for EEG recording of resting state before and after tDCS), using an excitatory electric field 
in the target area of 0.25 V/m.  
 
The standard safety constraints were applied with maximal injected current into the brain at any given 
time being below 2 mA. In the target map, the rDLPFC was identified as Broadmann area 46 on the 
right hemisphere, which was selected to receive the excitation, and no stimulation was directed to the 
rest of the cortex. The optimised montage included electrodes with currents: Cz (-200 uA), AF8 (909 
uA), AF4 (1268 uA), Fpz (-1692 uA), F4 (2018 uA) and FC6 (-1303 uA). The tDCS montage is 




                                                 
6 In Experiments I and II the current employed was 1.5 mA given that this was a commonly used parameter in previous 
tDCS studies (Lefaucheur et al., 2016). However, in this experiment a computational model was used, resulting in the 









Figure 4-3. Optimized transcranial direct current stimulation montage. I Max = 1:7mA, 6 electrodes montage. From left 
to right: normal component of the E-field En (V=m), target E-field. (V=m), target weight and ERNI (mV 2=m2) for grey 






4.3.5 Electroencephalogram (EEG) data processing 
EEG resting state eyes open was recorded for five minutes pre-tDCS stimulation and five minutes 
post-tDCS stimulation, with 8 Ag/Ag electrodes with frontal locations (Cz, Fpz, F4, AF8, AF4, FC6, 
F3, AF7). EEG was sampled at 500 Hz and channels were referenced to the right mastoid. Resting 
state EEG was used for spectral analysis for each electrode individually. Recordings were segmented 
into two second epochs that were fast Fourier transformed (FFT) with a Hamming window with 25% 
overlap, and filtered with a 50 Hz filter applied online, and offline digital filters (0,1 Hz high pass 
filter, followed by a 40 Hz low pass filter). EEG data was visually inspected and automatic artefact 
detection (threshold of 100 μV) was used to identify and reject epochs containing muscle and eye 
blink artefacts. Each session had a minimum of 70 artefact free epochs, with a total minimum duration 
of one minute. Mean frequency band was calculated, as well as the absolute and relative power was 
measured in four frequency bands delta (1-4 Hz), theta (4-8 Hz), alpha (8-12 Hz) and beta (12-30 Hz) 
and theta/beta ratio for each electrode in each EEG recording (pre/post tDCS), with the aim to compare 
tDCS effects in each session. 
 
4.3.6 Analysis plan 
The clinical trial design originally planned at the NPGC consisted of two randomised controlled 
groups with parallel assignment with a duration of eight sessions. Given the unsuccessful recruitment 
situation described in section 4.3.1 of this chapter, data that was collected during the clinical trial was 
analysed according to single participant designs to investigate treatment progression. The data was 
analysed following case reports designs, as in previous studies where repeated sessions of tDCS and 
rTMS, respectively, were applied to a single participant with GD (Martinotti et al., 2018; Pettorruso 
et al., 2019), and obsessive compulsive disorder (Palm et al., 2017), with variables being analysed as 
simple percentage change in scores across sessions. Although data could be analysed according case 
report designs, access to patient personal clinical data was not approved for this trial, and therefore it 
was not possible to include an assessment of clinical outcomes, as usual in case reports. Data was 
analysed by measuring the percentage change in questionnaire and task scores between session one 
(S1) and the other sessions (S2-8) with the formula: [(S2-8-S1)/ S1] x 100.  
 
To strengthen data analysis, a part from presenting results as two separate case reports, an adjusted 
analysis for single-case studies (Meiron et al., 2018) was also conducted. The current study design 




consists of data collected from several observations during a baseline phase (denoted “A”), prior to 
implementing a treatment phase (denoted “B”), with the aim to provide a standard (the baseline), to 
which to compare the effects of the treatment, with recommended minimum of five data points in 
each phase (Ellis, 1999; Lobo et al., 2017). As mentioned, due to this study not being originally 
planned as a single-case design, the analysis plan had to be adjusted to fit the existing data, which 
implied that measures had to be directly compared within baselines and within intervention periods 
(except for the EEG data that could be compared as usual), and that two outcome variables (CGT, G-
SAS) had fewer observation points than the recommended in single-case studies.  
 
The measures that were taken before the intervention took place (A) were G-SAS, CGT, PG-YBOCS, 
VAS, IST and EEG1 (pre-tDCS), in session one. During the intervention phase (B) the SST was 
measured, and EEG2 (post-tDCS) was recorded. All these variables were measured again in session 
eight, after the participant received weekly sessions of tDCS (real stimulation or sham) and CBT 
sessions. Considering that the effects of tDCS have been shown to accumulate across sessions (Boggio 
et al., 2009; Jansen et al., 2013; Mondino et al., 2018), those variables were compared between 
sessions to investigate the changes during the intervention, given that the variables (PG-YBOCS, 
VAS, IST and EEG1) were measured prior the tDCS in all sessions, as well as (SST and EEG2) during 
and after tDCS, therefore having eight observation points in each phase. In addition, the change of 
EEG frequency power before and after tDCS was assessed in each session (in this case EEG1 was A, 
and EEG2 was B), having eight observation points in each phase, and being able to compare A vs B. 
To evaluate the final intervention outcome, sessions one and eight were directly compared between 
(A in session one (A S1) vs A S8) and (B S1 vs B S8). A graphical representation of the variables 
comparisons is presented in Figure 4-4. Lastly, correlations between variables were investigated with 
the aim to find potential behavioural and physiological markers that indicated intervention response.  
 
For statistical analysis, IBM SPSS (Statistical Package of the Social Sciences, Version 23, SPSS Inc., 
Chicago, IL) was used. Significance threshold was set at α = 0.05. Data was checked for skewness, 
kurtosis and normality. Non-normally distributed data according to one sample Kolmogorov-Smirnov 
test was transformed using logarithmic transformation (SST – total correct go trials, total correct stop 
trials and total correct go  and stop trials), and arc sin transformation in the case of QDM. G-SAS was 
analysed using Wilcoxon Signed Ranks Test, and VAS was analysed with one sample Kolmogorov-
Smirnov when data was not normally distributed. When sphericity was not satisfied we employed 





The single case design statistical analysis was conducted using one way repeated measures ANOVA, 
with within factors session, with eight levels (except VAS that was analysed with one sample t-test). 
Paired t-tests were used (Meiron et al., 2018; Rojo et al., 2011) to compare scores between session 
one and session eight to assess the final outcome of the treatment. Questionnaire subscales and task 
conditions had to be collapsed in order to have enough data points to perform the statistical analysis. 
CGT variables (QDM, RT and DA) were analysed collapsing risk conditions and 
ascending/descending conditions. G-SAS total score was used adding all questionnaire items. VAS 
had only one data point per session, therefore sessions were collapsed together. PG-YBOCS total 
score was used adding the subscales urges and behaviours. IST variables (probability of correct 
response (P (Correct)), number of boxes opened and discrimination errors) scores were collapsed 
across fixed and decreased conditions. SST variables (stop signal reaction time (SSRT), total correct 
in go and stop trials, total correct in go trials and total correct in stop trials) scores were collapsed 
across the blocks of the task.  
 
To investigate the EEG mean frequency power, the theta/beta ratio as well as the absolute and relative 
power were analysed for each frequency band separately and for each electrode separately (Keeser et 
al., 2011). Relative power was calculated as the percentage of the sum of the four frequency bands in 
absolute power (Rajamanickam Yuvaraj et al., 2014). Absolute and relative power results are included 
in Appendix B. To investigate the differences in EEG mean frequency power and theta/beta ratio 
before and after tDCS across sessions, a 2 x 8 x 8 repeated measures ANOVA with within factors 
tDCS time (pre-tDCS or post-tDCS), session (1, 2, 3, 4, 5, 6, 7 and 8) and electrode position (Cz, 
AF8, AF4, Fz, F4, FC6, F3 and AF7) was conducted. To assess the final outcome of the intervention, 
EEG frequency power results were compared between session one and session eight with paired t-
tests (2-tailed) for each electrode position and each frequency band separately. To compare the effects 
of tDCS on EEG frequency power before and after the stimulation within each session, paired t-test 
(2-tailed) were conducted, considering within session comparisons only in sessions one and eight. A 






Figure 4-4. Experimental protocol at the National Problem Gambling Clinic. Questionnaires and tasks administration 
across sessions. In sessions one and eight participants completed the Cambridge gambling task (CGT) and the gambling 
symptoms assessment scale (G-SAS). In all sessions (one to eight) participants completed the Yale Brown obsessive 
compulsive scale for pathological gambling (PG-YBOCS), the visual analogue scale (VAS), the information sampling 
task (IST) and the stop signal task (SST). Electroencephalogram (EEG) resting state was recorded before (EEG1) and 
after (EEG2) tDCS. Variables A represent the measurements taken before the intervention using tDCS, and variables B 
represent the measurements taken during and after the intervention using tDCS. Analysis plan for single case studies 
involved comparing variable outcomes across sessions (blue colour) as well as comparing variables between the first and 

















4.4.1 Participant allocated to tDCS sham condition 
4.4.1.1 Self-report measures and cognitive task performance 
The percentage change of questionnaires and tasks scores across all sessions is presented in Table 4-1. 
Results on percentage change in scores at the end of the treatment (session eight) compared with 
session one, indicated that there was a reduction of 44% in gambling severity measured with PG-
YBOCS, a reduction of 86% in cravings measured with VAS, and a reduction of 38% of gambling 
symptoms measured with G-SAS. In addition, CGT variables showed a reduction of 64% of DA, an 
increase of 3% of QDM, and an increase of 11% of RT. Moreover, IST scores showed a reduction of 
mean number of boxes opened of 10%, a reduction of mean P (Correct) of 18% and no change of 
scores in total correct responses. In SST there was an increase of 10% of the total correct stop and go 
trials, an increase of 100% of the total correct stop trials, no change of total correct go trials and a 
decrease of 16% in SSRT.  
 
One sample t-test results revealed significant differences between VAS scores across sessions (t (7) 
= 2.949, p =.021). One way repeated measures ANOVA results revealed significant differences across 
sessions in PG-YBOCS total scores (F (7, 42) = 11.364, p= .001, ηp2 = .654) and in SSRT (F (7, 7) 
= 11.650, p= .002, ηp2 = .921). There were no significant differences in the other variables from IST 
and SST. IST condition order (fixed, decreased) was not significant for any of the variables. GCT 
variables and GSAS data were collected only in the first and last session, therefore, they were analysed 
with t-tests. Paired samples t-test (2-tailed) analysis to assess the final outcomes of the eight week  
intervention by comparing test scores between session one and session eight are presented in Table 
4-1, and showed a significant reduction of total PG-YBOCS (t (9) = 3.498, p =.007), from the first 
session. In addition, G-SAS was assessed with Wilcoxon signed-ranks test and showed a significant 
reduction of gambling symptoms (Z = -2.547, p = .011).  
 
CGT variables showed a significant reduction of DA (t (3) = 10.312, p =.002), but not significant 
changes in QDM or RT. Reflection impulsivity measured with IST showed no significant changes in 
the number of boxes opened or the mean probability of making a correct decision. SST scores across 




and a significant decrease in SSRT (t (1) =22.196, p =.029) from the first to the last session. The IST 
variable total correct, and SST variables total correct stop trials and total correct go trials, could not 
be assessed with t-tests, because the standard error of the difference was 0, and therefore, the statistic 
t could not be computed. PG-YBOCS, VAS, SSRT and SST total correct stop and go scores across 
sessions are represented in Figure 4-5. In addition, the participant completed the tDCS events sham 
questionnaire at the end of the last session, revealing that the patient thought was allocated to real 
























Table 4-1. Questionnaires and tasks scores across sessions in participant allocated to sham condition. Percentage change from session 
























Note: PG-YBOCS, Yale Brown obsessive compulsive scale for pathological gambling; VAS, visual analogue scale; G-SAS, gambling symptoms 
assessment scale; CGT, Cambridge gambling task; DA, delay aversion; QDM, quality of decision-making; RT, risk-taking; IST, information sampling 
task; SST, stop signal task; SSRT, stop signal reaction time. Data represents test scores and inside the parenthesis percentage change from session 1 [(S1-




Sessions Test Statistic 
(S1 vs S8) 












































- - - - - - 
24  
(-38%) 





- - - - - - 
0.16  
(-64%) 





- - - - - - 
1  
(+3 %) 





- - - - - - 
0.76 
(+11%) 






























































Not Computed  
** 
SST Total 




































































Figure 4-5. Questionnaires and stop signal task (SST) performance across sessions in the participant allocated to sham 
condition. Scores across sessions for gambling severity measured with the Yale Brown obsessive compulsive scale for 
pathological gambling (PG-YBOCS), gambling cravings measured with the visual analogue scale (VAS), stop signal task 
reaction time (SSRT) and total correct stop and go trials. Data represent mean and SEM, except in VAS in which each bar 













4.4.1.2 Theta/beta ratio:  
There were no significant results in theta/beta ratio across sessions (F (1.039, 73.752) = 1.909, p= 
.171, ηp2 = .026), electrodes (F (1, 71) = 1.456, p= .231, ηp2 = .020) or tDCS time (F (1.084, 76.973) 
= 1.786, p= .185, ηp2 = .025).  
 
4.4.1.3 Mean frequency power:  
One way repeated measures ANOVA analysis of mean frequency power revealed a significant main 
effect of session (F (5.300, 370.972) = 17.179, p= .001, ηp2 = .197), showing that session four had the 
highest mean frequency power in the range of beta frequency, followed by the rest of the sessions in 
the range of alpha frequency. There was also a main effect of tDCS time (F (1, 70) = 12.531, p= .001, 
ηp2 = .152), showing that mean frequency power was lower in EEG1 (pre-tDCS) compared with 
EEG2 (post-tDCS), and a main effect of electrode (F (3.697, 258.789) = 275.477, p= .001, ηp2 = .797) 
indicating that electrodes from the highest to the lowest mean frequency power were AF7, F3, AF8, 
F4, FC6, Cz, AF4 and Fpz. In addition, there was an interaction session x electrode (F (16.434, 
1150.389) = 49.576, p= .001, ηp2 = .415), showing that session four had the highest mean frequency 
power in electrodes F4, AF7 and AF8.  
 
There was also an interaction tDCS time x electrode (F (3.243, 227.021) = 16.594, p= .001, ηp2 = 
.192), showing that in all electrodes except for Cz, higher mean frequency power was associated with 
EEG2 compared with EEG1. A three way interaction session x tDCS time x electrode (F (17.457, 
1222.023) = 30.267, p= .001, ηp2 = .302), showed that in EEG1 the electrode with highest mean 
frequency power was AF7, however in EEG2 the electrode with highest mean frequency power was 
F4. Also, the session with highest frequency power by electrode in EEG1 was session seven in AF7, 
session five in AF8, F3, Cz, AF4 and Fpz, and session four in F4 and FC6. In EEG2, session four 
showed the highest mean frequency power in all electrodes except for F3, in which session five 
showed the highest mean frequency power. Mean frequency power values across sessions and 
electrode positions are represented in Figure 4-6.  
 
To assess the final outcome of the intervention, EEG mean frequency power results were compared 
between session one and session eight with paired t-tests for each electrode position and each 




significantly higher than EEG1 mean frequency power in session eight, for electrodes AF8 (t (117) 
=6.641, p =.001), Fpz (t (117) =4.007, p =.001) and FC6 (t (117) =3.533, p =.001). EEG2 mean 
frequency power in session one was significantly lower than EEG2 mean frequency power in session 
eight for all electrodes: Cz (t (116) = -4.550, p =.001), AF8 (t (116) = -2.422, p =.017), AF4 (t (116) 
= -3.211, p =.002), Fpz (t (116) = -3.428, p =.001),  F4 (t (116) = -5.450, p =.001),  FC6 (t (116) = -
6.763, p =.001), F3 (t (116) = -4.251, p =.001) and AF7 (t (116) = -2.565, p =.012).  
 
To compare the effects of tDCS on EEG mean frequency power before and after the stimulation within 
each session, considering sessions one and eight, paired t-test revealed that mean frequency power 
was lower in EEG1 than in EEG2 in session one for electrodes AF8 (t (120) = 2.358, p =.020), Fpz (t 
(120) = 3.440, p =.001) and F3 (t (120) = 2.229, p =.028), and in session eight for all electrodes except 
F3: Cz (t (116) = -3.080, p =.003), AF8 (t (116) = -5.848, p =.001), AF4 (t (116) = -3.865, p =.001), 
Fpz (t (116) = -3.435, p =.001), F4 (t (116) = -4.291, p =.001), FC6 (t (116) = -8.943, p =.001) and 


























Figure 4-6. Electroencephalogram (EEG) mean frequency power in sham condition. Mean frequency power (Hz) of EEG 
resting state recordings before tDCS (EEG1) and after tDCS (EEG2) across eight sessions, and across electrode positions 
with the international EEG 10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7). Data represents mean and SEM (* 
p < .05; ** p ≤ .01). Note: significant differences between EEG1 in session one and EEG1 in session eight were found 
only in electrodes AF8, Fpz and FC6. Significant differences between EEG2 in session one and EEG2 in session eight 
were found in all electrodes. Furthermore, significant differences between EEG1 and EEG2 in session one were found 
only in electrodes AF8, Fpz and F3, however in session eight EEG1 and EEG2 were significantly different in all electrodes 








4.4.1.4 Correlations  
To investigate the relationship between gambling severity and the rest of the variables, 2-tailed 
Pearson’s correlation indicated that gambling severity measured with PG-YBOCS correlated 
positively with VAS for gambling cravings (r =.835, n = 8, p =.010) and with EEG2 theta/beta ratio 
in F3 (r = .948, n = 8, p =.001). In addition, PG-YBOCS correlated negatively with SST total correct 
stop and go trials (r = -.737, n = 8, p =.037), total correct stop trials (r = -.715, n = 8, p =.046), total 
correct go trials (r = -.771, n = 8, p =.025). Correlations with CGT could not be computed due to the 
lack of enough data points. Other significant correlations with EEG variables were included in 
Appendix A.  
 
Having found all significant correlations between gambling severity and EEG variables, specifically 
in the electrode position F3, during the post-tDCS recordings (EEG2), these variables were further 
explored with the aim to find physiological markers that could inform about individuals gambling 
severity, gambling-related behaviours and symptomatology. Results showed that VAS gambling 
cravings correlated positively with theta/beta ratio in F3 (r = .739, n = 8, p =.036). In addition, IST 






4.4.2 Participant allocated to tDCS real stimulation condition 
4.4.2.1 Self-report measures and cognitive task performance  
The percentage change of questionnaires and tasks scores across all sessions is presented in Table 4-2. 
Results on percentage change in scores at the end of the treatment (session eight) compared with 
session one, indicated that there was a reduction of 66% in gambling severity measured with PG-
YBOCS, a reduction of 71% in cravings measured with VAS, and a reduction of 6% of gambling 
symptoms measured with G-SAS. In addition, CGT variables showed an increase of 21% of DA, no 
changes in QDM, and an increase of 6% of RT. Moreover, IST scores showed an increase of mean 
number of boxes opened of 46%, an increase of mean P (Correct) of 8% and an increase in total 
correct responses of 6%. In SST, there was an increase of 11% of the total correct stop and go trials, 
an increase of 200% of the total correct stop trials, no change of total correct go trials, and an increase 
of 2% in SSRT. One sample Kolmogorov-Smirnov test results revealed significant differences 
between VAS scores across sessions (D (8) = .436, p =.001). One way repeated measures ANOVA 
results revealed significant differences across sessions in PG-YBOCS total scores (F (7, 63) = 37.807, 
p= .001, ηp2 = .808). There were differences across sessions in IST number of boxes opened per trial 
(F (7, 7) = 10.817, p= .012, ηp2 = .866), mean P (correct; F (7, 7) = 7.643, p= .008, ηp2 = .884), but 
no significant differences were found in total correct. IST condition order (fixed, decreased; all effects 
p > .05). In SST, there were significant differences across sessions in SSRT (F (7, 7) = 27.391, p= 
.004, ηp2 = .965). There were no significant differences in the total correct go and total correct stop 
in SST (all effects p > .05). GCT variables and GSAS data were collected only in the first and last 
session, therefore, they were analysed with t-tests. 
 
Paired samples t-test (2-tailed) analysis to assess the final outcomes of the eight week intervention by 
comparing test scores between session one and session eight are presented in Table 4-2, showing a 
significant reduction of PG-YBOCS (t (9) = 3.674, p =.005) from the first session. No other variables 
showed significant differences in scores between session one and session eight. All questionnaires 
and tasks scores across sessions, as well as final outcome statistics are represented in Figure 4-7. In 
addition, the participant completed the tDCS events sham questionnaire at the end of the last session, 
revealing that the participant thought was allocated to real stimulation, marking the certainty in three, 





Table 4-2.Questionnaires and tasks scores across sessions in participant allocated to real stimulation condition. Percentage change 

























Note: PG-YBOCS, Yale Brown obsessive compulsive scale for pathological gambling; VAS, visual analogue scale; G-SAS, gambling symptoms 
assessment scale; CGT, Cambridge gambling task; DA, delay aversion; QDM, quality of decision-making; RT, risk-taking; IST, information sampling 
task; SST, stop signal task; SSRT, stop signal reaction time. Data represents test scores and inside the parenthesis percentage change from session 1 [(S1-

















































- - - - - - 
19 
(-6%) 
Z = -1.980, p = 
.059  
CGT DA 0.19  - - - - - - 
0.23 
(+21 %) 
t (3) = -.595, p 
=.594 
CGT QDM 1.00 - - - - - - 
1.00 
(0%) 
Not Computed  
** 
CGT RT 0.53  - - - - - - 
0.56 
(+6%) 






























































t (1) = -.200, p 
=.874 
SST Total 




































































Figure 4-7. Questionnaires and stop signal task (SST) performance across sessions in participant allocated to real 
stimulation condition. Scores across sessions for gambling severity measured with the Yale Brown obsessive compulsive 
scale for pathological gambling (PG-YBOCS), gambling cravings measured with the visual analogue scale (VAS), 
information sampling task (IST) variables of mean number of boxes opened and mean probability correct (mean P 
(correct)) at point of the decision and stop signal task (SST) reaction time (SSRT). Data represent mean and SEM, except 








4.4.2.2 Theta/beta ratio:  
There were no significant results in theta/beta ratio across sessions (F (1.007, 98.678) = 1.862, p= 
.175, ηp2 = .019), electrodes (F (1.043, 102.257) = 2.240, p= .137, ηp2 = .022) or tDCS time (F (1, 
98) = 2.630, p= .108, ηp2 = .026). 
 
4.4.2.3 Mean frequency power:  
One way repeated measures ANOVA analysis of mean frequency power revealed a significant main 
effect of session (F (5.994, 587.403) = 99.409, p= .001, ηp2 = .504), showing that session four 
followed by session seven had the highest mean frequency power in the range of beta frequency, and 
the lowest mean frequency power was found in session eight, in the range of delta frequency. There 
was also a main effect of tDCS time (F (1, 98) = 202.135, p= .001, ηp2 = .673), showing that mean 
frequency power was lower in EEG1 (pre-tDCS) compared with EEG2 (post-tDCS), and a main effect 
of electrode (F (3.697, 258.789) = 345.346, p= .001, ηp2 = .779) indicating that the electrode with 
slightly higher mean frequency power was FC6 reaching alpha frequency, but the rest had all similar 
mean frequency power in the range of theta.  
 
In addition, there was an interaction sessions x tDCS time (F (6.009, 588.911) = 20.890, p= .001, ηp2 
= .176), showing that sessions five and eight had similar mean frequency power in both EEG1 and 
EEG2, but in the rest of the sessions EEG1 was lower than EEG2. An interaction session x electrode 
(F (16.982, 1664.283) = 25.608, p= .001, ηp2 = .207), showed that session four had the highest mean 
frequency power in all electrodes, being the highest FC6, followed by session seven, three, one, five, 
six and eight. There was also an interaction tDCS time x electrode (F (16.881, 1654.322) = 14.830, 
p= .001, ηp2 = .949), showing that in all electrodes higher mean frequency power was associated with 
EEG2 compared with EEG1. A three way interaction session x tDCS time x electrode (F (16.881, 
1654.322) = 14.830, p= .001, ηp2 = .131), showed that in all electrodes there was lower mean 
frequency power in EEG1 compared with EEG2, but the greatest difference between EEG1 and EEG2 
was found in electrode FC6, showing similar differences in each session between EEG1 and EEG2 in 
mean frequency power, with the smallest difference being in session eight. Mean frequency power 





To assess the final outcome of the intervention, EEG mean frequency power results were compared 
between session one and session eight with paired t-tests for each electrode position and each 
frequency band separately. Results showed that EEG1 mean power frequency in session one was 
significantly higher than EEG1 mean power frequency in session eight, in all electrodes except in Fpz 
and AF7: Cz (t (100) = 3.263, p =.002), AF8 (t (100) = 2.564, p =.002), AF4 (t (117) =4.104, p =.012), 
F4 (t (100) = 3.108, p =.002),  FC6 (t (100) = 3.621, p =.001) and F3 (t (100) = 4.117, p =.001). EEG2 
mean frequency power in session one was significantly higher than EEG2 mean frequency power in 
session eight, in all electrodes: Cz (t (110) = 10.157, p =.001), AF8 (t (110) = 7.526, p =.001), AF4 (t 
(110) = 7.493, p =.001), Fpz  (t (110) = 5.671, p =.001),  F4 (t (110) = 9.019, p =.001),  FC6 (t (110) 
= 11.475, p =.001), F3 (t (110) = 6.416, p =.001) and AF7 (t (110) = 2.329, p =.022).  
 
To compare the effects of tDCS on EEG mean frequency power before and after the stimulation within 
each session, considering sessions one and eight, paired t-test revealed that mean frequency power 
was lower in EEG1 than in EEG2 in session one in all electrodes: Cz (t (118) = -9.231, p =.001), AF8 
(t (118) = -5.936, p =.001), AF4 (t (118) = -4.538, p =.001), Fpz (t (118) = -3.689, p =.001), F4 (t 
(118) = -6.965, p =.001), FC6 (t (118) = -8.205, p =.001), F3 (t (118) = -2.768, p =.007), and AF7 (t 
(118) = -3.120, p =.002), however in session eight there were no significant differences between EEG1 
and EEG2 mean frequency power.   
 
4.4.2.4 Correlations 
To investigate the relationship between gambling severity and the rest of the variables, 2-tailed 
Pearson’s correlation indicated no significant correlations with the main variables studied. However, 
there were positive correlations between gambling severity measured with PG-YBOCS and EEG1 

















Figure 4-8. Electroencephalogram (EEG) mean frequency power in real stimulation condition. Mean frequency power 
(Hz) of EEG resting state recordings before tDCS (EEG1) and after tDCS (EEG2) across eight sessions, and across 
electrode positions with the international EEG 10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7). Data represents 
mean and SEM (* p < .05). Note: significant differences between EEG1 in session one and EEG1 in session eight were 
found in all electrodes except in Fpz and AF7. Significant differences between EEG2 in session one and EEG2 in session 
eight were found in all electrodes. Furthermore, significant differences between EEG1 and EEG2 in session one were 
found in all electrodes, however in session eight there were no significant differences between EEG1 and EEG2 mean 








This experiment was originally designed as an RCT to study the effects of tDCS across sessions in 
combination with the CBT treatment offered at the NPGC, with the aim to investigate the potential 
use of this particular intervention to improve current treatment approaches for GD. The trial planned 
followed a longitudinal controlled design with two groups, real stimulation and sham, with parallel 
assignment. The data was collected according to the RCT design, however, the analysis plan had to 
be adapted to fit a single-participant design, due to the recruitment complications described in section 
4.3.1 of this chapter. The data collected consisted of gambling symptomatology self-report measures, 
cognitive behavioural tasks and EEG resting state, from two participants who attended eight sessions 
of tDCS combined with CBT.  
 
The participants were assigned to two different tDCS groups (one participant received real 
stimulation, and the other participant received sham). Data was analysed according to two different 
methodologies usually employed to analyse single-participant designs: percentage change of scores 
across sessions was calculated as in case report studies, and statistical analysis was performed, based 
on single-case study analysis methods. However, given that data was collected following the RCT 
design, both, the case report and the single-case study analysis approaches employed had to be adapted 
to fit the existing data, as described in section 4.3.6 of this chapter. Results revealed significant effects 
of the intervention combining the tDCS procedure with CBT on gambling severity, cravings, 
cognitive task performance, and EEG power frequency, in both participants.  
 
4.5.1 Participant allocated to sham condition 
In the participant allocated to sham condition, results showed significant differences across sessions 
in gambling severity measured with PG-YBOCS, gambling cravings measured with VAS, and 
inhibitory control measured with SSRT (which indicates de ability to stop a prominent response). To 
assess the final outcome of the intervention, session eight was compared against session one, revealing 
that there were statistically significant changes, which were also quantified using percentage change 
of scores: a decrease in PG-YBOCS, G-SAS, DA and SSRT, and an increase in SST total correct 
trials. VAS statistics could only be calculated across sessions due to a lack of enough data points, 
which showed significant differences across sessions, and in addition, percentage change between the 
last and the first session revealed a reduction in gambling cravings. Across sessions, it was identified 




session five in the cognitive behavioural tasks variables show the lowest scores in: IST mean number 
of boxes opened and total correct, and SST total correct stop and go, total correct stop and SSRT7. 
The final outcome of the intervention showed that the sham tDCS procedure combined with CBT was 
associated with a significant improvement of GD severity and symptomatology, including cravings, 
as well as behavioural impulsivity, and the ability to inhibit prominent responses. Another GD case 
study using a longitudinal intervention with real stimulation tDCS over bilateral DLPFC reported 
similar improvements, showing a reduction of 62.5% of PG-YBOCS, a reduction of 100% of VAS 
for gambling cravings, a reduction of 69.2% in G-SAS and a reduction of 23.6% of self-reported 
impulsivity (Martinotti et al., 2018).  
 
The effectiveness of tDCS to improve addiction symptomatology is still unclear (Trojak et al., 2017). 
Literature reviews identified a medium size effect in favour of active tDCS compared with sham to 
reduce cravings (Jansen et al., 2013), however, beyond cravings modulation, research also found no 
differences between active and sham groups in cigarette consumption, suggesting that real tDCS 
might not be more effective than sham to reduce addictive behaviours (Mondino et al., 2018). The 
effectiveness of tDCS to treat addictive behaviours needs to be further investigated (Coles et al., 
2018).  
 
Overall, mean frequency power was highest around left DLPFC (lDLPFC), and lowest around 
vmPFC8. In particular, in EEG1 (which was recorded just after the participant completed the IST, and 
before receiving tDCS sham), mean frequency power was highest around left DLPFC, whereas in 
EEG2 (recorded after the participant received tDCS sham coupled with SST performance), the highest 
mean frequency power was found in right DLPFC (rDLPFC), which is the target of the stimulation 
protocol. This switch of activity from left to right PFC, could be interpreted as an effect of SST 
performance, assuming that sham tDCS had no effects on cortical excitability. Given that the SST 
requires participant to inhibit a prominent response, these results would be consistent with research 
showing that suppression of the rDLPFC (but not the lDPFC) by repetitive transcranial direct current 
stimulation (rTMS) reduced inhibitory control, demonstrating the specific role of rDLFC in inhibition 
                                                 
7 Statistical analysis comparing each of the eight sessions against the rest was not performed (paired comparisons were 
conducted only between the first and the last session), and therefore, the results discussed about any other specific session, 
refer simply to the variables values observed. The statistical analysis was more focused on assessing the final outcome of 
the intervention, and to compare each session against the others (involving between and within sessions analysis), would 
extend the work load and amount of data reported excessively, considering the limitations associated to the adapted 
analysis methodologies used, the time available for the project and the limited space to report the results. Nevertheless, 
this will be considered to further explore the data in the future. 




(Knoch et al., 2006). In addition, these results are consistent with research that associated higher 
activity in rDLPFC due to executive functions related task performance, compared with lDPFC 
(Cerqueira, Almeida, & Sousa, 2008).  
 
However, the absence of physiological effects on the brain associated with sham tDCS is still under 
debate (Neri et al., 2020). Therefore, an alternative explanation of these results would be that the 
electrical current delivered during the ramp up and ramp down of the sham condition, contributed to 
increase the cortical activity around the stimulation target in rDLPFC. Furthermore, this possibility, 
could have an added psychological influence, due to the fact that the participant was confident that 
received real stimulation condition. These interpretations would be supported by previous research 
that showed influences on cortical excitability produced by participants motivations and expectations 
(Brangioni et al., 2018; Rabipour, Wu, Davidson, & Iacoboni, 2018).  
 
Results showed significant differences in mean frequency power, across sessions, between the first 
and the last session, and within session one and session eight. Mean frequency power was the highest 
in EEG2 during session four, whereas in EEG1, sessions four and five showed the highest mean 
frequency power. Interestingly, the participant showed the lowest gambling severity, cravings and 
SSRT in session five. These results would be consistent by research showing a negative association 
between high impulsive patients with GD and EEG power (Lee et al., 2017a).  
 
In particular, examining separately EEG recordings before and after the tDCS (EEG1 and EEG2, 
respectively), and considering sessions one and eight in each frequency band, results revealed 
significant short term effects of the intervention, showing that in both sessions, one and eight, there 
was an increase of mean frequency power after tDCS coupled with SST. In addition, results revealed 
significant long term effects of the intervention, showing that in session eight, mean frequency power 
decreased in EEG1, but increased in EEG2, compared with session one. Assuming that tDCS sham 
had no effects, the short term increase of mean frequency power could be explained by task 
performance effects on cortical excitability (Gill, Shah-basak, & Hamilton, 2015; Newson & 
Thiagarajan, 2019).  Moreover, the reduction of EEG1 mean frequency power in session eight could 
be a result of the CBT treatment effects across sessions, whereas the increase of EEG2 in session 
eight, could be interpreted as a cognitive enhancement due to recurrent practice on SST performance 





Previous research showed a reduction of EEG mean frequency power after both real stimulation and 
sham tDCS (Boonstra et al., 2016). However, they did not coupled tDCS with any cognitive task, as 
it was done in the current experiment. Therefore, the inconsistent results showing an increase mean 
frequency power in sham tDCS in this experiment, might be explained by the task related effect 
produced by the SST (Gill et al., 2015; Newson & Thiagarajan, 2019). Another study employing 
cognitive tasks found improved cognitive performance after sham but not after real stimulation 
(Nikolin, Boonstra, Loo, & Martin, 2017). Neuromodulation interventions have been associated with 
improvements in both real stimulation, but also in sham conditions (Ulam et al., 2015), which have 
raised the debate about the applicability of sham as a control condition in tDCS research (Boonstra et 
al., 2016). In fact, a study found that there was a placebo effect caused by sham stimulation, showing 
effects on EEG features that were not shown under a non-stimulation condition (Petersen & 
Puthusserypady, 2019). Therefore, it is not possible to rule out a possible placebo effect that could 
account for the results found in this experiment.  
 
In addition, correlation analysis showed that gambling severity correlated negatively with SST 
variables total correct stop and go trials, total correct stop trials and total correct go trials, as well as 
with EEG2 mean power frequency in left DLPFC. An additional assessment of the neurophysiological 
variables that correlated with gambling severity was conducted, and correlation analysis between EEG 
variables in left DLPFC and gambling related behavioural and self-report measures revealed that 
theta/beta ratio correlated positively with cravings and with IST total correct. Additional relevant 
correlations from this analysis were found, and are presented in Appendix A, including negative 
correlations between gambling severity and beta relative power in left DLPFC, and a negative 
correlation between beta relative power with cravings, and between absolute power in all frequency 
bands with SSRT. 
 
Previous research showed that decreased theta/beta ratio has been associated with several psychiatric 
disorders including addition (Newson & Thiagarajan, 2019), and with decreased inhibition control 
measured with SSRT (Lansbergen, Schutter, & Kenemans, 2007). Previous studies also found a 
negative correlation between theta/beta ratio and reward and punishment-related reversal learning 
(Schutte, Kenemans, & Schutter, 2017), and considering that reversal learning has been associated 




consistent with the positive correlation between gambling severity and theta/beta ratio found in this 
experiment.   
 
4.5.2 Participant allocated to real stimulation condition 
In the participant allocated to real stimulation condition, results showed significant differences across 
sessions in gambling severity measured with PG-YBOCS, reflection impulsivity measured with IST, 
in particular results showed differences in IST variables number of boxes opened per trial, probability 
of a correct decision, and in addition, there were significant differences in in the SST variable SSRT. 
VAS statistics could only be calculated across sessions due to a lack of enough data points, which 
showed significant differences across sessions, and also, percentage change between the last and the 
first session revealed a reduction of 71% in gambling cravings. To assess the final outcome of the 
intervention, session eight was compared against session one, revealing that there were statistically 
significant changes only in PG-YBOCS, which showed a reduction of 66%. In addition, at the end of 
the intervention, the participant thought that received tDCS real stimulation. These results are 
consistent with the findings from the case study mentioned previously, showing a reduction of 62.5% 
of PG-YBOCS, and a reduction of 100% of VAS for gambling cravings after a longitudinal 
intervention with real stimulation tDCS over DLPFC in GD (Martinotti et al., 2018).  
 
EEG frequency power analysis results showed significant differences in mean power frequency across 
sessions, between the first and the last session, and within session one and session eight. The highest 
mean frequency power was seen in sessions four and seven, and the lowest in session eight9. 
Interestingly, gambling severity was the highest in session four, and the mean number of boxes opened 
in IST (therefore less impulsive decision-making) was higher in sessions four and seven. These results 
could indicate a possible positive association between EEG mean frequency power and gambling 
severity, and a negative association between EEG mean frequency power and behavioural impulsivity. 
However, it would be in part inconsistent (regarding the impulsivity component) with previous 
research showing that high impulsive patients with GD showed decreased EEG power, but consistent 
considering GD severity outcomes in previous results (Lee et al., 2017a).  
 
                                                 




In particular, examining separately EEG recordings before and after the tDCS (EEG1 and EEG2, 
respectively), and considering sessions one and eight in each frequency band, results revealed short 
term effects of the intervention in session one, showing that in mean frequency power increased from 
EEG1 to EEG2, however in session eight, there were no significant differences between mean 
frequency power in EEG1 and EEG2. Results revealed also long term effects of the intervention, 
showing that mean frequency power significantly decreased from session one to session eight in both 
EEG1 and EEG2. Comparing only session eight against session one, the long term effects of the 
intervention seemed to produce a general decrease of mean frequency power, however, tDCS effects 
within each session varied. In general, there was a short term increase of mean frequency power 
associated with tDCS in all sessions, except for session five and session eight10, and high variability 
on mean frequency power across sessions. Moreover, no significant correlations were found 
considering mean frequency power and theta/beta ratio. Nonetheless, significant correlations between 
gambling severity and EEG relative power have been included in Appendix A. 
 
Differences between neuromodulation effects across sessions have been described also in previous 
research, showing that the reduction of cravings increased after each tDCS session, except for the last 
stimulation session (Boggio et al., 2009). In addition, other studies showed certain variability on tDCS 
results, revealing that stimulation over left DLPFC was associated with a decrease of mean frequency 
power (Boonstra et al., 2016), but also with an increase of mean frequency power (Accornero et al., 
2014). Overall, the heterogeneity of results might reflect inter-individual variability, while intra-
individual variability could account for differences found across sessions in the present study 
(Newson & Thiagarajan, 2019).   
 
To hold these results, it is essential to consider the particular experimental conditions that did not 
follow the planned procedure: the participant had a break of one weak between session two and 
session three, in which the CBT treatment was delivered remotely without the combined tDCS 
protocol. In session six, the participant received two sessions of CBT after the tDCS procedure, and 
in sessions seven and eight only the tDCS procedure was administered, without the following CBT 
                                                 
10 Statistical analysis comparing each of the eight sessions against the rest was not performed (paired comparisons were 
conducted only between the first and the last session), and therefore, the results discussed about any other specific session, 
refer simply to the variables values observed. The statistical analysis was more focused on assessing the final outcome of 
the intervention, and to compare each session against the others (involving between and within sessions analysis), would 
extend the work load and amount of data reported excessively, considering the limitations associated to the adapted 
analysis methodologies used, the time available for the project and the limited space to report the results. Nevertheless, 





session. In addition, the participant was tested during hot days in the summer season, in a room 
without controlled temperature, after traveling for four hours to attend the treatment at the clinic. 
There were considerable amounts of sweat on the scalp that probably affected the EEG data, which 
would explain the high amount of artefacts that could not be completely removed after data 
processing, and the extremely high absolute power values, especially in low EEG frequencies 
(Thompson, Steffert, Ros, Leach, & Gruzelier, 2008). Under these conditions, unfortunately it is not 
possible to draw reliable conclusions about the effectiveness of the intervention, however data from 
each session might provide some information about the mechanisms of tDCS.  
 
4.5.3 General conclusions and limitations 
Results revealed that the interventions combining tDCS (real stimulation and sham) and cognitive 
behavioural therapy (CBT) reduced gambling severity, cravings and modulated cortical excitability, 
in both patients. Particularly, EEG results showed short and long term effects of the intervention on 
cortical excitability. In the patient receiving tDCS real stimulation, there were further alterations on 
the experimental procedure due to changes of schedule in the CGT treatment, which seem to match 
with a high variability in EEG results across sessions. Although tDCS seemed to produce a short term 
increase of mean frequency power in the majority of sessions, no clear direction of long term effects 
was found.  
 
The electrophysiological findings in the patient allocated to sham tDCS appeared to have more 
consistent interpretations. In particular, concurrent SST performance could have explained both, the 
short term and long term changes in EEG power. There was an increase of mean frequency power 
from EEG1 to EEG2 after the patient received sham tDCS coupled with the SST, and also an increase 
of mean frequency power associated with EEG2 in session eight compared with session one. 
Therefore, SST effects could explain the short and long term effects found after tDCS, whereas 
cumulative effects of CBT could account for a reduction of mean frequency power in EEG1 at the 
end of the intervention. This interpretation would be consistent with the distribution of EEG power 
found in the PFC, indicating that the highest mean frequency power changed from left DLPFC during 
EEG1 to right DLPFC during EEG2, after having performed the SST. This would be based on 
previous results that showed a crucial response inhibition role associated with right but not left 





In addition, in the patient allocated to sham, gambling severity correlated with behavioural measures, 
and EEG variables. Particularly, gambling severity correlated negatively with SST total correct trials 
and with EEG2 mean frequency power in left DLPFC. In addition, theta/beta ratio in left DLPFC 
correlated positively with cravings and IST total correct. The significant correlations found between 
these variables are particularly relevant for neuromodulation research in GD, given that these 
electrophysiological measures could be used in future research as biomarkers to assess changes in 
cognitive states, and as targets for neuromodulation studies.  
 
In this experiment, some of the limitations highlighted in previous experiments were addressed: a 
triple-blinded design (in which neither the participant, nor the researcher conducting the experiment 
and the data analysis were aware of the stimulation condition) was used to ensure that data analysis 
was less likely to be biased; a longitudinal design was conducted to investigate the potential 
cumulative effects of tDCS; a computational model was used to create the most effective tDCS 
montage to target the brain area of interest more accurately; and neurophysiological data (EEG) was 
used to quantify the effects of the intervention.   
 
Nevertheless, even though previous limitations were tackled, additional limitations arose in this 
experiment, given that the original design planned as an RCT had to be adapted to analyse data 
following single-participant designs. Therefore, the results obtained cannot be used to establish 
conclusions about the effectiveness of the intervention combining tDCS and CBT. The results are 
from single cases, with unavoidable differences in testing protocols with the originally planned RCT, 
and so it is not possible to reliably infer the validity of any observed qualitative differences or 
similarities between the cases. Therefore, results obtained cannot be used to draw conclusions about 
the effectiveness of the intervention combining tDCS and CBT, and the particular adaptations prevent 
from contrasting the findings consistently against previous studies results.  
 
Especially, in the participant allocated to real stimulation condition (with whom the testing procedure 
did not follow the planned protocol, and multiple artefacts contaminated the EEG data), results 
obtained are not reliable to interpret the intervention outcomes congruently. However, in the 
participant allocated to sham condition (with whom experimental testing was carried out as planned), 




neurophysiological data that support further investigation of these variables to study potential 






5 Chapter 5. Experiment IV: physiological mechanisms associated 
with transcranial direct current stimulation during gambling-
related task performance 
5.1 Summary 
This experiment investigated the effects of tDCS on the autonomous nervous system (ANS) during 
different reward phases in gamblers grouped according to their self-reported impulsivity levels. 
Results showed that tDCS real stimulation was associated with an increase of sympathetic activation 
and changes in cortical excitability compared with tDCS sham. The findings suggested also that 
changes of cortical excitability could have been explained by task-related effects, which seemed to 
have a higher influence in low impulsive (LI) gamblers compared with high impulsive (HI) gamblers. 
Inter-individual differences were identified during gambling-related task performance through heart 
rate variability (HRV), heart rate (HR) and skin conductance responses (SCRs). Particularly, 
increased sympathetic activation was found in HI compared with LI, and during wins compared with 
losses in a gambling task. Results showed positive correlations between gambling severity and 
cravings, EDA and HR, and negative correlations between gambling severity and EEG outcomes. In 
addition, EDA baseline correlated with different variables measuring reward response and cortical 
excitability, which could indicate the potential usefulness of EDA as a biomarker in future studies in 
GD. In conclusion, results demonstrated the role of impulsivity in gambling behaviour, and provided 
some evidence of the capability of tDCS to modulate ANS and cortical excitability. However, results 
should be carefully interpreted considering that the blinding of tDCS conditions was not effective, 
and participants awareness of the stimulation could have also explained the increase of sympathetic 
activation, rather than this being directly caused by tDCS.  
 
5.2 Introduction  
Altered physiological responses to positive and negative reward outcomes have been associated with 
the development and maintenance of GD (Blaszczynski & Nower, 2002; Sharpe, 2002). The 
prefrontal cortex (PFC) modulates subcortical pathways that regulate the sympathetic and 
parasympathetic branches of the autonomic nervous system (ANS). The sympathetic nervous system 




nervous system inhibits this activity. In particular, addiction has been related with increased 
sympathetic dominance (Huang, 2017). PFC activity has been associated with changes in heart rate 
variability (HRV), which is associated with sympathetic and parasympathetic tone, and might serve 
as an index to inform about emotional regulation through the interactions with the brain.  
 
The neuro-visceral integration model, suggests that increased activity in the PFC is associated with 
increased parasympathetic and decreased sympathetic activity (Park et al., 2019; Thayer & Lane, 
2000). In line with this model, previous research showed that HRV can be modulated with tDCS 
applied over the PFC (Montenegro et al., 2011), and through cognitive task performance (Luque-
Casado et al., 2016), as well as with the combination of tDCS and cognitive task performance (Nikolin 
et al., 2017). One of the most widely studied characteristics of addiction, and that has been shown to 
be modulated with NIBS, is inhibitory control (Jacobson, Javitt, & Lavidor, 2011; Verdejo-García et 
al., 2008). Particularly, the neuro-visceral integration model describes inhibitory processes as negative 
feedback mechanisms that allow the interruption of ongoing behaviours. When these inhibitory 
processes are impaired, disinhibited behaviours in the form of positive feedback might arise (Thayer 
& Lane, 2000).  
 
Research using NIBS and cognitive tasks (the SST) in GD has demonstrated that activity in the motor 
cortex explained individual differences in response inhibition (Chowdhury, Livesey, Blaszczynski, & 
Harris, 2018). In addition, tDCS has been shown to increase HF HRV and reduce LF HRV, indicating 
a potential enhancing effect of parasympathetic activity, and reduction of sympathetic activity 
associated with real stimulation (Montenegro et al., 2011). Therefore, the prospect of developing 
NIBS protocols that could help regulate the ANS, could offer promising opportunities for the 
treatment of addiction and GD.  
 
Physiological responses, including heart rate (HR) and electrodermal activity (EDA), have been 
associated with GD (Clark, Crooks, Clarke, Aitken, & Dunn, 2012; Peterson et al., 2010a). EDA 
captures autonomic changes in electrical properties of the skin, and has two main components: the 
skin conductance level (SCL), which is a slow tonic background component, and a fast phasic 
component, the skin conductance responses (SCRs), that result from sympathetic neuronal activity. 
EDA has been described as the only autonomic physiological variable not contaminated by 




et al., 2015). Previous studies showed that gamblers using their own money during a “real life” 
gambling scenario had increased HR (Meyer et al., 2000). In particular, HR was predicted by the 
outcomes during play, in which winning was necessary to maintain HR elevated (Coventry & Hudson, 
2001).  
 
Furthermore, the severity of gambling problems was associated with increased EDA, and smaller HR  
inter-beat interval (Ulrich, Ambach, & Hewig, 2016a). However, different studies have found 
contrasting results regarding EDA levels associated with reward outcomes and GD. While higher 
EDA was associated with increased bet sizes, being higher in losses than in wins in a sample of healthy 
participants (Studer & Clark, 2011), comparing a sample of healthy participants and participants with 
GD, SCRs to wins were lower for GD participants, but there were no differences in SCRs related to 
losses between the groups. More research will help to clarify EDA-related sensitivity to reward in 
different populations.  
 
The somatic marker hypothesis (Damasio, 1996), suggests that unconscious physiological states 
developed through pleasurable or adverse experiences, and referred to as somatic markers (such as 
HR and SCRs), have a direct influence on consequent behaviours. Research has shown that in GD 
individuals these markers are weaker, and when dealing with risky situations, SCRs are lower when 
comparing with healthy individuals (Goudriaan et al., 2006). Previous studies showed that NIBS can 
modulate EDA and HRV (Feeser et al., 2014; Morales-Quezada et al., 2014; Wang et al., 2016), 
showing that tDCS real stimulation was associated with a decrease of SCRs (Herrmann et al., 2018), 
and therefore reduced sympathetic arousal. Therefore, considering the somatic marker hypothesis, 
research investigating the particular physiological characteristics in different types of participants 
during reward and punishment outcomes, could inform the development of NIBS protocols that might 
help to control specific physiological features that influence risky behaviours during gambling.  
 
Electroencephalogram (EEG) resting state has also been used to study neuro-correlates of cognition 
and behaviour in relation to other physiological outcomes. Increased theta/beta ratio has been 
associated with reduced cortical inhibition (Lansbergen et al., 2007), poor reversal learning (Schutte 
et al., 2017) and risky decision-making (Massar, Rossi, Schutter, & Kenemans, 2012). Low cortical 
arousal has been associated with increased power of slow waves (delta and theta bands), whereas 




nervous system (Kim et al., 2018). Decreased delta power was associated with decreased HR, and 
with higher HF HRV component, indicating increased parasympathetic activity (Patron et al., 2019).  
 
Research has suggested that GD participants with higher impulsivity levels would show increased 
delta and theta bands and decreased alpha and beta bands, compared with lower impulsive participants 
(Lee et al., 2017b). In addition, research showed that gambling severity correlated positively with 
theta activity (Dymond et al., 2014). Moreover, studies using tDCS over the DLPFC showed that real 
stimulation increased beta frequency power (Song et al., 2014), and reduced left frontal delta absolute 
power (Keeser et al., 2011). Investigating the relationship between EEG resting state and gambling-
related physiological and cognitive characteristics, and the effects of tDCS on specific frequency 
bands on the PFC, could inform about potential biological markers associated with different types of 
gamblers, and therefore help develop more individualised treatment interventions.  
 
Therefore, physiological assessment of tDCS delivered during gambling-related task performance to 
participants with different gambling severity and impulsivity levels, might help explain specific 
neurophysiological and behavioural features associated with low risk and high risk gambling, and 
help to understand the underlying mechanisms of tDCS on the PFC and the ANS.  
 
In this experiment, physiological measures, including ECG, EDA and resting-state EEG were 
recorded while participants completed gambling-related cognitive tasks on a computer and received 
tDCS (real stimulation and sham), in a mixed factor crossover design. It was hypothesised that real 
stimulation would be associated with improved task performance compared with sham: in IST, higher 
number of boxes opened, P (correct) at point of decision and total correct trials. In SST, lower SSRT, 
higher total correct stop trials and total correct go trials. CGT was performed before tDCS, therefore, 
results expected would be dependent of the participant groups and task-conditions (lower QDM, 
higher RT and higher DA in HI compared with LI, and larger differences between the groups in higher 
risk conditions of the task)11.  
                                                 
11 Specific predictions about cognitive performance are included also in this chapter (although the current tasks were 
performed already in earlier experiments), because the procedure and participant samples are different across experiments. 
In addition, although previous experiments showed an increase of RT and mixed results on DA after tDCS, it was 
hypothesised that tDCS might reduce RT and DA due to the different sample characteristics, and based on more extensive 






In EDA, it was expected to find decreased SCL in real stimulation, which would be higher during task 
performance than at rest. Higher SCRs would be associated with task-related wins compared with 
losses. Nevertheless, EDA responses might depend on the participant characteristics, and considering 
that previous research suggested that the altered brain reward network in behavioural addictions might 
be linked to higher sensitivity to positive reinforcement (Gomis-Vicent et al., 2019), it was 
hypothesised that participants with higher impulsivity levels and gambling severity, might show 
higher SCRs associated to wins than to losses, whereas participants with lower impulsivity levels and 
gambling severity might show increased SCRs associated with losses.  
 
Similarly, in ECG, it was expected that HR would be higher in wins than in losses. In addition, tDCS 
real stimulation would help to shift HRV towards parasympathetic dominance, determined by 
decreased LF and increased HF components. It was therefore predicted that cognitive and 
physiological measures would differ between participant groups divided by impulsivity levels, with 
poorer task performance associated with HI participants compared with LI participants. Higher 
sympathetic activity, increased EDA, LF/HF ratio, HR and delta and theta bands, but decreased alpha 
and beta bands, would be associated with HI compared with LI. Similarly, correlations would be 
expected to be positive between gambling severity and poorer task performance, sympathetic activity 
(determined by higher LF, HR and EDA), and with EEG slow waves activation. Therefore, the main 
goals of this experiment were to investigate the physiological responses associated with gambling-
related cognitive and behavioural variables, to explore whether participants with more severe 
gambling problems and impulsivity levels would show sympathetic dominance and lower cortical 
arousal, and if tDCS could help shifting to increased parasympathetic activity and cortical activation, 




In this experiment, 17 participants were recruited through online advertisements on research 
participation websites, social media and advertisements posted at the University of East London. 
Participants received two counterbalanced sessions of tDCS (real stimulation and sham) one week 
apart, and were compensated for their time with shopping vouchers. All participants were screened 




Index (PGSI). For tDCS exclusion criteria details please see section 3.3.1 in Chapter 3. Two 
participants were classified as low-risk gamblers (PGSI=1-2), four participants as moderate-risk 
gamblers (PGSI= 3-7) and 11 participants were classified as high-risk gamblers (PGSI=+8). Using 
this data, a median split of UPPS-P NU scores was carried out to create two groups of participants: 
LI (n= 8, mean age = 38 ± 4.7 years) and HI (n = 9, mean age = 35.6 ± 3.6 years).  
 
Participants groups were created using impulsivity self-report scores for different reasons: in 
Experiments I and II participant groups were also created using UPPS-NU median split, and therefore, 
continuing to do so consistently, would allow a better understanding of the results across experiments 
in the project. In addition, multiple regression analysis revealed that the impulsivity trait of negative 
urgency (UPPS-P NU) was a significant predictor of PGSI (F (1, 15) = 10.829, p =.005, R2 = .419). 
Lastly, using UPPS-P NU median split allowed sample size to be more balanced between groups than 
using PGSI scores, which should strengthen data analysis. The sample size was based on studies 
employing similar methodologies and outcome measures: in a tDCS study, it was calculated that the 
number of participants to detect a difference in HRV of 40% with a power of 0.8 at α=0.05 was 8 
participants per group, recruiting 17 participants in total (Clancy et al., 2014); studies combining tDCS 
and EEG, had sample sizes of 6 participants (Leite et al., 2017), 10 participants (Keeser et al., 2011) 
and 20 participants (Boonstra et al., 2016).  
 
5.3.2 Materials 
Details of the tDCS and EEG device and electrodes used in this experiment are described in section 
4.3.2 in Chapter 4. Data collection and analysis of EDA and ECG, as well as EEG spectral analysis, 
was conducted with Powerlab 26T and the software LabChart 8 (ADInstruments, Australia), including 
the HRV analysis module. The CANTAB battery of tasks was used to measure gambling-related 
behavioural performance including the CGT, IST and SST. The CGT was used as a priming task, 
measuring QDM, RT and DA. IST was used to assess reflection-impulsivity during tDCS, measuring 
the variables mean probability of making a correct decision (Mean P (correct)) and number of boxes 
opened per trial. The SST was used to measure inhibition control during tDCS, through the variables 
total correct on go and stop trials, and stop signal reaction time (SSRT).  
 
The PGSI was used to measure gambling severity, whereas GRCS was used to measure gambling 




gambling cravings. In addition, alcohol use disorders identification test (AUDIT) was used to control 
for alcohol dependence, and the adult ADHD self-report scale (ASRS) to control for comorbid 
attention deficit hyperactivity disorder (ADHD). AUDIT and ASRS are often used in GD research 
(Chowdhury et al., 2018) to control for comorbid alcohol use and ADHD symptomatology, as both 
could influence the outcomes measured with the cognitive tasks. Lastly, the tDCS events sham 
questionnaire was used to control for participants sensations associated to tDCS. For more detailed 
information about the CGT, GRCS and UPPS-P, please refer to section 3.3.2 in Chapter 3; for VAS, 
IST, SST and events sham questionnaire, refer to section 4.3.2, in Chapter 4. 
 
- Problem Gambling Severity Index (PGSI; Ferris & Wynne, 2001)12: it is a nine question self-report 
scale that was developed specifically to measure problem gambling in the general population, 
identifying different subgroups of problem gamblers with different levels of risk status (no risk (scores 
= 0), low risk (scores = 1-2), moderate risk (scores = 3-7), and high risk (scores = 8 or higher)). 
Participants were asked about the frequency (never/sometimes/most of the time/almost always) they 
have experienced specific situations in the past year (e.g., have you bet more than you could really 
afford to lose?).  
 
- Alcohol Use Disorders Identification Test (AUDIT; Reinert & Allen, 2002): it is a 10-item scale 
designed to assess three conceptual domains: alcohol intake (items 1–3), dependence (items 4–6), and 
adverse consequences (items 7–10). The score is obtained by adding the values associated with the 
various response alternatives. Scores range from 0 to 40.  
 
- Adult ADHD Self-Report Scale (ASRS-v.1.1; Daigre et al., 2009): it is a self-report scale to assess 
symptoms of ADHD based on the DSM-IV symptom criteria. It is comprised of two parts: part A (6 
questions) and part B (12 questions). Positive scores start from 4 or more in part A. Part B is not used 
for diagnostic purposes, but these items provide insight into the frequency of symptoms13.  
                                                 
12 The PGSI was chosen to measure gambling severity in this experiment (instead of the questionnaires SOGS and PG-
YBOCS that were used in previous experiments), because the PGSI was designed to be used also in non-clinical settings 
(Orford, Wardle, Griffiths, Sproston, & Erens, 2010), and therefore was more adequate for the expected participant sample 
characteristics.  






The experiment involved two sessions with crossover design, in which each participant received tDCS 
in a counterbalanced order (real stimulation and sham) one week apart, using a triple blind mode 
(neither the participant nor the researcher conducting the experiment and analysing the data were 
aware of the tDCS condition). Each testing session had a duration of one and a half hours, and in 
addition, the setting up and cleaning of the equipment took around 40 minutes. A total of 34 sessions 
were conducted in this experiment. Before participation in the study, written informed consent was 
obtained, which was approved by the University of East London Research Ethics Committee 
(UREC_161731, see Appendix D). All experimental procedures were conducted following the 
General Data Protection Regulation (GDPR).  
 
On each session, EDA and ECG were recorded from the beginning to the end of the experimental 
procedure. Participants completed a series of questionnaires to measure individual gambling-related 
characteristics (PGSI and UPPS-P in the first session, and AUDIT and ASRS in the second session). 
After that, participants completed the CGT, which was followed by a recording of five minutes of 
EEG resting state with eyes opened, then participants completed the IST and SST while receiving 20 
minutes of tDCS, which was followed by five minutes of EEG resting state with eyes opened, and 
lastly participants completed the VAS for gambling cravings and the events sham questionnaire to 
assess the blinding procedure. The procedure is represented in Figure 5-1.  
 
The CGT was used before tDCS as a priming task, with the aim to help activate the brain areas 
involved in gambling-related cognitive functions that were targeted with tDCS, to increase the effects 
of neuromodulation by facilitating reaching the membrane action potential during real stimulation 
(Colombo et al., 2015; Fertonani et al., 2014; Fujiyama et al., 2017). All participants completed the 
CGT ascending condition first (Zois et al., 2014), because it was demonstrated that 
ascending/descending conditions order did not influence CGT performance (Lawrence, Luty, Bogdan, 
Sahakian, & Clark, 2009). Similarly, all participants completed the IST fixed condition first, given 
that previous research did not find significant differences on task performance depending on condition 






Figure 5-1. Experimental procedure in Experiment IV. Electrodermal activity and electrocardiogram were recorded from 
the baseline for two minutes and continued for the entire session. Questionnaires completed in the first session included 
the urgency premeditation, sensation-seeking scale (UPPS-P) and problem gambling severity index (PGSI), whereas the 
alcohol use disorder identification test (AUDIT) and attention deficit hyperactivity disorder self-report scale (ASRS) were 
completed in the second session, with counterbalanced order in each session. Participants completed the Cambridge 
gambling task (CGT), before receiving transcranial direct current stimulation (tDCS) for 20 minutes while performing the 
information sampling task (IST) and the stop signal task (SST). Before and after the tDCS, five minutes of 
electroencephalogram (EEG) resting state were recorded (EEG1 and EEG2, respectively). After the tDCS the visual 


















5.3.4 Transcranial direct current stimulation high definition montage modelling  
A computational model created by Neuroelectrics (STIMWEAVER SPR0122), was used to identify 
the most effective tDCS montage to target the rDLPFC (Ruffini et al., 2013). The details of this 
montage were described in section 4.3.4 in Chapter 414. 
 
5.3.5 Physiological data collection and processing 
5.3.5.1 Electroencephalogram (EEG) data processing 
EEG data was processed as specified in section 4.3.5 in Chapter 4.  
 
5.3.5.2 Electrodermal activity (EDA) and electrocardiogram (ECG) data collection 
EDA and ECG were sampled with Powerlab 26T software LabChart 8 (ADInstruments) at 1000 
samples/second. Skin conductance was measured from the non-dominant hand using two stainless 
steel bipolar finger electrodes attached to the distal phalanges of the index and middle finger. The 
channel range was set at 2 V, and an anti-alias fitter was used to remove signal component frequencies 
> 0.5 of the sampling frequency. Electrodes were attached for around five minutes prior to beginning 
of the task to allow EDA levels to stabilize (Boucsein et al., 2012; Braithwaite et al., 2015). ECG was 
recorded with three Ag/Ag-Cl disposable electrodes placed according to the Einthoven II lead (ground 
electrode below the left collarbone, negative electrode below the right collarbone and positive 
electrode on the left side below the rib cage). The range was set at 20 mV, and was sampled with a 
high pass filter of 0.5 Hz to minimise baseline drift, and a mains filter to suppress electrical 
interference (Nikolin et al., 2017; Zimmerman & Thompson, 2016).  
 
EDA and ECG baseline were recorded for two minutes before the experiment tasks started and during 
the entire session. Events occurring during tasks performance were logged in LabChart manually by 
the researcher, through inserting pre-set comments that indicated the section of the experimental 
session. These events are referred to as conditioned stimuli (CS), and include the different cognitive 
tasks conditions (ascending/descending, fixed/decreased), CGT risk-conditions (9:1, 8:2, 7:3, 6:4), 
and performance outcomes (whether the participant won or lost in each trial). The rate of change of 
                                                 
14 In Experiments I and II the current employed was 1.5 mA given that this was a commonly used parameter in previous 
tDCS studies (Lefaucheur et al., 2016). However, in this experiment a computational model was used, resulting in the 




the physiological measures should be shorter than the speed of the researcher´s reaction time to insert 
the pre-set comments (pressing a key on the computer). Nevertheless, as cognitive tasks and LabChart 
software were not interfaced as is common in other studies, it was assumed that there was a certain 
delay (around 0.5 seconds) on the presentation of stimuli in the recordings that was taken into account 
for the data analysis.  
 
5.3.5.3 Electrodermal activity (EDA) data processing 
EDA captures autonomic changes in electrical properties of the skin, and has two main components: 
the skin conductance level (SCL), which is a slow tonic background component, and a fast phasic 
component, the skin conductance responses (SCRs).  LabChart software applies an automatic zeroing 
to the signal, therefore comparisons between participants are acceptable despite inter-individual 
differences in SCL. Two different ways to obtain the SCL were used in this experiment: measurements 
of SCL were taken from periods outside the SCRs signal, and measurements of local SCL were taken 
just before each SCR (Braithwaite et al., 2015). The average SCL was calculated from the baseline 
resting periods, from data segmented into one second epochs. To obtain the SCL outside the SCRs 
periods, the signal amplitude in micro Siemens (μS) was measured from three rest periods: the 
baseline (two minutes), and the EEG periods before and after tDCS stimulation (EEG1 and EEG2) 
(Braithwaite et al., 2015; Pappens et al., 2014).  
 
SCL was expected to change as a result of the tDCS and tasks performance, and specifically, it was 
expected that changes might be more detectable during the start of the resting period, rather than 
during the whole EEG duration (five minutes). Therefore, it was decided to divide the EDA recording 
during the EEG periods into two parts that were called “EEGa” and “EEGb”, which corresponded to 
the first half and second half of the recording, respectively. In addition, the local SCL during the risk 
conditions in the CGT was obtained by measuring the signal amplitude of the two seconds preceding 
each SCR (which corresponded with the CS associated with each CGT risk condition). Local SCL 
can be calculated from segments shorter than one second preceding the SCRs (Braithwaite et al., 
2015), however in this experiment two seconds were a more reliable measure to take into account the 
delay caused by logging manually the presentation of the stimuli.  
 
To obtain the SCRs, the SCL signal was filtered with a high pass filter at 0.05 Hz, to eliminate the 




2016b). The minimum threshold to consider the classification of SCRs was set to 0.03 μS (Braithwaite 
et al., 2015). SCRs were calculated as the maximum positive change in a time window (0-5 seconds) 
from the CS, with a minimum inter-trial interval of six seconds (Denburg, Recknor, Bechara, & 
Tranel, 2006; Figner & Murphy, 2011). A broader time window was used as in (Ulrich et al., 2016b) 
compared to the most commonly used (1-4s) in EDA research, due to the delay in the presentation of 
the stimulus.  
 
The SCRs were divided into reward anticipatory responses and feedback responses: the amplitude of 
the signal was measured for two seconds before of the CS to obtain the reward anticipatory response. 
To obtain the reward feedback response, the amplitude of the five seconds after the CS associated 
with task outcomes won and lost was measured. Anticipatory responses correspond to the two second 
period before the participant received the reward outcome, and feedback responses correspond to the 
five second period after the participant received the reward outcome. The relationship between 
anticipatory and feedback responses was analysed during participants task-performance. Similarly, 
other studies calculated the anticipatory response using the time between the end of the five seconds 
reward CS interval and the next CS (Miu, Heilman, & Houser, 2008). 
 
5.3.5.4 Electrocardiogram (ECG) data processing 
The LabChart HRV analysis module software (ADInstruments) was used to obtain measures of heart 
rate variability (HRV) frequency domain, and automatically remove artefacts and ectopic beats. In 
addition, visual analysis was performed to ensure that all beats were classified correctly before the 
analysis. The frequency domain measures were analysed, including low frequency (LF = 0.04-0.15 
Hz), high frequency (HF = 0.15-0.40 Hz) and the (LF/HF) ratio. The heart rate (HR) was calculated 
from the ECG in beats per minute (bpm). The R-R interval considered normal was set between 500 
ms and 1200 ms, except for one participant that had to be changed between 500 ms and 1300 ms due 
to having slower HR (lower than 50 bpm in rest periods). ECG data was divided into five minutes 
segments (except for the baseline that was two minutes long) according to short-term recording 
metrics norms (Shaffer & Ginsberg, 2017), and to ensure that HRV reflected similar levels of task 
stress-related load in each variable.  
 
Total power measured in ms2/Hz, as well as low frequency (LF) and high frequency (HF) power 




performance, with a minimum of two minutes recording period in each section. In addition, during 
task performance, HR was measured using the mean, minimum and maximum HR during the five 
seconds after the conditioned stimuli (risk conditions and wins/losses). HRV frequency measures 
cannot be obtained during task performance conditions (risk, wins and losses) because it is required 
a minimum epoch length of one minute. HRV frequency measures were analysed separately for tasks 
performance and rest periods (as well as during the whole session), with the aim to obtain more 
information about the association of HRV measures within each particular phase of the experiment 
and to create a more comparable outcome between tasks and rest periods.  
 
5.3.6 Analysis plan 
Data was analysed with IBM SPSS (Statistical Package of the Social Sciences, Version 23, SPSS Inc., 
Chicago, IL). Significance threshold was set at α = 0.05. Demographic data (age/gender) were 
analysed using t-tests and Chi-square tests. Data was checked for skewness, kurtosis and normality. 
Non-normally distributed data according to Kolmogorov-Smirnov test was transformed using 
logarithmic transformation (SCL and SCRs; IST variables mean probability correct and 
discrimination errors; SST variables stop signal reaction time (SSRT) and total correct responses), 
and arc sin transformation in the case of QDM. When sphericity was not satisfied Greenhouse-Geisser 
correction was used.  
 
The effects of tDCS condition order between sessions on CGT performance were analysed with a 
repeated measures ANOVA with between participants factor being session order, with two levels (real 
stimulation first or sham first). To take into account the interaction of the tDCS stimulation condition 
with the order of the session when session order was significant (in QDM and RT), session order was 
used as a covariate and a repeated measures mixed factor ANCOVA was conducted. tDCS session 
order was not significant for any of the other tasks variables or any of the physiological measures. 
Group interactions were analysed using independent sample t-tests (2-tailed), and tDCS condition 
interactions were analysed using paired sample t-tests (2-tailed). Pearson´s correlation analysis was 
conducted to investigate the relationships between gambling severity and self-report measures, 





5.3.6.1 Blinding procedure 
The blinding procedure was assessed with the events sham questionnaire, using non-parametric 
McNemar test (2-tailed) for paired samples with two categorical end points (guess correct or guess 
not correct) for variables tDCS real stimulation and sham (Du Prel, Röhrig, Hommel, & Blettner, 
2010; Nikolin et al., 2017). 
 
5.3.6.2 CANTAB tasks performance 
The CGT variable QDM was analysed with a 2 x 2 x 2 x 4 mixed-factor repeated measures ANCOVA, 
within-participants factors being tDCS with two levels (real stimulation and sham), condition with two 
levels (ascending and descending) and risk conditions (box ratio) with four levels (6:4, 7:3, 8:2, 9:1), 
and the between-participants factor groups (HI and LI), and session order as a covariate. RT was 
analysed using a 2 x 2 x 2 x 4 mixed-factor repeated measures ANCOVA with within-participants 
factors being condition with two levels (ascending and descending), tDCS with two levels (real 
stimulation and sham) and box ratio with four levels (6:4, 7:3, 8:2, 9:1), and the between-participants 
factor group (HI and LI), and session order as a covariate. DA was analysed using a 2 x 2 x 4 mixed 
factor repeated measures ANOVA with within-participants factor tDCS with two levels (real 
stimulation and sham), box ratio with four levels (6:4, 7:3, 8:2, 9:1), and between-participants factor 
group (LI and HI).  
 
IST variables (mean P (correct), total correct and mean number of boxes opened) were analysed using 
a 2 x 2 x 2 mixed factor repeated measures ANOVA, with within-participants factor tDCS with two 
levels (real stimulation and sham), task condition with two levels (fixed and decreased) and between-
participants factor group (LI and HI).  
 
SST variables were analysed using a 2 x 2 mixed factor repeated measures ANOVA, with within-
participants factors tDCS with two levels (real stimulation and sham) and between-participants factor 





5.3.6.3 EEG resting state 
To investigate the differences in EEG power before and after tDCS, a 2 x 2 x 2 x 8 mixed factor 
ANOVA was conducted, with within factors tDCS (real stimulation and sham), time (EEG1 (pre-
tDCS) and EEG2 (post-tDCS)) and electrode (Cz, Fpz, F4, AF8, AF4, FC6, F3 and AF7) and between 
factor group (LI and HI).  
 
5.3.6.4 Electrodermal activity (EDA) 
To investigate the SCL during the entire session (including rest phases and cognitive tasks 
performance), a 2 x 2 x 8 repeated measures ANOVA was conducted, with within participant factors 
tDCS (stimulation or sham) and period (baseline, CGT ascendant, CGT descendent, EEG1, IST fixed, 
IST decreased, SST and EEG2) and between participant factor group (LI and HI). To investigate SCL 
during the rest periods EEG1 (pre-tDCS) and EEG2 (post-tDCS), including the mentioned 
subdivisions of the EEG (EEGa and EEGb), a 2 x 2 x 2 mixed factor repeated measures ANOVA was 
conducted with within participant factors tDCS (stimulation or sham) and time (pre-tDCS and post-
tDCS), and between participant factor group (LI or HI).  
 
To investigate the local SCL during CGT performance, a 2 x 2 x 2 x 4 mixed factor repeated measures 
ANOVA was conducted, with within participant factors tDCS (stimulation or sham), condition 
(ascending and descending) and risk (9:1, 8:2, 7:3 and 6:4), and between participant factor group (LI 
and HI).  To investigate SCRs (involving anticipatory and feedback responses) in CGT, a 2 x 2 x 2 x 
2 x 2 mixed factor repeated measures ANOVA with within participant factors tDCS (stimulation and 
sham), condition (ascending and descending), outcome (wins and losses) and response (anticipatory 
and feedback) and between participant factor group (LI and HI).  In IST, SCRs were analysed with a 
2 x 2 x 2 x 2 x 2 mixed factor repeated measures ANOVA with within participant factors tDCS 
(stimulation and sham), condition (fixed and decreased), outcome (wins and losses) and response 
(anticipatory and feedback15), and between participant factor group (LI and HI). In SST, SCRs were 
analysed with a 2 x 2 x 2 x 2 mixed factor repeated measures ANOVA with within participant factors 
tDCS (stimulation and sham), outcome (wins and losses) and response (anticipatory and feedback), 
and between participant factor group (LI and HI). 
                                                 
15 Reminder: anticipatory responses correspond to the two second period before the participant received the reward 





5.3.6.5 Electrocardiogram (ECG) 
To investigate HRV frequency measures during the entire session, including rest phases and cognitive 
tasks performance, a 2 x 2 x 8 mixed factor repeated measures ANOVA was conducted, with within 
participant factors tDCS with two levels (stimulation and sham) and period with eight levels (baseline, 
CGT ascendant, CGT descendent, EEG1, IST ascendant, IST descendent, SST and EEG2) and 
between participant factor group (LI and HI).  
 
To investigate HRV before and after tDCS (EEG1 and EEG2), a 2 x 2 x 2 repeated measures ANOVA 
was conducted, with within participant factors tDCS with two levels (stimulation and sham) and tDCS 
time with two levels (EEG1 and EEG2), and between participant factor group with two levels (LI and 
HI). To investigate HRV during task performance periods, a 2 x 2 x 5 mixed factor repeated measures 
ANOVA was conducted, with within participant factors tDCS with two levels (stimulation and sham) 
and period with five levels (CGT ascendant, CGT descendent, IST ascendant, IST descendent and 
SST) and between participant factor UPPS group with two levels (LI and HI). To investigate heart 
rate (HR) during tasks performance periods, a 2 x 2 x 5 mixed factor repeated measures ANOVA was 
conducted, with within participant factors tDCS with two levels (stimulation and sham) and period 
with five levels (CGT ascendant, CGT descendent, IST ascendant, IST descendent and SST) and 
between participant factor UPPS group with two levels (LI and HI).  
 
To investigate HR during risk conditions in the CGT, a 2 x 2 x 2 x 4 mixed factor repeated measures 
ANOVA was conducted, with within participant factors tDCS with two levels (stimulation and sham), 
condition with two levels (ascending and descending) and risk with four levels (9:1, 8:2, 7:3 and 6:4), 
and between participant factor group with two levels (LI and HI). To investigate HR during CGT and 
IST reward outcomes, a 2 x 2 x 2 x 2 mixed factor repeated measures ANOVA was conducted, with 
within participant factors tDCS with two levels (stimulation and sham), condition with two levels 
(ascending and descending in CGT; or fixed decreased in IST) and outcome with two levels (wins 
and losses), and between participant factor group (LI and HI). Finally, to investigate HR during SST 
performance, a 2 x 2 x 2 repeated measures ANOVA was conducted with within participant factors 
tDCS with two levels (stimulation and sham) and outcome with two levels (wins or losses), and 






5.4.1 Demographics and questionnaires 
Demographics and questionnaire results by group are presented in Table 5-1. Results revealed that 
groups did not differ in age, gender, alcohol dependence, ADHD symptomatology, gambling severity 
or gambling cravings. Groups were created using median split of NU scores (median = 32). Therefore 
participants scoring 31 or lower in NU were allocated to LI group, and participants scoring 32 or 
higher in NU were allocated to the HI group. The distribution of UPPS-P NU scores across 
participants is presented in Figure 5-2. Independent sample t-test (2-tailed) analysis for age differences 
between LI (mean age 38 ± 4.70 years) and HI (mean age 35.6 ± 3.60) were not significant (t (15) 
=.523, p = .608). Chi-square tests were not significant for gender interactions with groups (X2 (1) = 
.275, p = .600) and not significant for education level interaction with groups (X2 (2) = 1.733, p = 
.420). UPPS-P total average score was not significantly different between LI and HI (t (15) = -1.474, 
p = .161). There were no significant differences between LI and HI in alcohol consumption (t (15) = 
.973, p = .346) or ADHD symptoms (t (15) = -.002, p = .998). There were no significant differences 
between LI and HI in VAS after real stimulation (t (15) = -1.520, p = .149), or sham (t (15) = -.374, 
p = .713). In addition, there were no significant differences in VAS between real stimulation and sham 
(t (16) = -.523, p = 608). The blinding procedure was assessed with the events sham questionnaire, 
showing that 100% of participants in the real stimulation session were able to guess the tDCS 
condition, whereas when participants received sham, 65% of participants guessed correctly the tDCS 
condition. A McNemar test (2-tailed) for paired samples with two categorical end points (correct or 
not correct), showed that when participants received real stimulation, were able to guess significantly 



























 LI (n=8) 
HI 
(n=9) Test Statistic 
Age in years 38.00 (4.70) 35.60 (3.60) t (15) =.523, p = .608 
Gender 
  
X2 (1) = .275, p = .600 Females 1 2 
Males 7 7 
Education    
Primary  1 1 
X2 (2) = 1.733, p = .420 Secondary 2 5 
Higher 5 3 
PGSI 6.37 (4.53)  11.11 (5.35) t (15) =  -1.955, p = .069 
UPPS-P Total 27.67 (2.29) 30.42 (4.79) t (15) =  -1.474, p = .161 
AUDIT 4.30 (1.40) 2.60 (1.40) t (15) = .973, p = .346 
ASRS 28.30 (3.50) 42.40 (4.40) t (15) = -.002, p = .998 
VAS (Real stimulation) 2.75 (2.37) 4.78 (3.03)  t (15) = -1.520, p = .149 
VAS (Sham) 3.87 (2.80) 4.45 (3.40) t (15) = -.374, p = .713 
Notes: PGSI, problem gambling severity index; UPPS-P, urgency, premeditation, perseveration, sensation 
seeking scale; AUDIT, alcohol use disorder identification test; ASRS, attention deficit hyperactivity disorder 
(ADHD) self-report scale; VAS, visual analogue scale for cravings. Participant groups are divided by 
impulsivity (low: LI; high: HI). Values represent mean and inside the parenthesis standard deviation except in 





Figure 5-2. Histogram in Experiment IV. Distribution of the negative urgency (NU) scores across participants from the urgency, 










5.4.2 CANTAB cognitive tasks 
CGT results16 in QDM revealed a significant main effect of condition (F (1, 14) = 4.823, p =.045, ηp2 
=.256), showing that QDM was lower in ascending condition compared with descending condition. 
There were no main effects of tDCS or risk (all effects p > .05). However, there were interactions 
between tDCS x session order (F (1, 14) = 5.742, p =.031, ηp2 =.291), showing that in real stimulation, 
QDM was higher when the first session was real stimulation, and QDM was lower when the second 
session was real stimulation, however in sham, there was no difference in session order (p > .05). An 
interaction tDCS x condition (F (1, 14) = 5.939, p =.029, ηp2 =.298), showed that real stimulation was 
associated with lower QDM in both ascending and descending conditions. In real stimulation, 
ascending condition had higher QDM than descending condition, whereas in sham, descending 
condition was associated with higher QDM than ascending condition. A four way interaction tDCS x 
condition x risk x group (F (3, 42) = 3.480, p =.024, ηp2 =.199), represented in Figure 5-3, showed 
that in real stimulation, both tasks conditions had similar QDM across risk conditions, and that the 
largest difference in QDM between LI and HI was found in descending highest risk condition (6:4). 
However, in sham, descending condition was associated with higher QDM, compared with ascending 
condition.  
 
In RT, there was a main effect of tDCS (F (1, 15) = 35.591, p =.001, ηp2 =.704), showing that real 
stimulation was associated with lower RT compared with sham, and a main effect of risk (F (3, 45) = 
24.987, p =.001, ηp2 =.625), showing that RT decreased with increasing risk conditions. There was 
an interaction condition x session order (F (1, 15) = 6.321, p =.024, ηp2 =.296), showing that 
descending condition was associated with higher RT when real stimulation was delivered the first 
session, but with lower RT when real stimulation was delivered in the second session. RT in ascending 
condition was similar in both real stimulation and sham. There were no significant main effect of 
tDCS or risk in DA (all effects p > .05).  
 
In IST, there was a main effect of tDCS in total correct (F (1, 15) = 14.131, p =.002, ηp2 =.485), 
showing that tDCS was associated with higher total correct trials in real stimulation compared with 
sham. In mean P (correct) there was a main effect of tDCS (F (1, 14) = 112.284, p =.001, ηp2 =.889), 
showing that real stimulation was associated with lower mean P (correct) compared with sham. There 
                                                 
16 Although the CGT is performed before tDCS, and therefore potential effects of tDCS will be interpreted as a session 
effect, it was decided to use the same terminology as with the other variables to refer to the factor analysed (tDCS 
condition, rather than session), for simplicity, and to retain as much information as possible that could be related to each 




was also a main effect of condition (F (1, 15) = 35.591, p =.001, ηp2 =.704), showing that mean P 
(correct) was lower in fixed condition. An interaction tDCS x condition (F (1, 14) = 326.238, p =.001, 
ηp2 =.959) represented in Figure 5-4, showed that in real stimulation mean P (correct) was similar 
between fixed and decreased conditions, however in sham, fixed condition was associated with lower 
mean P (correct) than decreased condition. There were no significant differences in mean number of 
boxes opened (p > .05). In SST, there was a main effect of tDCS in total correct stop trials (F (1, 14) 
= 6.535, p =.023, ηp2 =.318), showing that total correct stop trials was lower in real stimulation 
compared with sham. There were no significant differences in SSRT or total correct go trials. Paired 
t-tests to compare significant interactions with tDCS conditions showed no significant differences 
between real stimulation and sham in any of the variables (all effects p > .05). Independent t-test to 
compare group interactions showed no significant differences between LI and HI participants in any 











Figure 5-3. Quality of decision-making (QDM) in Experiment IV. Cambridge gambling task (CGT) variable QDM across 
risk conditions represented by box ratios (9:1, 8:2, 7:3 and 6:4) in low impulsive (LI) and high impulsive (HI) groups in 








Figure 5-4. Mean probability correct (P (correct) at point of decision in Experiment IV. Information sampling task (IST) 
variable mean P (correct) at decision during fixed and decreased conditions in tDCS real stimulation and sham. Data 


















5.4.3 Electrodermal activity (EDA) 
5.4.3.1 Skin conductance level during the whole session (including rest periods and cognitive tasks 
performance) 
Results showed a main effect of period (F (7,105) = 19.147,  p =.001, ηp2 =.561), indicating that from 
the lowest to the highest levels, SCL was lowest in the rest phases EEG1, baseline and EEG2, followed 
by the IST decreased and fixed conditions, and SCL was the highest in the SST, CGT ascending and 
CGT descending conditions. There were no significant main effects of tDCS (p > .05). However, there 
was a significant interaction tDCS x period (F (1, 15) = 5.377, p =.035, ηp2 =.264), showing that SCL 
was lower in real stimulation compared with sham in the baseline and IST ascending condition. In the 
rest of the phases of the experiment, SCL was higher in real stimulation compared with sham. There 
was also an interaction tDCS x period x group (F (1,15) = 5.754,  p =.030, ηp2 =.277) which is 
represented in Figure 5-5, showing that in real stimulation: LI had lower SCL compared with HI in 
all periods of the experiment except for the IST descending condition, in which SCL was slightly 
lower in HI. In the rest of the periods (baseline and EEG phases), SCL was lower in both groups in 
comparison with the tasks periods. Specifically, in LI, EEG2 showed the highest SCL, whereas the 
lowest SCL was shown in the baseline and EEG1. In HI, the lowest SCL was found also in EEG1, 
however, SCL in baseline and EEG2 were similar.  
 
Independent sample t-tests to compare SCL differences between groups during baseline and task 
performance revealed that SCL was significantly higher in HI compared with LI in real stimulation 
periods: in the baseline (t (15) = -2.829, p = .013), EEG1a (t (15) = -2.207, p = .043), EEG2 (t (15) = 
-2.393, p = .030) and EEG2b (t (15) = -2.667, p = .018), and in sham periods: CGT descendent 
condition (t (15) = -2.326, p = .034), EEG1 (t (15) = -2.533, p = .023), EEG1a (t (15) = -2.506, p = 
.024), EEG1b (t (15) = -2.461, p = .026), IST fixed condition (t (15) = -2.398, p = .010), and IST 
decreased condition (t (15) = -2.545, p = .022), EEG2 (t (15) = -2.196, p = .044), and EEG2b (t (15) 
= -2.351, p = .033). Paired t-test to compare tDCS interactions showed the only significant difference 
between real stimulation and sham was found in IST fixed condition (t (16) = 2.341, p = .033), 







Figure 5-5. Skin conductance level (SCL) during the whole session in Experiment IV. SCL log amplitude (µS) in low 
impulsive (LI) and high impulsive (HI) participants, during tDCS real stimulation and sham conditions, across rest periods 
(baseline, pre-tDCS electroencephalogram (EEG1) and post-tDCS (EEG2)) and tasks performance periods (Cambridge 
gambling task (CGT) in ascending (asc) and descending (des) conditions; information sampling task (IST) in fixed (fix) 
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5.4.3.2 Skin conductance level during pre-tDCS and post-tDCS rest periods 
Results showed no significant differences in tDCS time (p > .05) in SCL between pre-tDCS (EEG1) 
and post-tDCS (EEG2) conditions. However, SCL during EEG1 and EEG2 was also analysed 
subdividing the EEG recordings into two parts (EEGa and EEGb, for first and second half of the 
recordings, respectively). EEGb showed no significant main effects of tDCS time, nor significant 
interactions (all effects p > .05). However, in EEGa, there was a main effect of tDCS (F (1, 15) = 
14.063, p =.002, ηp2 =.484) indicating that SCL was lower in condition real stimulation compared 
with sham. A main effect of tDCS time (F (1, 15) = 69.110, p =.001, ηp2 =.822), showed that SCL 
was lower in EEG1 compared with EEG2. An interaction tDCS x tDCS time (F (1, 15) = 19.994, p 
=.001, ηp2 =.571), showing that both real stimulation and sham conditions had similar SCL in EEG1. 
In EEG2, SCL increased compared with EEG1, however the increase in real stimulation condition 
was lower compared with the increase in sham condition.  
 
There was also an interaction time x group (F (1, 15) = 9.679, p =.007, ηp2 =.392), showing that HI 
had higher SCL compared with LI in both EEG1 and EEG2, and that the difference between the 
groups was lower in EEG2, compared with EEG1. In EEGb, there was an interaction tDCS x tDCS 
time x group (F (1, 15) = 4.930, p =.042, ηp2 =.247), showing that LI had lower SCL than HI in both 
tDCS conditions. Also, in real stimulation, LI had similar SCL in EEG1 and EEG2, and HI had higher 
SCL in EEG2 compared with EEG1, but in sham both groups LI and HI, had higher SCL in EEG2 
compared with EEG1. The largest difference between the groups was found in EEG2 in real 
stimulation, but in EEG1 in sham.  
 
To analyse SCL interactions found between EEG1 and EEG2 periods, paired samples t-tests showed 
that SCL was significantly lower in EEG1 compared with EEG2 (t (16) = -2.409, p = .028) and in 
EEG1a compared with EEG2a (t (16) = -3.807, p =.002) in real stimulation, but not significantly 
different in EEGb in real stimulation, or in any of the EEG subdivisions in sham. Independent sample 
(2-tailed) t-tests to analyse SCL interactions with groups revealed that SCL was higher in HI 
compared with LI in real stimulation, in EEG1a (t (15) = -2.207, p = .028), in EEG2 (t (15) = -2.393, 
p = .028) and EEG2b (t (15) = -2.682, p = .017), as well as in sham, in EEG1 (t (15) = -2.533, p = 
.023), EEG1a (t (15) = -2.506, p = .024), EEG1b (t (15) = -2.461, p = .026), EEG2 (t (15) = -2.196, p 






Figure 5-6. Skin conductance level (SCL) before and after tDCS. SCL log amplitude (µS) during the first half of the five 
minutes electroencephalogram (EEGa) recordings during pre-tDCS (EEG1) and post-tDCS (EEG2), in tDCS conditions 
real stimulation and sham with low impulsive (LI) and high impulsive (HI) participants. Data represents mean and SEM 






















5.4.3.3 Local skin conductance level during Cambridge gambling task risk conditions  
Results showed that main effects were not significant for tDCS, tDCS time, risk or condition (all 
effects p > .05). However, there was a significant three way interaction tDCS x condition x group (F 
(1, 15) = 6.551, p =.022, ηp2 =.304), indicating that in real stimulation, LI had lower SCL in CGT 
ascending condition compared with descending condition, however, HI had higher SCL in ascending 
condition compared with descending condition. In sham, LI had no different SCL between both task 
conditions, but HI had slightly higher SCL in descending condition. In both tDCS conditions, HI 
showed higher SCL than LI, but their levels were closer in real stimulation descending condition. 
Moreover, a three way interaction tDCS x risk x group (F (1, 15) = 3.732, p =.018, ηp2 =.199), showed 
that in real stimulation, SCL decreased with increasing CGT risk conditions in LI, however in HI, 
SCL increased with increasing risk conditions, with the largest difference between groups found in 
the most risky condition (6:4), and the smallest difference between groups in the lowest risk condition 
(9:1). In sham, LI showed higher SCL in the 6:4 compared with 9:1, however in HI, 6:4 was associated 
with similar SCL than 9:1. In all conditions, SCL was higher in HI than in LI.  
 
Independent t-tests (2-tailed) to investigate the differences in CGT SCL between groups showed that 
in real stimulation, LI had significantly lower SCL in ascending 6:4 (t (15) = -2.643, p = .018) 
compared with HI, however in sham, LI had lower SCL in the ascending 9:1 (t (15) = -2.388, p = 
.031) and descending 8:2 (t (15) = -2.292, p = .037) and 6:4 (t (15) = -2.541, p = .023), compared with 
HI. Paired t-tests to investigate differences in tDCS condition showed no significant results. These 







Figure 5-7. Skin conductance level (SCL) during different risk conditions (box ratio) in Experiment IV. SCL amplitude 
(µS) in low impulsive (LI) and high impulsive (HI) participants during tDCS real stimulation and sham conditions, across 
Cambridge gambling task (CGT) risk conditions represented by box ratios (9:1, 8:2, 7:3 and 6:4) in ascending and 
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5.4.3.4 Skin conductance responses (SCRs) during task reward outcomes (wins and losses) 
Cambridge gambling task (CGT) 
Results showed a main effect of outcome (F (1, 15) = 5.667, p =.031, ηp2 =.274), indicating that SCRs 
were higher in wins than in losses. There was a main effect of response (F (1, 15) = 43.923, p =.001, 
ηp2 =.745), showing that SCRs were higher in feedback response compared with anticipatory 
response. However, there were no main effects of tDCS (p > .05). A three way interaction tDCS x 
outcome x group (F (1, 15) = 5.082, p =.040, ηp2 =.253), showed that in both sessions, HI showed 
higher SCRs compared with LI, and in both groups SCRs were higher in wins than loses, however in 
the session in which real stimulation was delivered, SCRs were higher in wins than in losses in HI, 
but had similar levels between wins and losses in LI. In the session with sham tDCS, SCRs were more 
similar between wins and losses in HI, with greater difference between wins and losses found in LI. 
There was also an interaction outcome x response (F (1, 15) = 11.345, p =.004, ηp2 =.431), indicating 
that there was a larger difference between anticipatory response and feedback response in losses 
compared to wins.  
 
Independent t-tests (2-talied) to investigate the differences in CGT SCRs between groups showed that 
in sham condition, LI had lower feedback SCRs associated to wins in ascending condition compared 
with HI (t (15) = -2.336, p = .034). In addition, LI had lower anticipatory SCRs (t (15) = -2.495, p = 
.025) and feedback response (t (15) = -2.382, p = .031) associated with losses compared with HI. To 
investigate the differences in SCRs between tDCS conditions, paired t-tests revealed no significant 
differences between real stimulation and sham. To investigate the interactions outcome x response, 
paired t-tests were conducted revealing significant differences between anticipatory and feedback 
SCRs in real stimulation in ascending wins (t (16) = -5.475, p = .001), and losses (t (16) = -4.102, p 
= .001) and descending wins (t (16) = -5.449, p = .001) and losses (t (16) = -4.111, p = .001). In sham 
condition, differences between anticipatory and feedback response were found in CGT ascending 
wins (t (16) = -4.477, p = .001), and losses (t (16) = -5.042, p = .001), descending wins (t (16) = -
5.037, p = .001) and losses (t (16) = -5.247, p = .001). In real stimulation condition, differences in 
SCRs between wins and losses in CGT ascending anticipatory responses (t (16) = 2.335, p = .033), 
showing higher anticipatory responses associated with wins than with losses. In sham condition 
differences between wins and losses in CGT descending anticipatory responses (t (16) = 2.489, p = 







Figure 5-8. Skin conductance responses (SCRs) during Cambridge gambling task (CGT) performance in Experiment IV. 
SCRs log amplitude (µS), including reward anticipatory (A) and feedback (F) responses, when low impulsive (LI) and 
high impulsive (HI) participants won or lost each trial in the CGT, during tDCS real stimulation and sham and ascending 
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Information sampling task (IST) 
Results showed a main effect of response (F (1, 15) = 36.090, p =.001, ηp2 =.706), indicating that the 
SCRs were higher in feedback responses than in anticipatory responses. However there were no 
significant main effects of tDCS or outcome (all effects p > .05). In addition, there was an interaction 
tDCS x response (F (1, 15) = 5.106, p =.039, ηp2 =.254), showing that SCRs were higher in real 
stimulation than in sham, and that the difference between anticipatory responses and feedback 
responses was larger in sham compared with real stimulation. There was a four way interaction tDCS 
x response x condition x groups (F (1, 15) = 5.660, p =.031, ηp2 =.274), showing that HI had higher 
SCRs than LI. In real stimulation, SCRs were higher in ascending condition in HI, but lower compared 
with descending condition in LI, however in sham condition, both groups had similar SCRs between 
ascending and descending task conditions, with higher SCRs in HI compared with LI. The anticipatory 
responses had lower amplitude than feedback responses, however the difference between them seem 
to be greater in sham compared to real stimulation.  
 
To investigate groups differences in SCRs in IST independent t-tests (2-tailed) analysis showed that, 
in fixed condition, LI had lower feedback SCRs associated to wins in real stimulation (t (15) = -2.169, 
p = .047), and in sham (t (15) = -2.334, p = .034), as well as lower anticipatory SCRs associated with 
losses (t (15) = -2.798, p = .014) and feedback SCRs (t (15) = -2.456, p = .027) in sham. Moreover, 
in decreased condition, LI had lower anticipatory SCRs and feedback SCRs (t (15) = -2.273, p = .038) 
associated with wins (t (15) = -2.410, p = .029), and lower anticipatory responses (t (15) = -2.517, p 
= .024) and feedback responses (t (15) = -2.271, p = .038) associated with losses in sham.  
 
To investigate the interactions outcome x response, paired t-tests were conducted revealing that in 
real stimulation, the anticipatory responses were significantly lower compared with feedback 
responses in fixed condition wins (t (16) = -5.080, p = .001), and losses (t (16) = -2.354, p = .032), 
and in decreased condition wins (t (16) = -3.631, p = .002) and losses (t (16) = -4.072, p = .001). In 
sham condition, differences between anticipatory and feedback response were found in fixed 
condition wins (t (16) = -2.495, p = .002), and losses (t (16) = -2.495, p = .001), and decreased wins 
(t (16) = -6.488, p = .001) and losses (t (16) = -5.701, p = .001). There were no significant differences 
between wins and losses in any of the variables (all effects p > .05). Paired t-tests to investigate 
interactions with tDCS showed that there were no significant differences in SCRs between real 






Figure 5-9. Skin conductance responses (SCRs) during information sampling task (IST) performance in Experiment IV. 
SCRs log amplitude (µS), including reward anticipatory (A) and feedback (F) responses, when low impulsive (LI) and 
high impulsive (HI) participants won or lost each trial in the IST, during tDCS real stimulation and sham, and fixed and 
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Stop signal task (SST) 
Results showed a main effect of outcome in SST (F (1, 15) = 8.529, p =.011, ηp2 =.362), indicating 
that the SCRs were higher in losses than in wins. There was also a main effect of response (F (1, 15) 
= 62.043, p =.001, ηp2 =.805), showing that SCRs were higher in the feedback responses than in the 
anticipatory responses. There were no significant main effects of tDCS (p > .05). Results revealed an 
interaction outcome x response (F (1, 15) = 4.776, p =.045, ηp2 =.241), showing that anticipatory 
responses were similar between wins and losses, however feedback responses were higher in losses 
compared to wins.  
 
To investigate the interactions outcome x response, paired t-tests revealed lower anticipatory 
responses compared with feedback responses in SST wins (t (16) = -5.140, p = .001) and in losses (t 
(16) = -2.495, p = .001) in real stimulation. In sham condition, differences between anticipatory and 
feedback response were also found in wins (t (16) = -4.375, p = .001), and losses (t (16) = -6.019, p = 
.001). In real stimulation condition, there were lower feedback responses associated with wins than 
with losses (t (16) = -4.118, p = .025), as well as in sham condition, in which feedback responses had 











Figure 5-10. Skin conductance responses (SCRs) during stop signal task (SST) performance in Experiment IV. SCRs log 
amplitude (µS), including reward anticipatory (A) and feedback (F) responses, when low impulsive (LI) and high 
impulsive (HI) participants won or lost each trial in the SST during tDCS real stimulation and sham. Data represents mean 
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5.4.4 Heart Rate Variability (HRV) 
5.4.4.1 Low frequency (LF) and high frequency (HF) measures during the whole session 
Results showed a main effect of period in total power (F (1, 15) = 2.586, p =.017, ηp2 =.147), 
indicating that the periods from lowest to highest total power were: baseline, CGT descending, EEG1, 
CGT ascending, SST, EEG2, IST fixed and IST decreased. However, there were no significant main 
effects of tDCS, or significant interactions (all effects p > .05).  
 
5.4.4.2 Low frequency (LF) and high frequency (HF) measures during pre-tDCS and post-tDCS rest 
periods 
Results revealed no significant main effects of tDCS, period or any interactions (all effects p > .05).  
 
5.4.4.3 Low frequency (LF) and high frequency (HF) measures during task performance 
Results showed a main effect of period in absolute LF power (F (1, 15) = 2.823, p =.033, ηp2 =.158) 
showing that the tasks from lowest to highest total power were: CGT descending, CGT ascending, 
SST, IST decreased and IST fixed. However there were no significant main effects of tDCS (p > .05). 
In LF relative power there was an interaction tDCS x period x group (F (1,15) = 3.617,  p =.010, ηp2 
=.194), showing that in real stimulation, LF relative power was higher in HI compared with LI in all 
periods except in SST, in which both groups had similar LF power. The largest difference between 
HI and LI was found in IST decreased condition. In contrast, in sham, HI had higher LF power in all 
tasks compared to LI, with the smallest difference between groups being IST decreased condition and 
the largest being CGT ascending condition and SST.  
 
There were no main effects of tDCS or period in HF absolute and relative power (all effects p > .05). 
However, in HF relative power there was an interaction tDCS x task x group (F (1,15) = 3.563,  p 
=.011, ηp2 =.192), showing that in real stimulation, relative HF power was higher in LI compared with 
HI in all tasks, except in SST, in which both groups had the same level. The largest difference between 
the groups was found in IST decreased condition. In sham, LI had higher HF power than LI in all 
tasks, with the smallest difference between the groups found in IST decreased condition, and the 





To investigate HRV interactions with groups, independent t-tests revealed that LI had significantly 
lower LF relative power than HI in real stimulation during IST decreased condition (t (15) = -3.246, 
p = .005) and in sham, during CGT descending condition (t (15) = -3.432, p = .004) and SST (t (15) 
= -3.475, p = .003). Moreover, LI had significantly higher HF relative power than HI in real 
stimulation during IST decreased condition (t (15) = 3.156, p = .007), and in sham, during CGT 
descending condition (t (15) = 3.392, p = .004) and SST (t (15) = 3.451, p = .004). These results are 
represented in Figure 5-11. To investigate tDCS interactions, paired t-tests comparing LF and HF 









Figure 5-11. Heart rate variability (HRV) during task performance periods in Experiment IV. Low frequency (LF) and 
high frequency (HF) relative power (nu) in low impulsive (LI) and high impulsive (HI) participants, in tDCS real 
stimulation and sham conditions, during tasks performance periods including: Cambridge gambling task (CGT) ascending 
(asc) and descending (des) conditions; information sampling task (IST) fixed (fix) and decreased (dec) conditions; and 
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5.4.4.4 Heart rate during the tasks performance periods  
HR during task performance results showed no differences between tasks in mean HR, or maximum 
HR (all effects p > .05). However, a main effect of period in minimum HR (F (2.510, 37.649) = 3.421, 
p = .034, ηp2 =.186) showed that minimum HR was higher in CGT descending condition with around 
60 bpm, followed by CGT ascending and SST, IST decreased and lowest in IST fixed condition, with 
around 45 bpm.  
 
5.4.4.5 Heart rate during Cambridge gambling task risk conditions 
Results revealed no significant effects of HR during CGT risk conditions (all effects p > .05). 
 
5.4.4.6 Heart rate during task reward outcomes (wins and losses) 
Cambridge gambling task (CGT) 
Results showed no significant effects in CGT during reward outcomes (all effects p > .05).  
 
Information sampling task (IST) 
Mean HR showed a significant main effect of outcome (F (1, 15) = 5.931, p =.028, ηp2 =.283), 
indicating that mean HR was higher in wins than in losses. However no significant main effects of 
tDCS or condition were found (all effects p > .05). There was an interaction outcome x group (F (1, 
15) = 4.920, p =.042, ηp2 =.247), showing that LI had similar mean HR between wins and losses, 
however HI showed a large difference between wins (with higher mean HR) and losses. HI had higher 
mean HR in wins than LI, but lower mean HR in losses compared to LI. There was also an interaction 
tDCS x outcome (F (1, 15) = 4.559, p =.050, ηp2 =.233), showing that in both, real stimulation and 
sham, mean HR was higher in wins than in losses, but the difference between wins and losses was 
larger in real stimulation, being slightly higher for wins than sham, but much lower than sham in 
losses.  
 
In maximum HR, there was a main effect of condition (F (1, 15) = 5.509, p =.033, ηp2 =.269), 
indicating that maximum HR was higher in IST decreased condition, and a main effect of outcome (F 




losses. There was no main effect of tDCS (p > .05). Results showed an interaction outcome x group 
(F (1, 15) = 4.878, p =.043, ηp2 =.245), showing that both groups had higher maximum HR in wins 
than in losses, but maximum HR was higher in HI compared to LI in wins but lower than LI in losses, 
and the difference between the groups was larger in wins than in losses.  
 
Similarly, in minimum HR, there was a main effect of condition (F (1, 15) = 4.958, p =.042, ηp2 
=.248), showing that minimum HR was lower in fixed condition compared to deceased condition. No 
main effects of tDCS were found (p > .05). There was an interaction condition x group (F (1,15) = 
4.867,  p =.043, ηp2 =.245), showing that in LI minimum HR was similar between both conditions, 
but in HI, minimum HR was lower in fixed condition, and higher in decreased condition. The 
difference between the groups was small in fixed condition, in which LI had higher minimum HR 
compared to HR, and larger in decreased condition, where HI had greater minimum HR than LI. There 
was an interaction outcome x groups (F (1,15) = 4.652,  p =.048, ηp2 =.237), showing that in LI had 
lower minimum HR in wins compared with HI, The difference between groups was larger in wins 
than in losses. There was an interaction condition x outcome (F (1, 15) = 4.761, p =.045, ηp2 =.241), 
showing that the difference in minimum HR between tasks conditions fixed and decreased was larger 
in losses than in wins.  
 
Stop signal task (SST) 
In SST, there were no main effects of tDCS or outcome (all effects p > .05). However, there was an 
interaction outcome x groups (F (1, 15) = 4.678, p =.047, ηp2 =.238) in minimum HR, showing that 
LI had lower minimum HR than HI in wins and losses, and that the difference between the groups 
was larger in losses. LI had higher minimum HR in wins compared to losses, but HI had lower 
minimum HR in wins compared to losses.  
 
To investigate the group interactions with mean HR, minimum HR and maximum HR, during task 
performance outcomes, independent samples t-tests revealed that in sham, LI had significantly lower 
mean HR (t (15) = -2.627, p = .019) and lower minimum HR (t (15) = -2.523, p = .023) in IST 
decreased wins, compared with HI. In SST, LI had lower minimum HR (t (15) = -3.405, p = .004) 
associated with wins, and losses (t (15) = -3.214, p = .006) compared with HI. To investigate tDCS 
condition interactions, paired t-tests revealed no significant differences between mean HR during IST 







Figure 5-12. Heart rate (HR) during task performance outcomes in Experiment IV. Mean HR (bpm) in information 
sampling task (IST), and minimum HR (bpm) in stop signal task (SST), in low impulsive (LI) and high impulsive (HI) 
participants, in tDCS real stimulation and sham conditions, during tasks performance outcomes won and lost. Data 
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5.4.5 Electroencephalogram (EEG) 
5.4.5.1 Theta/beta ratio  
Results showed a main effect of tDCS (F (1, 105) = 5.244, p =.037, ηp2 =.259), indicating that 
theta/beta ratio was lower in real stimulation compared with sham. There was a main effect of 
electrode (F (7, 15) = 7.906, p =.001, ηp2 =.345), indicating that the electrodes with higher to lower 
theta/beta ratio were Fpz followed by Cz and AF7 followed by AF4 and F4, then AF8 and lastly FC6. 
There were no significant main effects of tDCS or interactions (all effects p > .05).  
 
5.4.5.2 Mean frequency power  
Results showed a main effect of electrode, indicating that the electrodes with higher to lower mean 
frequency power were: FC6, F3, AF8, F4, AF4, Cz, AF7, and Fpz. There were no main effects of 
tDCS or tDCS time (all effects p > .05). There was an interaction tDCS condition x tDCS time, 
showing that in real stimulation, mean frequency power decreased from EEG1 (pre-tDCS) to EEG2 
(post-tDCS), but in sham, mean frequency increased from EEG1 to EEG2. There was an interaction 
tDCS x group, showing that LI had higher mean frequency power in real stimulation compared with 
sham, however HI showed lower mean frequency power in real stimulation compared with sham. In 
addition, the difference between real stimulation and sham was smaller in HI. In addition, HI showed 
higher mean frequency power than LI, with the difference between the groups being smaller in real 
stimulation and larger in sham.  
 
To investigate interactions with group, independent t-tests  revealed that LI had lower mean frequency 
power than HI in sham EEG2, in AF8 (t (15) = -2.597, p = .020) and F3 (t (15) = -2.587, p = .021). 
To investigate interactions with tDCS time, paired sample t-tests showed that EEG1 was lower than 
EEG2 in sham, electrode position F3 (t (15) = -2.292, p = .036). To investigate interactions with tDCS 
condition, paired t-tests showed that mean frequency power was higher in real stimulation compared 
with sham in EEG1 in all electrodes except in Cz and F3: AF8 (t (16) = 2.434, p = .027), AF4 (t (16) 
= 2.885, p = .011), Fpz (t (16) = 2.403, p = .029), F4 (t (16) = 2.615, p = .019), FC6 (t (16) = 3.015, 
p = .008) and AF7 (t (16) = 2.220, p = .041). However, in EEG2 there were no significant differences 
between real stimulation and sham (all effects p > .05). These results are represented in Figure 5-13. 
In addition, EEG power spectrograms showing inter-individual and intra-individual variability across 






Figure 5-13. Electroencephalogram (EEG) mean frequency power in Experiment IV. Mean frequency power (Hz) of EEG 
resting state recordings pre-tDCS (EEG1) and post-tDCS (EEG2), across electrode positions with the international EEG 
10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7) for low impulsive (LI) and high impulsive (HI) participants in 
tDCS real stimulation and sham conditions. Data represents mean and SEM (* p < .05). 
 
                                          * 
                                        *                   * 




5.4.5.3 Delta absolute and relative power  
Results showed no significant effects in delta absolute power in (all effects p > .05). In delta relative 
power, there was a main effect of tDCS (F (1, 15) = 9.350, p =.008, ηp2 =.384), showing that lower 
relative delta power was associated with real stimulation compared with sham. There was also a main 
effect of electrode (F (7, 105) = 10.490, p =.001, ηp2 =.412), showing that electrodes from highest to 
lowest delta relative power were AF7, Fpz, AF8, AF4, F3, FC6, F4 and Cz. There was an interaction 
time x group F (1,15) = 5.229,  p =.037, ηp2 =.258, showing that in LI, delta relative power increased 
from EEG1 to EEG2, however in HI relative delta power decreased from EEG1 to EEG2. The groups 
showed a greater difference in EEG1, where HI had higher delta relative power than LI, and a smaller 
difference in EEG2, where HI had lower delta relative power than LI. There was also an interaction 
tDCS x tDCS time (F (1,15) = 9.252,  p =.008, ηp2 =.381), showing that in real stimulation, delta 
relative power increased from EEG1 to EEG2, however in sham, delta relative power decreased from 
EEG1 to EEG2. In both, EEG1 and EEG2, real stimulation was associated with lower delta relative 
power compared to sham, finding the largest difference between real stimulation and sham in EEG1.  
 
To investigate groups interactions, independent t-tests revealed that LI had higher relative delta power 
than HI in sham EEG2, in electrode position F3 (t (15) = 2.334, p = .034). To investigate tDCS time 
interactions, paired t-tests showed that EEG1 was lower than EEG2 in real stimulation, in electrode 
positions AF8 (t (16) = -2.400, p = .029), AF4 (t (16) = -2.400, p = .015), Fpz (t (16) = -2.400, p = 
.002) and FC6 (t (16) = -2.400, p = .011). However, EEG1 was higher than EEG2 in sham, in electrode 
positions Cz (t (16) = 2.876, p = .011), AF8 (t (16) = 2.160, p = .046), AF4 (t (16) = 2.494, p = .024), 
Fpz (t (16) = 2.202, p = .043), and F4 (t (16) = 2.722, p = .015). To investigate tDCS condition 
interactions, paired t-tests showed that delta relative power was lower in real stimulation compared 
with sham, in EEG1, in all electrode positions: Cz (t (16) = -3.212, p = .005), AF8 (t (16) = -2.964, p 
= .009), AF4 (t (16) = -3.719, p = .002), Fpz (t (16) = -3.423, p = .003), F4 (t (16) = -3.518, p = .003), 
FC6 (t (16) = -3.794, p = .002), F3 (t (16) = -2.710, p = .015) and AF7 (t (16) = -2.494, p = .024). 
However, in EEG2, there were no significant differences between real stimulation and sham 






5.4.5.4 Theta absolute and relative power 
Results showed a main effect of electrode (F (7, 105) = 20.262, p =.001, ηp2 =.575) in theta absolute 
power, showing that electrodes from highest to lowest theta absolute power were: Fpz, AF7, F3, Cz, 
F4, AF4, AF8 and FC6. There were no main effects of tDCS or tDCS time (all effects p > .05). There 
was an interaction tDCS x electrode x group (F (7, 105) = 3.168, p =.037, ηp2 =.174), showing that LI 
had higher theta absolute power than HI in real stimulation in all electrodes, and that the largest 
difference between the groups was found in F4. However, in sham LI had lower absolute theta power 
than HI in all electrodes. Independent t-tests to compare absolute theta power between groups revealed 
that there were no significant differences (all effects p > .05).  
 
In theta relative power, results showed a main effect of tDCS (F (1, 15) = 38.627, p =.001, ηp2 =.720) 
indicating that real stimulation was associated with lower theta relative power compared with sham. 
There was a main effect of tDCS time (F (1, 15) = 39.274, p =.001, ηp2 =.724), showing that theta 
relative power decreased from EEG1 to EEG2. There was a main effect of electrode (F (7, 105) = 
44.268, p =.001, ηp2 =.747), showing that the electrode with higher theta relative power was F4, and 
the rest of electrodes showed lower theta relative power. There was an interaction tDCS x tDCS time 
(F (1,15) = 42.082,  p =.001, ηp2 =.737), showing that in real stimulation, similar theta relative power 
was found in both EEG1 and EEG2 conditions, however in sham, theta relative power decreased from 
EEG1 to EEG2. There was an interaction tDCS x electrode (F (7, 105) = 44.268, p =.001, ηp2 =.747), 
showing that the only electrode that differed between real stimulation and sham was F4, which showed 
higher theta relative power in sham compared with real stimulation. There was also an interaction 
time x electrode (F (7, 105) = 44.088, p =.001, ηp2 =.746), showing that the only electrode that differed 
between EEG1 and EEG2 was F4, showing higher theta relative power in EEG1. Lastly, there was a 
three way interaction tDCS x tDCS time x electrode (F (7, 105) = 43.884, p =.001, ηp2 =.745), showing 
that in real stimulation, all electrodes showed an increase in theta relative power from EEG1 to EEG2, 
however in sham, all electrodes showed no difference between EEG1 and EEG2 conditions, except 
for F4 that showed higher theta relative power in EEG1, whereas in EEG2 theta relative power was 
lower, as in the rest of electrodes.  
 
To investigate group interactions, independent sample t-tests showed no significant differences in 
theta absolute power between LI and HI (all effects p > .05). To investigate tDCS time interactions, 




investigate tDCS condition interactions, paired t-tests showed no significant differences between real 
stimulation and sham in EEG1 (all effects p > .05). However, in EEG2, theta relative power was 
higher in real stimulation compared with sham in electrode positions: AF8 (t (16) = 2.180, p = .045), 
Fpz (16) = 2.608, p = .019), FC6 (16) = 2.397, p = .029) and AF7 (16) = 3.474, p = .003).  
 
5.4.5.5 Alpha absolute and relative power 
Results showed a main effect of electrode (F (7, 105) = 15.981, p =.001, ηp2 =.516) in alpha absolute 
power, indicating that electrodes from highest to lowest alpha absolute power were: Cz, F3, AF7, Fpz, 
F4 and AF4, AF8 and the lowest was FC6. There were no main effects of tDCS or tDCS time, nor 
interactions (all effects p > .05).  
 
In relative power, results showed a main effect of tDCS (F (1, 15) = 5.066, p =.040, ηp2 =.252), 
indicating that real stimulation was associated with higher alpha relative power compared to sham. 
There was also a main effect of electrode (F (7, 105) = 19.926, p =.001, ηp2 =.571), showing that 
electrodes from highest to lowest alpha relative power were: Cz, F4, AF4, F3, FC6, Fpz, AF7 and 
AF8. However there was no main effect of tDCS time (p > .05). There was also a four way interaction 
tDCS x tDCS time x electrode x group (F (7, 105) = 3.801  p =.009, ηp2 =.202), showing that in real 
stimulation, alpha relative power decreased from EEG1 to EEG2 in all electrodes, and in greater 
amount for LI compared with HI. However, in sham, alpha relative power increased from EEG1 to 
EEG2, and the increase was greater in HI than in LI. In both tDCS conditions LI had higher relative 
alpha power than HI.  
 
To investigate group interactions, independent sample t-tests revealed that LI had significantly higher 
relative alpha power than HI in real stimulation EEG1 in electrodes positions Fpz (t (15) = 2.261, p = 
.039) and AF7 (t (15) = 2.324, p = .035), as well as in EEG2, in electrodes AF8 (t (15) = 3.108, p = 
.007), AF4 (t (15) = 2.636, p = .019),  Fpz (t (15) = 2.257, p = .039) and AF7 (t (15) = 2.630, p = 
.019). In sham condition, LI had higher alpha relative power compared with HI in EEG1 in electrodes 
Cz (t (15) = 3.170, p = .006),  AF8 (t (15) = 2.406, p = .029),  AF4 (t (15) = 2.638, p = .019), Fpz (t 
(15) = 2.576, p = .021), F4 (t (15) = 2.859, p = .012),  F3 (t (15) = 2.653, p = .018) and AF7 (t (15) = 
2.382, p = .031), whereas no differences were found in EEG2 (all effects p > .05). To investigate 
tDCS time interactions, paired t-tests showed no significant differences between EEG1 and EEG2. 




significantly higher in real stimulation compared with sham in EEG1, in electrode positions: Cz (16) 
= 2.384, p = .030), AF4 (16) = 2.168, p = .046), Fpz (16) = 2.179, p = .045), F4 (16) = 2.388, p = 
.030) and FC6 (16) = 2.502, p = .024). However, in EEG2 there were no significant differences 
between real stimulation and sham (all effects p > .05).  
 
5.4.5.6 Beta absolute and relative power 
There were no main effect of tDCS, tDCS time or electrode (all effects p > .05). However results 
revealed an interaction tDCS x group (F (1, 15) = 16.518, p =.005, ηp2 =.412) in beta absolute power 
showing that LI had higher beta absolute power in real stimulation compared with sham. In contrast, 
HI had higher beta absolute power in sham compared with real stimulation. The largest difference 
between the groups was found in sham condition, where HI had higher beta absolute power than LI, 
but in real stimulation, the levels were higher in LI, but with a smaller difference between the groups. 
Beta relative power analysis revealed a main effect of electrode, indicating that electrodes from 
highest to lowest beta relative power were: FC6, F3, F4, AF8, AF4, Cz, AF7 and Fpz. There were no 
main effects of tDCS, tDCS time or interactions (all effects p > .05).   
 
To investigate group interactions, independent samples t-tests showed no significant differences 
between LI and HI in beta absolute power. To investigate interactions with tDCS condition, paired 
samples t-tests showed no significant differences in beta absolute power between real stimulation and 
sham (all effects p > .05).  
 
5.4.6 Correlations 
Correlations between questionnaires and physiological measures during task performance with 
gambling severity and physiological measures in the baseline are summarised in Table 5-217. 
 
                                                 




5.4.6.1 Correlations between gambling severity and self-report measures  
Gambling severity measured with PGSI correlated positively with UPPS-NU (r = .647, n = 17, p = 
.005), and with VAS in both sessions, real stimulation (r = .796, n = 17, p = .001), and sham (r = .521, 
n = 17, p = .032).  
 
5.4.6.2 Correlations between gambling severity and electrodermal activity measures  
During CGT performance, gambling severity (PGSI) correlated positively in real stimulation with: 
SCL in CGT ascending condition (r = .585, n = 17,  p = .014); with SCL in CGT ascending highest 
risk condition (r = .536, n = 17,  p = .027); with SCRs in CGT wins (r = .617, n = 17,  p = .008) and 
losses (r = .616, n = 17,  p = .009) in ascending condition; with SCL in CGT descending condition (r 
= .483, n = 17,  p = .049); with SCL in risk condition 8:2 (r = .503, n = 17,  p = .040); with SCL in 
risk condition 7:3 (r = .492, n = 17,  p = .045); and with SCRs during wins (r = .551, n = 17,  p = .022) 
and losses (r = .508, n = 17,  p = .038). In sham, PGSI correlated positively with: SCL during CGT 
ascending condition (r = .823, n = 17,  p = .001); with SCL in CGT risk condition 9:1 (r = .755, n = 
17,  p = .001); with SCL in risk condition 8:2 (r = .733, n = 17,  p = .001); with SCL in CGT risk 
condition 7:3 (r = .862, n = 17,  p = .001); and with SCL in risk condition 6:4 (r = .631, n = 17,  p = 
.007); with SCRs during wins (r = .799, n = 17,  p = .001) and losses (r = .797, n = 17,  p = .001); with 
SCL CGT descending condition (r = .771, n = 17,  p = .001); with SCL in risk condition 9:1 (r = .712, 
n = 17,  p = .001); with SCL in risk condition 8:2 (r = .703, n = 17,  p = .002); with SCL in risk 
condition 7:3 (r = .796, n = 17,  p = .001); and with SCL in risk condition 6:4 (r = .632, n = 17,  p = 
.006); and also with SCRs during wins (r = .696, n = 17,  p = .002) and losses (r = .738, n = 17,  p = 
.001).  
 
During IST performance, PGSI correlated positively with real stimulation SCRs during wins in fixed 
condition (r = .528, n = 17, p = .030). In sham, PGSI correlated positively with: SCL in IST fixed 
condition (r = .533, n = 17,  p = .028); with SCRs during decreased condition in wins (r = .682, n = 
17,  p = .003) and losses (r = .531, n = 17,  p = .028); with SCL in decreased condition (r = .581, n = 
17,  p = .015); and with SCRs during wins (r = .686, n = 17,  p = .002) and losses (r = .504, n = 17,  p 





During SST performance, PGSI correlated positively with anticipatory SCRs in losses (r = .503, n = 
17, p = .039) in real stimulation, and in sham with SCL during SST (r = .568, n = 17, p = .017); with 
feedback SCRs during wins (r = .491, n = 17, p = .046), and with anticipatory SCRs in losses (r = 
.517, n = 17, p = .034).  
 
Furthermore, baseline EDA recordings were used to assess the relationship between skin conductance 
at rest and gambling-related behavioural and physiological measures during the experimental session. 
Pearson´s correlation analysis showed that baseline EDA in the session of real stimulation correlated 
positively with variables in the same session: ASRS total (r = .732, n = 17, p = .001), with EDA during 
EEG1 (r = .896, n = 17, p = .001), and EEG2 (r = .880, n = 17, p = .001), with maximum HR during 
the baseline (r = .675, n = 17, p = .003), with mean HR during CGT ascending condition wins (r = 
.852, n = 17, p = .001) and losses (r = .853, n = 17, p = .001), and with descending condition wins (r 
= .875, n = 17, p = .001), and losses (r = .881, n = 17, p = .001), as well as with mean HR during IST 
fixed condition wins (r = .801, n = 17, p = .001) but not losses, and with decreased condition wins (r 
= .801, n = 17, p = .001) and losses (r = .818, n = 17, p = .001), and also with mean HR during SST 
wins (r = .792, n = 17, p = .001) and losses (r = .705, n = 17, p = .002). Lastly, baseline EDA correlated 
negatively with EEG1 delta absolute power in electrode positions Cz (r = .535, n = 17, p = .027), AF4 
(r = .595, n = 17, p = .012), Fpz (r = .543, n = 17, p = .024), F4 (r = .562, n = 17, p = .019), and F3 (r 
= .646, n = 17, p = .005), as well as with delta relative power in electrode positions AF8 (r = .604, n 
= 17, p = .010), Fpz (r = .646, n = 17, p = .005), F4 (r = .604, n = 17, p = .010), F3 (r = .654, n = 17, 
p = .004), and AF7 (r = .599, n = 17, p = .011). Baseline EDA correlated positively also with EEG2 
delta absolute power in AF8 (r = .522, n = 17, p = .032) and with relative power in AF8 (r = .558, n 
= 17, p = .020) and F3 (r = .499, n = 17, p = .041). However, there were no significant correlations 
between baseline EDA in sham session and other variables except for EDA during EEG1a (r = .718, 
n = 17, p = .001), and EEG2a (r = .659, n = 17, p = .004). 
 
In addition, baseline EDA in the session of real stimulation correlated positively with variables in the 
session of sham: EDA during EEG1 (r = .507, n = 17, p = .038), and EEG2 (r = .727, n = 17, p = 
.001), with mean HR during baseline (r = .486, n = 17, p = .048), with mean HR during CGT ascending 
condition wins (r = .712, n = 17, p = .001) and losses (r = .749, n = 17, p = .001), and descending 
condition wins (r = .737, n = 17, p = .001) and losses (r = .770, n = 17, p = .001), as well as with mean 
HR during IST fixed condition wins (r = .687, n = 17, p = .002), but not losses, and with decreased 




HR during SST wins (r = .679, n = 17, p = .003) and losses (r = .698, n = 17, p = .002), and with mean 
HR during EEG2 (r = .604, n = 17, p = .010), but there were no significant correlations with EEG in 
sham.  
 
5.4.6.3 Correlations between gambling severity and electrocardiogram measures 
Gambling severity correlated negatively with maximum HR during CGT ascending condition (r = -
.373, n = 17, p = .003), and positively with maximum HR during wins (r = . 651, n = 17,  p = .005) 
and losses (r = .630, n = 17,  p = .007), and with CGT descending condition (r = .664, n = 17,  p = 
.004) and descending 9:1 (r = .638, n = 17,  p = .006). In addition, gambling severity correlated 
negatively with minimum HR during EEG1; r = -.497, n = 17, p = .042), and in IST during fixed 
condition losses with mean HR (r = -.557, n = 17, p = .020), minimum HR (r = -.575, n = 17, p = .016) 
and maximum HR (r = -.541, n = 17, p = .025).  
 
Furthermore, baseline ECG recordings were used to assess the relationship between HRV measures 
at rest and gambling-related behavioural and physiological measures during the experimental session. 
Pearson´s correlation analysis showed that baseline ECG in the session of real stimulation correlated 
with variables in the same session: UPPS-P total score correlated positively with minimum HR (r = 
.551, n = 17, p = .022) and LF/HF (r = .674, n = 17, p = .003). ASRS symptomatology correlated 
positively with LF power (r = .702, n = 17, p = .002) and LF/HF ratio (r = .638, n = 17, p = .006), and 
negatively with HF power (r = -.734, n = 17, p = .001). Delay aversion correlated positively with 
LF/HF ratio in both sessions, real stimulation (r = .552, n = 17, p = .022) and sham (r = .510, n = 17, 
p = .037). Maximum HR correlated negatively with SCRs during CGT ascending wins (r = -.554, n = 
17, p = .021) and losses (r = -.507, n = 17, p = .038) and descending wins (r = -.537, n = 17, p = .026) 
but not in losses. Baseline HR variables correlated positively with HR during CGT wins (r = .853, n 
= 17, p = .001) and losses (r = .852, n = 17, p = .001), IST wins (r = .794, n = 17, p = .001) and losses 
(r = .591, n = 17, p = .012) and SST wins (r = .844, n = 17, p = .001) and losses (r = .844, n = 17, p = 
.001), and also with HR during EEG1 (r = .813, n = 17, p = .001) and EEG2 (r = .656, n = 17, p = 
.004). In addition, minimum HR correlated negatively with beta absolute power in Cz EEG1 (r = -
.484, n = 17, p = .049), and EEG2 (r = -.495, n = 17, p = .043), and beta relative power in Cz EEG1 
(r = -.611, n = 17, p = .009), and EEG2 (r = -.560, n = 17, p = .019), and delta absolute power in Fpz 
EEG1 (r = -.575, n = 17, p = .016). Minimum HR correlated positively with delta relative power in 




relative power in AF4 (r = .554, n = 17, p = .021). LF power correlated negatively with EEG1 beta 
absolute power in AF8 (r = -.561, n = 17, p = .019), beta relative power in AF8 (r = -.618, n = 17, p = 
.008), in Fpz (r = -.557, n = 17, p = .020), and in beta relative power in EEG2 AF7 (r = -.500, n = 17, 
p = .041). LF power correlated positively with theta/beta ratio in AF8 (r = .527, n = 17, p = .030), Fpz 
(r = .501, n = 17, p = .041), AF7 (r = .546, n = 17, p = .023), and in EEG2 delta relative power in AF7 
(r = .508, n = 17, p = .037). HF power correlated positively with beta absolute power in AF8 (r = .537, 
n = 17, p = .026), with beta relative power in AF8 (r = .586, n = 17, p = .014), and in Fpz (r = -.518, 
n = 17, p = .033), and negatively with theta/beta ratio in AF8 (r = -.511, n = 17, p = .036), Fpz (r = -
.488, n = 17, p = .047),  AF7 (r = -.525, n = 17, p = .030),  and in with delta relative power in EEG2 
AF7 (r = -.529, n = 17, p = .029),  and beta relative power in AF7 (r = .499, n = 17, p = .041). 
 
Lastly, baseline ECG variables in the real stimulation session correlated with baseline ECG variables 
in the sham session: variables that correlated positively between both sessions included total power (r 
= .652, n = 17, p = .005), maximum HR (r = .550, n = 17, p = .022) and minimum HR (r = .647, n = 
17, p = .005). In addition, total power correlated negatively with LF/HF ratio (r = -.498, n = 17, p = 
.042), maximum HR correlated with LF power (r = .544, n = 17, p = .024) and mean HR (r = .520, n 
= 17, p = .033), and negatively with HF power (r = -.545, n = 17, p = .024). 
 
5.4.6.4 Correlations between gambling severity and electroencephalogram measures  
Gambling severity in real stimulation EEG1, correlated negatively with beta absolute power in 
electrode AF8 (r = -.525 n = 17,  p = .030), and with alpha relative power in electrode positions: AF4 
(r = -.500, n = 17,  p = .041), Fpz (r = -.533, n = 17,  p = .028), F4 (r = -.525, n = 17,  p = .030), FC6 
(r = -.549, n = 17,  p = .023), F3 (r = -.492, n = 17,  p = .045) and AF7 (r = -.486, n = 17,  p = .048), 
as well as with theta/beta ratio in electrode positions AF4 (r = -.546, n = 17,  p = .023), F4 (r = -.595, 
n = 17,  p = .012), FC6 (r = -.565, n = 17,  p = .018), ), and theta/beta ratio in AF7 (r = -.528, n = 17,  
p = .029). In EEG2, gambling severity correlated negatively with absolute theta power in AF4 (r = -
.512, n = 17, p = .036), and with relative theta power in Fpz (r = -.570, n = 17, p = .017) and F4 (r = -
.512, n = 17,  p = .035) and AF7 (r = -.499, n = 17,  p = .041) as well as with theta/beta ratio in FC6 
(r = -.492, n = 17,  p = .045), In sham EEG1, gambling severity correlated positively with mean power 
frequency in F3 (r = .559, n = 17, p = .020) and alpha relative power in F3 (r = .560, n = 17,  p = .020). 
In sham EEG2, gambling severity correlated positively with mean power frequency in F3 (r = .701, n 




(r = .672, n = 17,  p = .003), and negatively with theta absolute power in electrode positions Cz (r = -
.483, n = 17,  p = .050), AF4 (r = -.569, n = 17,  p = .017), Fpz (r = -.500, n = 17,  p = .041), F4 (r = -
.506, n = 17,  p = .038) F3 (r = -.522, n = 17,  p = .032) and AF7 (r = -.518, n = 17,  p = .033), and 
with delta relative power in F3 (r = -.494, n = 17,  p = .044), theta relative power in F3 (r = -.491, n = 
17,  p = .045),and also with theta/beta ratio in FC6 (r = -.505, n = 17,  p = .039), and F3 (r = .626, n = 







Table 5-2. Summary of correlations between questionnaires and physiological measures during task performance with 
gambling severity and physiological measures in the baseline, in Experiment IV.   
 
 PGSI Baseline EDA Baseline HR Baseline  HRV 
 r p r p r p r p 
UPPS-P NU .647 .005 * .178 .493 .110 .675 .425 .089 
UPPS-P total .372 .142 .199 .445 .551 .022 * .674 .003 * 
VAS .796 .001 ** .092 .727 .183 .483 .013 .961 
ASRS .092 .724 .732 .001 ** .308 .229 .638 .006 * 
AUDIT -.260 .314 .271 .293 .382 .131 -.044 .866 
SCRs in CGT wins .617 .008 * .037 .887 -.554 .021 * .336 .187 
SCRs in CGT losses .616 .009 * -.099 .705 -.507 .038 * -.052 .844 
SCRs in IST wins .682 .003 * -.075 .775 .424 .090 .384 .128 
SCRs in IST losses .531 .028 * .039 .882 .302 .239 .244 .345 
SCRs in SST wins .491 .046 * .311 .225 .143 .585 .336 .187 
SCRs in SST losses .517 .034 * .236 .363 .273 .289 .058 .825 
SCL in baseline -.031 .905 - - .675 .003 * .339 .183 
SCL in EEG1 -.277 .380 .896 .001 ** .724 .001 ** .283 .271 
SCL in EEG2 -.268 .298 .880 .001 ** 731 .001 ** .106 .687 
HR in baseline .274 .288 .675 .003 * - - - - 
HR in EEG1 -.497 .042 * .829 .001 ** .813 .001 ** .279 .278 
HR in EEG2 -.020 .941 .180 .490 .656 .004 * .514 .035 * 
HR in CGT wins .651 .005 * .852 .001 ** .853 .001 ** .303 .236 
HR in CGT losses .630 .007 * .881 .001 ** .852 .001 ** .288 .262 
HR in IST wins -.069 .792 .801 .001 ** .794 .001 ** .251 .331 
HR in IST losses -.557 .020 * .818 .001 ** .591 .012 * .311 .224 
HR in SST wins .090 .732 .792 .001 ** .844 .001 ** .339 .183 
HR in SST losses .016 .950 .705 .002 * .844 .001 ** .313 .222 
EEG delta power .120 .647 .562 .019 * -.575 .016 * -.529 .029 * 
EEG theta power -.512 .036 * .083 .752 .222 .392 -.149 .569 
EEG alpha power -.533 .028 * .130 .620 -.168 .519 -.262 .310 
EEG beta power -.525 .030 * -.041 .875 -.484 .049 * -.557 .020 * 
EEG theta/beta ratio -.546 .023 * -.073 .780 -.241 .352 -.488 .047 * 
Note: UPPS-P NU, negative urgency trait of urgency, premeditation, perseverance and sensation seeking scale; VAS, 
visual analogue scale; ASRS, attention deficit hyperactivity disorder self-report scale; CGT, Cambridge gambling task; 
IST, information sampling task; SST, stop signal task; SCL, skin conductance level; SCRs, skin conductance responses; 
EDA, electrodermal activity; HR, heart rate; EEG; electroencephalogram; PGSI, problem gambling severity index; HRV, 





In this experiment, the assessment of physiological characteristics of participants with different 
impulsivity levels during gambling-related task performance was used to investigate the effects of 
tDCS over the rDLPFC. The PFC modulates subcortical pathways that regulate the sympathetic and 
parasympathetic nervous systems. The sympathetic nervous system is linked to increased LF HRV, 
EDA and to cortical hyperactivity of slow waves (delta and theta), whereas the parasympathetic 
nervous system plays a role in inhibiting these physiological activations. In particular, it was 
investigated whether participants with higher impulsivity levels would show higher sympathetic 
activity compared with lower impulsive participants, and whether tDCS could help shifting the ANS 
towards parasympathetic dominance. Sympathetic dominance would indicate a state of stress and 
higher arousal, whereas parasympathetic dominance would be associated with relaxation.   
 
Participants attended two tDCS sessions (real stimulation and sham) one week apart, in a 
counterbalanced order. Groups of participants were divided by UPPS-P NU scores into LI and HI 
groups. Assessment included self-report measures (PGSI, VAS), CANTAB cognitive tasks (CGT, 
IST and SST) as well as EDA, ECG and EEG resting state physiological measures. Alcohol 
dependence was assessed and controlled for with the AUDIT; ADHD symptoms with ASRS; and the 
blinding procedure with the events sham questionnaire. Overall, there were tDCS effects on cognitive 
task performance in all tasks, however post-hoc comparisons revealed that none of the interactions 
with tDCS conditions reached significance, nor did the interaction effects between LI and HI groups. 
Nevertheless, physiological data helped to demonstrate the effects of tDCS at rest and during 
gambling-task performance. EDA and EEG showed tDCS effects within session, comparing variables 
during pre-tDCS and post-tDCS periods, and in addition, all physiological measures (ECG, EEG, 
EDA) showed specific physiological characteristics associated with each participant group (LI and 
HI) at rest, and during gambling task performance.   
 
5.5.1 Self-reported measures and CANTAB cognitive task performance 
Results showed no differences in demographic and participant characteristics between LI and HI 
groups, including gambling severity measured with PGSI. The blinding procedure was assessed with 
the events sham questionnaire, showing that all participants were aware of the real stimulation 
condition and 65% of participants were aware of the sham condition, which means that beyond the 




through the arousal created by the sensations during stimulation, or by participants expectations 
(Rabipour et al., 2018). No adverse events were reported.  
 
Regarding CANTAB tasks performance, to study all phases of the experiment in regards to the 
stimulation it has to be taken into account that only IST, SST are performed during tDCS, and only 
EEG2 after the stimulation, therefore, comparisons of the other tasks between real stimulation and 
sham have to be carefully interpreted. Results are reported from each phase according to the session 
type, even though some parts are performed before the stimulation, to not discard the potential 
cumulative effect of the stimulation across sessions (see section 5.4.2 of this chapter). There is some 
controversy between studies that assume no carry-over effects with sessions conducted one week apart 
(Shahbabaie et al., 2014; Wu et al., 2020) to compare stimulation and sham conditions, however other 
studies suggest that crossover designs might not be free of  carry-over effects (Spagnolo et al., 2020; 
Zucchella et al., 2020). In any case, tDCS session order effects were not significant for any of the 
physiological measures, so if there is an effect of tDCS in phases that have been performed before the 
stimulation, beyond the potential accumulative effect of tDCS if real stimulation has been conducted 
in the first session, it could also be interpreted as a session effect regardless of the stimulation type, 
instead of a tDCS effect.  
 
The tasks IST and SST were performed during tDCS, however CGT was used as a priming task before 
tDCS, and therefore results indicating differences between real stimulation and sham conditions in 
this task, have been interpreted as a session effect, rather than a tDCS effect18. There were significant 
main effects of tDCS in all tasks, showing that the real stimulation session was associated with lower 
RT in CGT, higher total correct trials, but lower P (correct) in IST, and lower total correct stop trials 
in SST, compared with sham. In addition, there were also interaction effects of tDCS in all tasks, 
however pairwise comparisons revealed that none of the differences between real stimulation and 
sham conditions reached significance, nor differences found in the interaction effects between LI and 
HI groups.  
 
                                                 
18 Although the CGT is performed before tDCS, and therefore potential effects of tDCS have been interpreted as a session 
effect. Nevertheless, it was decided to use the same terminology as with the other variables to refer to the factor analysed 
(tDCS condition, rather than session), for simplicity, and to consider as much information as possible that could, directly 




As mentioned in CGT, the tDCS condition factor has been interpreted as a session effect. Beyond 
tDCS effects, there was also a main effect of condition. The fact that QDM was lower in the ascending 
condition could be due to the descending condition being performed after the ascending condition, 
and participants having more practice in the task, however previous studies found no effects on 
condition order in the CGT (Lawrence et al., 2009). QDM was lower in higher risk conditions as it 
was expected, but there were no significant differences in task performance between groups, in 
contrast with previous experiments conducted in the project, and previous research showing that GD 
participants showed higher RT than non GD participants in the CGT, and that decision-making 
impairments were associated with increased urgency trait of impulsivity (Kräplin et al., 2014). 
However, differences in results might be due to discrepancies in the type of participant samples 
between studies. 
 
The tDCS results obtained in the IST indicating an increase in total correct trials in real stimulation 
compared with sham was consistent with the hypothesis, however there was also a decrease of P 
(correct), and a lack of difference in number of boxes opened between tDCS conditions, contrary to 
the hypothesised. It is possible that the increase of number of total correct trials was not an effect of 
tDCS, given that the results on the other two variables did not support the effects on total correct 
trials: the number of boxes opened did not differ between tDCS conditions, and the fact that the P 
(correct) was lower in real stimulation (which relates to the level of  uncertainty tolerated during 
decision-making), could be a result of the participant guessing the majority of the colour on the IST 
by chance, but not choosing the most advantageous option. Nevertheless, a recent systematic review 
suggested that while tDCS seems to modulate response inhibition, RT and cravings, results on 
impulsivity are not consistent, which would be in line with the lack of tDCS results found in reflection 
impulsivity measured with the IST in this experiment (Mayer et al., 2020).  
 
In addition, real stimulation was associated with lower total correct stop trials than sham in the SST. 
This result indicates that participants were less able to inhibit their responses under real stimulation. 
This might be similar to the effect found in previous experiments of the project, showing higher RT 
associated with real stimulation compared with sham. It was hypothesised that tDCS would help 
improve inhibitory control, based on previous studies showing that anodal tDCS improved response 
inhibition in the SST (Jacobson et al., 2011), however the results found are consistent with other 





5.5.2 Electrodermal activity  
EDA was measured in different situations: SCL was measured during rest periods and task 
performance; SCL was measured at rest before and after the tDCS; local SCL was measured in 
different task-related risk conditions; and SCRs associated with reward outcomes (wins and losses) 
were measured during task performance. Results showed that SCL was lowest in rest phases, followed 
by IST and SST, and was highest during CGT. Changes in SCL reflect general changes in autonomic 
arousal, therefore it is reasonable that rest periods present the lowest SCL. Considering the cognitive 
tasks, the IST is the task that has the lowest work-load in terms of the inter-stimulus interval (ISI), 
which is around 30-45 seconds, compared with ISIs of around 10-15 seconds in the SST and CGT. 
And beyond ISI influence, SST requires more activation from the participant to react quickly and to 
try to inhibit a prominent response, and CGT is the task that resembles more a gambling activity, with 
the descending condition requiring the participant to select quickly the highest bet, or otherwise wait 
for the lowest bet to appear on the screen. Therefore, this could explain why the CGT descending 
condition was associated with the highest SCL in this experiment.  
 
These results are consistent with the changes that would be expected in SCL, and importantly, help 
support the rational for using CGT to be performed before tDCS, as a priming task to influence the 
brain state, with the aim to facilitate the potential stimulation effects of tDCS on gambling-related 
cognitive functions. In addition, there was an interaction tDCS x period, which pairwise comparisons 
showed a significant difference between real stimulation and sham in the IST fixed condition, 
indicating that real stimulation was associated with higher SCL than sham. This result might be 
explained by the fact that the IST fixed condition was the first task and condition that participants 
performed during tDCS, so it could be that the initial sensations from real stimulation affected 
participants arousal, resulting in increased SCL compared with sham.  
 
Analysis of SCL before and after tDCS (EEG1 and EEG2, respectively) showed no significant 
differences in SCL between EEG1 and EEG2. However, EEG recordings were subdivided in two 
halves to investigate whether tDCS effects would be more detectable during the first parts of the 
recordings after the stimulation. As predicted, dividing the SCL data recorded during the EEG section 
into two parts (see section 5.3.5.3), allowed to identify significant effects that were not detectable 
during the EEG period as a whole. Significant effects were found in the first part of the EEG (a). SCL 
was lower in EEG1a compared with EEG2a in real stimulation, but not in EEG1b, EEG2b, or any of 




on the sympathetic branch of the ANS. In this case, real stimulation was associated with increased 
sympathetic activity reflected by higher SCL, contrary to the hypothesis, nevertheless, other research 
also found that tDCS increased SCRs (Feeser et al., 2014). However, in the current study, the blinding 
procedure was not effective, and participants in the real stimulation condition were able identify the 
electrical current sensations. This could have had a direct influence on the increase of sympathetic 
activation in this condition, and therefore the changes of arousal might not be directly related to the 
effects of tDCS on cortical excitability.   
 
In addition, SCL was higher in HI compared with LI in both real stimulation and sham. The 
differences between groups seemed to be more consistent in sham than in real stimulation. In real 
stimulation, there were significant differences between the groups only in pre-tDCS, in EEG1a, (but 
not in EEG2a) or only in post-tDCS, in EEG2 and EEG2b (but not in EEG1 or EEG1b). However, in 
sham, differences were found in both pre-tDCS and post-tDCS subdivisions (in EEG1 and EEG2, and 
in EEG1b and EEG2b). This might indicate that real stimulation affected in a different way both 
impulsive groups, in comparison with sham. Furthermore, results of local skin conductance associated 
with different risk conditions in the CGT, showed also that LI had lower SCL than HI, in the highest 
risk condition (6:4) in both ascending and descending conditions of the task. These results are not 
consistent with the hypothesis, and with previous research that showed decreased SCRs to reward in 
GD compared with healthy controls (Lole et al., 2014). In addition, results also indictaed that 
participants in high risk-taking groups showed decreased SCRs compared with lower risk-taking 
groups (Agren et al., 2019), and that risk-taking was associated negatively with SCRs in high 
impulsive participants (Hüpen, Habel, Schneider, Kable, & Wagels, 2019). Nonetheless, there are no 
enough studies investigating differences in SCRs and SCL between different types of gamblers, and 
therefore these results warrant further exploration.  
 
Results from SCRs during reward outcomes revealed that SCRs were higher in wins than in losses in 
the CGT. This is consistent with the hypothesis, and with previous studies with healthy participants, 
showing that wins produced increases of SCL, but losses did not elicit physiological changes (Wilkes, 
Gonsalvez, & Blaszczynski, 2010). In the IST, there were no differences between wins and losses, 
consistent also with other research measuring SCRs during gambling task performance (Agren et al., 
2019). In the SST, SCRs were higher in losses than in wins. In this case, wins refer to successful stops 
to inhibit a response, whereas losses refer to unsuccessful stops to inhibit a response, however for 




inhibition mechanisms different to the reward processing associated with the CGT or IST. Therefore, 
results are consistent with research that found increased brain activation in medial PFC with SCRs 
following unsuccessful stops in SST, but decreased activation following a stop success (Zhang et al., 
2012).  
 
In addition, results showed that SCRs were higher in feedback responses than in anticipatory 
responses in wins and losses in CGT, IST and SST, and higher anticipatory SCRs were associated 
with wins than with losses in CGT. On the contrary, previous research showed that the anticipation 
phase (when participants wait to receive the outcome) was associated with higher arousal response 
than the outcome phase, suggesting that anticipation is a major contributor during gambling (Agren 
et al., 2019). In this study, feedback responses produced increased arousal levels, however, it is 
possible that the manual method employed to log in the stimuli on the computer causing some delays, 
as specified in section 5.3.5 of this chapter, would have affected the measurements and results, making 
it more difficult to compare consistently with other studies.  
 
Considering the groups, HI had higher feedback SCRs in wins than LI, and higher anticipatory and 
feedback SCRs associated with losses compared with LI in the CGT. Therefore, HI showed increased 
SCRs compared with LI, except in feedback SCRs losses, in which groups did not differ. This is in 
line with a study that showed no differences between GD participants and healthy participants in 
losses, but different SCRs in wins, with the difference that in that case, lower SCRs associated with 
wins was linked with GD participants (Lole et al., 2014). In IST, HI had higher anticipatory and 
feedback SCRs than LI in wins and losses. In none of the three tasks there were significant differences 
in SCRs associated with wins and losses between both sessions, which makes sense in the case of 
CGT, given that tDCS was delivered after CGT performance. However, this is contrary to the 
hypothesis in the case of IST and SST, as in these tasks it was expected to find lower SCL in real 
stimulation compared with sham, based on previous research (Wang et al., 2016).  
 
5.5.3 Electrocardiogram  
Results comparing at rest and task periods, showed that the lowest total power, which reflects overall 
ANS activity, was found in the baseline, and the highest in IST. No other significant results were 
found on HF or LF components of HRV. There were no significant differences between pre/post tDCS 




the highest total power in IST. The fact that HRV total power was lowest during CGT (indicating 
lower activation of inhibitory processes), coincides with the higher SCL effect (see above) indicative 
of sympathetic predominance, and therefore supporting the function of the task as a priming 
mechanism to activate the brain network before tDCS.  
 
There were no significant tDCS effects in HF or LF components between real stimulation and sham. 
This is not consistent with the hypothesis, and research showing that real stimulation tDCS increased 
HF compared with sham, including a task-related reduction of HF (Nikolin et al., 2017). In addition, 
considering participant groups, results showed that LI had lower LF and higher HF relative power 
than HI during CGT, IST and SST performance. This is consistent with the hypothesis, and with 
research showing that higher impulsive individuals had lower HRV, independently of the presence of 
GD (Maniaci, Goudriaan, Cannizzaro, & van Holst, 2018).  
 
HR during task performance periods, results showed no differences between tasks in mean HR or 
maximum HR, however minimum HR was highest in CGT descending condition. This is in line with 
the results obtained in SCL, in which CGT descending condition had the highest SCL (indicative of 
sympathetic activation), supporting the choice of this task as a priming mechanism to activate the 
gambling-related brain network before tDCS. During the different risk conditions of the CGT, there 
were no significant effects of HR. This is not consistent with the hypothesis, however, it is possible 
that the actual risk conditions in the CGT did not provoke a physiological response, as would happen 
in other types of tasks, in which participants could choose between more risky and safer options in 
the same trial, like in the Iowa gambling task (IGT). Previous research showed that IGT performance 
correlated with LF HRV (Drucaroff et al., 2011), and that anticipatory HR was lower in 
disadvantageous relative to advantageous options in the IGT (Crone, Somsen, Beek, & Der, 2004).  
 
There were no differences in HR during wins and losses in the CGT, contrary to the hypothesis. 
However considering that across tasks, minimum HR was highest during CGT, it is possible that there 
was a smaller range for variation of HR in this task. This could explain the lack of differences detected 
in HR during reward outcomes, which would be supported by the fact that total power HRV was 
lowest in CGT too. In IST, mean HR and maximum HR were higher in wins than in losses, and 
maximum HR and minimum HR were higher in decreased condition than in fixed condition. There 




measures and tDCS effects over ANS (Nikolin et al., 2017), but in line with previous research showing 
no differences of anodal or cathodal tDCS on HR (Vitor-Costa, Okuno, & Bortolotti, 2015). 
Regarding to the participant groups, HI had higher mean and minimum HR in wins than LI in IST, 
and HI had higher minimum HR in wins (successful stops) and losses (unsuccessful stops) than LI in 
SST. These results are supported by research showing that lower HR response to disadvantageous 
options compared to advantageous options was seen only in participants who were classified as good 




Theta/beta ratio was lower in real stimulation compared with sham, with the highest power found in 
vmPFC, and the lowest in right PFC. This is in line with the hypothesis, and research showing that 
tDCS over the DLPFC increased beta frequency power (Song et al., 2014) and reduced theta activity 
over frontal areas (Powell, Boonstra, Martin, Loo, & Breakspear, 2014). Mean frequency power 
increased from EEG1 to EEG2 in left DLPFC, in the sham condition. In addition, mean frequency 
power was higher in real stimulation compared with sham in EEG1, but in EEG2 there were no 
differences in mean frequency power between real stimulation and sham. These results indicate that 
during tDCS real stimulation, mean frequency power remained stable, whereas in sham, mean 
frequency power increased from EEG1 to EEG2. Previous research showed a decrease in mean 
frequency power after tDCS real stimulation and after sham, using a tDCS protocol without cognitive 
tasks coupling (Boonstra et al., 2016). Considering that in this experiment, IST and SST were 
performed during tDCS, the possible increase of mean frequency power between EEG1 and EEG2 in 
sham, and the lack of significant decreases found in real stimulation, could be explained by task-
related cognitive effects, which could have augmented mean frequency power (Gill et al., 2015; 
Newson & Thiagarajan, 2019). 
 
Moreover, real stimulation was associated with lower delta relative power compared with sham, 
especially in the left PFC. This is in line with the hypothesis, and research that found reduced left 
frontal delta absolute power after tDCS real stimulation (Keeser et al., 2011). However, post-hoc 
analysis showed that in real stimulation, delta relative power increased in EEG2 in relation with 
EEG1, however, in sham, delta relative power decreased from EEG1 to EEG2, and that differences 
between real stimulation and sham were significant in EEG1, but not in EEG2. This might indicate 




initial resting state might have been different between sessions (with lower delta relative power before 
the tDCS in the session of real stimulation, compared with the sham session). This result is contrary 
to the hypothesis and previous research that showed reduced delta in left PFC (Keeser et al., 2011), 
but it would be consistent with research that also showed increased delta power after anodal tDCS 
(Donaldson, Kirkovski, Yang, Bekkali, & Enticott, 2019).  
 
Furthermore, theta absolute power was highest in vmPFC, being lower in real stimulation compared 
with sham. Theta absolute power decreased from EEG1 to EEG2, especially in right DLPFC. Post-
hoc analysis showed that in pre-tDCS, there were no differences in theta relative power between real 
stimulation and sham, but in post-tDCS, theta relative power was higher in real stimulation compared 
with sham. These results might indicate that theta relative power decreased in both real stimulation 
and sham sessions, however the decrease in sham might have been stronger than in real stimulation, 
showing larger differences in EEG2. This is consistent with previous research with tDCS that showed 
a reduction of theta power after real stimulation (Jacobson, Ezra, Berger, & Lavidor, 2012).  
 
Alpha absolute power was higher in central and left PFC. In addition, alpha relative power was higher 
in real stimulation compared with sham, especially in central and right PFC. In particular, real 
stimulation was associated with higher relative alpha power in EEG1, whereas in EEG2, there were 
no differences between real stimulation and sham. This might indicate that real stimulation decreased 
alpha relative power, whereas in sham alpha relative power could have remained constant or increased 
from EEG1 to EEG2, with participants having different initial resting states between both sessions 
(higher alpha relative power in the real stimulation session compared with the sham session).This 
result is contrary to previous research (Ulam et al., 2015) and the hypothesis that tDCS would increase 
alpha power. However, other research also found a reduction of alpha in frontal, parietal and temporal 
regions after tDCS real stimulation (de Melo, de Oliveira, dos Santos Andrade, Fernández-Calvo, & 
Torro, 2020; Maeoka, Matsuo, Hiyamizu, Morioka, & Ando, 2012).  
 
Lastly, beta relative power was higher in right and left DLPFC, and lowest in vmPFC, and there were 
no significant differences between real stimulation and sham conditions. This distribution of power is 
consistent with research indicating that beta power is associated with cognitive effort (Schestatsky, 
Morales-Quezada, & Fregni, 2013) and that DLPFC is associated with executive functions (Koenigs 




compared with sham, contrary to results found, and previous research in healthy controls (Mangia et 
al., 2014; Song et al., 2014). Nevertheless, another tDCS study found also effects on delta, theta and 
alpha but not in beta, consistently with the current results (Ulam et al., 2015). 
 
Regarding participant groups, LI had lower mean frequency power than HI in sham EEG2. In addition, 
LI showed higher delta relative power than HI in sham EEG2, which perhaps could be interpreted as 
a higher task performance effect on cognitive activation in LI compared with HI. LI had higher alpha 
relative power than HI in left and ventral PFC in EEG1, and in right PFC in EEG2, during real 
stimulation. In sham EEG1, LI had higher alpha power across the whole PFC, whereas no differences 
between the groups where found in EEG2. These results might indicate that real stimulation over 
rDLPFC decreased alpha relative power in higher extent in LI compared with HI. There were no 
significant differences between LI and HI in theta or beta frequencies.  
 
In this experiment, it was hypothesised that tDCS would help decrease EEG slow waves (delta and 
theta) and theta/beta ratio, associated with low cortical arousal and lower inhibition control, while 
helping increase fast waves, associated with hyperexcitability of the nervous system (Kim et al., 2018; 
Lansbergen et al., 2007), and that HI participants would show increased slow wave and decreased fast 
wave bands compared with LI (Lee et al., 2017b). Results showed that theta/beta ratio activity was 
higher in vmPFC, and lower in DLPFC areas. Similarly, theta absolute power was higher in vmPFC, 
whereas beta relative power was higher in DLPFC and lower in vmPFC areas.  
 
These results are consistent with research associating dorsal areas of the PFC with cognitive functions, 
such as goal-directed behaviour and attention, and ventral PFC with reward, emotions and 
motivational processing (Koenigs & Grafman, 2009; Miller & Cohen, 2001). In line with the 
hypothesis, results showed that tDCS real stimulation decreased theta/beta ratio, mean frequency 
power and theta relative power, and increased alpha relative power compared with sham. Participants 
initial resting state, before the tDCS procedure, was different between the sessions of real stimulation 
and sham, therefore, studying the effects of tDCS within each session has provided more accurate 
information about the actual effects of each condition, rather than comparing only results between 
sessions. In addition, LI showed lower mean frequency power, and higher delta and alpha relative 





Differences in EEG power between LI and HI were seen especially in EEG2 periods, suggesting that 
the stimulation combined with cognitive task performance affected both groups differently. These 
results add evidence to research investigating the effects of tDCS on gambling-related cognitive 
mechanisms in gamblers according to their impulsivity levels. However, research results are not 
homogeneous, with studies showing that high impulsive GD participants had decreased theta, alpha 
and beta absolute power in left, right and midline PFC (Lee et al., 2017b), and others showing that 
high impulsive individuals did not show high theta, theta/beta ratio or decreased beta power 
(Lansbergen et al., 2007). The effects of tDCS on EEG waves and reward processing mechanisms are 
still not clear. While these results are supported by previous research (as mentioned above), other 
studies found that tDCS over DLPFC showed an increase of delta, theta and alpha frequencies and a 
decrease of beta frequencies, resulting on a general slowing of the resting state (Boonstra et al., 2016). 
The heterogeneity of the results is in part influenced by the variety of outcome measures used, tDCS 
protocols, and participant characteristics. Further research might help to clarify the specific effects of 
tDCS on gambling-related behaviour.  
 
5.5.5 Correlations  
Gambling severity correlated positively with the impulsivity subscale of negative urgency (NU) and 
with gambling cravings. In addition, gambling severity correlated positively with EDA, particularly 
with SCL in CGT, and SCRs associated with wins and losses in CGT, IST, and with anticipatory 
SCRs in losses and feedback SCRs in wins in SST. Moreover, gambling severity correlated positively 
with maximum HR during wins and losses in CGT, and negatively with minimum HR during EEG1. 
Considering that EEG1 was recorded just after CGT performance, the correlations found between 
gambling severity and HR measures during and just after CGT performance support the results 
obtained in EDA, showing that the highest SCL across tasks was during CGT, and ECG results 
showing the highest minimum HR and the lowest HRV total power in CGT. Moreover, gambling 
severity correlated negatively with HR during IST fixed condition. This could be due to the work load 
of this task and the associated characteristics of the condition. Since this was the task with longer 
inter-stimulus interval (see section 5.5.2 of this chapter), and particularly, the fixed condition had not 
the same incentive of risk as compared with the decreased condition (see section 4.3.2, Chapter 4), it 
is possible that participants with higher GD severity would lose motivation to play during this task 
condition, and therefore display a slower HR. Lastly, gambling severity correlated negatively with 
beta absolute power in right PFC, and alpha relative power, theta absolute, and theta relative power 





In addition, with the aim to find biological markers that could be used to identify individual variability 
factors between gamblers, baseline EDA was compared against the rest of the variables. Results 
revealed that baseline EDA correlated positively with ADHD symptomatology, with mean HR during 
wins and losses in CGT and SST, and with mean HR during IST wins (but not losses) in fixed 
condition, and mean HR in wins and losses in decreased condition. Considering that the chances of 
losing in IST fixed condition are lower compared with the chances of losing in the decreased condition 
(because participants can open all the boxes to identify the dominant colour without losing points in 
the fixed condition, but in decreased condition participants would lose points for every box opened), 
therefore, this might explain the difference in results regarding losses between task conditions in IST.  
 
In addition, baseline EDA correlated negatively with delta absolute and relative power in EEG1, and 
positively with delta absolute and relative power in EEG2. However, these correlations were found 
only in one of the sessions (in real stimulation). Nevertheless, baseline EDA in real stimulation 
correlated positively with EEG periods in sham (but not with baseline EDA in sham), and mean HR 
during wins and losses in each task in sham, in the same way that it did in the real stimulation session. 
Therefore, this might indicate that similar mechanisms were present in both sessions during task 
performance involving EDA and HR during reward outcomes, even though baseline EDA recording 
in the sham session did not correlate with the variables during the same session. Given that gambling 
severity correlated with EDA during task performance, and that baseline EDA correlated with HR 
during reward based task performance in both sessions, EDA might be a useful biological marker that 
could inform about GD symptoms during situations involving reward.  
 
Furthermore, correlation analysis to assess the relationship between baseline ECG measures and 
gambling-related behavioural and physiological measures during the experimental session, revealed 
that UPPS-P total score correlated positively with minimum HR and LF/HF ratio, and that ADHD 
symptomatology correlated positively with LF power and LF/HF ratio and negatively with HF power. 
Moreover, DA correlated with LF/HF ratio. These results highlight the link between impulsivity and 
HRV variables. This is consistent with research showing that impulsivity correlated positively with 
inter beat interval (Maniaci et al., 2018), and that increased HR and decreased HRV was associated 
with internet gaming disorder, which has been associated with high impulsivity (Park et al., 2019). In 
addition, maximum HR correlated negatively with EDA during wins and losses in CGT, whereas 




relative power. LF power correlated negatively with theta/beta ratio and negatively with beta absolute 
and relative power in right, left and ventral PFC. Similarly, HF power correlated negatively with 
theta/beta ratio, and positively with beta absolute power in right, left and ventral PFC. Nevertheless, 
correlation analysis in small sample sizes are vulnerable to type I and type II statistical errors, 
therefore these results should be interpreted carefully (Knudson & Lindsey, 2014).   
 
Results are overall consistent with the hypothesis, and with research that has found that participants 
with gambling problems showed increased brain activation associated with wins (Dymond et al., 
2014), increased EDA associated with reward outcomes (Lole et al., 2014), with research suggesting 
that parasympathetic dominance is associated with improved cognitive performance (Nikolin et al., 
2017), and with research that showed positive correlations of gambling severity with theta activity 
(Dymond et al., 2014), and negative correlations between alpha power in frontal and central regions 
and impulsivity (Lee et al., 2017b).  
 
5.5.6 General conclusions and limitations 
In summary, tDCS results on gambling-task performance were not consistent with the hypothesis. 
However, task performance was used in this experiment not only to assess the cognitive results 
associated with the tasks, but to inform about physiological states during gambling-related scenarios. 
Previous research suggested that the combination of behavioural and physiological variables could 
help reveal results that might not be detected using only behavioural variables (Gomis-Vicent et al., 
2019), and that it can be difficult to relate personality traits to the underlying brain function (Grant et 
al., 2016). EDA results revealed that sympathetic activation was associated with task performance, 
particularly higher SCL in CGT (which was the task used as a priming mechanism to activate the 
brain network before tDCS). The effects of tDCS were measurable through SCL at rest, being more 
evident during the first part of the EEG recording, when comparing the effects within session 
(pre/post-tDCS periods).  
 
In addition, different reward outcomes were associated with EDA during task performance, with 
higher EDA in HI compared with LI, and showing higher SCRs associated with wins in CGT and IST 
compared with losses, and higher SCRs associated with losses, compared with wins, in SST. ECG 
results did not reveal tDCS effects on HRV variables, however results showed that LI had higher HF 




participants. EEG results helped to demonstrate the effects of tDCS, showing that real stimulation 
was associated with lower theta/beta ratio, theta relative power and mean frequency power, but higher 
delta and alpha relative power compared with sham. In addition, participant groups showed different 
EEG wave activation with lower mean frequency power and higher delta relative power in LI 
compared with HI. Lastly, correlation analysis showed that baseline EDA might be a useful biological 
marker to inform about gambling-related behavioural and physiological states.  
 
In this experiment, some of the limitations highlighted in the first experiments were addressed. A 
triple-blinded design (in which neither the participant, nor the researcher when conducting the 
experiment and the data analysis were aware of the stimulation condition) was used to ensure that 
data analysis was less likely to be biased. In addition, a computational model was used to create the 
most effective tDCS montage to target the brain area of interest more accurately. Finally, 
neurophysiological data, including EEG, EDA and ECG, were used to further quantify the effects of 
the intervention.  
 
However, other limitations might have influenced the results of this experiment. Firstly, the blinding 
of the participants during real stimulation was not effective, and this could have influenced the results 
of the experiment. Future studies would benefit from the use of “ActiSham”, an algorithm that creates 
and an active sham condition, that induces the same sensations than the tDCS real stimulation without 
affecting cortical excitability, therefore improving participants blinding (Neri et al., 2020). Secondly, 
participant groups were created by using a median-split of the impulsivity self-report measures which 
is less than optimal given that GD is a key focus of the PhD. Recruiting a larger sample of participants 
that allowed groups to be divided by gambling severity measures, would yield results more 
comparable with other studies about GD. Moreover, there was large number of significant correlations 
found in this experiment, however correlation analysis in small sample sizes are vulnerable to type I 
and type II statistical errors (Knudson & Lindsey, 2014), therefore replication of the results are 
warranted for a more reliable interpretation. Additionally, self-report questionnaires were used to 
control for ADHD and alcohol dependence, however controlling for other common GD comorbid 
psychiatric disorders, such as other addictive behaviours, anxiety or depression, might provide a better 
understanding of the individual characteristics of the sample. Finally, the manual method of logging 
the physiological data caused a delay that had to be accounted for in the analysis, and therefore the 
data obtained was not as accurate as it could be, compared to interfacing with a software prepared for 





In conclusion, this study broadened understanding of the mechanism of tDCS during gambling task-
performance, informing about cognitive and physiological mechanisms associated with tDCS, and 
with particular characteristics of different groups of gamblers according to self-reported impulsivity 
levels. Results might help refine knowledge of the effects of tDCS at an individualised level, and 






6 Chapter 6. General discussion 
6.1 General overview 
The overall aim of this research project was to investigate the potential use of transcranial direct 
current stimulation (tDCS) as a neuromodulation intervention to improve treatment approaches for 
gambling disorder (GD), and to inform current understanding of the neurophysiology of decision-
making related of gambling behaviours. According to previous literature, results from non-invasive 
brain stimulation (NIBS) research are highly heterogeneous (Buss, Fried, & Pascual-Leone, 2019; 
Coles et al., 2018; Zucchella et al., 2020). This is in part due to the variability of methodologies and 
protocols used, together with participants individual differences that directly impact the 
responsiveness to NIBS.  
 
There is a lack of consensus on which protocols might be more effective to potentially treat specific 
conditions. In particular, GD is not an homogeneous disorder (Quintero, 2017), and although 
impulsivity appears to be a shared characteristic across the majority of gamblers and individuals with 
GD (Grant et al., 2016), multiple interrelated factors, such as heritability, traumatic background, 
personality traits and psychiatric comorbidities, contribute to the complexity of finding adequate 
treatment interventions for each individual (Yau & Potenza, 2015). In order to develop more 
individualised treatment interventions, the understanding of specific cognitive and neurophysiological 
characteristics underlying GD needs to be refined, as the knowledge of how neuromodulation 
interventions act on brain circuits. Specifically, investigating autonomic responses during reward 
anticipation, decision-making and reward outcomes, might help to capture particular risk-factors 
associated with GD in more realistic scenarios. 
 
6.2 Summary of results 
In Experiment I, high definition (HD) tDCS montages with a 1 x 4 ring configuration were designed 
to target right dorsolateral prefrontal cortex (rDLPFC) and ventromedial prefrontal cortex (vmPFC), 
brain areas that have been previously associated with GD. Results showed tDCS effects on Cambridge 
gambling task (CGT) performance, but no difference between tDCS effects depending on brain target 
or participant groups split by impulsivity self-reported levels. In Experiment II, the HD montage to 
target rDLPFC was manipulated to explore whether altering tDCS focality would reveal differences 




Therefore, the same HD tDCS montage designed for vmPFC used in Experiment I was compared 
against a new montage designed to target rDLPFC. This new montage was created to increase the 
amount of current traveling through the scalp to the target area, by expanding the distance between 
the anode and the return electrodes. Results in Experiment II replicated the findings found in the 
previous experiment, showing tDCS effects on CGT performance, but no difference between the 
effects depending on brain target or participant impulsive groups. In both experiments participant 
samples included non-gamblers and at risk gamblers that were grouped according to their impulsivity 
negative urgency (NU) scores. Results showed that tDCS was associated with higher quality of 
decision-making (QDM) and risk-taking (RT) behaviour, but did not affect delay aversion (DA).  
 
In Experiment III, the cumulative effects of tDCS, in combination with cognitive behavioural therapy 
(CBT), were investigated across eight weekly sessions, through two separate case studies conducted 
at the National Problem Gambling Clinic (NPGC). The experimental design was originally planned 
as a randomised control trial (RCT), however a necessary change of approach due to recruitment 
complications, meant that data analysis had to be conducted according to a single participant design. 
Results indicated that in both patients diagnosed with GD (each allocated to one tDCS condition, real 
stimulation or sham), gambling severity and cravings were reduced at the end of the intervention. In 
addition, electrophysiological measures revealed correlations between gambling severity and 
electroencephalogram (EEG) power. Importantly, however, in the patient receiving tDCS real 
stimulation, there were further alterations in the experimental procedure due to changes of schedule 
in the individualised CBT treatment. These changes themselves could have increased the variability 
in EEG results across sessions, not allowing to establish reliable conclusions. Although tDCS seemed 
to produce a short term increase of mean frequency power in the majority of sessions, no clear 
direction of long term effects was found. 
 
The electrophysiological findings in the patient allocated to sham tDCS appeared to have more 
consistent interpretations. In particular, concurrent SST performance could have explained both, the 
short and long term changes in EEG power in the period after receiving sham tDCS (that was coupled 
with SST), whereas cumulative effects of CBT could account for the reduction of mean frequency 
power, in the period before receiving sham tDCS with SST at the end of the intervention. In addition, 
in the patient allocated to sham, gambling severity correlated negatively with SST total correct trials 
and with mean frequency power in left DLPFC. Moreover, theta/beta ratio in left DLPFC correlated 




relevant for neuromodulation research in GD, given that these electrophysiological measures could 
be used in future research as biomarkers to assess changes in cognitive states, and as targets for 
neuromodulation studies.  
 
The results from Experiment III are from single cases, with unavoidable differences in testing 
protocols compared to the originally planned RCT, and so it is not possible to reliably infer the validity 
of any observed qualitative differences or similarities between the cases. As such, the limitations did 
not allow direct comparisons between tDCS real stimulation and sham conditions, or to distinguish 
between the effects of the tDCS protocol, involving cognitive task performance, and the effects of the 
CBT. In sum, with no qualitative differences in outcomes between the patients allocated to sham and 
real stimulation, it could be argued that there is no evidence here to support the use of tDCS to improve 
CBT treatment outcomes, contrary to the hypothesised. However, based on previous studies, 
cumulative effects of tDCS across multiple sessions might increase when delivered daily (Alonzo et 
al., 2012; Martinotti et al., 2018), compared with weekly administration (Boggio, 2007)19. Further 
research investigating the combination of tDCS and CBT using a more frequent schedule, might help 
to clarify the potential use of neuromodulation interventions to improve current treatment approaches 
for GD.  
 
Experiment IV sought for a deeper understanding of the tDCS effects over the autonomous nervous 
system (ANS) during different reward phases, in participants with low and high risk gambling 
behaviour, grouped by their self-reported impulsivity levels. Results demonstrated the capability of 
tDCS to modulate the ANS, producing an increase of skin conductance level (SCL) after real 
stimulation compared with sham. Results also revealed tDCS effects on cortical excitability. In 
particular, tDCS produced an increase of delta power and a decrease of alpha power compared with 
sham, and a decrease of theta power in both real stimulation and sham, whereas no changes were 
found in beta power. These results are contrary to the hypothesis, however are supported by previous 
tDCS research (see section 5.5.4 in Chapter 5), and highlight the existent variability on tDCS results 
between studies. The results also revealed participant intra-individual variability, showing that pre-
tDCS EEG measures were different between sessions. In addition, results suggested that cortical 
excitability might have changed due to task-related effects. In fact, task related effects on cortical 
                                                 
19 At the National Problem Gambling Clinic (where the case studies were conducted), the CBT sessions were delivered to 
patients on a weekly basis. Therefore, it was decided to investigate a weekly neuromodulation protocol to explore the 




excitability might have had higher effects on low impulsive (LI) gamblers compared with high 
impulsive (HI) gamblers, indicated by an increased delta power in the sham post-tDCS period in LI. 
 
In addition, tDCS seemed to produce a higher decrease in alpha power in LI compared with HI, 
whereas no differences were found in theta and beta power between the groups. Moreover, inter 
individual differences during gambling-related task performance were identified through heart rate 
variability (HRV), heart rate (HR) and skin conductance responses (SCRs). In particular, higher 
sympathetic activation was found in HI compared with LI, during reward outcome phases compared 
with anticipation phases, and during wins compared with losses. Lastly, gambling severity correlated 
positively with cravings, with EDA and HR during task-performance reward outcomes and negatively 
with EEG measures.  
 
Correlations between baseline EDA and various variables measuring response to reward and cortical 
excitability might indicate the potential use of this measure as a biomarker to disentangle specific 
features of GD during different reward phases. To summarise, this experiment showed that autonomic 
arousal was different between groups of low and high impulsive gamblers, and between different 
reward phases during gambling-related task performance. The findings suggested that EDA might be 
a useful biomarker to use in future neuromodulation studies in GD. The results showed certain 
evidence of the capability of tDCS to modulate the ANS and cortical excitability. However, due to 
the lack of effectiveness of blinding during real stimulation, these results should be carefully 
interpreted, given that participants awareness of the stimulation sensations during tDCS could have 
caused the increase of sympathetic arousal, rather than this being directly affected by the 
neuromodulation of PFC activity.  
 
6.3 Novel contributions 
The majority of tDCS studies have investigated the effects of neuromodulation targeting one brain 
area, exploring separately decision-making mechanisms related to dorsal PFC areas (Fecteau et al., 
2014; Feeser et al., 2014; Ouellet et al., 2015), and reward processing mechanisms related to ventral 
PFC areas (Abend et al., 2019; Bertossi et al., 2017; Manuel et al., 2019; Vergallito et al., 2018). The 
evidence about the functional connectivity between these two areas has been widely discussed (Hare 
et al., 2014; Kahnt, Heinzle, Park, & Haynes, 2011; Koenigs & Grafman, 2009). Furthermore, tDCS 




was not until very recently that research has started to compare directly the effects of tDCS on both 
brain circuits.  
 
Neuromodulation of DLPFC has been compared with orbitofrontal cortex (Nejati, Salehinejad, & 
Nitsche, 2018), and ventrolateral PFC (Marques, Morello, & Boggio, 2018). More recently, tDCS 
effects over DLPFC and vmPFC have been directly compared in a study investigating attentional 
processing (Martínez-Pérez, Campoy, Palmero, & Fuentes, 2020), and in a study investigating 
smoking (Fischell, Ross, Deng, Salmeron, & Stein, 2020). The latter, found significant tDCS effects 
using functional magnetic resonance imaging, showing that anodal tDCS over left DLPFC and 
cathodal over the right vmPFC, modified the cognitive circuit associated with nicotine withdrawal. 
They found that tDCS had no significant effects on behavioural measures. However, they revealed 
that neuromodulation helped to reduce the default mode network (associated with ventral areas of the 
PFC) that is involved in self-referential thought and rumination, while increasing the salience network 
(associated with the anterior cingulate cortex (ACC)), which is involved in attention and inhibitory 
control. To the author´s knowledge no studies seem to have compared DLPFC and vmPFC as tDCS 
targets regarding gambling-related cognitive processing. Therefore, the current experiments 
contribute to the field of NIBS in the context of normative gambling behaviour and GD.  
 
Results from Experiments I and II showed that both tDCS montages designed to target rDLPFC and 
vmPFC modulated decision-making and risk-taking behaviour, but did not show significant 
differences on tDCS results between brain targets. The significant tDCS effects found on cognitive-
task performance, together with the lack of significant differences identified on tDCS effects between 
both brain areas, raised the need for further research investigating neuromodulation effects over this 
circuitry in combination with neuroimaging techniques. This might help to disentangle interrelated 
factors influencing gambling behaviour, such us decision-making, risk-taking, delay aversion, 
inhibition control and behavioural impulsivity, and help identify specific anatomical targets for future 
tDCS studies. Nevertheless, to interpret the current results, it has to be considered the lack of data 
about the tDCS focality and electrical current distribution in the brain in these experiments. Therefore, 
it is possible that shunting effects produced that the electrical current reached similarly the two brain 
areas with both tDCS montages, or that reciprocal connections between DLPFC and vmPFC produced 





A recent systematic review identified only four studies that have investigated the effects of tDCS in 
GD (Zucchella et al., 2020). None of these have investigated a combination of tDCS with cognitive 
behavioural therapy (CBT) as a potential intervention to improve current treatment approaches for 
GD. Currently, CBT shows the strongest evidence base of any therapeutic approaches (Cowlishaw et 
al., 2012; Menchon et al., 2018), and therefore, investigating the potential improvements of CBT 
outcomes through its combination with neuromodulation interventions seems a promising approach.  
Additionally, no studies using tDCS on GD have measured EEG neuro-correlates. In fact, only one 
study using tDCS in GD included physiological measures (Dickler et al., 2018).  
 
Therefore, Experiment III, which investigated tDCS in combination with CBT using EEG measures 
in GD, represents a further contribution to novel research. Results showed that GD symptomatology 
decreased after the intervention with both tDCS real stimulation and sham conditions, in combination 
with CBT. Short and long term effects associated with the intervention with tDCS were recognised in 
cortical excitability, and individual biomarkers were identified, showing that EEG mean frequency 
power correlated negatively with gambling severity and inhibitory control, whereas theta/beta ratio 
correlated positively with cravings. However, due to the numerous limitations related to the changes 
of experimental design, the results represent preliminary pilot work from which valid extrapolations 
cannot easily be made. Nonetheless, there are methodological implications from the study (see section 
6.4 of this chapter) which provide insights for future research attempting to conduct clinical trials 
involving neuromodulation in GD.  
 
Lastly, tDCS capability to modulate autonomic control has not been broadly investigated (Clancy et 
al., 2014). Research investigating emotional regulation has studied tDCS effects using SCRs and SCL 
(Allaert, De Raedt, Sanchez-Lopez, Baeken, & Vanderhasselt, 2020; Feeser et al., 2014), showing a 
reduction of arousal associated with tDCS compared with sham. Internet gaming disorder has also 
been investigated using rDLPFC tDCS and SCRs, revealing improved arousal regulation after tDCS 
compared with sham (Wu et al., 2020). However, there are no tDCS studies using EDA in 
gamblers/gambling research. Similarly, some tDCS studies have investigated the effects of 
neuromodulation on cardiovascular measures (Beeli, Casutt, Baumgartner, & Jäncke, 2008; 
Montenegro et al., 2011; Nikolin et al., 2017), however no studies have investigated tDCS effects 
using HRV and HR measures in relation to gambling. Only one study using repetitive transcranial 
magnetic stimulation (rTMS) in GD measured also HR (Sauvaget et al., 2018). Lastly, several studies 




Miller, Berger, & Sauseng, 2015; Schestatsky, Morales-Quezada, et al., 2013), however, again, no 
studies have done so in gamblers.  
 
This research project has investigated tDCS effects on SCL, SCRs, HRV, HR and EEG in gamblers, 
and furthermore, all measures were obtained in the same experiment. Concurrent measurement of 
EDA and HR has been suggested to offer deeper understanding of individual variability factors that 
characterise specific behaviours, because both measures provide different information (Sohn et al., 
2001; Studer et al., 2016). Generally, EDA is more sensitive to affective states and HR is more 
sensitive to the valence of the emotion and cognitive load. In addition, this research complements the 
information provided by these measures through the investigation of physiological responses during 
different gambling phases (anticipation of reward outcome and reward outcome receipt), and to wins 
and losses, during gambling-related task performance. The majority of research has investigated tonic 
SCL in gambling, however phasic SCRs provide more detailed information about the underlying 
mechanisms of gambling behaviour (Agren et al., 2019).  
 
In the current study, SCL results demonstrated the capability of tDCS to modulate ANS, showing an 
increase of sympathetic activity. Furthermore, sympathetic activation was higher during reward 
feedback phases compared with anticipatory phases, and during wins compared with losses. In 
addition, HI gamblers showed increased sympathetic dominance compared with LI. This has potential 
implications for how HI gamblers engage in gambling activities, respond to gambling related stimuli 
and the management of treatment for such individuals. It potentially represents a problematic cycle 
where impulsivity and arousal feed one another in relation to certain stimuli. Therefore, Experiment 
IV, offered a novel approach to investigate neuromodulation and physiological responses during 
different gambling phases. Results are relevant for the understanding on tDCS effects on the ANS 
during reward processing, and contributed to identify differences in autonomic arousal between LI 
and HI gamblers. Collectively, the data from this experiment support the development of more 
individualised neuromodulation interventions for GD, and highlight the potential significance of 
physiological differences between high and low impulsive gamblers, which may have important 





6.4 General methodological implications and future directions 
In reviewing the extensive literature on tDCS and other NIBS work, and its importance for the 
development of the studies in this thesis, the protocols, procedures and analysis, and in embedding 
findings within this literature base, a number of concerns have emerged which appear to challenge 
aspects of the research landscape in this field. This section highlights some of these key issues, 
alongside suggestions for future directions arising from the studies conducted.  
 
There is a need for standardisation of neuromodulation procedures and outcome measures in tDCS 
research to improve the reproducibility of results. Studies need to adhere to rigorous reporting 
practices, in which stimulation protocols should be described in detail. This would include the type 
and location of electrodes according to standard references, direction, intensity and duration of the 
electrical current, reference electrode location, description of the sham or control condition, and when 
possible, details of current distribution when using computational modelling approaches (Miranda, 
Callejón-leblic, Salvador, & Ruffini, 2018). Particularly, the use of active sham conditions in tDCS 
studies, known as “ActiSham”, improves participant blinding by inducing the same sensations as real 
stimulation but avoiding significant effects on cortical excitability (Neri et al., 2020).  
 
In addition, details on the stimulation procedure should be described, including for example the timing 
of events that may be coupled with the stimulation (such as cognitive tasks performance), the type of 
blinding (that may be accompanied by blinding control questionnaires), the tDCS exclusion criteria 
employed, and other relevant characteristics such as room temperature (Mikkonen, Laakso, Tanaka, 
& Hirata, 2020; Nitsche et al., 2008). Similarly, outcome measures should be standardised, including 
questionnaire and cognitive tasks, reporting detailed information about specific characteristics of the 
variables measured. In addition, analysis methodologies should be described in detail, including data 
pre-processing protocols and exact definition of calculated variables (for example providing a specific 
range of frequency in each EEG band, rather than noting the nomenclature).  
 
Ecological validity of the studies could improve by using incentives, such as real money in GD 
research, and considering different characteristics associated with different types of gambling 
products (such as roulette, sports betting etc.), which would allow the investigation of behaviours in 
more realistic scenarios (Newson & Thiagarajan, 2019; Sharpe, 2002). Lastly, pre-registration of 




collection, should help to ensure that the research is conducted according to the design and analysis 
planned, and addresses the outlined research questions. This would require that researchers 
distinguish between confirmatory analysis through hypothesis testing and exploratory analysis.  
 
Considering that tDCS effects are highly dependent on participant brain states (Hsu, Juan, & Tseng, 
2016), controlling for influencing factors might help improve reproducibility of results. For example, 
controlling for substance intake (including energy drinks and caffeine) prior the experiment would 
help identify factors that might influence the results (Newson & Thiagarajan, 2019). This may be 
particularly relevant in research involving addiction and GD, given the high comorbidity with SUDs 
(Yip & Potenza, 2014). Specifically, using biological tests (such as blood tests), to control both acute 
use (intoxication or hangover at time of testing) and more chronic, undisclosed drug misuse (which 
could be captured through hair analysis to some extent, possibly other hepatic function measures), 
would be more rigorous than the use of self-report questionnaires. In addition, controlling for the time 
of the day during which the study is conducted, sleep quality, and participants physiological and 
emotional states through questionnaires and baseline recordings of physiological arousal, including 
hormonal influences such as cortisol, would inform about intra-individual variability across sessions, 
which in turn, might help interpret inter-individual variability factors (Krause & Kadosh, 2014; 
Spagnolo et al., 2020).  
 
Moreover, neuromodulation research would benefit from the use of computational modelling 
approaches that evaluate the most effective tDCS montage to stimulate the brain area of interest, by 
considering electrical flow through anatomical and tissue characteristics (Ruffini et al., 2013). In 
addition, the application of control sites for the stimulation would allow further investigation of 
anatomical specificity (Bertossi et al., 2017). Functional specificity of tDCS can be improved through 
the combination of cognitive tasks or therapeutic interventions during the stimulation. Improving 
anatomical and functional specificity, and the combination of tDCS with neuroimaging techniques, 
would also facilitate the investigation of functional connectivity between different regions, helping to 
identify behaviours associated with the underlying network, and study whether it is possible to 
disentangle specific cognitive components that may, or not, be associated to particular brain regions 





It is also clear that the number of stimulation sessions influences tDCS effects, however standard 
practices are not established yet, and there is no evidence that indicates the most effective number and 
frequency of sessions to modulate each clinical condition (Lefaucheur et al., 2017). Short and long 
terms effects of tDCS should also be investigated. In addition, in crossover designs, studies should 
control for condition order, and account for possible stimulation carry-over effects according to the 
time interval between sessions (Nitsche et al., 2008).  
 
Participant samples should generally be larger and more representative, including all ages and gender 
groups, multiple sessions to control for both, intra and inter-individual variability, with a detailed 
description of demographic characteristics that may be relevant for the condition investigated 
(Newson & Thiagarajan, 2019). Studies should also investigate common comorbid disorders, and 
interactions of neuromodulation with other treatment interventions. Appropriate distribution of 
participants across groups regarding relevant characteristics, is also warranted. Consistency of 
stimulation protocols across sessions and across participants is crucial to maintain experimental 
variability to a minimum. Similarly, having the same time interval between sessions across all 
participants would allow to better understand long term effects of the intervention, avoiding to add 
more external factors influencing the results.  
 
In research involving clinical samples, particular attention is given to ethical approval procedures, 
given the potential complexity and vulnerability associated with this population. The ethical 
application procedures usually requires extensive documentation that is reviewed through multiple 
phases and different clinical and research teams, which can take several months to complete, if not 
longer. In addition, once ethical approval is in place, a significant number of factors that may have 
direct implications in the development of the trials should be considered: notably, the number and 
availability of clinical sites. Low level availability of clinics (for treatment and research locations) 
might imply that treatment demand outweighs the site capability to treat patients, and could result on 
waiting lists, which might impact research recruitment procedures. The existence of adequate 
available facilities on the clinical site to conduct the experiment procedures should also be considered. 
There may be a need to invest clinical staff time to collaborate with the research trial, and to establish 
a continuous coordination between the research team and the clinical team during identification, 





The data for the 2019/20 period presented in the Annual Statistics from the National Gambling 
Treatment Service report in Great Britain (GambleAware, 2020), which includes data from health 
care providers GamCare, Gordon Moody Association and Central and North West London NHS 
Foundation Trust (London National Problem Gambling Clinic), shows that a total of 60,413 
appointments were recorded for clients treated in 2019/2020, which 80% were made for treatment 
purposes. From those, a small proportion of 9,008 individuals were treated within gambling services 
within that period. Crucially, those numbers include only people who contacted treatment services, 
however previous studies showed that only 7-12% of individuals with GD seek treatment (Slutske, 
2006), which was in part explained by the limited availability of services offering treatment for GD 
(Petry et al., 2017). Treatment services continue to increase since previous reports indicating that 5909 
individuals received treatment in 2015/2016. Nevertheless, current data, highlights the important 
shortfall in provision, and the urgent need to improve treatment delivery and strategies in GD.  
 
Additional complications may arise in cases when different treatments are intended to be coupled. In 
these cases, it will be crucial to coordinate the patient testing and treatment session, considering the 
availability of the facilities and the clinicians for the whole duration of the research intervention. Also, 
there may be different treatment formats offered at the clinical site depending on the patient 
characteristics. This could interact with the research inclusion criteria, if patients allocated to the type 
of treatment of interest have specific features that exclude them from participation in the trial.  
 
Therefore, in view of all these potential complications, it would be advisable to conduct a feasibility 
study prior a clinical trial, which would allow to identify potential problems to consider, and 
determine the possibilities to complete the clinical trial. As an alternative, home-based treatment 
through remote therapy interventions has already shown to have specific benefits, such as the 
increased accessibility and convenience, reduced costs, anonymity and privacy (Gainsbury & 
Blaszczynski, 2011). This type of treatment could potentially be applied in combination of remotely 
controlled and supervised tDCS, which represents a promising approach for clinical neuromodulation 
(Palm et al., 2018). However, further research is necessary to assess safety and technical monitoring 






This research has a number of limitations that compromise the potential implications of the results. 
Some of the existing limitations in the first experiments were addressed as the project progressed, 
however other limitations arose with new designs and methodologies used in later experiments. In 
Experiments I and II, a single blinding design was used, however this was substituted by a more 
rigorous triple blinding design in Experiments III and IV. Moreover, in Experiment I participant 
allocation to groups was not randomised due to changes of experimental design during recruitment, 
but randomisation of participant allocation to groups was applied in the rest of the experiments. In 
addition, in Experiments I and II, HD tDCS montages were created using a 1 x 4 ring configuration 
without current flow calculations (Villamar et al., 2013), but in Experiments III and IV a 
computational model was used to identify the most effective montage to target the brain area of 
interest (Ruffini et al., 2013).  
 
Moreover, in Experiments I and II only behavioural measures were used to investigate the effects of 
tDCS, which might have left undetected effects that could have been identified with 
neurophysiological techniques. Therefore, whether the current reached the desired brain areas could 
only be speculated based on previous studies using similar protocols. However, in Experiment III, 
behavioural measures were accompanied by neurophysiological data, including EEG measures to 
investigate cortical excitability. In addition, Experiment IV, included EEG, electrocardiogram (ECG) 
and electrodermal activity (EDA) measures to quantify the physiological effects of tDCS on the ANS, 
which provided a more complete and rigorous approach for the study of neuromodulation effects. 
Experiments I, II and IV followed a two session crossover design to investigate the short term effects 
of tDCS, however possible carry over effects between sessions separated a week cannot be 
disregarded since there is not consensus on how long the short and long term effects of tDCS last 
(Nitsche et al., 2008).  
 
Experiment III had numerous limitations due to changes of experimental design, which did not match 
the type of intervention conducted. Consequently, the results obtained did not allow to differentiate 
the intervention effects between real stimulation and sham conditions, or the specific effects of tDCS 
and CBT. Therefore, it was not possible to reach a conclusion about the effectiveness of the tDCS 
intervention. In Experiment IV, the methodology to log in the physiological data caused a delay that 




compromise the generalisation to other studies that may have interfaced the tasks with experimental 
software, producing more reliable data. In addition, participants blinding the in real stimulation 
condition was not effective, which may have influenced results of the experiment. Future studies 
employing active sham protocols might be able to avoid this issue.  
 
6.6 Final remarks 
Elucidating the underlying cognitive and neurobiological mechanisms associated with dysfunctional 
decision-making, inhibitory control and emotion regulation, is essential for prevention and treatment 
of psychiatric disorders, including addiction (Goschke, 2014). The prospect of creating more effective 
individualised treatment interventions for GD has been reinforced by tDCS research. This is 
particularly relevant in view of the rising incidence of GD, and the preliminary state of its treatment 
(Paglieri et al., 2014).  
 
This project represents a further contribution to the scientific literature pursuing a more profound 
understanding of tDCS neuromodulation capabilities. The findings embrace previous evidence 
suggesting that there is not a unique mechanism explaining how all neuromodulation interventions 
act (Bashir & Yoo, 2016). Refining neuromodulation protocols to modify dysfunctional behaviours 
is a rapidly evolving field, which is likely to be facilitated by the identification of cognitive and 
physiological underpinnings of GD. The current work sheds more light on the influence of impulsivity 
in gambling, and highlights the importance of studying the psychophysiological impact of tDCS, and 
the interface between such measures, impulsivity and gambling-related behaviour. And through it 
utilises a range of measures and interventions which could in the future be embedded in research and 
also treatment approaches for GD, addictions and other areas of psychiatric illness, as potentially cost 
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Electroencephalogram (EEG) absolute and relative power results and discussion  
Results 
Participant allocated to tDCS sham condition 
Delta relative power: 
One way repeated measures ANOVA analysis of delta relative power revealed a significant main 
effect of session (F (5.553, 394.262) = 7.121, p= .001, ηp2 = .091), showing that session four had the 
lowest delta relative power (≈ 50%), and sessions five, six and seven had the highest (≈ 60-80%). 
There was also a significant main effect of electrode (F (4.197, 297.987) = 62.794, p= .001, ηp2 = 
.469) indicating that Fpz had the highest delta relative power (≈ 60%), and similar levels were found 
across the other electrodes (≈ 60%). In addition, there was an interaction session x tDCS time (F 
(5.818, 413.104) = 7.292, p= .001, ηp2 = .093) showing that delta relative power was lower in EEG1 
(≈ 55%) compared with EEG2 (≈ 80%) in session five, whereas delta relative power was higher in 
EEG1 compared with EEG2 in sessions four (≈ 50% and 45%), seven (≈ 70% and 60%), and eight (≈ 
60% and 55%). Similar levels between both tDCS conditions were found in sessions one, two (≈ 55%) 
and six (≈ 75%). There was a significant interaction session x electrode (F (18.675, 1325.910) = 
21.058, p= .001, ηp2 = .229), showing that sessions six and five had the highest relative delta power 
in Fpz (≈ 65%), and the lowest delta relative power was in session four for F4 (≈ 55%).  
 
There was also an interaction tDCS time x electrode (F (3.288, 282.730) = 11.057, p= .001, ηp2 = 
.135), indicating that all electrodes showed similar levels of delta relative power between tDCS 
conditions (a slight difference of ≈ 5% of the power between EEG1 and EEG2), with lower delta 
relative power in EEG1 compared with EEG2 in electrodes Fpz and Cz, and higher delta relative 
power in EEG1 compared with EEG2 in electrodes F4, FC6, F3 and AF7. A three way interaction 
session x tDCS time x electrode (F (19.030, 1351.137) = 16.511, p= .001, ηp2 = .189), showed that 
session five had the highest delta relative power in EEG2 (≈ 80%) while EEG1 was around 55%, and 
sessions six and seven had the highest delta relative power in EEG1 (≈ 70%). Higher delta relative 
power in EEG1 compared with EEG2 was found in session 7 (≈ 70% and 60%) and eight (≈ 60% and 






To assess the final outcome of the intervention, delta relative power results were compared between 
sessions one and eight with paired t-tests (2-tailed) for each electrode position and each frequency 
band separately. Results showed that EEG1 delta relative power in session one was significantly lower 
than EEG1 delta relative power in session eight, only in electrode positions Fpz (t (117) = -3.606, p 
=.001) and AF4 (t (117) = -5.902, p =.001). EEG2 delta relative power in session one was significantly 
higher than EEG2 delta relative power in session eight, for all electrodes except for AF7: Cz (t (116) 
= 3.536, p =.001), AF8 (t (116) = 2.472, p =.015), AF4 (t (116) = 2.519, p =.013), Fpz (t (116) = 
3.909, p =.001),  F4 (t (116) = 5.016, p =.001),  FC6 (t (116) = 5.533, p =.001) and F3 (t (116) = 
3.737, p =.001). To compare the effects of tDCS before and after the stimulation within session, 
considering sessions one and eight, paired t-test (2-tailed) revealed that EEG1 was significantly lower 
than EEG2 in session one for electrodes AF4 (t (120) = -3.343, p =.001), Fpz (t (120) = -4.095, p 
=.001) and F4 (t (120) = -2.161, p =.033) and higher in EEG1 compared with EEG2 in F3 (t (120) = 
18.336, p =.001). In session eight EEG1 was higher than EEG2 in all electrodes except in Cz and F3: 
AF8 (t (116) = 2.044, p =.043), AF4 (t (116) = 3.898, p =.001), Fpz (t (116) = 2.530, p =.013), F4 (t 




















Figure 0-1. Electroencephalogram (EEG) delta relative power in sham condition. Delta relative power (%) of EEG resting state 
recordings before tDCS (EEG1) and after tDCS (EEG2), across eight sessions, and across electrode positions with the international 
EEG 10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7). Data represents mean and SEM (* p < .05; ** p ≤ .01). Note: significant 
differences between EEG1 in session one and EEG1 in session eight were found only in electrodes Fpz and AF4. Significant differences 
between EEG2 in session one and EEG2 in session eight, were found in all electrodes except in AF7. Furthermore, significant 
differences between EEG1 and EEG2 in session one were found in electrodes AF4, Fpz, F4 and F3, however in session eight EEG1 



















Delta absolute power: 
One way repeated measures ANOVA analysis of delta absolute power revealed a significant main 
effect of session (F (1, 71) = 138.740, p= .001, ηp2 = .661), showing that session five had the highest 
delta absolute power at around 50 µV2, whereas the rest of the sessions had delta absolute power 
around 10 µV2, except in session six, which was approximately 20 µV2. There was also a significant 
main effect of tDCS time (F (1, 71) = 138.740, p= .001, ηp2 = .661), showing that delta absolute power 
was higher in EEG2 compared with EEG1, and a significant main effect of electrode (F (1.722, 
122.288) = 14.242, p= .001, ηp2 = .167) indicating that electrodes from the highest (≈ 20 µV2) to the 
lowest (≈ 10 µV2) delta absolute power were AF8, AF7, Fpz, F3, Cz, AF4, F4 and FC6. In addition, 
there was an interaction session x tDCS time (F (1, 71) = 138.740, p= .001, ηp2 = .661), showing that 
lower delta absolute power in EEG1 compared with EEG2 was found especially in session five (≈ 5 
µV2 and 50 µV2, respectively) and six (≈ 10 µV2 and 20 µV2, respectively). However, in the rest of 
sessions both tDCS time conditions had similar delta absolute power.  
 
There was a significant interaction session x electrode (F (1.722, 122.288) = 14.242, p= .001, ηp2 = 
.167), showing that session two had the highest delta absolute power in all electrodes. A significant 
interaction tDCS time x electrode (F (1.722, 122.288) = 14.242, p= .001, ηp2 = .167), showed that in 
all electrodes, lower delta absolute power was associated with EEG1 compared with EEG2. Lastly, a 
three way interaction session x tDCS time x electrode (F (1.722, 122.288) = 14.242, p= .001, ηp2 = 
.167), showed that in EEG1, session two had the highest delta absolute power in all electrodes, 
however in EEG2, session six had the highest in all electrodes except for AF8, in which session five 
had the highest delta absolute power. In addition these data indicated that in EEG1, all sessions had 
similar delta absolute power, with the exception of session two, but in EEG2, session six had the 
highest delta absolute power followed by sessions five, seven, three, one, and lastly, session eight that 
the lowest. Delta absolute power values across sessions and electrode positions are represented in 
Figure 0-2. 
 
To assess the final outcome of the intervention, delta absolute power results were compared between 
sessions one and eight with paired t-tests (2-tailed) for each electrode position and each frequency 
band separately. Results showed that EEG1 delta absolute power in session one was significantly 
lower than EEG1 delta absolute power in session eight, in all electrode positions except F3: Cz (t 




(117) = -3.233, p =.002), F4 (t (117) = -2.690, p =.008), FC6 (t (117) = -2.351, p =.020) and AF7 (t 
(117) = -2.243, p =.027). EEG2 delta absolute power in session one was significantly higher than 
EEG2 delta absolute power in session eight, for all electrodes: Cz (t (116) = 5.933, p =.001), AF8 (t 
(116) = 7.515, p =.001), AF4 (t (116) = 8.329, p =.001), Fpz (t (116) = 5.902, p =.001),  F4 (t (116) = 
5.918, p =.001),  FC6 (t (116) = 5.761, p =.001), F3 (t (116) = 5.941, p =.001) and AF7 (t (116) = 
5.835, p =.001).  
 
To compare the effects of tDCS before and after the stimulation within session, considering sessions 
one and eight, paired t-test (2-tailed) revealed that EEG1 delta absolute power was significantly lower 
than EEG2 delta absolute power in session one, for all electrodes except AF7: Cz (t (120) = -4.394, p 
=.001), AF8 (t (120) = -4.164, p =.001),  AF4 (t (120) = -2.553, p =.012), Fpz (t (120) = -3.233, p 
=.002) and F4 (t (120) = -4.465, p =.001), FC6  (t (120) = -4.053, p =.001) and F3 (t (120) = -4.508, 
p =.001). In session eight, EEG1 delta absolute power was higher than EEG2 delta absolute power in 
all electrodes: Cz (t (116) = 2.044, p =.043),  AF8 (t (116) = 2.044, p =.043), AF4 (t (116) = 3.898, p 
=.001), Fpz (t (116) = 2.530, p =.013), F4 (t (116) = 2.451, p =.016), FC6 (t (116) = 4.142, p =.001), 





















Figure 0-2. Electroencephalogram (EEG) delta absolute power in sham condition. Delta absolute power (µV2) of EEG resting state 
recordings before tDCS (EEG1) and after tDCS (EEG2), across eight sessions, and across electrode positions with the international 
EEG 10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7). Data represents mean and SEM (* p < .05; ** p ≤ .01). Note: significant 
differences between EEG1 in session one and EEG1 in session eight were found in all electrodes except in F3. Significant differences 
between EEG2 in session one and EEG2 in session eight were found in all electrodes. Furthermore, significant differences between 
EEG1 and EEG2 in session one were found in ell electrodes except AF7, and in session eight, EEG1 and EEG2 were significantly 




















Theta relative power: 
One way repeated measures ANOVA analysis of theta relative power revealed a significant main 
effect of session (F (7, 497) = 7.694, p= .001, ηp2 = .098), showing that session three had the highest 
theta relative power (≈ 15%) and session five had the lowest (≈ 8%). There was also a significant 
main effect of electrode (F (3.886, 275.939) = 138.430, p= .001, ηp2 = .661) indicating that electrodes 
from the highest (≈ 15%) to the lowest (≈ 10%) theta relative power were AF4, Fpz, F4, FC6, Cz, F3, 
AF8 and AF7. In addition, there was an interaction session x tDCS time (F (7, 497) = 2.589, p= .012, 
ηp2 = .035), showing that theta relative power was lower in EEG1 compared with EEG2 (≈ 10 % and 
14 %, respectively) in sessions six and seven, however in session five EEG1 had higher theta relative 
power than EEG2 (≈ 12 % and 8 %, respectively) and in the rest of the sessions both tDCS time 
conditions seem to have similar theta relative power.  
 
There was a significant interaction session x electrode (F (18.500, 1313.496) = 9.917, p= .001, ηp2 = 
.123), showing that sessions seven and three had the highest theta relative power in all electrodes, and 
the lowest was in session five for the rest of electrodes, except for AF7, in which the lowest theta 
relative power was session five. There was also an interaction tDCS time x electrode (F (4.288, 
304.427) = 4.311, p= .001, ηp2 = .057), indicating that electrodes Fpz and AF4 showed the highest 
relative theta power, and the lowest in AF7 and AF8 in both with EEG1 and EEG2. A three way 
interaction session x tDCS time x electrode (F (18.959, 1345.982) = 5.087, p= .001, ηp2 = .067), 
showed that session three had the highest relative theta power in both EEG1 and EEG2, whereas 
session five had the lowest, particularly in EEG2. All electrodes had similar theta relative power 
between tDCS time conditions. Relative theta power values across sessions and electrode positions 
are represented in Figure 0-3. 
 
To assess the final outcome of the intervention, theta relative power results were compared between 
sessions one and eight with paired t-tests (2-tailed) for each electrode position and each frequency 
band separately. Results showed that EEG1 theta relative power in session one was significantly 
higher than EEG1 theta relative power in session eight, only in electrode positions AF4 (t (117) = 
2.896, p =.005) and Fpz (t (117) = 2.254, p =.026). EEG2 theta relative power in session one was 
significantly higher than EEG2 theta relative power in session eight, only in electrode position Fpz (t 
(116) = 2.571, p =.011). To compare the effects of tDCS before and after the stimulation within 




power was significantly higher than EEG2 theta relative power in session one for electrodes AF4 (t 
(120) = 2.866, p =.005) and Fpz (t (120) = 3.442, p =.001) and lower in EEG1 compared with EEG2 
in AF8 (t (120) = -18.004, p =.005). In session eight there were not significant differences between 






























Figure 0-3. Electroencephalogram (EEG) theta relative power in sham condition. Theta relative power (%) of EEG resting state 
recordings before tDCS (EEG1) and after tDCS (EEG2), across eight sessions, and across electrode positions with the international 
EEG 10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7). Data represents mean and SEM (* p < .05). Note: significant differences 
between EEG1 in session one and EEG1 in session eight were found only in electrodes AF4 and Fpz. Significant differences between 
EEG2 in session one and EEG2 in session eight were found only in Fpz. Furthermore, significant differences between EEG1 and EEG2 
in session one were found only in electrodes AF8, AF4 and Fpz. However, in session eight, there were no significant differences 




















Theta absolute power:  
One way repeated measures ANOVA analysis of theta absolute power revealed a significant main 
effect of session (F (1, 71) = 138.740, p= .001, ηp2 = .661), showing that session five and six had the 
highest theta absolute power (≈ 3.8 µV2) whereas in the rest of the sessions it was around 1 µV2. There 
was also a significant main effect of tDCS time (F (1, 71) = 138.740, p= .001, ηp2 = .661), showing 
that theta absolute power was lower in EEG1 compared with EEG2. A significant main effect of 
electrode (F (1.722, 122.288) = 14.242, p= .001, ηp2 = .167) indicated that electrodes from the highest 
to the lowest absolute power were AF7, Fpz, F3, Cz, F4, AF4, AF8 and FC6 . In addition, there was 
an interaction session x tDCS time (F (1, 71) = 138.740, p= .001, ηp2 = .661) showing that EEG1 had 
lower theta absolute power compared with EEG2 (≈ 1 µV2 and 3.8 µV2, respectively)  in sessions five 
and six, however in the rest of sessions both tDCS time conditions seem to have similar theta absolute 
power. There was a significant interaction session x electrode (F (1.722, 122.288) = 14.242, p= .001, 
ηp2 = .167), showing that session two had the highest theta absolute power in all electrodes. There 
was also an interaction tDCS time x electrode (F (1.722, 122.288) = 14.242, p= .001, ηp2 = .167), 
showing that in all electrodes lower theta absolute power was associated with EEG1 compared with 
EEG2. A three way interaction session x tDCS time x electrode (F (1.722, 122.288) = 14.242, p= 
.001, ηp2 = .167), showed that in EEG1 session two had the highest absolute theta power in all 
electrodes, however in EEG2 session six had the  highest theta absolute power in all electrodes except 
for AF8, in which session five showed the highest theta relative power. Theta absolute power values 
across sessions and electrode positions are represented in Figure 0-4. 
 
To assess the final outcome of the intervention, theta absolute power results were compared between 
sessions one and eight with paired t-tests (2-tailed) for each electrode position and each frequency 
band separately. Results showed that EEG1 theta absolute power in session one was significantly 
lower than EEG1 theta absolute power in session eight, in all electrode positions: Cz (t (117) = -4.232, 
p =.001), AF8 (t (117) = -4.836, p =.001),  AF4 (t (117) = -4.292, p =.001), Fpz (t (117) = -3.044, p 
=.003), F4 (t (117) = -4.320, p =.001), FC6 (t (117) = -4.920, p =.001), F3 (t (117) = -3.834, p =.001) 
and AF7 (t (117) = -2.147, p =.034). EEG2 theta absolute power in session one was significantly 
higher than EEG2 theta absolute power in session eight, for all electrodes: Cz (t (116) = 4.134, p 
=.001), AF8 (t (116) = 9.318, p =.001), AF4 (t (116) = 10.362, p =.001), Fpz (t (116) = 7.657, p 
=.001),  F4 (t (116) = 4.241, p =.001),  FC6 (t (116) = 4.322, p =.001), F3 (t (116) = 3.842, p =.001) 
and AF7 (t (116) = 8.086, p =.001). To compare the effects of tDCS before and after the stimulation 




absolute power was significantly lower than EEG2 theta absolute power in session one, in all 
electrodes except for AF4 and AF7: Cz (t (120) = -2.168, p =.032), AF8 (t (120) = -2.820, p =.006),  
Fpz (t (120) = -2.337, p =.021) and F4 (t (120) = -2.097, p =.038), FC6  (t (120) = -2.027, p =.045) 
and F3 (t (120) = -2.058, p =.042). In session eight, EEG1 theta absolute power was higher than EEG2 
theta absolute power in all electrodes: Cz (t (116) = 15.511, p =.001),  AF8 (t (116) = 13.303, p =.001), 
AF4 (t (116) = 14.452, p =.001), Fpz (t (116) = 12.367, p =.001), F4 (t (116) = 15.758, p =.016), FC6 
























Figure 0-4. Electroencephalogram (EEG) theta absolute power in sham condition. Theta absolute power (µV2) of EEG resting state 
recordings before tDCS (EEG1) and after tDCS (EEG2), across eight sessions, and across electrode positions with the international 
EEG 10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7). Data represents mean and SEM (* p < .05; ** p ≤ .01). Note: significant 
differences between EEG1 in session one and EEG1 in session eight were found in all electrodes except in F3. Significant differences 
between EEG2 in session one and EEG2 in session eight were found in all electrodes. Furthermore, significant differences between 
EEG1 and EEG2 in session one were found in all electrodes except in AF7, and in session eight EEG1 and EEG2 were significantly 




















Alpha relative power: 
One way repeated measures ANOVA analysis of alpha relative power revealed a significant main 
effect of session (F (5.742, 407.651) = 7.693, p= .001, ηp2 = .098), showing that sessions three, four 
and eight  had the highest alpha relative power (≈ 10%), and sessions five, six and seven had the 
lowest (≈ 5%). A significant main effect of tDCS time (F (1, 71) = 26.854, p= .001, ηp2 = .274) 
showed that EEG1 had higher alpha relative power than EEG2, (but the differences were only around 
2% of the power). There was also a significant main effect of electrode (F (3.897, 276.654) = 69.441, 
p= .001, ηp2 = .494), indicating that AF7 had the highest alpha relative power (≈ 10%), and similar 
levels were found across the other electrodes (≈ 7%). In addition, there was an interaction session x 
tDCS time (F (5.716, 405.844) = 5.279, p= .001, ηp2 = .069) showing that alpha relative power was 
higher in EEG1 compared with EEG2 in sessions four (≈ 10% and 7%), five (≈ 9% and 3%) and eight 
(≈ 10% and 8%), whereas alpha relative power was lower in EEG1 compared with EEG2 in session 
seven (≈ 5% and 7%). Similar levels between both tDCS conditions were found the rest of the 
sessions.  
 
There was a significant interaction session x electrode (F (20.681, 1468.366) = 9.834, p= .001, ηp2 = 
.122), showing that sessions two, four and eight had the highest alpha relative power across all 
electrodes, whereas the lowest alpha relative power was in session five for all electrodes, except for 
AF4 and AF8, in which session seven was the lowest. There was also an interaction tDCS time x 
electrode (F (4.320, 306.719) = 2.604, p= .032, ηp2 = .035), indicating that all electrodes showed 
similar levels of alpha relative power between tDCS conditions (with a small difference of ≈ 2% of 
the power between EEG1 and EEG2). A three way interaction session x tDCS time x electrode (F 
(20.589, 1461.821) = 3.922, p= .001, ηp2 = .052), showed that the largest difference between tDCS 
time conditions was found in session five, which had the lowest alpha relative power in EEG2 (≈ 3%) 
while EEG1 was around 8%. All electrodes had similar levels of alpha relative power in each session. 
Alpha relative power values across sessions and electrode positions are represented in Figure 0-5. 
 
To assess the final outcome of the intervention, alpha relative power results were compared between 
sessions one and eight with paired t-tests (2-tailed) for each electrode position and each frequency 
band separately. Results showed that EEG1 alpha relative power in session one was significantly 
lower than EEG1 alpha relative power in session eight, in electrode positions F4 (t (117) = -2.591, p 




power in session one compared with EEG1 alpha relative power in session eight in AF7 (t (117) = 
2.245, p =.027). EEG2 alpha relative power in session one was significantly lower than EEG2 alpha 
relative power in session eight in electrodes Fpz (t (116) = -2.822, p =.006),  F4 (t (116) = -2.803, p 
=.006) and F3 (t (116) = -3.455, p =.001). To compare the effects of tDCS before and after the 
stimulation within session, considering sessions one and eight, paired t-test (2-tailed) revealed that 
EEG1 alpha relative power was significantly higher than EEG2 alpha relative power in session one 
for electrodes AF4 (t (120) = 2.870, p =.005), Fpz (t (120) = 2.653, p =.009), and F3 (t (120) = 2.360, 
p =.019). Lower EEG1 alpha relative power compared with EEG2 alpha relative power was found in 
session one in FC6 (t (120) = -2.001, p =.048). In session eight EEG1 was higher than EEG2 only in 






















Figure 0-5. Electroencephalogram (EEG) alpha relative power in sham condition. Alpha relative power (%) of EEG resting state 
recordings before tDCS (EEG1) and after tDCS (EEG2), across eight sessions, and across electrode positions with the international 
EEG 10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7). Data represents mean and SEM (* p < .05). Note: significant differences 
between EEG1 in session one and EEG1 in session eight were found only in electrodes F4, FC6, F3 and AF7. Significant differences 
between EEG2 in session one and EEG2 in session eight were found only in electrodes Fpz, F4 and F3. Furthermore, significant 
differences between EEG1 and EEG2 in session one were found in electrodes AF4, Fpz, FC6 and F3, whereas in session eight EEG1 




















Alpha absolute power: 
One way repeated measures ANOVA analysis of alpha absolute power revealed a significant main 
effect of session (F (1, 71) = 138.740, p= .001, ηp2 = .661), showing that sessions four and eight had 
the highest alpha absolute power at around 1.5 µV2, whereas the lowest was alpha absolute power 
was found in session seven with approximately 1 µV2. There was also a significant main effect of 
tDCS time (F (1, 71) = 138.740, p= .001, ηp2 = .661), showing that alpha absolute power was higher 
in EEG1 compared with EEG2. A significant main effect of electrode (F (1.722, 122.288) = 14.242, 
p= .001, ηp2 = .167) indicated one electrode (AF8) showed the highest alpha absolute power at around 
4.5 µV2, and the rest of electrodes showed similar alpha absolute power (1 µV2). In addition, there 
was a significant interaction session x tDCS time (F (1, 71) = 138.740, p= .001, ηp2 = .661), showing 
that higher alpha absolute power in EEG1 compared with EEG2 was found in all sessions except 
sessions five and six. There was a significant interaction session x electrode (F (1.722, 122.288) = 
14.242, p= .001, ηp2 = .167), showing that session two had the highest alpha absolute power in all 
electrodes. A significant interaction tDCS time x electrode (F (1.722, 122.288) = 14.242, p= .001, ηp2 
= .167), showed that in all electrodes higher alpha absolute power was associated with EEG1 
compared with EEG2. Lastly, a three way interaction session x tDCS time x electrode (F (1.722, 
122.288) = 14.242, p= .001, ηp2 = .167), showed that in EEG1, session two had the highest alpha 
absolute power in all electrodes, however in EEG2, session five had the highest alpha absolute power 
in all electrodes. Alpha absolute power values across sessions and electrode positions are represented 
in Figure 0-6. 
 
To assess the final outcome of the intervention, alpha absolute power results were compared between 
sessions one and eight with paired t-tests (2-tailed) for each electrode position and each frequency 
band separately. Results showed that EEG1 alpha absolute power in session one was significantly 
lower than EEG1 alpha absolute power in session eight, in all electrode positions: Cz (t (117) = -
4.137, p =.001), AF8 (t (117) = -5.143, p =.001),  AF4 (t (117) = -4.660, p =.001), Fpz (t (117) = -
5.073, p =.001), F4 (t (117) = -4.598, p =.001), FC6 (t (117) = -4.141, p =.001), F3 (t (117) = -4.517, 
p =.001) and AF7 (t (117) = -5.110, p =.001). EEG2 alpha absolute power in session one was 
significantly higher than EEG2 alpha absolute power in session eight, for all electrodes: Cz (t (116) 
= 5.701, p =.001), AF8 (t (116) = 13.671, p =.001), AF4 (t (116) = 15.683, p =.001), Fpz (t (116) = 
12.246, p =.001),  F4 (t (116) = 6.759, p =.001),  FC6 (t (116) = 7.646, p =.001), F3 (t (116) = 5.189, 
p =.001) and AF7 (t (116) = 13.101, p =.001). To compare the effects of tDCS before and after the 




EEG1 alpha absolute power was significantly lower than EEG2 alpha absolute power in session one, 
only in electrode AF8 (t (120) = -2.038, p =.044). In session eight, EEG1 alpha absolute power was 
significantly higher than EEG2 alpha absolute power in all electrodes: Cz (t (116) = 8.897, p =.001),  
AF8 (t (116) = 8.676, p =.001), AF4 (t (116) = 8.635, p =.001), Fpz (t (116) = 9.147, p =.001), F4 (t 
(116) = 8.463, p =.016), FC6 (t (116) = 8.492, p =.001), F3(t (116) = 9.687, p =.001) and AF7 (t (116) 



























Figure 0-6. Electroencephalogram (EEG) alpha absolute power in sham condition. Alpha absolute power (µV2) of EEG resting state 
recordings before tDCS (EEG1) and after tDCS (EEG2), across eight sessions, and across electrode positions with the international 
EEG 10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7). Data represents mean and SEM (* p < .05; ** p ≤ .01). Note: significant 
differences between EEG1 in session one and EEG1 in session eight were found in all electrode positions. Significant differences 
between EEG2 in session one and EEG2 in session eight were found in all electrodes. Furthermore, significant differences between 
EEG1 and EEG2 in session one were found only in electrode AF8, however in session eight, EEG1 and EEG2 were significantly 




















Beta relative power:  
One way repeated measures ANOVA analysis of beta relative power revealed a significant main effect 
of session (F (5.369, 381.201) = 14.479, p= .001, ηp2 = .169), showing that session four had the 
highest beta relative power (≈ 40%), and session six the lowest (≈ 20%). A significant main effect of 
tDCS time (F (1, 71) = 1.229, p= .003, ηp2 = .118) showed that EEG1 had lower beta relative power 
than in EEG2. There was also a significant main effect of electrode (F (3.582, 254.321) = 296.778, 
p= .001, ηp2 = .807), indicating that F4 and AF7 had the highest beta relative power (≈ 30%), and the 
lowest was in Fpz (≈ 20%). In addition, there was an interaction session x tDCS time (F (5.831, 
414.026) = 11.778, p= .001, ηp2 = .142) showing that beta relative power was lower in EEG1 
compared with EEG2. The difference between both tDCS conditions was around less than 5% 
difference of power in sessions one, two and six, and larger in sessions three (≈ 20% and 30%, 
respectively), four (≈ 28% and 40%, respectively), seven (≈ 18% and 28%, respectively), and eight 
(≈ 20% and 30%, respectively). However, in session five, EEG1 was higher than EEG2 (≈ 28% and 
18%, respectively).  
 
There was also a significant interaction session x electrode (F (17.199, 1221.126) = 40.381, p= .001, 
ηp2 = .363), showing that session four had the highest beta relative power in all electrodes, except for 
F3, in which beta relative power was highest in session five, and Fpz in session two. A significant 
interaction tDCS time x electrode (F (3.478, 246.924) = 15.764, p= .001, ηp2 = .182), indicated that 
the largest difference between tDCS time conditions was in AF7 (EEG1 was around 10% and EEG2 
around 35%), and in the rest of electrodes the difference between tDCS time conditions was around 
5% of the power. A three way interaction session x tDCS time x electrode (F (18.363, 1303.740) = 
25.176, p= .001, ηp2 = .262), showed that the largest difference between tDCS time conditions was 
found in session four, which had the highest beta relative power in EEG2 (≈ 40%), while EEG1 was 
around 28%. In EEG2, beta relative power increased from sessions one to four, decreased in session 
five, and increased again from sessions six to eight. Beta relative power was similar across electrodes, 
except in Fpz and AF7, which had the lowest levels. Beta relative power values across sessions and 
electrode positions are represented in Figure 0-7. 
 
To assess the final outcome of the intervention, beta relative power results were compared between 
sessions one and eight with paired t-tests (2-tailed) for each electrode position and each frequency 




than EEG1 beta relative power in session eight, in electrode positions AF4 (t (117) = 6.355, p =.001), 
Fpz (t (117) = 4.184, p =.001) and FC6 (t (117) = 3.370, p =.001). EEG2 beta relative power in session 
one was significantly lower than EEG2 beta relative power in session eight in all electrodes except 
AF7: Cz (t (116) = -4.547, p =.001),  AF8 (t (116) = -2.247, p =.027),  AF4 (t (116) = -3.190, p =.002),  
Fpz (t (116) = -2.856, p =.005),  F4 (t (116) = -5.492, p =.001), FC6 (t (116) = -5.994, p =.001) and 
F3 (t (116) = -3.561, p =.001). To compare the effects of tDCS before and after the stimulation within 
session, considering sessions one and eight, paired t-test (2-tailed) revealed that EEG1 beta relative 
power was significantly higher than EEG2 beta relative power in session one, in electrodes AF4 (t 
(120) = 2.062, p =.041), Fpz (t (120) = 3.078, p =.003), and F3 (t (120) = 2.066, p =.041). In session 
eight EEG1 was lower than EEG2 in all electrodes except in F3: Cz (t (116) = -3.258, p =.001),  AF8 
(t (116) = -5.742, p =.001), AF4 (t (116) = -3.801, p =.001), Fpz (t (116) = -3.477, p =.001), F4 (t 


















Figure 0-7. Electroencephalogram (EEG) beta relative power in sham condition. Delta relative power (%) of EEG resting state 
recordings before tDCS (EEG1) and after tDCS (EEG2), across eight sessions, and across electrode positions with the international 
EEG 10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7). Data represents mean and SEM (* p < .05; ** p ≤ .01). Note: significant 
differences between EEG1 in session one and EEG1 in session eight were found only in electrodes AF4, Fpz and FC6. Significant 
differences between EEG2 in session one and EEG2 in session eight were found in all electrodes except in AF7. Furthermore, significant 
differences between EEG1 and EEG2 in session one were found in electrodes AF4, Fpz and F3, and in session eight EEG1 and EEG2 




















Beta absolute power:  
One way repeated measures ANOVA analysis of beta absolute power revealed a significant main 
effect of session (F (1, 71) = 138.740, p= .001, ηp2 = .661), showing that sessions four and five had 
the highest beta absolute power at around 8 µV2, whereas the lowest was beta absolute power was 
found in sessions one, two and three with approximately 3 µV2. There was also a significant main 
effect of tDCS time (F (1, 71) = 138.740, p= .001, ηp2 = .661), showing that beta absolute power was 
lower in EEG1 compared with EEG2. A significant main effect of electrode (F (1.722, 122.288) = 
14.242, p= .001, ηp2 = .167) indicated the electrode AF8 showed the highest beta absolute power at 
around 15 µV2, followed by AF7 and F3, with around 8 µV2, and the rest of electrodes showed similar 
beta absolute power (around 3 µV2). In addition, there was a significant interaction session x tDCS 
time (F (1, 71) = 138.740, p= .001, ηp2 = .661), showing that lower beta absolute power in EEG1 
compared with EEG2 was found in all sessions, with the greatest differences (from 3 µV2 to 8 µV2) 
in sessions four and five.  
 
There was a significant interaction session x electrode (F (1.722, 122.288) = 14.242, p= .001, ηp2 = 
.167), showing that session two had the highest beta absolute power in all electrodes. A significant 
interaction tDCS time x electrode (F (1.722, 122.288) = 14.242, p= .001, ηp2 = .167), showed that 
lower beta absolute power was associated with EEG1 compared with EEG2 with the greatest 
difference in AF8 (from 3 µV2 to 15 µV2) followed by AF7, F3 and F4, with differences of around 4 
µV2 of the power. Lastly, a three way interaction session x tDCS time x electrode (F (1.722, 122.288) 
= 14.242, p= .001, ηp2 = .167), showed that EEG1 had similar levels of beta absolute power across 
sessions and across electrodes, however EEG2 beta absolute power increased specially in sessions 
four and five, and electrodes AF8 and AF7. Beta absolute power values across sessions and electrode 
positions are represented in Figure 0-8.  
 
To assess the final outcome of the intervention, beta absolute power results were compared between 
sessions one and eight with paired t-tests (2-tailed) for each electrode position and each frequency 
band separately. Results showed that EEG1 beta absolute power in session one was significantly lower 
than EEG1 beta absolute power in session eight, in all electrode positions except in FC6: Cz (t (117) 
= -4.490, p =.001), AF8 (t (117) = -4.108, p =.001),  AF4 (t (117) = -4.858, p =.001), Fpz (t (117) = -
5.150, p =.001), F4 (t (117) = -4.728, p =.001), F3 (t (117) = -4.634, p =.001) and AF7 (t (117) = -




absolute power in session eight, in all electrodes: Cz (t (116) = 21.197, p =.001), AF8 (t (116) = 
23.526, p =.001), AF4 (t (116) = 22.413, p =.001), Fpz (t (116) = 19.963, p =.001),  F4 (t (116) = 
21.324, p =.001),  FC6 (t (116) = 21.184, p =.001), F3 (t (116) = 20.805, p =.001) and AF7 (t (116) = 
18.161, p =.001).  
 
To compare the effects of tDCS before and after the stimulation within each session, considering 
sessions one and eight, paired t-test (2-tailed) revealed that EEG1 beta absolute power was 
significantly lower than EEG2 beta absolute power in session one, only in electrode Cz (t (120) = -
11.894, p =.001). In session eight, EEG1 beta absolute power was significantly higher than EEG2 
beta absolute power in all electrodes: Cz (t (116) = 21.987, p =.001),  AF8 (t (116) = 19.628, p =.001), 
AF4 (t (116) = 20.527, p =.001), Fpz (t (116) = 19.599, p =.001), F4 (t (116) = 21.392, p =.016), FC6 










Figure 0-8. Electroencephalogram (EEG) beta absolute power in sham condition. Beta absolute power (µV2) of EEG resting state 
recordings before tDCS (EEG1) and after tDCS (EEG2), across eight sessions, and across electrode positions with the international 
EEG 10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7). Data represents mean and SEM (* p < .05; ** p ≤ .01). Note: significant 
differences between EEG1 in session one and EEG1 in session eight were found in all electrodes except in FC6. Significant differences 
between EEG2 in session one and EEG2 in session eight were found in all electrodes. Furthermore, significant differences between 
EEG1 and EEG2 in session one were found only in electrode Cz, however in session eight EEG1 and EEG2 were significantly different 







To investigate the relationship between gambling severity and the rest of the variables, 2-tailed 
Pearson’s correlation indicated that gambling severity measured with PG-YBOCS correlated 
positively with VAS for gambling cravings (r =.835, n = 8, p =.010). In addition, PG-YBOCS 
correlated negatively with SST total correct stop and go trials (r = -.737, n = 8, p =.037), total correct 
stop trials (r = -.715, n = 8, p =.046), total correct go trials (r = -.771, n = 8, p =.025) and with EEG2 
beta relative power (r = -.942, n = 8, p =.001) in F3. Correlations with CGT could not be computed 
due to the lack of enough data points.  
 
Having found all significant correlations between gambling severity and EEG variables, specifically 
in the electrode position F3, during the post-tDCS recordings (EEG2), these variables were further 
explored with the aim to find physiological markers that could inform about individuals gambling 
severity, gambling-related behaviours and symptomatology. Results showed that VAS gambling 
cravings correlated positively with theta/beta ratio in F3 (r = .739, n = 8, p =.036), and negatively with 
beta relative power in F3 (r = -.942, n = 8, p =.001). Moreover, negative correlations were found 
between SSRT and EEG2 absolute power, in all frequency bands in F3: delta (r = -.843, n = 8, p 
=.009), theta (r = -.742, n = 8, p =.035), alpha (r = -.860, n = 8, p =.006) and beta (r = -.844, n = 8, p 
=.008). In addition, IST total correct in win condition fixed, correlated negatively with EEG2 absolute 
power in F3, in frequency bands delta (r = -.780, n = 8, p =.022), theta (r = -.792, n = 8, p =.019) and 
alpha (r = -.774, n = 8, p =.024), and also with relative power in delta frequency (r = -.838, n = 8, p 
=.009), and positively in alpha frequency (r = .739, n = 8, p =.036). In addition, IST total correct 
correlated negatively with EEG2 in F3, in absolute beta power (r = -.837, n = 8, p =.010), and 
positively with relative theta power (r = .793, n = 8, p =.019.) Lastly, EEG2 absolute alpha power in 
F3, correlated negatively with IST mean number of boxes opened per trial (r = -.757, n = 8, p =.030) 
and mean number of boxes opened per trial in condition fixed (r = -.744, n = 8, p =.034). An EEG 
power spectrogram displaying electrode positions Fpz, F4 and F3 for ventral, right and left PFC 





































































































































































































    
 
Figure 0-9. Electroencephalography (EEG) spectrogram during transcranial direct current stimulation (tDCS) in sham 
condition. EEG power (µV2) in frequencies 0-30 Hz during five minutes EEG resting state recordings before tDCS (EEG1) 
and after tDCS (EEG2), across eight sessions in sham condition. Electrodes positions displayed in the spectrogram with 











Participant allocated to tDCS real stimulation condition 
Delta relative power: 
One way repeated measures ANOVA analysis of delta relative power revealed a significant main 
effect of session (F (6.123, 600.006) = 83.760, p= .001, ηp2 = .461), showing that session four had the 
lowest delta relative power (≈ 50%), and the rest of the sessions had around (≈ 75-90 %) delta relative 
power. A main effect of tDCS time (F (1, 98) = 188.496, p= .001, ηp2 = .658), showed that EEG1 was 
higher than EEG2. There was also a significant main effect of electrode (F (3.733, 365.828) = 113.298, 
p= .001, ηp2 = .536) indicating that similar levels of delta relative power were found across electrodes 
with FC6 having slightly lower delta relative power. In addition, there was an interaction session x 
tDCS time (F (6.185, 606.140) = 22.095, p= .001, ηp2 = .184) showing that delta relative power was 
higher in EEG1 (≈ 90%) in all sessions but session four that had around 75% delta relative power, 
however EEG2 delta relative power changed from sessions one, two, three, four and six (≈ 85%, 75%, 
65%, 55% and 60%, respectively) whereas it was higher (≈ 90%) in sessions five, six and eight. There 
was a significant interaction session x electrode (F (17.406, 1705.782) = 15.728, p= .001, ηp2 = .138), 
showing that sessions six and eight had the highest relative delta power in all electrodes and the lowest 
delta relative power was in sessions four and three, especially in FC6.  
 
There was also an interaction tDCS time x electrode (F (4.254, 416.915) = 44.280, p= .001, ηp2 = 
.311), indicating that all electrodes showed similar levels of delta relative power between tDCS 
conditions with higher delta relative power in EEG1 compared with EEG2 with the highest difference 
being in FC6. A three way interaction session x tDCS time x electrode (F (16.960, 1662.096) = 10.209, 
p= .001, ηp2 = .094), showed that session four had the lowest delta relative power in EEG2 (≈ 55%) 
while EEG1 was around 80%, and sessions three showed the largest difference between EEG1 and 
EEG2 delta relative power (≈ 90% and 65%, respectively), whereas in sessions five, six and eight the 
difference was the smallest. Delta relative power values across sessions and electrode positions are 
represented in Figure 0-10. 
 
To assess the final outcome of the intervention, delta relative power results were compared between 
sessions one and eight with paired t-tests (2-tailed) for each electrode position and each frequency 
band separately. Results showed that EEG1 delta relative power in session one was significantly lower 
than EEG1 delta relative power in session eight, in all electrodes except in AF7: Cz (t (100) = -3.765, 




=.003),  F4 (t (100) = -3.623, p =.001),  FC6 (t (100) = -3.664, p =.001) and F3 (t (100) = -4.527, p 
=.001). EEG2 delta relative power in session one was significantly higher than EEG2 delta relative 
power in session eight, in all electrodes: Cz (t (100) = 17.560, p =.001), AF8 (t (100) = 22.635, p 
=.001), AF4 (t (100) = 21.618, p =.001), Fpz (t (100) = 22.735, p =.001),  F4 (t (100) = 19.683, p 
=.001),  FC6 (t (100) = 15.401, p =.001), F3 (t (100) = 24.231, p =.001) and AF7 (t (100) = 28.615, p 
=.001). To compare the effects of tDCS before and after the stimulation within session, considering 
sessions one and eight, paired t-test (2-tailed) revealed that EEG1 was significantly higher than EEG2 
in session one in all electrodes: Cz (t (125) = 34.349, p =.001), AF8 (t (125) = 40.882, p =.001), AF4 
(t (125) = 30.776, p =.001), Fpz (t (125) = 28.605, p =.001),  F4 (t (125) = 36.382, p =.001),  FC6 (t 
(125) = 31.116, p =.001), F3 (t (125) = 29.893, p =.001) and AF7 (t (125) = 34.327, p =.001). In 
session eight EEG1 was higher than EEG2 in all electrodes: Cz (t (100) = 53.398, p =.001), AF8 (t 
(100) = 55.544, p =.001), AF4 (t (100) = 57.657, p =.001), Fpz (t (100) = 35.690, p =.001),  F4 (t 
(100) = 58.003, p =.001),  FC6 (t (100) = 47.525, p =.001), F3 (t (100) = 48.540, p =.001) and AF7 (t 




















Figure 0-10. Electroencephalogram (EEG) delta relative power in real stimulation condition. Delta relative power (%) of EEG resting 
state recordings before tDCS (EEG1) and after tDCS (EEG2), across eight sessions, and across electrode positions with the international 
EEG 10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7). Data represents mean and SEM (* p < .05; ** p ≤ .01). Note: significant 
differences between EEG1 in session one and EEG1 in session eight were found in all electrodes except in AF7. Significant differences 
between EEG2 in session one and EEG2 in session eight were found in all electrodes. Furthermore, significant differences between 




















Delta absolute power: 
One way repeated measures ANOVA analysis of delta absolute power revealed a significant main 
effect of session (F (2.091, 204.958) = 21.748, p= .001, ηp2 = .182), showing that session eight had 
the highest delta absolute power (over 1000 µV2)20, followed by session two with around 500 µV2 
delta absolute power and with minimum values in sessions three and four (around 45 µV2). There was 
also a significant main effect of tDCS time (F (1, 98) = 39.544, p= .001, ηp2 = .288), showing that 
delta absolute power was higher in EEG1 compared with EEG2, and a significant main effect of 
electrode (F (1.208, 118.415) = 75.130, p= .001, ηp2 = .434) indicating that electrodes from the highest 
(≈ 550 µV2) to the lowest (≈ 20 µV2) delta absolute power were Cz, F4, AF8, FC6, Af4, F3, Fpz and 
AF7.  
 
In addition, there was an interaction session x tDCS time (F (2.097, 205.510) = 6.905, p= .001, ηp2 = 
.066), showing that higher delta absolute power in EEG1 compared with EEG2 was found especially 
in sessions eight (≈ 1000 µV2 and 500 µV2, respectively), two (≈ 500 µV2 and 40 µV2, respectively), 
one (≈ 400 µV2 and 70 µV2, respectively) and three (≈ 400 µV2 and 15 µV2, respectively). In the rest 
of sessions a more similar delta absolute power was found between both tDCS time conditions. There 
was a significant interaction session x electrode (F (2.647, 259.453) = 17.870, p= .001, ηp2 = .154), 
showing that session eight had the highest delta absolute power in all electrodes followed by session 
two, in which electrodes Fpz and AF7 had the lowest delta absolute power. The session with lowest 
delta absolute power in all electrodes was session three.  
 
A significant interaction tDCS time x electrode (F (1.195, 117.145) = 35.422, p= .001, ηp2 = .265), 
showed that in all electrodes higher delta absolute power was associated with EEG1 compared with 
EEG2, but this difference was smallest in electrodes Fpz and AF7. Lastly, a three way interaction 
session x tDCS time x electrode (F (2.620, 256.807) = 8.320, p= .001, ηp2 = .078), showed that in 
EEG1, session eight followed by session two had the highest delta absolute power in all electrodes 
reaching over 1000 µV2, however in EEG2, delta absolute power values were lower (maximum 
around 500 in session eight followed by session six showing around 200 µV2), but lower than 100 
µV2 in the rest of the sessions. Delta absolute power values across sessions and electrode positions 
are represented in Figure 0-11. 
                                                 
20 Data processing was not able to remove all artefacts in this frequency band and absolute power values appear extremely 





To assess the final outcome of the intervention, delta absolute power results were compared between 
sessions one and eight with paired t-tests (2-tailed) for each electrode position and each frequency 
band separately. Results showed that EEG1 delta absolute power in session one was significantly 
lower than EEG1 delta absolute power in session eight, in all electrode positions: Cz (t (100) = -3.696, 
p =.001), AF8 (t (100) = -3.485, p =.001),  AF4 (t (100) = -4.202, p =.001), Fpz (t (100) = -2.566, p 
=.012), F4 (t (100) = -3.487, p =.001), FC6 (t (100) = -3.293, p =.001), F3 (t (100) = -3.951, p =.001)  
and AF7 (t (100) = -2.065, p =.041). EEG2 delta absolute power in session one was significantly 
lower than EEG2 delta absolute power in session eight, for all electrodes: Cz (t (110) = -5.370, p 
=.001), AF8 (t (110) = -5.222, p =.001),  AF4 (t (110) = -5.296, p =.001), Fpz (t (110) = -4.899, p 
=.001), F4 (t (110) = -5.322, p =.001), FC6 (t (110) = -5.300, p =.001), F3 (t (110) = -5.157, p =.001)  
and AF7 (t (110) = -3.373, p =.001).  
 
To compare the effects of tDCS before and after the stimulation within session, considering sessions 
one and eight, paired t-test (2-tailed) revealed that EEG1 delta absolute power was significantly higher 
than EEG2 delta absolute power in session one, in all electrodes except AF7: Cz (t (118) = 6.528, p 
=.001), AF8 (t (118) = 6.429, p =.001),  AF4 (t (118) = 5.480, p =.001), Fpz (t (118) = 3.246, p =.001) 
and F4 (t (118) = 6.552, p =.001), FC6  (t (118) = 6.646, p =.001) and F3 (t (118) = 5.345, p =.001). 
In session eight, EEG1 delta absolute power was higher than EEG2 delta absolute power in all 
electrodes except in Fpz and AF7: Cz (t (100) = 2.986, p =.004),  AF8 (t (100) = 2.759, p =.007), AF4 
(t (100) = 2.726, p =.008), F4 (t (100) = 2.738, p =.007), FC6 (t (100) = 2.855, p =.005) and F3 (t 


















Figure 0-11. Electroencephalogram (EEG) delta absolute power in real stimulation condition. Delta absolute power (µV2) of EEG 
resting state recordings before tDCS (EEG1) and after tDCS (EEG2), across eight sessions, and across electrode positions with the 
international EEG 10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7). Data represents mean and SEM (* p < .05; ** p ≤ .01). 
Notes: data was contaminated with multiple artefacts that were not completely removed after data processing, possibly due to sweating 
during the experimental sessions, which would explain that absolute power values appear extremely high low frequencies. Significant 
differences between EEG1 in session one and EEG1 in session eight were found in all electrodes locations. Significant differences 
between EEG2 in session one and EEG2 in session eight were found in all electrodes. Furthermore, significant differences between 
EEG1 and EEG2 in session one were found in ell electrodes except AF7, and in session eight, EEG1 and EEG2 were significantly 



















Theta relative power: 
One way repeated measures ANOVA analysis of theta relative power revealed a significant main 
effect of session (F (6.117, 599.506) = 48.927, p= .001, ηp2 = .333), showing that sessions three, seven 
and four had the highest theta relative power (≈ 7%) and session eight had the lowest level of theta 
relative power (≈ 1%). A main effect of tDCS time (F (1, 98) = 65.568, p= .001, ηp2 = .401), showed 
that EEG1 had lower theta relative power than EEG2. There was also a significant main effect of 
electrode (F (3.785, 272.769) = 138.430, p= .001, ηp2 = .736) indicating that electrodes from the 
highest (≈ 7%) to the lowest (≈ 1%) theta relative power were AF4, F3, Fpz, AF8, Cz, F4, AF7 and 
FC6. In addition, there was an interaction session x tDCS time (F (7, 686) = 28.298, p= .001, ηp2 = 
.224), showing that theta relative power was lower in EEG1 compared with EEG2 in sessions one (≈ 
2 % and 4%, respectively), two (≈ 1 % and 5 %, respectively), three (≈ 1 % and 7 %, respectively), 
four (≈ 5 % and 7 %, respectively) and seven (≈ 1 % and 7 %, respectively), whereas in the rest of the 
sessions both tDCS time conditions had more similar levels of theta relative power. There was a 
significant interaction session x electrode (F (18.943, 1859.359) = 10.932, p= .001, ηp2 = .100), 
showing that sessions three had the highest theta relative power in all electrodes, followed by session 
seven, and the lowest theta relative power was in session eight.  
 
There was also an interaction tDCS time x electrode (F (3.955, 387.632) = 28.164, p= .001, ηp2 = 
.223), indicating that electrodes AF4, F3 and Fpz showed the highest relative theta power in EEG2, 
and the lowest was in EEG1, especially in electrodes Cz, F4 and FC6. A three way interaction session 
x tDCS time x electrode (F (19.459, 1906.991) = 8.452, p= .001, ηp2 = .079), showed that in EEG1 
session three had the highest delta relative power in all electrodes, and in EEG2 session seven and 
session two had the highest theta relative power in all electrodes, whereas in both tDCS conditions 
the lowest theta relative power was in session eight. Relative theta power values across sessions and 
electrode positions are represented in Figure 0-12. 
 
To assess the final outcome of the intervention, theta relative power results were compared between 
sessions one and eight with paired t-tests (2-tailed) for each electrode position and each frequency 
band separately. Results showed that EEG1 theta relative power in session one was significantly 
higher than EEG1 delta relative power in session eight, in all electrode positions except in AF7: Cz (t 
(100) = 3.090, p =.003), AF8 (t (100) = 3.081, p =.003),  AF4 (t (100) = 4.872, p =.001), Fpz (t (100) 




3.193, p =.002).  EEG2 theta relative power in session one was significantly higher than EEG2 theta 
relative power in session eight, in all electrode positions: Cz (t (110) = 6.304, p =.001), AF8 (t (110) 
= 5.548, p =.001),  AF4 (t (110) = 6.219, p =.001), Fpz (t (110) = 5.617, p =.001) and F4 (t (110) = 
5.924, p =.001), FC6  (t (110) = 5.050, p =.001), F3 (t (110) = 3.940, p =.001) and AF7 (t (110) = 
3.041, p =.003). To compare the effects of tDCS before and after the stimulation within session, 
considering sessions one and eight, paired t-test (2-tailed) revealed that EEG1 theta relative power 
was significantly lower than EEG2 theta relative power in session one in all electrodes: Cz (t (118) = 
-6.773, p =.001), AF8 (t (118) = -7.119, p =.001),  AF4 (t (118) = -5.712, p =.001), Fpz (t (118) = -
5.048, p =.001), F4 (t (118) = -6.659, p =.001), FC6 (t (118) = -6.088, p =.001), F3 (t (118) = -4.137, 
p =.001)  and AF7 (t (118) = -5.134, p =.001). In session eight, EEG1 theta relative power was lower 





























Figure 0-12. Electroencephalogram (EEG) theta relative power in real stimulation condition. Theta relative power (%) of EEG resting 
state recordings before tDCS (EEG1) and after tDCS (EEG2), across eight sessions, and across electrode positions with the international 
EEG 10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7). Data represents mean and SEM (* p < .05; ** p ≤ .01). Note: significant 
differences between EEG1 in session one and EEG1 in session eight were found in all electrodes positions except in AF7. Significant 
differences between EEG2 in session one and EEG2 in session eight were found in all electrode positions. Furthermore, significant 




















Theta absolute power:  
One way repeated measures ANOVA analysis of theta absolute power revealed a significant main 
effect of session (F (2.713, 265.880) = 15.134, p= .001, ηp2 = .134), showing that sessions eight (≈ 8 
µV2), one and two (≈ 7 µV2) had the highest theta absolute power, whereas the lowest theta absolute 
power was found in sessions three, four and seven (≈ 1 µV2). There was also a significant main effect 
of tDCS time (F (1, 98) = 24.140, p= .001, ηp2 = .198), showing that theta absolute power was higher 
in EEG1 compared with EEG2. A significant main effect of electrode (F (1.418, 139.008) = 14.242, 
p= .001, ηp2 = .129) indicated that theta absolute power was similar across electrodes, with slightly 
higher values shown in Cz and Fpz, and the lowest in FC6. In addition, there was a significant 
interaction session x electrode (F (5.050, 494.882) = 3.738, p= .002, ηp2 = .037), showing that session 
eight had the highest theta absolute power in all electrodes, followed by session two, and the lowest 
in session three. There was also an interaction tDCS time x electrode (F (1.479, 144.944) = 6.912, p= 
.004, ηp2 = .066), showing that in all electrodes higher theta absolute power was associated with EEG1 
compared with EEG2. A three way interaction session x tDCS time x electrode (F (4.921, 482.240) = 
4.696, p= .001, ηp2 = .046), showed that in EEG1 sessions eight and two had the highest delta relative 
power in all electrodes except in Fpz in which session one and session six where the highest, and in 
EEG2 session eight had the highest theta relative power in all electrodes, whereas in both tDCS 
conditions the lowest theta relative power was in session eight. Theta absolute power values across 
sessions and electrode positions are represented in Figure 0-13. 
 
To assess the final outcome of the intervention, theta absolute power results were compared between 
sessions one and eight with paired t-tests (2-tailed) for each electrode position and each frequency 
band separately. Results showed that EEG1 theta absolute power in session one was significantly 
lower than EEG1 theta absolute power in session eight, in electrode positions: Cz (t (100) = -2.093, p 
=.039),  AF4 (t (100) = -1.475, p =.036) and F3 (t (100) = -2.120, p =.039). EEG2 theta absolute 
power in session one was significantly lower than EEG2 theta absolute power in session eight, in all 
electrodes: Cz (t (100) = -3.078, p =.003), AF8 (t (100) = -2.961, p =.004), AF4 (t (100) = -2.776, p 
=.006), Fpz (t (100) = -2.166, p =.032),  F4 (t (100) = -3.523, p =.001),  FC6 (t (100) = -3.627, p 
=.001), F3 (t (100) = -3.978, p =.001) and AF7 (t (100) = -2.765, p =.007). To compare the effects of 
tDCS before and after the stimulation within session, considering sessions one and eight, paired t-test 
(2-tailed) revealed that EEG1 theta absolute power was significantly higher than EEG2 theta absolute 
power in session one, in all electrodes except for Fpz and AF7: Cz (t (118) = 6.521, p =.001), AF8 (t 




(118) = 6.983, p =.001) and F3 (t (118) = 2.351, p =.020). In session eight, EEG1 theta absolute power 
was higher than EEG2 theta absolute power in electrodes Cz (t (100) = 3.039, p =.003), and FC6 (t 
























Figure 0-13. Electroencephalogram (EEG) theta absolute power in real stimulation condition. Theta absolute power (µV2) of EEG 
resting state recordings before tDCS (EEG1) and after tDCS (EEG2), across eight sessions, and across electrode positions with the 
international EEG 10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7). Data represents mean and SEM (* p < .05). Note: 
significant differences between EEG1 in session one and EEG1 in session eight were found in electrode positions Cz, AF4 and F3. 
Significant differences between EEG2 in session one and EEG2 in session eight were found in all electrodes. Furthermore, significant 
differences between EEG1 and EEG2 in session one were found in all electrodes except in Fpz and AF7, and in session eight EEG1 


















Alpha relative power: 
One way repeated measures ANOVA analysis of alpha relative power revealed a significant main 
effect of session (F (4.860, 476.277) = 40.781, p= .001, ηp2 = .294), showing that sessions two, three, 
four and seven had the highest alpha relative power (≈ 6%), and sessions six and eight had the lowest 
(≈ 1%). A significant main effect of tDCS time (F (1, 98) = 127.890, p= .001, ηp2 = .566) showed that 
EEG1 had lower alpha relative power than in all sessions except in sessions six and eight. There was 
also a significant main effect of electrode (F (4.278, 419.223) = 228.116, p= .001, ηp2 = .699), 
indicating that relative alpha power was similar across electrodes being slightly higher in Cz and 
lower in FC6. In addition, there was an interaction session x tDCS time (F (4.849, 475.207) = 14.217, 
p= .001, ηp2 = .127) showing that alpha relative power was lower in EEG1 compared with EEG2 in 
sessions one (≈ 1% and 3%), two (≈ 1% and 6%), three (≈ 1% and 6%), four (≈ 4% and 6%), five (≈ 
1% and 2%) and seven (≈ 1% and 6%), whereas similar levels between both tDCS conditions were 
found in sessions six and eight (≈ 1%).  
 
There was a significant interaction session x electrode (F (18.732, 1835.708) = 10.182, p= .001, ηp2 
= .094), showing that sessions two, and three had the highest alpha relative power across all electrodes, 
whereas the lowest alpha relative power was in session eight for all electrodes. There was also an 
interaction tDCS time x electrode (F (3.874, 379.603) = 26.172, p= .001, ηp2 = .211), indicating that 
all electrodes showed similar levels of alpha relative power between tDCS conditions (EEG1 having 
around 1-2% and EEG2 around 3-5%). A three way interaction session x tDCS time x electrode (F 
(17.442, 1709.364) = 7.419, p= .001, ηp2 = .070), showed that in all electrodes in EEG1 the highest 
alpha relative power was in session three, whereas in EEG2 the highest was session two. In both tDCS 
conditions the lowest alpha relative power was shown in session eight and the lowest alpha relative 
power was in electrode FC6 in both conditions. Alpha relative power values across sessions and 
electrode positions are represented in Figure 0-14. 
 
To assess the final outcome of the intervention, alpha relative power results were compared between 
sessions one and eight with paired t-tests (2-tailed) for each electrode position and each frequency 
band separately. Results showed that EEG1 alpha relative power in session one was significantly 
higher than EEG1 alpha relative power in session eight, in all electrode positions: Cz (t (100) = 4.479, 
p =.001),  AF8 (t (100) = 4.296, p =.001), AF4 (100) = 5.503, p =.001), Fpz (t (100) = 4.487, p =.001), 




(t (100) = 3.457, p =.001). EEG2 alpha relative power in session one was significantly higher than 
EEG2 alpha relative power in session eight in all electrodes: Cz (t (110) = 3.124, p =.002),  AF8 (t 
(110) = 4.085, p =.001), AF4 (110) = 5.198, p =.001), Fpz (t (110) = 5.114, p =.001), F4 (t (110) = 
4.135, p =.001), FC6 (t (110) = 3.609, p =.001) F3 (t (110) = 4.336, p =.001) and AF7 (t (110) = 2.902, 
p =.004). To compare the effects of tDCS before and after the stimulation within session, considering 
sessions one and eight, paired t-test (2-tailed) revealed that EEG1 alpha relative power was 
significantly lower than EEG2 alpha relative power in session one, in all electrodes: Cz (t (118) = -
6.489, p =.001),  AF8 (t (118) = -4.310, p =.001), AF4 (118) = -3.560, p =.027), Fpz (t (118) = -3.006, 
p =.003),  F4 (t (118) = -5.489, p =.001), FC6 (t (118) = -5.681, p =.001), F3 (t (118) = -2.249, p 
=.026) and AF7 (t (118) = -2.492, p =.014). In session eight there were no significant differences in 




















Figure 0-14. Electroencephalogram (EEG) alpha relative power in real stimulation condition. Alpha relative power (%) of EEG resting 
state recordings before tDCS (EEG1) and after tDCS (EEG2), across eight sessions, and across electrode positions with the international 
EEG 10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7). Data represents mean and SEM (* p < .05; ** p ≤ .01). Note: significant 
differences between EEG1 in session one and EEG1 in session eight were found in all electrode positions. Significant differences 
between EEG2 in session one and EEG2 in session eight were found in all electrodes. Furthermore, significant differences between 
EEG1 and EEG2 in session one were found in all electrodes, however in session eight, there were no significant differences between 




















Alpha absolute power: 
One way repeated measures ANOVA analysis of alpha absolute power revealed a significant main 
effect of session (F (4.731, 463.328) = 32.697, p= .001, ηp2 = .250), showing that sessions three, eight 
and one had the highest alpha absolute power at around 3-4 µV2, whereas the lowest was alpha 
absolute power was found in sessions three and seven with approximately 1 µV2. There was also a 
significant main effect of tDCS time (F (1, 98) = 31.214, p= .001, ηp2 = .242), showing that alpha 
absolute power was higher in EEG1 compared with EEG2. A significant main effect of electrode (F 
(3.165, 310.174) = 332.581, p= .001, ηp2 = .772) indicated Cz showed the highest alpha absolute 
power at around 4 µV2, the lowest was FC6 with around 1.5 µV2, and the rest of electrodes showed 
similar alpha absolute power (1.5-2.5 µV2). In addition, there was a significant interaction session x 
tDCS time (F (4.834, 473.737) = 3.396, p= .006, ηp2 = .033), showing that higher alpha absolute 
power in EEG1 compared with EEG2 was found in all sessions except in session five. There was a 
significant interaction session x electrode (F (3.266, 320.105) = 16.325, p= .001, ηp2 = .143), showing 
that session two had the highest alpha absolute power in all electrodes followed by session five in all 
electrodes except in Cz in which session six was the second highest, and the lowest alpha absolute 
power was found in session three, in all electrodes.  
 
A significant interaction tDCS time x electrode (F (1.722, 122.288) = 14.242, p= .001, ηp2 = .167), 
showed that in all electrodes higher alpha absolute power was associated with EEG1 compared with 
EEG2 with the smallest difference shown in AF7. Lastly, a three way interaction session x tDCS time 
x electrode (F (11.892, 1165.459) = 9.903, p= .001, ηp2 = .092), showed that in both EEG1 and EEG2, 
session two had the highest alpha absolute power in all electrodes, and session three had the lowest, 
however in EEG2, session two still had the highest alpha absolute power but sessions three and seven 
were associated with the lowest alpha absolute power in all electrodes. Alpha absolute power values 
across sessions and electrode positions are represented in Figure 0-15. 
 
To assess the final outcome of the intervention, alpha absolute power results were compared between 
sessions one and eight with paired t-tests (2-tailed) for each electrode position and each frequency 
band separately. Results showed that EEG1 alpha absolute power in session one was significantly 
lower than EEG1 alpha relative power in session eight, in electrode positions AF8 (t (100) = -2.068, 
p =.011) and AF4 (t (100) = -2.539, p =.027). EEG2 alpha absolute power in session one was 




p =.001),  F4 (t (110) = 2.601, p =.011), FC6 (110) = 2.163, p =.033), F3 (t (110) = -2.047, p =.043) 
and AF7 (110) = 3.371, p =.011). To compare the effects of tDCS before and after the stimulation 
within session, considering sessions one and eight, paired t-test (2-tailed) revealed that EEG1 alpha 
absolute power was significantly higher than EEG2 alpha absolute power in session one, in all 
electrodes except Fpz and AF7: Cz (t (118) = 3.474, p =.001),  AF8 (t (118) = 3.755, p =.001), AF4 
(118) = 3.305, p =.027), F4 (t (118) = 4.825, p =.001), FC6 (t (118) = 2.224, p =.001), and F3 (t (118) 
= -2.360, p =.028). In session eight EEG1 alpha absolute power was higher than EEG2 alpha absolute 
power in all electrodes except in Fpz: Cz (t (100) = 5.269, p =.001),  AF8 (t (100) = 4.762, p =.001), 
AF4 (100) = 4.840, p =.001), F4 (t (100) = 4.864, p =.001), FC6 (t (100) = 5.630, p =.001), F3 (t (100) 




























Figure 0-15. Electroencephalogram (EEG) alpha absolute power in real stimulation condition. Alpha absolute power (µV2) of EEG 
resting state recordings before tDCS (EEG1) and after tDCS (EEG2), across eight sessions, and across electrode positions with the 
international EEG 10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7). Data represents mean and SEM (* p < .05). Note: 
significant differences between EEG1 in session one and EEG1 in session eight were found only in electrodes AF8 and AF4. Significant 
differences between EEG2 in session one and EEG2 in session eight were found in electrodes Cz, F4, FC6. F3 and AF7. Furthermore, 
significant differences between EEG1 and EEG2 in session one were found in all electrodes except in Fpz and AF7, and in session 



















Beta relative power:  
One way repeated measures ANOVA analysis of beta relative power revealed a significant main effect 
of session (F (5.910, 579.132) = 101.779, p= .001, ηp2 = .509), showing that session four had the 
highest beta relative power (≈ 30%), and session eight had the lowest (≈ 3%). A significant main 
effect of tDCS time (F (1, 98) = 176.341, p= .001, ηp2 = .643) showed that EEG1 had lower beta 
relative power than in EEG2. There was also a significant main effect of electrode (F (3.505, 343.510) 
= 446.450, p= .001, ηp2 = .820), indicating that FC6 had the highest beta relative power (≈ 20%), and 
the lowest was in Cz (≈ 3%), but all electrodes had similar levels of beta relative power except the 
highest (FC6). In addition, there was an interaction session x tDCS time (F (5.891, 557.340) = 20.332, 
p= .001, ηp2 = .172) showing that beta relative power was lower in EEG1 compared with EEG2. The 
difference between both tDCS conditions was around less than 5% difference of power in sessions 
one, five, six and eight, but larger in sessions three (≈ 3% and 20%, respectively), four (≈ 13% and 
30%, respectively) and seven (≈ 5% and 25%, respectively).  
 
There was also a significant interaction session x electrode (F (16.741, 1640.593) = 27.571, p= .001, 
ηp2 = .220), showing that session four (especially in FC6) had the highest beta relative power in all 
electrodes, followed by session seven, and the lowest beta relative power in all electrodes was found 
in sessions six and eight. A significant interaction tDCS time x electrode (F (4.176, 409.285) = 
103.483, p= .001, ηp2 = .514), indicated that the largest difference between tDCS time conditions was 
in FC6 (EEG1 was around 6% and EEG2 around 22%), and in the rest of electrodes the difference 
between tDCS time conditions was around 10% of the power. A three way interaction session x tDCS 
time x electrode (F (17.017, 1667.620) = 15.529, p= .001, ηp2 = .137), showed that in EEG1 the 
highest beta relative power was found in session three in all electrodes except in FC6 in which session 
five was the highest. In EEG2 the highest beta relative power was found in session four in all 
electrodes. Session eight had the lowest beta relative power in both tDCS conditions. Beta relative 
power was similar across electrodes except for FC6 that had the highest levels. Beta relative power 
values across sessions and electrode positions are represented in Figure 0-16. 
 
To assess the final outcome of the intervention, beta relative power results were compared between 
sessions one and eight with paired t-tests (2-tailed) for each electrode position and each frequency 
band separately. Results showed that EEG1 beta relative power in session one was significantly higher 




(t (100) = 2.977, p =.004),  AF8 (t (100) = 2.221, p =.029), AF4 (100) = 3.604, p =.001), F4 (t (100) 
= 2.734, p =.007), FC6 (t (100) = 3.538, p =.001) and F3 (t (100) = 3.827, p =.001). EEG2 beta relative 
power in session one was significantly higher than EEG2 beta relative power in session eight in all 
electrodes: Cz (t (110) = 9.717, p =.001),  AF8 (t (110) = 7.245, p =.001),  AF4 (t (110) = 6.998, p 
=.001),  Fpz (t (110) = 5.059, p =.001),  F4 (t (110) = 8.646, p =.001), FC6 (t (110) = 11.212, p =.001), 
F3 (t (110) = 6.369, p =.001) and AF7 (t (110) = 2.031, p =.045).  
 
To compare the effects of tDCS before and after the stimulation within session, considering sessions 
one and eight, paired t-test (2-tailed) revealed that EEG1 beta relative power was significantly lower 
than EEG2 beta relative power in session one, in all electrodes: Cz (t (118) = -8.713, p =.001),  AF8 
(t (118) = -5.592, p =.001), AF4 (t (118) = -4.192, p =.001), Fpz (t (118) = -3.354, p =.001), F4 (t 
(118) = -6.654, p =.001), FC6 (t (118) = -8.097, p =.001), F3 (t (118) = -2.614, p =.010) and AF7 (t 
(118) = -3.016, p =.003). In session eight there were no significant differences between beta relative 





















Figure 0-16. Electroencephalogram (EEG) beta relative power in real stimulation condition. Delta relative power (%) of EEG resting 
state recordings before tDCS (EEG1) and after tDCS (EEG2), across eight sessions, and across electrode positions with the international 
EEG 10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7). Data represents mean and SEM (* p < .05). Note: significant differences 
between EEG1 in session one and EEG1 in session eight were found in all electrodes positions except in Fpz and AF7. Significant 
differences between EEG2 in session one and EEG2 in session eight were found in all electrodes. Furthermore, significant differences 
between EEG1 and EEG2 in session one were found in all electrodes, however in session eight, there were no significant differences 




















Beta absolute power:  
One way repeated measures ANOVA analysis of beta absolute power revealed a significant main 
effect of session (F (2.760, 270.448) = 14.672, p= .001, ηp2 = .130), showing that sessions five and 
eight had the highest beta absolute power at around 10 µV2, whereas the lowest beta absolute power 
was found in sessions three and six, with approximately 4 µV2. There was also a significant main 
effect of tDCS time (F (1, 98) = 10.883, p= .001, ηp2 = .100), showing that beta absolute power was 
higher in EEG1 compared with EEG2. A significant main effect of electrode (F (2.023, 198.268) = 
95.886, p= .001, ηp2 = .495) indicated the electrode FC6 showed the highest beta absolute power at 
around 12 µV2, and the rest of electrodes showed similar beta absolute power (4-7 µV2). In addition, 
there was a significant interaction session x tDCS time (F (2.846, 278.870) = 4.619, p= .004, ηp2 = 
.045), showing that higher beta absolute power in EEG1 compared with EEG2 was found in all 
sessions except in sessions four and five (in which tDCS conditions had similar beta absolute power), 
with the greatest difference between EEG1 and EEG2 found in session eight (10 µV2 to 5 µV2, 
respectively). There was a significant interaction session x electrode (F (2.245, 219.965) = 13.608, p= 
.001, ηp2 = .122), showing that sessions two and four had the highest beta absolute power in all 
electrodes except in FC6 and F3 in which session five had the highest absolute beta power. Beta 
absolute power values across sessions and electrode positions are represented in Figure 0-17. 
 
To assess the final outcome of the intervention, beta absolute power results were compared between 
sessions one and eight with paired t-tests (2-tailed) for each electrode position and each frequency 
band separately. Results showed that EEG1 beta absolute power in session one was significantly lower 
than EEG1 beta absolute power in session eight, in all electrode positions except in FC6: Cz (t (100) 
= -3.227, p =.002), AF8 (t (100) = -4.906, p =.001),  AF4 (t (117) = -5.330, p =.001), Fpz (t (117) = -
8.303, p =.001), F4 (t (100) = -3.256, p =.002), F3 (t (100) = -4.483, p =.001) and AF7 (t (100) = -
3.758, p =.001). EEG2 beta absolute power in session one was significantly higher than EEG2 beta 
absolute power in session eight, in electrodes Cz (t (110) = 2.679, p =.009) and FC6 (t (110) = 3.162, 
p =.002), and absolute beta power was significantly lower in EEG1 than in EEG2 in Fpz (t (110) = -
2.203, p =.030). To compare the effects of tDCS before and after the stimulation within each session, 
considering sessions one and eight, paired t-test (2-tailed) revealed that EEG1 beta absolute power 
was significantly higher than EEG2 beta absolute power in session one, in all electrodes, except in 
Fpz in which absolute beta power was lower in EEG1 compared with EGG2: Cz (t (118) = 4.243, p 
=.001),  AF8 (t (118) = 6.398, p =.001), AF4 (t (118) = 5.147, p =.001), Fpz (t (118) = -7.086, p 




and AF7 (t (118) = 3.835, p =.001). In session eight, EEG1 beta absolute power was significantly 
higher than EEG2 beta absolute power in all electrodes: Cz (t (100) = 5.962, p =.001),  AF8 (t (100) 
= 6.647, p =.001), AF4 (t (100) = 4.465, p =.001), Fpz (t (100) = 4.662, p =.001), F4 (t (100) = 4.275, 
p =.016), FC6 (t (100) = 4.731, p =.001), F3 (t (100) = 5.092, p =.001) and AF7 (t (100) = 3.923, p 












Figure 0-17. Electroencephalogram (EEG) beta absolute power in real stimulation condition. Beta absolute power (µV2) of EEG resting 
state recordings before tDCS (EEG1) and after tDCS (EEG2), across eight sessions, and across electrode positions with the international 
EEG 10/10 system (Cz, AF8, AF4, Fpz, F4, FC6, F3 and AF7). Data represents mean and SEM (* p < .05; ** p ≤ .01). Note: significant 
differences between EEG1 in session one and EEG1 in session eight were found in all electrodes except in FC6. Significant differences 
between EEG2 in session one and EEG2 in session eight were found in electrodes Cz, Fpz and FC6. Furthermore, significant differences 
between EEG1 and EEG2 in session one were found in all electrodes, and in session eight EEG1 and EEG2 were significantly different 









To investigate the relationship between gambling severity and the rest of the variables, 2-tailed 
Pearson’s correlation indicated that gambling severity measured with PG-YBOCS correlated 
positively with EEG1 relative power across different electrode positions and frequency bands: PG-
YBOCS correlated negatively with delta relative power in AF8 (r = -.743, n = 8, p =.035), AF4 (r =-
.764, n = 8, p =.027), Fpz (r =-.751, n = 8, p =.032), F4 (r =-.709, n = 8, p =.049), F3 (r = -.735, n = 
8, p =.038) and AF7 (r = -.811, n = 8, p =.015). PG-YBOCS correlated positively with theta relative 
power in Cz (r =.744, n = 8, p =.034), AF8 (r =.804, n = 8, p =.016), AF4 (r =.840, n = 8, p =.009), 
Fpz (r =.909, n = 8, p =.002), F4 (r =.812, n = 8, p =.014), FC6 (r =.774, n = 8, p =.024), F3 (r =.845, 
n = 8, p =.008) and AF7 (r =.921, n = 8, p =.001). PG-YBOCS correlated positively with alpha relative 
power in AF8 (r =.742, n = 8, p =.035), AF4 (r =.771, n = 8, p =.025), Fpz (r =.737, n = 8, p =.037), 
F4 (r =.725, n = 8, p =.042), F3 (r =.725, n = 8, p =.042) and AF7 (r =.725, n = 8, p =.042). PG-
YBOCS correlated positively with beta relative power in AF8 (r =.717, n = 8, p =.045), AF4 (r =.729, 
n = 8, p =.040) and AF7 (r =.727, n = 8, p =.041). Correlations with CGT could not be computed due 
to the lack of enough data points.  
 
Having found all significant correlations between gambling severity and EEG variables, in the EEG1 
relative power (pre-tDCS) recordings, these variables were further explored with the aim to find 
physiological markers that could inform about gambling-related behaviours and symptomatology. 
There were no significant correlations between EEG1 relative power variables and any other self-
report or behavioural variable. An EEG power spectrogram displaying electrode positions Fpz, F4 
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Figure 0-18. Electroencephalography (EEG) spectrogram during transcranial direct current stimulation (tDCS) in real stimulation 
condition. EEG power (µV2) in frequencies 0-30 Hz during five minutes EEG resting state recordings before tDCS (EEG1) and after 
tDCS (EEG2), across eight sessions in real stimulation condition. Electrodes positions displayed in the spectrogram with the 












This experiment was originally designed as an RCT, with the aim to study the effects of tDCS across 
sessions in combination with the CBT treatment offered at the NPGC, to investigate the potential use 
of this particular intervention to improve current treatment approaches for GD. The trial planned 
followed a crossover design with two groups, real stimulation and sham, with parallel assignment. 
The data was collected according to the RCT design, however, the analysis plan had to be adapted to 
fit a single-participant design, due to the recruitment complications described in the clinical settings 
at the NPGC section 4.1.3 in Chapter 4. The data collected consisted of gambling symptomatology 
self-report measures, cognitive behavioural tasks and EEG resting state, from two participants who 
attended eight sessions of tDCS combined with CBT. The participants were assigned to two different 
tDCS groups (one participant received real stimulation, and the other participant received sham). Data 
was analysed according to two different methodologies usually employed to analyse single-participant 
designs: percentage change of scores across sessions was calculated as in case report studies, and 
statistical analysis was performed, based on single-case study analysis methods. However, given that 
data was collected following the RCT design, both, the case report and the single-case study analysis 
approaches employed, had to be adapted to fit the existing data, as described in the analysis plan 
section 4.3.6 in Chapter 4. Results revealed significant effects of the intervention combining the tDCS 
procedure with CBT on gambling severity, cravings, cognitive task performance, and EEG power 
frequency, in both participants.  
 
Participant allocated to tDCS sham condition 
In the participant allocated to sham condition, results showed significant differences across sessions 
in gambling severity measured with PG-YBOCS, gambling cravings measured with VAS, and 
inhibitory control measured with SSRT (which indicates de ability to stop a prominent response). To 
assess the final outcome of the intervention, session eight was compared against session one, revealing 
that there were statistically significant changes, which were also quantified using percentage change 
of scores: a decrease of 44% in PG-YBOCS, a decrease of 38% in G-SAS, a decrease of 64% in DA, 
an increase of 10% of SST total correct trials and a decrease of 16% of SSRT. VAS statistics could 
only be calculated across sessions due to a lack of enough data points, which showed significant 
differences across sessions, and in addition, percentage change between the last and the first session 
revealed a reduction of 86% in gambling cravings. Across sessions, it was identified that session five 
had the lowest scores in self-report measures PG-YBOCS and VAS. Similarly, session five in the 




and total correct, and SST total correct stop and go, total correct stop and SSRT21. The final outcome 
of the intervention showed that the sham tDCS procedure combined with CBT was associated with a 
significant improvement of GD severity and symptomatology, including cravings, as well as 
behavioural impulsivity, and the ability to inhibit prominent responses. Another GD case study using 
a longitudinal intervention with real stimulation tDCS over bilateral DLPFC reported similar 
improvements, showing a reduction of 62.5% of PG-YBOCS, a reduction of 100% of VAS for 
gambling cravings, a reduction of 69.2% in G-SAS and a reduction of 23.6% of self-reported 
impulsivity (Martinotti et al., 2018). The effectiveness of tDCS to improve addiction symptomatology 
is still unclear (Trojak et al., 2017). Literature reviews identified a medium size effect in favour of 
active tDCS compared with sham to reduce cravings (Jansen et al., 2013), however, beyond cravings 
modulation, research also found no differences between active and sham groups in cigarette 
consumption, suggesting that real tDCS might not be more effective than sham to reduce addictive 
behaviours (Mondino et al., 2018). The effectiveness of tDCS to treat addictive behaviours needs to 
be further investigated (Coles et al., 2018). 
 
EEG frequency power analysis results showed significant differences in relative and absolute power 
of the four frequency bands (delta, theta, alpha and beta), across sessions, between the first and the 
last session, and within session one and session eight. In particular, to measure of the cumulative 
effects of tDCS, the EEG outcomes were compared at the beginning and at the end of the eight session 
intervention, considering separately the EEG recordings before and after the tDCS. Results revealed 
an increase of EEG1 delta, theta, alpha and beta absolute power, an increase of EEG2 mean frequency 
power, delta and beta relative power, and an increase of alpha relative power in both EEG1 and EEG2 
in session eight compared with session one. However, there was also a decrease in session eight 
compared with session one in EEG1 mean frequency power, delta relative power and beta relative 
power, as well as a decrease of EEG2 delta, theta, alpha and beta absolute power, and an increase of 
theta relative power in both EEG1 and EEG2. To quantify the short term effects of tDCS, results 
within each session showed that there were EEG power changes after the participant received sham 
tDCS while completing the cognitive task SST: in session one, there was an increase delta, theta and 
beta absolute power, and an increase of delta and beta relative power. There was also a decrease of 
                                                 
21 Statistical analysis comparing each of the eight sessions against the rest was not performed (paired comparisons were 
conducted only between the first and the last session), and therefore, the results discussed about any other specific session, 
refer simply to the variables values observed. The statistical analysis was more focused on assessing the final outcome of 
the intervention, and to compare each session against the others (involving between and within sessions analysis), would 
extend the work load and amount of data reported excessively, considering the limitations associated to the adapted 
analysis methodologies used, the time available for the project and the limited space to report the results. Nevertheless, 




theta and alpha relative power and a decrease of alpha absolute power. In session eight, there was an 
increase of delta, theta and beta relative power, as well as a decrease of delta, theta, alpha and beta 
absolute power and alpha relative power.  
 
These results showed that there was an increase of absolute power across all frequency bands (delta, 
theta, alpha and beta) in session eight compared with session one. Particularly, the increase was in the 
pre-tDCS EEG recording (EEG1), which occurred just after the participant completed the IST (which 
measures reflection impulsivity, and was used as a priming task to activate the brain networks 
associated with gambling behaviours), and just before the participant received sham tDCS. 
Furthermore, there was a decrease of absolute power across all frequency bands (delta, theta, alpha 
and beta) in session eight compared with session one, in the post-tDCS EEG recording (EEG2), just 
after the participant received sham tDCS and completed the SST, which measures inhibition control. 
Across all EEG variables, changes of power frequency comparing session one against session eight 
were more consistent between electrode locations in EEG2 compared with EEG1, showing that 
significant differences were shown in a higher number of electrodes in EEG2.  
 
Within each session, significant differences were shown in a higher number of electrodes in session 
eight, compared with session one. In addition, the increases of EEG power within each session were 
more consistent between session one and session eight, however, the decreases of EEG power 
involved more frequency variables in session eight compared with session one, which could perhaps 
be interpreted as a result of the accumulative effects of the intervention. However, the more 
widespread decrease of EEG power within session eight compared with session one, could also be 
explained by the fact that EEG1 power increased between session one and session eight, and therefore 
the decrease seen from EEG1 to EEG2 within session eight, might have been driven more by the 
increase of EEG1 between sessions, than by a greater decrease from EEG1.  
 
Assuming that sham tDCS had no effects over physiological substrates, the changes of EEG absolute 
power observed could be explained, in part, by an effect of the cognitive task performance before 
each EEG recording, on the brain circuitry underlying the associated cognitive functions to each task. 
This would mean that IST performance across sessions could have facilitated the increase of EEG 
absolute power in all frequency bands, whereas SST performance might have facilitated the decrease 




tDCS procedure, and with the current data is not possible to differentiate the specific effects of CBT 
from the effects of the experimental procedure, which includes the cognitive tasks and sham tDCS. 
Therefore, the changes in EEG power seen across sessions could have been facilitated by the tDCS 
experimental protocol, which included cognitive task performance, the CBT alone, or the combination 
of the tDCS protocol with CBT.  
 
Moreover, the absence of physiological effects on the brain associated with sham tDCS is still under 
debate (Neri et al., 2020), so an alternative explanation of the results could be that the electrical current 
delivered during the ramp up and ramp down of the sham condition, contributed to produce the 
changes observed in the EEG data, showing the mentioned increase of absolute power in all frequency 
bands from session one to session eight before the sham tDCS, but the decrease of absolute power in 
all frequency bands from session one to session eight after the sham tDCS. Furthermore, this 
possibility, could have an added psychological influence, due to the fact that the participant was 
confident that received real stimulation condition. These interpretations would be supported by 
previous research that sham tDCS modulated EEG mean frequency power (Boonstra et al., 2016), and 
studies investigating the brain state dependent effects of tDCS, including influences produced by task 
performance (Gill et al., 2015), and participants motivations and expectations (Brangioni et al., 2018; 
Rabipour et al., 2018).  
 
A closer examination of the EEG data, revealed that there were also other common findings between 
EEG frequency bands results, when comparing outcome values across sessions22: in delta frequency, 
session five showed the highest relative power in EEG2, and the largest difference between EEG1 
and EEG2 absolute power; in theta frequency, session five showed the lowest EEG2 relative power 
and the largest difference between EEG1 and EEG2, whereas sessions five and six showed the highest 
EEG2 absolute power; in alpha frequency, session five showed the lowest relative power in all 
electrodes and the largest difference between EEG1 and EEG2, as well as the highest EEG2 absolute 
power in all electrodes; and in beta frequency, relative power values in EEG2 increased from sessions 
one to four, decreased to the lowest value in session five, and increased again from sessions six to 
                                                 
22 Statistical analysis comparing each of the eight sessions against the rest was not performed (paired comparisons were 
conducted only between the first and the last session), and therefore, the results discussed about any other specific session, 
refer simply to the variables values observed. The statistical analysis was more focused on assessing the final outcome of 
the intervention, and to compare each session against the others (involving between and within sessions analysis), would 
extend the work load and amount of data reported excessively, considering the limitations associated to the adapted 
analysis methodologies used, the time available for the project and the limited space to report the results. Nevertheless, 




eight, whereas the greatest difference in absolute power between EEG1 and EEG2 was shown in 
sessions four and five. Results showing that session five outcomes differentiated from the outcomes 
of the rest of the sessions, are consistent between EEG variables, self-reported measures and 
behavioural task performance, as reported above. In line with this findings, correlation analysis 
showed that gambling severity correlated positively with cravings and EEG2 theta/beta ratio in F3 
(electrode position associated with left DLPFC). In addition, correlation analysis showed that 
gambling severity correlated negatively with SST variables total correct stop and go trials, total 
correct stop trials and total correct go trials, as well as with EEG2 beta relative power in left DLPFC 
(lDPFC). An additional assessment of the neurophysiological variables that correlated with gambling 
severity was conducted, and correlation analysis between EEG2 variables in F3 and gambling related 
behavioural and self-report measures revealed that: theta/beta ratio correlated positively with cravings 
and with IST total correct, whereas beta relative power correlated negatively with cravings. Also, beta 
absolute power correlated negatively with IST total correct and total correct in win condition fixed. 
In addition, absolute power in all frequency bands (delta, theta, alpha and beta) correlated negatively 
with SSRT. In addition, relative alpha power correlated positively with IST total correct in win 
condition fixed, whereas relative delta power correlated negatively with IST total correct in win 
condition fixed. Lastly, absolute alpha power correlated negatively with IST mean number of boxes 
opened and mean number of boxes opened in win condition fixed.  
Previous research showed that gambling severity correlated positively with beta absolute power in the 
left PFC (Kim et al., 2018), however in this experiment gambling severity correlated negatively with 
beta relative power in the left DLPFC. Negative correlations between self-reported impulsivity and 
alpha absolute power were shown in previous GD research (Lee et al., 2017b), whereas this 
experiment revealed negative correlations between behavioural impulsivity measured with IST and 
absolute alpha power. Also, decreased theta/beta ratio has been associated with several psychiatric 
disorders including addition (Newson & Thiagarajan, 2019), and with decreased inhibition control 
measured with SSRT (Lansbergen et al., 2007). Research also found a negative correlation between 
theta/beta ratio and reward and punishment-related reversal learning (Schutte et al., 2017), and 
considering that reversal learning has been associated with gambling problems (Jara-rizzo et al., 
2020), those findings would be consistent with the positive correlation between gambling severity and 





Participant allocated to tDCS real stimulation condition 
In the participant allocated to real stimulation condition, results showed significant differences across 
sessions in gambling severity measured with PG-YBOCS, reflection impulsivity measured with IST, 
in particular results showed differences in IST variables number of boxes opened per trial, probability 
of a correct decision, and in addition there were significant differences in in the SST variable SSRT. 
VAS statistics could only be calculated across sessions due to a lack of enough data points, which 
showed significant differences across sessions, and in addition, percentage change between the last 
and the first session revealed a reduction of 71% in gambling cravings. To assess the final outcome 
of the intervention, session eight was compared against session one, revealing that there were 
statistically significant changes only in PG-YBOCS, which showed a reduction of 66%. In addition, 
at the end of the intervention the participant thought that received tDCS real stimulation. These results 
are consistent with the findings from the case study mentioned previously showing a reduction of 
62.5% of PG-YBOCS, and a reduction of 100% of VAS for gambling cravings after a longitudinal 
intervention with real stimulation tDCS over DLPFC in GD (Martinotti et al., 2018).  
 
EEG frequency power analysis results showed significant differences in relative and absolute power 
of the four frequency bands (delta, theta, alpha and beta), across sessions, between the first and the 
last session, and within session one and session eight. In particular, comparing the EEG outcomes at 
the beginning and at the end of the eight session intervention, and considering separately the EEG 
recordings before and after the tDCS, results revealed long term effect of tDCS, showing an increase 
of EEG1 delta and theta relative power, delta, theta, alpha and beta absolute power, and a decrease of 
EEG1 alpha and beta relative power, in session eight compared with session one. There was also an 
increase of EEG2 delta and theta absolute power, and a decrease of EEG2 delta, theta, alpha and beta 
relative power, and alpha and beta absolute power, in session eight compared with session one. To 
assess short term effects of tDCS, within each session, there were EEG power changes after the 
participant received real stimulation tDCS while completing the cognitive task SST: in session one, 
there was an increase of theta, alpha and beta relative power, and a decrease of delta relative power, 
and delta, theta, alpha and beta absolute power. In session eight, there was an increase of theta relative 
power (only in electrode position AF7), and a decrease of delta relative power, and delta, theta, alpha 
and beta absolute power, however there were no changes in in alpha and beta relative power. Previous 
research combining tDCS and EEG, showed an increase of theta, alpha and beta power (Mangia et 
al., 2014), as well as an increase of delta, theta and alpha power, a reduction of beta power (Boonstra 
et al., 2016), and a reduction of delta power after real stimulation tDCS (Keeser et al., 2011), which 




gambling severity and EEG relative power were found, particularly in the pre-tDCS recording 
(EEG1): gambling severity correlated positively with delta, theta, alpha and beta relative power, 
which is consistent with previous research that showed that gambling severity correlated positively 
with beta absolute power (Kim et al., 2018).  
 
The results showed that there was an increase of absolute power across all frequency bands (delta, 
theta, alpha and beta) as well as an increase of delta and theta relative power and a decrease of alpha 
and beta relative power in session eight compared with session one. Particularly, the increase of 
absolute power across all frequency bands was in the pre-tDCS EEG recording (EEG1), which 
occurred just after the participant completed the IST (which measures reflection impulsivity, and was 
used as a priming task to activate the brain networks associated with gambling behaviours), and just 
before the participant received real stimulation tDCS. Furthermore, in the post-tDCS EEG recording 
(EEG2), just after the participant received sham tDCS and completed the SST (which measures 
inhibition control), there was an increase of delta and theta absolute power, as well as a decrease of 
relative power across all frequency bands (delta, theta, alpha and beta) and alpha and beta absolute 
power, in session eight compared with session one. Across all EEG variables, changes of EEG power 
comparing session one against session eight were more consistent between electrode locations in 
EEG2 compared with EEG1, showing that significant differences were shown in a higher number of 
electrodes in EEG2. Within each session, significant differences were shown in a higher number of 
electrodes in session one, compared with session eight. In addition, in session one, the increases and 
decreases of EEG power happened in similar number of variables, however, in session eight, the 
decreases of EEG power were found across a higher number of variables than the increases of EEG 
power.  
 
To embrace these results, it is essential to consider the particular experimental conditions that did not 
follow the planned procedure: the participant had a break of one weak between session two and 
session three, in which the CBT treatment was delivered remotely without the combined tDCS 
protocol. In session six, the participant received two sessions of CBT after the tDCS procedure, and 
in sessions seven and eight only the tDCS procedure was administered, without CBT following the 
experimental session. In addition, the participant was tested during hot days in the summer season, in 
a room without controlled temperature, after traveling for four hours to attend the treatment at the 
clinic. There were considerable amounts of sweat on the scalp that probably affected the EEG data, 




processing, and the extremely high absolute power values, especially in low EEG frequencies 
(Thompson et al., 2008). Under these conditions, unfortunately it is not possible to draw reliable 
conclusions about the effectiveness of the intervention, however data from each session might provide 
some information about the mechanisms of tDCS.  
 
General discussion and limitations 
In this experiment, some of the limitations highlighted in previous experiments were addressed: a 
triple-blinded design (in which neither the participant, nor the researcher conducting the experiment 
and the data analysis were aware of the stimulation condition) was used to ensure that data analysis 
was less likely to be biased; a longitudinal design was planned to investigate the potential 
accumulative effects of tDCS; a computational model was used to create the most effective tDCS 
montage to target the brain area of interest more accurately; and neurophysiological data (EEG) was 
used to quantify the effects of the intervention.  Results revealed significant effects of the intervention 
with tDCS and cognitive behavioural therapy (CBT) on gambling severity, cognitive task 
performance, and changes on electroencephalogram (EEG) power frequency in both participant cases. 
In one case (in sham tDCS condition), gambling severity correlated with behavioural measures, and 
in both cases, gambling severity correlated with EEG variables. Nevertheless, even though previous 
limitations were tackled, additional limitations arose in this experiment, given that the original design 
planned as an RCT had to be adapted to analyse data following single-participant designs due to 
recruitment complications.  
 
Therefore, the results obtained cannot be used to draw conclusions about the effectiveness of the 
intervention combining tDCS and CBT, and the particular adaptations prevent contrasting the findings 
consistently against previous studies results. Especially, in the participant allocated to real stimulation 
condition (with whom the testing procedure did not follow the planned protocol, and multiple artefacts 
contaminated the EEG data), results obtained are not reliable to interpret the intervention outcomes 
congruently. However, in the participant allocated to sham condition (with whom experimental testing 
was carried out as planned), results revealed associations between self-report measures, behavioural 
outcomes and neurophysiological data that support further investigation of these variables to study 





























































































































































































































    
 
Figure 0-1. Electroencephalography (EEG) spectrogram across low impulsive (LI) participants during 
transcranial direct current stimulation (tDCS) in real stimulation condition. EEG power (µV2) in frequencies 
0-30 Hz during five minutes EEG resting state recordings pre-tDCS (EEG1) and post-tDCS (EEG2), across 
LI participants in tDCS real stimulation condition. Electrodes positions displayed in the spectrogram with 

















































































































































































































































    
 
Figure 0-2. Electroencephalography (EEG) spectrogram across high impulsive (HI) participants during 
transcranial direct current stimulation (tDCS) in real stimulation condition. EEG power (µV2) in frequencies 
0-30 Hz during five minutes EEG resting state recordings pre-tDCS (EEG1) and post-tDCS (EEG2), across 
HI participants in tDCS real stimulation condition. Electrodes positions displayed in the spectrogram with 


























































































































































































































    
 
Figure 0-3. Electroencephalography (EEG) spectrogram across low impulsive (LI) participants during transcranial 
direct current stimulation (tDCS) in sham condition. EEG power (µV2) in frequencies 0-30 Hz during five minutes EEG 
resting state recordings pre-tDCS (EEG1) and post-tDCS (EEG2), across LI participants in tDCS sham condition. 
Electrodes positions displayed in the spectrogram with the international EEG 10/10 system are Fpz, F4 and F3 for 






















































































































































































































































    
 
Figure 0-4. Electroencephalography (EEG) spectrogram across high impulsive (HI) participants during 
transcranial direct current stimulation (tDCS) in sham condition. EEG power (µV2) in frequencies 0-30 Hz 
during five minutes EEG resting state recordings pre-tDCS (EEG1) and post-tDCS (EEG2), across HI 
participants in tDCS sham condition. Electrodes positions displayed in the spectrogram with the 
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Dear Miss Gomis Vicent, 
 
Application ID: ETH2021-0004 
 
Original application ID: ETH1920-0081 
 
Amendment to change project title to: Cognitive and physiological assessment of prefrontal cortex 
neuromodulation in low and high risk gambling 
 
Former project title: 
 
The role of neuromodulation, cognitive processing and behavioural inhibition in problem gambling 
Lead researcher: Miss Elena Gomis Vicent 
Your application to University Research Ethics Sub-Committee (URES) was considered on 13th August 2020. 
The decision is: Approved 
In view of the Covid-19 pandemic, URES has taken the decision that all face-to-face projects that include participant 
interactions should cease to use this method of data collection. For example, in person participant interviews or focus 
groups. The University supports Microsoft Teams for remote work. New research projects must not recruit participants 
using face-to-face interactions and all data collection should occur remotely. These regulations should be followed until 
further notice by URES. 
The Committee’s response is based on the protocol described in the application form and supporting documentation. 
Your project has received ethical approval for 2 years from the approval date. 
If you have any questions regarding this application please contact your supervisor or the secretary for the University 
Research Ethics Sub-Committee. 
Approval has been given for the submitted application only and the research must be conducted accordingly. 
 
Should you wish to make any changes in connection with this research project you must complete 'An application for 
approval of an amendment to an existing application'. 
 
Approval is given on the understanding that the UEL Code of Practice for Research and the Code of Practice for 
Research Ethics is adhered to. 
Any adverse events or reactions that occur in connection with this research project should be reported using the 
University’s form for Reporting an Adverse/Serious Adverse Event/Reaction. 
The University will periodically audit a random sample of approved applications for ethical approval, to ensure that the 
research projects are conducted in compliance with the consent given by the Research Ethics Committee and to the 
highest standards of rigour and integrity. 
Please note, it is your responsibility to retain this letter for your records. 











Application ID: ETH1920-0081 
 
Original application ID: 161731 
 
Project title: The role of neuromodulation, cognitive processing and behavioural inhibition in 
problem gambling 
 
Lead researcher: Miss Elena Gomis Vicent 
 
Your application to Research, Research Degrees and Ethics Sub-Committee meeting was considered on the 
21st of November 2019. 
 
The decision is: Approved 
 
The Committee’s response is based on the protocol described in the application form and supporting 
documentation. Your project has received ethical approval for 2 years from the approval date. 
If you have any questions regarding this application please contact your supervisor or the secretary for the 
Research, Research Degrees and Ethics Sub-Committee meeting. 
 
Approval has been given for the submitted application only and the research must be conducted accordingly. 
 
Should you wish to make any changes in connection with this research project you must complete 'An 
application for approval of an amendment to an existing application'. 
 
Approval is given on the understanding that the UEL Code of Practice for Research and the Code of 
Practice for Research Ethics is adhered to. 
 
Any adverse events or reactions that occur in connection with this research project should be reported 
using the University’s form for Reporting an Adverse/Serious Adverse Event/Reaction. 
 
The University will periodically audit a random sample of approved applications for ethical approval, to ensure 
that the research projects are conducted in compliance with the consent given by the Research Ethics Committee 
and to the highest standards of rigour and integrity. 
 
Please note, it is your responsibility to retain this letter for your records.  
 





























I am writing to confirm that the application for the aforementioned NHS research study 
reference 241677 has received UREC ethical approval and is sponsored by the University of 
East London. 
 
The lapse date for ethical approval for this study is 13th December 2022. If you require UREC 
approval beyond this date you must submit satisfactory evidence from the NHS confirming 
that your study has current NHS R&D ethical approval and provide a reason why UREC 
approval should be extended. 
 
Please note as a condition of your sponsorship by the University of East London your research 
must be conducted in accordance with NHS regulations and any requirements specified as 
part of your NHS R&D ethical approval. 
 
Please confirm that you will conduct your study in accordance with the consent given by the 
Trust Research Ethics Committee by emailing researchethics@uel.ac.uk. 
 
Please ensure you retain this approval letter, as in the future you may be asked to 
provide proof of ethical approval. 
 





Administrative Officer for Research Governance 
For and on behalf of 
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UREC 1718 23 
 
I am writing to confirm that the application for an amendment to the aforementioned research 
study has now received ethical approval on behalf of University Research Ethics Committee 
(UREC). 
 
Should you wish to make any further changes in connection with your research project, this 
must be reported immediately to UREC. A Notification of Amendment form should be 





Approved Research Site 
 
I am pleased to confirm that the approval of the proposed research applies to the following 
research site: 
 
Research Site Principal Investigator / Local 
Collaborator 









Summary of Amendments 
Two UEL MSc students will collaborate with data collection at the NHS site, the 
National Problem Gambling Clinic. The volunteer assistants will help the PhD student, 
Elena Gomis Vicent with participant testing until data collection finishes, in June 2019. 
All the data will be anonymised in the study, as stated in the approved ethical 
application, and the volunteer assistants will not have access to the participant health 
records. The amendment has received approval from the NHS to include the 







Post: Volunteer Research Assistant 
Qualifications: BSc Biological Sciences (UCL); MSc Psychology (UEL) 
Approximately how much time you will allocate to this research (in Whole Time 
Equivalents, WTE): 0.40 








Post: Volunteer Research Assistant 
Qualifications: 
BA Philosophy and Theology, University of Oxford (2011) 
MA Legal & Political Theory, University College London (2014) 
Graduate Diploma in Law, BPP University (2015) 
Legal Practice Course, BPP University (2016) 
Admitted as a Solicitor in England and Wales (September 2018) 
Approximately how much time you will allocate to this research (in Whole Time 
Equivalents, WTE): 0.27 
Has this person has been accepted by the NHS organisation? YES 
 
 
Ethical approval for the original study was granted on 10th January 2018. 
 
Approval is given on the understanding that the UEL Code of Good Practice in Research is 
adhered to. 
With the Committee’s best wishes for the success of this project. 
Please ensure you retain this letter, as in the future you may be asked to provide 
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I am writing to confirm that the application for an amendment to the aforementioned research 
study has now received ethical approval on behalf of University Research Ethics Committee 
(UREC). 
 
Should you wish to make any further changes in connection with your research project, this 
must be reported immediately to UREC. A Notification of Amendment form should be 





Approved Research Site 
 
I am pleased to confirm that the approval of the proposed research applies to the following 
research site: 
 
Research Site Principal Investigator / Local 
Collaborator 









Summary of Amendments 
 
1. Nomenclature (substitute Gambling Disorder for Problem Gambling) 
2. Design: 
 Reducing the number of treatment arms to two (instead of 4). 
 Increasing the number of sessions that each participant will attend (8 instead 
of 5). 
3. Consent form, participant information sheet and other supporting documents format 
had to be changed to meet the specific requirements of a successful NHS application, 
and are enclosed in this document. 
In addition, two further changes were suggested after Ms Gomis’ summer training at Harvard 
medical school in July and August 2018: 
4. Materials: 
 Reduction of the number of cognitive tasks (3 instead of 5). 
 Change from the 3 original cognitive questionnaires for 3 new ones (all 
validated). 
5. tDCS Protocol: Change of the intensity of tDCS from 1.5mA to 2mA. 
 
 
Ethical approval for the original study was granted on 10th January 2018. 
 
Approval is given on the understanding that the UEL Code of Good Practice in Research is 
adhered to. 
With the Committee’s best wishes for the success of this project. 
Please ensure you retain this letter, as in the future you may be asked to provide 
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02 October 2018 
 
Dear Ms Gomis-Vicent 
Study title: The role of neuromodulation for cognitive processing and 
behavioural inhibition in gambling disorder 
IRAS project ID: 241677 
Protocol number: UREC 1718 23 
REC reference: 18/LO/1454 
Sponsor University of East London 
 
I am pleased to confirm that HRA and Health and Care Research Wales (HCRW) Approval has 
been given for the above referenced study, on the basis described in the application form, protocol, 
supporting documentation and any clarifications received. You should not expect to receive anything 
further relating to this application. 
 
How should I continue to work with participating NHS organisations in England and Wales? 
You should now provide a copy of this letter to all participating NHS organisations in England and 
Wales, as well as any documentation that has been updated as a result of the assessment . 
 
Following the arranging of capacity and capability, participating NHS organisations should formally 
confirm their capacity and capability to undertake the study. How this will be confirmed is detailed in 
the “summary of assessment” section towards the end of this letter. 
 
You should provide, if you have not already done so, detailed instructions to each organisation as to 
how you will notify them that research activities may commence at site following their confirmation of 
capacity and capability (e.g. provision by you of a ‘green light’ email, formal notification following a site 
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It is important that you involve both the research management function (e.g. R&D office) supporting 
each organisation and the local research team (where there is one) in setting up your study . Contact 
details of the research management function for each organisation can be accessed here. 
 
How should I work with participating NHS/HSC organisations in Northern Ireland and 
Scotland? 
HRA and HCRW Approval does not apply to NHS/HSC organisations within the devolved 
administrations of Northern Ireland and Scotland. 
 
If you indicated in your IRAS form that you do have participating organisations in either of these 
devolved administrations, the final document set and the study wide governance report (including this 
letter) has been sent to the coordinating centre of each participating nation. You should work with the 
relevant national coordinating functions to ensure any nation specific checks are complete, and with 
each site so that they are able to give management permission for the study to begin. 
 
Please see IRAS Help for information on working with NHS/HSC organisations in Northern Ireland and 
Scotland. 
 
How should I work with participating non-NHS organisations? 
HRA and HCRW Approval does not apply to non-NHS organisations. You should work with your non- 
NHS organisations to obtain local agreement in accordance with their procedures. 
 
What are my notification responsibilities during the study? 
The document “After Ethical Review – guidance for sponsors and investigators”, issued with your REC 
favourable opinion, gives detailed guidance on reporting expectations for studies, including: 
 Registration of research 
 Notifying amendments 
 Notifying the end of the study 
The HRA website also provides guidance on these topics, and is updated in the light of changes in 
reporting expectations or procedures. 
 
I am a participating NHS organisation in England or Wales. What should I do once I receive this 
letter? 
You should work with the applicant and sponsor to complete any outstanding arrangements so you 
are able to confirm capacity and capability in line with the information provided in this letter. 
The sponsor contact for this application is as follows: 
















Who should I contact for further information? 
Please do not hesitate to contact me for assistance with this application. My contact details are below. 










Copy to: Catherine Fieulleteau, Sponsor Contact 
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Document Version Date 
Contract/Study Agreement template 
[Study_Agreement_Funder_Sponsor_IRAS241677] 
 26 July 2016 
Covering letter on headed paper [Letter from Academic Supervisors]  16 September 2018 
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IRAS Application Form XML file [IRAS_Form_27072018]  27 July 2018 
IRAS Checklist XML [Checklist_27092018]  27 September 2018 
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Referee's report or other scientific critique report 
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[Peer_Review_IRAS241677] 
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Research protocol or project proposal [Protocol_IRAS241677v1.1] 1.1 10 September 2018 
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1 05 July 2018 
Summary CV for student [CV_CI_EGomisVicent_IRAS241677v1] 1 05 July 2018 
Summary CV for supervisor (student research) 
[CV_Supervisor_VThoma_IRAS241677v1] 
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Summary of any applicable exclusions to sponsor insurance (non- 
NHS sponsors only) [UEL_Insurance_IRAS241677v1] 
1 29 May 2018 
Summary of any applicable exclusions to sponsor insurance (non- 
NHS sponsors only) [UEL_Insurance_IRAS241677v1.1] 
1.1 18 July 2018 
Summary, synopsis or diagram (flowchart) of protocol in non 
technical language [Flow_Chart_IRAS241677v1] 
1 05 July 2018 
Validated questionnaire [Cognitive_Questionnaire_G- 
SAS_IRAS241677v1] 
1 05 July 2018 
Validated questionnaire [Cognitive_Questionnaire_PG- 
YBOCS_IRAS241677v1] 
1 05 July 2018 
Validated questionnaire 1 05 July 2018 






[Cognitive_Questionnaire_VAS_IRAS241677v1]   
Validated questionnaire 
[Screening_Questionnaire_NDQ_IRAS241677v1] 
1 29 May 2018 
Validated questionnaire 
[Screening_Questionnaire_SADQ_IRAS241677v1] 
1 29 May 2018 
Validated questionnaire 
[Screening_Questionnaire_SADQ_IRAS241677v1] 





Summary of assessment 
The following information provides assurance to you, the sponsor and the NHS in England and Wales 
that the study, as assessed for HRA and HCRW Approval, is compliant with relevant standards. It also 
provides information and clarification, where appropriate, to participating NHS organisations in 
England and Wales to assist in assessing, arranging and confirming capacity and capability. 
Assessment criteria 
 
Section Assessment Criteria Compliant with 
Standards 
Comments 
1.1 IRAS application completed 
correctly 
Yes No comments 
    
2.1 Participant information/consent 
documents and consent 
process 
Yes No comments 
    
3.1 Protocol assessment Yes No comments 
    
4.1 Allocation of responsibilities 
and rights are agreed and 
documented 
Yes The sponsor intends to use the 
Statement of Activities as the form of 




Yes Valid insurance certificate submitted. 
4.3 Financial arrangements 
assessed 
Yes Funded by Responsible Gambling 
Trust. No funds will be provided to the 
participating organisation to support this 
study. 
    
5.1 Compliance with the Data 
Protection Act and data 
Yes No comments 
 
 






Section Assessment Criteria Compliant with 
Standards 
Comments 
 security issues assessed   
5.2 CTIMPS – Arrangements for 
compliance with the Clinical 
Trials Regulations assessed 
Not Applicable No comments 
5.3 Compliance with any 
applicable laws or regulations 
Yes No comments 
    
6.1 NHS Research Ethics 
Committee favourable opinion 
received for applicable studies 
Yes Provisional Opinion issued 10 
September 2018. Further Information 
Favourable Opinion issued 02 October 
2018. 
6.2 CTIMPS – Clinical Trials 
Authorisation (CTA) letter 
received 
Not Applicable No comments 
6.3 Devices – MHRA notice of no 
objection received 
Not Applicable No comments 
6.4 Other regulatory approvals 
and authorisations received 
Not Applicable No comments 
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This is a non-commercial student (PhD) study and there is one site type. 
 
The Chief Investigator or sponsor should share relevant study documents with participating NHS 
organisations in England and Wales in order to put arrangements in place to deliver the study. The 
documents should be sent to both the local study team, where applicable, and the office providing 
the research management function at the participating organisation. Where applicable, the local 
LCRN contact should also be copied into this correspondence. 
 
If chief investigators, sponsors or principal investigators are asked to complete site level forms for 
participating NHS organisations in England and Wales which are not provided in IRAS, the HRA or 
HCRW websites, the chief investigator, sponsor or principal investigator should notify the HRA 
immediately at hra.approval@nhs.net or HCRW at Research-permissions@wales.nhs.uk. We will 
work with these organisations to achieve a consistent approach to information provision. 
This provides detail on the types of participating NHS organisations in the study and a statement as to whether 








HR Good Practice Resource Pack Expectations 
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A Local Collaborator is expected at the participating organisation. 
 
GCP training is not a generic training expectation, in line with the HRA/HCRW/MHRA statement on 
training expectations. 
This confirms whether the sponsor position on whether a PI, LC or neither should be in place is correct for each 
type of participating NHS organisation in England and Wales, and the minimum expectations for education, 
training and experience that PIs should meet (where applicable). 
Where arrangements are not already in place, network staff (or similar) undertaking any research 
activities that may impact on the quality of care of the participant (listed in A18 and A19), would be 
expected to obtain an honorary research contract from one NHS organisation (if university 
employed), followed by Letters of Access for subsequent organisations. This would be on the basis of 
a Research Passport (if university employed) or an NHS to NHS confirmation of pre-engagement 
checks letter (if NHS employed). These should confirm enhanced DBS checks, including appropriate 
barred list checks, and occupational health clearance. 
This confirms the HR Good Practice Resource Pack expectations for the study and the pre-engagement checks 
that should and should not be undertaken 
The applicant has indicated that they intend to apply for inclusion on the NIHR CRN Portfolio. 
This details any other information that may be helpful to sponsors and participating NHS organisations in 
England and Wales to aid study set-up. 
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UREC 1718 23 
 
 
I am writing to confirm the outcome of your application to the University Research Ethics Committee 
(UREC), which was considered by UREC on Wednesday 15 November 2017. 
 
The decision made by members of the Committee is Approved. The Committee’s response is 
based on the protocol described in the application form and supporting documentation. Your study 
has received ethical approval from the date of this letter. 
 
Should you wish to make any changes in connection with your research project, this must be 
reported immediately to UREC. A Notification of Amendment form should be submitted for 




Any adverse events that occur in connection with this research project must be reported 
immediately to UREC. 
 
Approved Research Site 
 
I am pleased to confirm that the approval of the proposed research applies to the 
following research site. 
 
Research Site Principal Investigator / Local 
Collaborator 









The final list of documents reviewed and approved by the Committee is as follows: 
 
 
Document Version Date 
UREC application form 2.0 4 January 2018 
Participant Information sheet 2.0 4 January 2018 
Consent form 1.0 31 October 2017 
Debrief sheet 2.0 4 January 2018 
Research advertisement 2.0 4 January 2018 
Cognitive Reflection Task (CRT) 1.0 31 October 2017 
The Gambling Related Cognition 
Scale (GRCS) 1.0 31 October 2017 
Severity of Alcohol Dependence 
Questionnaire (SADQ-C)¹ 1.0 31 October 2017 
Notes on the use of the SADQ 1.0 31 October 2017 
South Oaks Gambling Screen 
(SOGS) 1.0 31 October 2017 
South Oaks Gambling Screen – 
Score Sheet (SOGS) 1.0 31 October 2017 
The Actively Open Minded 
Thinking Scale 1.0 31 October 2017 
The Need for Cognition Scale 1.0 31 October 2017 
Severity of Dependence Scale 
(SCS) 1.0 31 October 2017 
Response Card 1.0 31 October 2017 




Approval is given on the understanding that the UEL Code of Practice in Research is adhered to. 
 
The University will periodically audit a random sample of applications for ethical approval, to ensure 
that the research study is conducted in compliance with the consent given by the ethics Committee 
and to the highest standards of rigour and integrity. 
Please note, it is your responsibility to retain this letter for your records. 
 







Administrative Officer for Research Governance 
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I am writing to confirm the outcome of your application to the University Research Ethics 
Committee (UREC), which was considered by UREC on Wednesday 18 January 2017. 
 
The decision made by members of the Committee is Approved. The Committee’s response is 
based on the protocol described in the application form and supporting documentation. Your study 
has received ethical approval from the date of this letter. 
 
Should you wish to make any changes in connection with your research project, this must 
be reported immediately to UREC. A Notification of Amendment form should be submitted 




Any adverse events that occur in connection with this research project must be reported 
immediately to UREC. 
 
Approved Research Site 
 
I am pleased to confirm that the approval of the proposed research applies to the 
following research site. 
 
Research Site Principal Investigator / Local 
Collaborator 
Behavioural, tCS testing will take place in the 
Cognitive Lab, Room AE.G. 12 in the School of 
Psychology 
 






The final list of documents reviewed and approved by the Committee is as follows: 
 
 
Document Version Date 
UREC application form 3.0 14 February 2017 
Annexe 1 – Participant 
Information sheet 2.0 13 February 2017 
Annexe 2 - Consent form 2.0 13 February 2017 
Debrief after tDCS (tCS) 
session 2.0 13 February 2017 
Standard procedure for 
Transcranial current 
stimulation (tCS) 





26 December 2016 
References 1.0 26 December 2016 
Recruitment Advertisement 2.0 13 February 2017 
Cognitive Reflection Task 
(CRT) 1.0 13 February 2017 
Kirby Monetary-Choice 
Questionnaire 2.0 13 February 2017 






26 December 2016 
Notes on the use of the 
SADQ 1.0 26 December 2016 
South Oaks Gambling 
Screen (SOGS) 2.0 13 February 2017 
South Oaks Gambling 





26 December 2016 
The Actively Open Minded 
Thinking Scale 1.0 26 December 2016 
The Gambling Related 
Cognition Scale (GRCS) 1.0 26 December 2016 
Scoring 1.0 26 December 2016 
The Need for Cognition Scale 1.0 26 December 2016 
Severity of Dependence 
scale (SDS) 1.0 26 December 2016 
Response Card SDS 1.0 26 December 2016 
UPPS-P 1.0 26 December 2016 
Scoring Instructions 1.0 26 December 2016 
Approval is given on the understanding that the UEL Code of Practice in Research is adhered to. 
The University will periodically audit a random sample of applications for ethical approval, to ensure 
that the research study is conducted in compliance with the consent given by the ethics Committee 
and to the highest standards of rigour and integrity. 
Please note, it is your responsibility to retain this letter for your records. 
With the Committee’s best wishes for the success of this project. 
Yours sincerely, 
Fernanda Silva 
Administrative Officer for Research Governance 
University Research Ethics Committee (UREC) 
Email: researchethics@uel.ac.uk 
Note: Journal article originally included in thesis submission replaced by linked 
citation for repository deposit.
Gomis‐Vicent, E. , Thoma, V. , Turner, J. J., Hill, K. P. and Pascual‐Leone, A. (2019), 
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comparisons with substance use disorders. Am J Addict., 28 (6) pp. 431-454.
https://doi.org/10.1111/ajad.12945
Accepted manuscript available on UEL Research Repository: 
https://repository.uel.ac.uk/item/8707w
